geneSet,link,size,overlap,expect,enrichmentRatio,pValue,FDR,overlapId,userId
GO:1902850,microtubule cytoskeleton organization involved in mitosis (GO:1902850),128,40,8.826686596,4.531711823,1.11E-16,6.67E-13,991;701;4085;6790;9212;5347;891;24137;81930;11004;1062;3832;9700;83540;10403;1063;11130;699;1104;9735;332;9787;1058;64946;2491;64105;91687;79019;79172;6491;51203;55143;3925;10460;284403;220134;147841;57405;54821;7272,AURKA;KNTC1;KIF2C;KIF4A;STIL;CDCA8;CENPF;NUF2;TTK;SKA1;CENPA;BIRC5;CDC20;KIF18A;ERCC6L;PLK1;BUB1;CENPO;BUB1B;CENPH;CCNB1;NDC80;KIF11;NUSAP1;DLGAP5;CENPK;CENPE;AURKB;CENPI;SPC25;WDR62;RCC1;MAD2L1;SPC24;TACC3;ESPL1;ZWINT;CENPL;STMN1;CENPM
GO:0007052,mitotic spindle organization (GO:0007052),157,42,10.82648278,3.879376235,9.55E-15,2.87E-11,2316;22974;991;701;4085;6790;9212;5347;891;24137;9493;81930;11004;1062;3832;83540;10403;1063;11130;699;1104;9735;332;9787;1058;64946;2491;64105;91687;79019;79172;6491;55143;3925;284403;220134;147841;57405;54821;7272;3833;9055,AURKA;KNTC1;KIF2C;KIF4A;STIL;CDCA8;CENPF;NUF2;TTK;SKA1;CENPA;BIRC5;CDC20;KIF18A;ERCC6L;PLK1;BUB1;TPX2;CENPO;BUB1B;CENPH;CCNB1;NDC80;KIF11;KIF23;KIFC1;FLNA;DLGAP5;CENPK;PRC1;CENPE;AURKB;CENPI;SPC25;WDR62;RCC1;MAD2L1;SPC24;ZWINT;CENPL;STMN1;CENPM
GO:0030198,extracellular matrix organization (GO:0030198),299,55,20.61858822,2.667495922,1.58E-11,3.17E-08,375790;2934;2621;3690;83700;80274;6696;79625;1511;56999;2006;3908;23768;2247;4322;2201;3678;8516;10319;10516;3679;81792;2824;4312;4320;4321;170689;7092;11096;9507;2;7177;4148;1634;1294;7373;1286;1292;81578;1288;1805;1301;8076;4237;64094;92949;54507;57188;58494;3680;8434;79875;9510;11095;90993,MMP11;COL14A1;A2M;CTSG;ITGA8;COL11A1;ADAMTS1;TPSAB1;JAM2;FGF2;THSD4;DPT;GSN;FBLN5;ADAMTS8;GAS6;ADAMTSL4;SPP1;DCN;ADAMTSL3;LAMA2;RECK;LAMC3;SMOC2;JAM3;COL21A1;ADAMTS15;MMP13;NDNF;COL4A4;ITGA7;TLL1;MATN3;ADAMTS5;ELN;MFAP5;AGRN;COL6A2;SCUBE1;CREB3L1;ITGA9;GPM6B;ITGA5;ADAMTSL1;MMP1;FBN2;ITGB3;COL7A1;COL4A6;ADAMTS9;MMP12;ADAMTS4;FLRT2;MFAP2;ADAMTS12
GO:0006936,muscle contraction (GO:0006936),129,32,8.895645085,3.597265819,1.27E-10,1.90E-07,800;7169;7168;58;25802;7111;70;1674;7139;1756;8912;1909;10580;9172;2775;1837;4638;624;6546;4629;6640;845;2593;1410;5348;59;10398;6525;8082;8736;72;6442,FXYD1;SGCA;ACTG2;CRYAB;DES;LMOD1;TMOD1;MYOM2;MYOM1;SORBS1;MYLK;CASQ2;ACTC1;MYL9;ACTA2;BDKRB2;CACNA1H;GNAO1;TPM2;DMD;SMTN;DTNA;TPM1;EDNRA;ACTA1;TNNT2;MYH11;SSPN;CALD1;GAMT;SLC8A1;SNTA1
GO:0043062,extracellular structure organization (GO:0043062),215,43,14.82607514,2.900295567,1.74E-10,2.04E-07,375790;3690;83700;6696;79625;56999;2006;3908;2247;4322;2201;3678;8516;10319;10516;3679;81792;4312;4320;4321;170689;11096;9507;4148;1634;1294;7373;1286;1292;1288;1301;8076;4237;64094;92949;54507;57188;58494;3680;8434;79875;9510;11095,MMP11;COL14A1;ITGA8;COL11A1;ADAMTS1;JAM2;FGF2;THSD4;FBLN5;ADAMTS8;ADAMTSL4;SPP1;DCN;ADAMTSL3;LAMA2;RECK;LAMC3;SMOC2;JAM3;ADAMTS15;MMP13;NDNF;COL4A4;ITGA7;MATN3;ADAMTS5;ELN;MFAP5;AGRN;COL6A2;ITGA9;ITGA5;ADAMTSL1;MMP1;FBN2;ITGB3;COL7A1;COL4A6;ADAMTS9;MMP12;ADAMTS4;MFAP2;ADAMTS12
GO:0045229,external encapsulating structure organization (GO:0045229),216,43,14.89503363,2.886868272,2.04E-10,2.04E-07,375790;3690;83700;6696;79625;56999;2006;3908;2247;4322;2201;3678;8516;10319;10516;3679;81792;4312;4320;4321;170689;11096;9507;4148;1634;1294;7373;1286;1292;1288;1301;8076;4237;64094;92949;54507;57188;58494;3680;8434;79875;9510;11095,MMP11;COL14A1;ITGA8;COL11A1;ADAMTS1;JAM2;FGF2;THSD4;FBLN5;ADAMTS8;ADAMTSL4;SPP1;DCN;ADAMTSL3;LAMA2;RECK;LAMC3;SMOC2;JAM3;ADAMTS15;MMP13;NDNF;COL4A4;ITGA7;MATN3;ADAMTS5;ELN;MFAP5;AGRN;COL6A2;ITGA9;ITGA5;ADAMTSL1;MMP1;FBN2;ITGB3;COL7A1;COL4A6;ADAMTS9;MMP12;ADAMTS4;MFAP2;ADAMTS12
GO:0034508,centromere complex assembly (GO:0034508),36,15,2.482505605,6.04228243,4.82E-09,4.14E-06,1062;1063;387103;9787;1058;54069;64946;2491;64105;91687;79019;79172;55355;11339;3070,HJURP;CENPF;CENPA;MIS18A;CENPO;CENPH;OIP5;DLGAP5;CENPK;CENPE;CENPI;CENPL;CENPM;HELLS;CENPW
GO:0042127,regulation of cell population proliferation (GO:0042127),755,95,52.06365922,1.824689264,5.56E-09,4.17E-06,3815;2252;10395;4915;3479;150;7048;9928;3624;51804;3569;3570;2172;104;5737;2869;2350;185;6196;563;596;3853;2006;7122;1191;4609;6659;6285;9759;2247;653;6495;6910;7483;6422;7472;5156;93649;225689;6376;1839;8317;1033;2305;4680;8061;7037;990;8914;3489;332;2260;8013;3726;3590;3572;1440;146433;3977;29923;7832;79801;9314;9863;85480;3398;6713;2146;374;144455;29128;25937;83595;4920;25959;89958;9510;11095;863;219790;4345;7272;894;9055;10290;26471;85004;127435;7041;138151;4072;683;80310;3727;83879,NR4A3;CLDN5;IL6;MYOCD;AGTR1;ADAMTS1;PTGFR;JUND;SFRP1;TGFBR2;FOXM1;FGF2;BMP5;KIF14;SOX4;KLF4;TIMELESS;IL34;ADAMTS8;CLU;INHBA;NACC2;SAPCD2;TTK;FGF7;UHRF1;CDC6;BIRC5;CDC7;TSLP;CSF3;E2F7;RERG;PODN;IL6ST;IGFBP6;RPS6KA2;CX3CL1;PRC1;KANK2;CCND2;BCL2;FOLR2;MAGI2;LIFR;WWTR1;TGFB1I1;EZH2;SIX4;FGFR1;GRK5;ADRA2A;CBFA2T3;PDGFD;IGF1;ELN;WNT2;CDKN3;SPEG;ID2;HDAC4;CD200;IL11RA;DLC1;KIT;HBEGF;MAPK15;S100B;CEACAM6;HILPDA;JUNB;SHCBP1;CDCA7;WNT9A;SIX1;TFRC;BTG2;NTRK2;SOX7;IL6R;PDGFRA;ROR2;ADARB1;FABP6;MYC;BST1;EPCAM;RTKN2;FOSL1;SQLE;AREG;TBX5;KRT6A;NUPR1;AZGP1
GO:0008016,regulation of heart contraction (GO:0008016),93,24,6.41313948,3.74231686,1.12E-08,7.51E-06,7168;1674;7139;8912;489;5144;287;4881;5350;493;6262;6546;6263;3708;7220;477;845;10060;482;4882;5348;10659;27129;53826,FXYD1;ATP1A2;DES;ANK2;CELF2;ITPR1;ATP1B2;NPR1;CASQ2;HSPB7;PLN;FXYD6;CACNA1H;RYR3;PDE4D;ABCC9;TPM1;ATP2A3;TNNT2;TRPC1;NPR2;ATP2B4;RYR2;SLC8A1
GO:0006260,DNA replication (GO:0006260),108,26,7.447516815,3.491096515,1.35E-08,7.65E-06,63967;983;1111;4171;1763;2237;8317;374393;83990;116028;990;80119;672;8914;9401;29980;5427;10535;641;4173;55388;23594;4998;8318;9156;11169,RECQL4;TIMELESS;ORC1;CLSPN;MCM2;DNA2;RNASEH2A;EXO1;BLM;CDC6;CDC45;CDC7;WDHD1;BRCA1;FAM111B;MCM10;ORC6;BRIP1;CDK1;MCM4;PIF1;CHEK1;FEN1;DONSON;POLE2;RMI2
GO:0000070,mitotic sister chromatid segregation (GO:0000070),101,25,6.964807392,3.589474711,1.40E-08,7.65E-06,9928;983;5347;891;9493;81930;11004;1062;9700;10403;11130;9787;64105;113130;54892;64151;23397;51203;55143;55165;84722;146909;3833;10615;9055,KIF18B;SPAG5;KIF14;KIF2C;CDCA8;NCAPH;CDCA5;KIF18A;PLK1;CCNB1;CDK1;NDC80;KIF23;KIFC1;NCAPG2;NCAPG;NUSAP1;DLGAP5;CENPK;PRC1;CENPE;CEP55;ESPL1;ZWINT;PSRC1
GO:0051383,kinetochore organization (GO:0051383),13,9,0.896460357,10.03948465,1.89E-08,9.48E-06,1062;81620;83540;10403;1063;387103;9787;1058;64946,CENPF;NUF2;CENPA;CENPH;CDT1;NDC80;DLGAP5;CENPE;CENPW
GO:0007517,muscle organ development (GO:0007517),58,18,3.999592364,4.500458638,3.44E-08,1.59E-05,1756;8912;3479;4208;3908;6444;1960;5463;6943;1839;11149;3679;8910;6876;2273;10290;6525;6442,TCF21;FHL1;SGCA;EGR3;MEF2C;TAGLN;LAMA2;CACNA1H;DMD;SMTN;BVES;ITGA7;IGF1;SPEG;HBEGF;POU6F1;SGCD;SGCE
GO:1903779,regulation of cardiac conduction (GO:1903779),55,17,3.792716897,4.482274966,8.82E-08,3.79E-05,489;287;4881;6910;493;6262;6546;6263;3708;7220;477;845;10060;482;4882;5348;53826,FXYD1;ATP1A2;ANK2;ITPR1;ATP1B2;NPR1;CASQ2;FXYD6;RYR3;ABCC9;ATP2A3;TRPC1;NPR2;ATP2B4;RYR2;SLC8A1;TBX5
GO:0007411,axon guidance (GO:0007411),202,36,13.92961478,2.584421792,1.20E-07,4.81E-05,399;5909;627;54437;9723;7869;56920;9378;6712;9353;6586;3897;152330;2048;2045;9638;2042;9423;6324;57549;2674;2676;4781;59352;6387;220164;91624;5649;10381;1944;4684;9369;9260;8633;23022;3908,SLIT3;SEMA5B;NCAM1;RELN;SEMA3G;DOK6;EPHA3;NRXN1;CXCL12;GFRA3;NEXN;EPHA7;LAMA2;SEMA3E;SLIT2;PALLD;L1CAM;BDNF;GFRA1;UNC5C;SEMA3B;CNTN4;RAP1GAP;NFIB;SCN1B;NTN1;TUBB3;LGR6;FEZ1;EPHB2;IGSF9;SPTBN2;EFNA3;NRXN3;PDLIM7;RHOH
GO:0000819,sister chromatid segregation (GO:0000819),34,13,2.344588627,5.544682701,1.75E-07,6.59E-05,5347;81930;7153;9700;10403;11130;64105;54892;51203;55143;146909;3833;10615,KIF18B;SPAG5;CDCA8;TOP2A;KIF18A;PLK1;NDC80;KIFC1;NCAPG2;NUSAP1;CENPK;ESPL1;ZWINT
GO:0008284,positive regulation of cell population proliferation (GO:0008284),471,63,32.47944833,1.939688118,2.73E-07,9.67E-05,2252;4915;3479;150;7048;2621;9928;3569;3570;5737;2869;2350;358;596;4208;3853;7122;4609;6659;6285;9759;2247;7049;653;10763;6422;7472;5156;23414;3373;225689;6376;1839;8317;1869;2305;55022;4680;8061;332;2260;8013;3590;3572;1440;146433;3977;29923;85480;3398;9760;2146;374;348093;25937;89958;219790;7272;894;9055;4072;683;80310,NR4A3;CLDN5;IL6;AQP1;PTGFR;SFRP1;TGFBR2;FOXM1;FGF2;BMP5;TGFBR3;KIF14;SOX4;MEF2C;IL34;GAS6;SAPCD2;TTK;FGF7;BIRC5;CDC7;TSLP;PID1;CSF3;HYAL1;IL6ST;RBPMS2;NES;CX3CL1;PRC1;CCND2;BCL2;FOLR2;E2F1;LIFR;WWTR1;EZH2;FGFR1;GRK5;ADRA2A;PDGFD;IGF1;WNT2;ID2;HDAC4;IL11RA;HBEGF;MAPK15;S100B;CEACAM6;HILPDA;NTRK2;IL6R;PDGFRA;TOX;MYC;ZFPM2;BST1;EPCAM;RTKN2;FOSL1;AREG;KRT6A
GO:0007094,mitotic spindle assembly checkpoint signaling (GO:0007094),21,10,1.44812827,6.905465635,4.07E-07,1.22E-04,991;701;4085;5347;1063;11130;699;9319;9735;7272,KNTC1;CENPF;TTK;TRIP13;CDC20;PLK1;BUB1;BUB1B;MAD2L1;ZWINT
GO:0071174,mitotic spindle checkpoint signaling (GO:0071174),21,10,1.44812827,6.905465635,4.07E-07,1.22E-04,991;701;4085;5347;1063;11130;699;9319;9735;7272,KNTC1;CENPF;TTK;TRIP13;CDC20;PLK1;BUB1;BUB1B;MAD2L1;ZWINT
GO:0071173,spindle assembly checkpoint signaling (GO:0071173),21,10,1.44812827,6.905465635,4.07E-07,1.22E-04,991;701;4085;5347;1063;11130;699;9319;9735;7272,KNTC1;CENPF;TTK;TRIP13;CDC20;PLK1;BUB1;BUB1B;MAD2L1;ZWINT
GO:0000281,mitotic cytokinesis (GO:0000281),48,15,3.310007473,4.531711823,4.31E-07,1.22E-04,388;1894;11113;5347;24137;29127;9493;9700;54443;1058;51203;10112;55165;26586;3925,KIF4A;KIF20A;CENPA;PLK1;RHOB;KIF23;NUSAP1;CIT;CEP55;ECT2;ANLN;ESPL1;RACGAP1;CKAP2;STMN1
GO:0031055,chromatin remodeling at centromere (GO:0031055),31,12,2.13771316,5.61347529,4.48E-07,1.22E-04,387103;1058;54069;64946;2491;64105;91687;79019;79172;55355;11339;3070,HJURP;CENPA;MIS18A;CENPO;CENPH;OIP5;CENPK;CENPI;CENPL;CENPM;HELLS;CENPW
GO:0045841,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),22,10,1.517086759,6.591580833,7.00E-07,1.83E-04,991;701;4085;5347;1063;11130;699;9319;9735;7272,KNTC1;CENPF;TTK;TRIP13;CDC20;PLK1;BUB1;BUB1B;MAD2L1;ZWINT
GO:0007409,axonogenesis (GO:0007409),238,38,16.41212039,2.315362007,9.79E-07,2.45E-04,5909;627;54437;9723;7869;56920;4130;9378;6712;9353;6586;3897;152330;322;6285;4131;4897;2048;2045;9638;2042;6324;57549;2674;2676;59352;6387;220164;91624;5649;10381;1944;4684;9369;9260;8633;23022;3908,SLIT3;SEMA5B;NCAM1;RELN;SEMA3G;DOK6;EPHA3;NRXN1;CXCL12;GFRA3;NEXN;EPHA7;LAMA2;SEMA3E;SLIT2;APBB1;PALLD;L1CAM;BDNF;GFRA1;UNC5C;SEMA3B;CNTN4;RAP1GAP;MAP1B;NRCAM;MAP1A;SCN1B;S100B;TUBB3;LGR6;FEZ1;EPHB2;IGSF9;SPTBN2;EFNA3;NRXN3;PDLIM7
GO:0061640,cytoskeleton-dependent cytokinesis (GO:0061640),59,16,4.068550853,3.932604158,1.52E-06,3.65E-04,388;1894;11113;9212;5347;24137;29127;9493;9700;54443;1058;51203;10112;55165;26586;3925,KIF4A;KIF20A;CENPA;PLK1;RHOB;KIF23;NUSAP1;CIT;AURKB;CEP55;ECT2;ANLN;ESPL1;RACGAP1;CKAP2;STMN1
GO:0061641,CENP-A containing chromatin organization (GO:0061641),29,11,1.999796182,5.500560557,1.73E-06,3.85E-04,387103;1058;54069;64946;2491;64105;91687;79019;79172;55355;11339,HJURP;CENPA;MIS18A;CENPO;CENPH;OIP5;CENPK;CENPI;CENPL;CENPM;CENPW
GO:0034080,CENP-A containing nucleosome assembly (GO:0034080),29,11,1.999796182,5.500560557,1.73E-06,3.85E-04,387103;1058;54069;64946;2491;64105;91687;79019;79172;55355;11339,HJURP;CENPA;MIS18A;CENPO;CENPH;OIP5;CENPK;CENPI;CENPL;CENPM;CENPW
GO:0048522,positive regulation of cellular process (GO:0048522),617,74,42.54738773,1.739237212,1.87E-06,4.01E-04,7538;32;2252;7168;9472;4915;3479;150;7048;2621;9928;3569;3570;857;5737;2869;2350;6722;4130;596;3853;7122;1111;4609;11076;6659;6285;6387;9759;8309;2247;653;1959;6262;6422;7472;8324;5563;5156;3373;225689;6376;1839;8317;2305;22943;4680;8061;990;332;2260;3590;3572;1440;146433;3977;29923;81035;85480;2146;374;25937;6886;89958;219790;7272;894;10615;9055;26471;4072;683;80310;7275,CLDN5;IL6;TPPP;ACOX2;ZFP36;PTGFR;SFRP1;TGFBR2;FOXM1;FGF2;SPAG5;BMP5;KIF14;SOX4;SRF;IL34;CXCL12;GAS6;SAPCD2;TTK;FGF7;CDC6;BIRC5;CDC7;TSLP;CSF3;CAV1;HYAL1;ACACB;IL6ST;CX3CL1;PRC1;CCND2;FZD7;BCL2;FOLR2;CHEK1;TPM1;AKAP6;LIFR;WWTR1;EZH2;FGFR1;GRK5;ADRA2A;PDGFD;IGF1;WNT2;HDAC4;COLEC12;IL11RA;HBEGF;EGR2;MAPK15;MAP1A;S100B;CEACAM6;HILPDA;RYR2;NTRK2;IL6R;PDGFRA;MYC;BST1;EPCAM;RTKN2;DKK1;FOSL1;TUB;TAL1;PRKAA2;AREG;KRT6A;NUPR1
GO:0006336,DNA replication-independent nucleosome assembly (GO:0006336),37,12,2.551464094,4.703182,4.00E-06,8.28E-04,387103;1058;54069;64946;2491;64105;91687;79019;79172;55355;11339;55723,HJURP;CENPA;MIS18A;CENPO;CENPH;OIP5;ASF1B;CENPK;CENPI;CENPL;CENPM;CENPW
GO:0030334,regulation of cell migration (GO:0030334),405,53,27.92818806,1.89772426,4.68E-06,9.38E-04,2316;3815;2252;11170;7168;388;4804;10395;3479;150;9928;857;104;10979;154810;54437;9723;7869;56920;4638;9353;7122;2048;59352;6387;91624;2247;6781;6910;6422;5156;225689;6376;3082;1839;91663;4680;4286;5168;3488;25932;9863;51512;2159;4920;8434;117581;89795;127435;131578;9079;80310;285313,F10;FAM107A;CLDN5;SEMA5B;SFRP1;SEMA3G;MYLK;FGF2;KIF14;LDB2;TWIST2;IGSF10;CXCL12;NGFR;MYADM;FGF7;NEXN;CAV1;GTSE1;SEMA3E;RHOB;RECK;SLIT2;PODN;FLNA;CX3CL1;FERMT2;NAV3;SEMA3B;TPM1;MAGI2;ADRA2A;PDGFD;AMOTL1;IGF1;HGF;DLC1;KIT;HBEGF;MAPK15;MITF;CEACAM6;ENPP2;LGR6;CLIC4;PDGFRA;LRRC15;EPHB2;ROR2;ADARB1;STC1;TBX5;IGFBP5
GO:0044772,mitotic cell cycle phase transition (GO:0044772),207,33,14.27440723,2.311829799,5.16E-06,0.001001387,5577;79866;3624;11065;983;6790;5347;891;6502;4609;9833;10763;5243;993;8317;1033;1869;890;9134;898;1978;1104;995;283807;10733;23194;9088;2305;9133;4751;4660;10460;894,AURKA;FOXM1;CCNE1;PPP1R12B;INHBA;UBE2C;NEK2;BORA;CDC7;MELK;CDC25C;PLK1;CCNE2;CCNB2;CCNB1;CDK1;NES;PKMYT1;CCND2;PLK4;CDC25A;SKP2;CCNA2;RCC1;PRKAR2B;E2F1;TACC3;FBXL22;FBXL7;CDKN3;ABCB1;EIF4EBP1;MYC
GO:0048523,negative regulation of cellular process (GO:0048523),561,67,38.68571234,1.731905552,6.67E-06,0.001252435,5167;388;10395;284;3624;3569;2172;104;10979;309;947;6196;563;596;9353;11117;6586;1191;4609;6659;322;2048;4881;2247;3164;7049;64321;653;6910;23208;7483;6422;4487;93649;3373;1033;2305;990;641;23594;3489;1843;7832;9314;1410;9863;144455;83595;4920;25959;58494;9510;11095;863;4345;2192;2273;64061;84722;10290;26471;147906;58189;85004;127435;7041;138151,NR4A1;DUSP1;IL6;SOX17;MYOCD;FHL1;CRYAB;ADAMTS1;SLIT3;WFDC1;JAM2;SFRP1;FOXM1;CD34;NPR1;FGF2;BMP5;TGFBR3;SOX4;KLF4;ADAMTS8;CLU;INHBA;NACC2;BLM;CDC6;ANXA6;HYAL1;RHOB;ORC6;E2F7;RERG;DACT3;SLIT2;PODN;IGFBP6;RPS6KA2;APBB1;KANK2;FERMT2;BCL2;TSPYL2;MSX1;MAGI2;EMILIN1;TGFB1I1;CBFA2T3;CDKN3;SPEG;CD200;DLC1;WNT9A;FBLN1;BTG2;PSRC1;SOX7;EPHB2;ROR2;ADARB1;FABP6;MYC;ANGPT1;SYT11;TBX5;ENPP1;NUPR1;AZGP1
GO:0086012,membrane depolarization during cardiac muscle cell action potential (GO:0086012),17,8,1.172294313,6.824224862,6.90E-06,0.001256449,783;775;287;6330;6324;781;6546;477,ATP1A2;ANK2;SCN4B;CACNB2;SCN1B;CACNA2D1;SLC8A1;CACNA1C
GO:0010564,regulation of cell cycle process (GO:0010564),105,21,7.240641348,2.900295567,8.09E-06,0.001429894,1894;79866;6790;9212;5347;29127;3832;1111;6422;699;1104;995;10733;9088;4751;116028;90293;10112;10615;9055;4288,AURKA;SFRP1;SPAG5;NEK2;BORA;KIF20A;CDC25C;PLK1;BUB1;KIF11;MKI67;PRC1;AURKB;PKMYT1;ECT2;PLK4;RCC1;CHEK1;RACGAP1;KLHL13;RMI2
GO:1904029,regulation of cyclin-dependent protein kinase activity (GO:1904029),53,14,3.654799918,3.83057905,9.52E-06,0.001635752,891;993;1033;890;9134;898;995;9088;9133;990;641;9077;894;1028,CCNE1;BLM;CDC6;CDC25C;CCNE2;CCNB2;CCNB1;PKMYT1;CCND2;CDC25A;CCNA2;CDKN3;CDKN1C;DIRAS3
GO:0060048,cardiac muscle contraction (GO:0060048),34,11,2.344588627,4.691654593,1.04E-05,0.001688416,2934;7168;7139;1756;3757;6330;6324;6262;6546;477;845,ATP1A2;CASQ2;GSN;KCNH2;SCN4B;DMD;TPM1;TNNT2;SCN1B;RYR2;SLC8A1
GO:0014706,striated muscle tissue development (GO:0014706),34,11,2.344588627,4.691654593,1.04E-05,0.001688416,6840;51804;5239;857;4208;140628;6444;653;6495;11149;64091,PGM5;GATA5;BMP5;MEF2C;CAV1;BVES;POPDC2;SIX4;SVIL;SIX1;SGCD
GO:0010880,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),23,9,1.586045248,5.674491326,1.15E-05,0.001818763,1756;9472;5144;775;287;6262;6546;477;845,ATP1A2;ANK2;CASQ2;PDE4D;DMD;AKAP6;RYR2;SLC8A1;CACNA1C
GO:0060047,heart contraction (GO:0060047),41,12,2.82729805,4.244334975,1.32E-05,0.002030265,7168;70;7139;1756;3757;6330;6324;6444;6262;6546;477;845,ATP1A2;CASQ2;ACTC1;KCNH2;SCN4B;DMD;TPM1;TNNT2;SCN1B;RYR2;SGCD;SLC8A1
GO:1903522,regulation of blood circulation (GO:1903522),35,11,2.413547116,4.557607319,1.42E-05,0.002136573,7168;1674;7139;8912;185;624;5350;8864;5348;10659;27129,FXYD1;DES;AGTR1;CELF2;HSPB7;PER2;PLN;BDKRB2;CACNA1H;TPM1;TNNT2
GO:0090068,positive regulation of cell cycle process (GO:0090068),101,20,6.964807392,2.871579769,1.54E-05,0.002260344,6840;1894;3479;9928;11113;4085;6790;9212;891;29127;9493;10403;2237;8317;10733;990;51203;144455;79733;10615,AURKA;SPAG5;KIF14;CDC6;CDC7;CCNB1;E2F7;NDC80;KIF23;NUSAP1;CIT;AURKB;ECT2;PLK4;FEN1;MAD2L1;RACGAP1;IGF1;SVIL;E2F8
GO:0006939,smooth muscle contraction (GO:0006939),14,7,0.965418846,7.250738916,1.62E-05,0.002320556,1909;4638;624;6546;4629;59;6525,MYLK;ACTA2;BDKRB2;SMTN;EDNRA;MYH11;SLC8A1
GO:0086001,cardiac muscle cell action potential (GO:0086001),30,10,2.068754671,4.833825944,1.96E-05,0.002735254,1756;3757;775;287;6330;6324;781;6546;3752;477,ATP1A2;ANK2;KCNH2;SCN4B;DMD;KCND3;SCN1B;CACNA2D1;SLC8A1;CACNA1C
GO:0048562,embryonic organ morphogenesis (GO:0048562),43,12,2.965215028,4.046924046,2.25E-05,0.003073226,2294;64321;6495;6943;6262;2201;2202;5156;3398;8076;348093;4237,TCF21;FOXF1;SOX17;RBPMS2;MFAP5;ID2;EFEMP1;RYR2;SIX1;FBN2;PDGFRA;MFAP2
GO:0043486,histone exchange (GO:0043486),37,11,2.551464094,4.311250166,2.56E-05,0.003425156,387103;1058;54069;64946;2491;64105;91687;79019;79172;55355;11339,HJURP;CENPA;MIS18A;CENPO;CENPH;OIP5;CENPK;CENPI;CENPL;CENPM;CENPW
GO:0007080,mitotic metaphase plate congression (GO:0007080),51,13,3.51688294,3.696455134,2.99E-05,0.00377755,9928;891;81930;11004;1062;81620;83540;10403;113130;55143;55165;84722;3833,KIF14;KIF2C;CDCA8;CDCA5;NUF2;KIF18A;CCNB1;CDT1;NDC80;KIFC1;CENPE;CEP55;PSRC1
GO:0051726,regulation of cell cycle (GO:0051726),295,40,20.34275426,1.966302079,3.01E-05,0.00377755,388;3624;104;2869;5347;891;6502;6196;1111;4609;322;8864;3164;1063;6422;2627;993;1033;283807;2305;9133;672;1843;332;51514;274;9787;3726;9863;7732;330;3398;64061;26471;4616;3727;4605;55771;1164;1163,NR4A1;DUSP1;JUND;SFRP1;FOXM1;PER2;GATA6;CENPF;INHBA;BIN1;DTL;PRR11;BIRC5;BRCA1;MYBL2;PLK1;CCNB2;CCNB1;RHOB;RNF112;CKS2;RPS6KA2;DLGAP5;APBB1;CKS1B;TSPYL2;CDC25A;SKP2;CHEK1;MAGI2;FBXL22;GRK5;BIRC3;CDKN3;ID2;GADD45B;JUNB;ADARB1;MYC;NUPR1
GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),81,17,5.585637611,3.043520039,3.02E-05,0.00377755,5347;891;93649;993;1033;890;9134;898;995;9088;9133;990;641;9077;84722;894;1028,MYOCD;CCNE1;BLM;CDC6;CDC25C;PLK1;CCNE2;CCNB2;CCNB1;PKMYT1;CCND2;CDC25A;CCNA2;CDKN3;CDKN1C;DIRAS3;PSRC1
GO:0140014,mitotic nuclear division (GO:0140014),74,16,5.102928188,3.135454666,3.49E-05,0.004280271,2316;22974;11065;5347;81930;3832;9700;10403;11130;64105;54892;51203;55143;146909;3833;10615,KIF18B;SPAG5;CDCA8;UBE2C;KIF18A;PLK1;TPX2;NDC80;KIF11;KIFC1;FLNA;NCAPG2;NUSAP1;CENPK;ESPL1;ZWINT
GO:0000083,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),32,10,2.206671649,4.531711823,3.70E-05,0.004449463,81620;6241;1869;898;990;7298;4998;8318;3398;144455,ORC1;CCNE1;CDC6;CDC45;E2F7;CDT1;RRM2;E2F1;ID2;TYMS
GO:0050730,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),91,18,6.275222502,2.868424187,4.12E-05,0.004855431,2252;2690;3479;284;3690;3569;3570;2045;5649;6422;3678;3082;5168;5590;1440;7804;1464;683,IL6;SFRP1;RELN;FGF7;CSF3;EPHA7;GHR;LRP8;IGF1;HGF;ITGA5;ENPP2;CSPG4;ITGB3;IL6R;PRKCZ;ANGPT1;BST1
GO:0086091,regulation of heart rate by cardiac conduction (GO:0086091),39,11,2.689381072,4.090160414,4.42E-05,0.005105318,23704;3757;857;783;775;287;6330;6324;781;3752;274,ANK2;BIN1;CAV1;KCNH2;SCN4B;KCND3;CACNB2;SCN1B;CACNA2D1;KCNE4;CACNA1C
GO:0060402,calcium ion transport into cytosol (GO:0060402),21,8,1.44812827,5.524372508,4.50E-05,0.005105318,775;2906;781;493;6262;57158;6546;7226,JPH2;GRIN2D;TRPM2;ATP2B4;RYR2;CACNA2D1;SLC8A1;CACNA1C
GO:0007507,heart development (GO:0007507),163,26,11.24023371,2.313119163,4.98E-05,0.005407992,8572;10395;7048;80274;9464;6722;4208;140628;2294;775;6659;9260;23768;6444;7049;64321;653;5463;6910;93649;23414;11149;3398;27295;64091;11155,FOXF1;SOX17;MYOCD;GATA5;LDB3;TGFBR2;BMP5;TGFBR3;SOX4;MEF2C;SRF;PDLIM4;PDLIM3;HAND2;BVES;POPDC2;ID2;DLC1;SCUBE1;POU6F1;SGCD;ZFPM2;CACNA1C;FLRT2;TBX5;PDLIM7
GO:0050919,negative chemotaxis (GO:0050919),33,10,2.275630138,4.394387222,4.98E-05,0.005407992,3690;9723;7869;56920;9353;6586;2045;9423;59352;8633,SLIT3;SEMA3G;EPHA7;SEMA3E;SLIT2;UNC5C;SEMA3B;NTN1;LGR6;ITGB3
GO:0031109,microtubule polymerization or depolymerization (GO:0031109),27,9,1.861879204,4.833825944,5.13E-05,0.005407992,9928;81930;11004;11076;2258;347240;3925;51673;146909,TPPP;KIF18B;KIF14;KIF2C;TPPP3;KIF18A;KIF24;FGF13;STMN1
GO:0086004,regulation of cardiac muscle cell contraction (GO:0086004),27,9,1.861879204,4.833825944,5.13E-05,0.005407992,857;5144;5142;775;287;5350;6781;6262;2258,ANK2;PDE4B;PLN;CAV1;FGF13;PDE4D;RYR2;CACNA1C;STC1
GO:0099623,regulation of cardiac muscle cell membrane repolarization (GO:0099623),22,8,1.517086759,5.273264666,6.65E-05,0.006471757,2316;23704;3757;287;6330;6324;781;6640,ANK2;FLNA;KCNH2;SCN4B;SCN1B;CACNA2D1;KCNE4;SNTA1
GO:1904752,regulation of vascular associated smooth muscle cell migration (GO:1904752),12,6,0.827501868,7.250738916,6.82E-05,0.006471757,7168;4208;3488;5592;8013;9510,NR4A3;ADAMTS1;MEF2C;TPM1;PRKG1;IGFBP5
GO:0051782,negative regulation of cell division (GO:0051782),12,6,0.827501868,7.250738916,6.82E-05,0.006471757,9212;4609;641;23594;144455;79733,BLM;ORC6;E2F7;AURKB;E2F8;MYC
GO:0000727,double-strand break repair via break-induced replication (GO:0000727),12,6,0.827501868,7.250738916,6.82E-05,0.006471757,4171;8317;4173;8318;51659;84296,MCM2;CDC45;CDC7;MCM4;GINS4;GINS2
GO:0051261,protein depolymerization (GO:0051261),28,9,1.930837693,4.661189303,7.10E-05,0.006471757,2934;1073;11034;9928;81930;11004;347240;3925;146909,KIF18B;KIF14;KIF2C;GSN;KIF18A;KIF24;CFL2;DSTN;STMN1
GO:0009968,negative regulation of signal transduction (GO:0009968),265,36,18.27399959,1.970012083,7.12E-05,0.006471757,5167;6622;627;26153;5579;596;11117;9423;347;2247;653;120892;6422;4929;10252;6376;22943;23542;55022;81792;27293;79094;3488;11213;5590;3090;8483;1634;2146;25959;90993;5064;147906;5997;147495;8643,RGS2;NR4A2;SPRY1;HIC1;PRKCB;SFRP1;FGF2;BMP5;LRRK2;DCN;PID1;KIF26A;DACT3;CX3CL1;KANK2;BCL2;BDNF;EMILIN1;CILP;EZH2;IRAK3;CREB3L1;MAPK8IP2;NTN1;APOD;APCDD1;PRKCZ;CHAC1;PALM;DKK1;SNCA;IGFBP5;ENPP1;SMPDL3B;ADAMTS12;PTCH2
GO:0045597,positive regulation of cell differentiation (GO:0045597),255,35,17.5844147,1.990398918,7.23E-05,0.006471757,7538;221662;1894;3479;7048;3569;3570;10979;6722;947;185;4208;140628;7704;10439;4897;55273;2201;6422;3082;2260;6935;3572;1440;3398;2146;5320;91461;25937;6237;7041;55885;5121;152007;91653,IL6;ZBTB16;RBM24;AGTR1;ZFP36;GATA5;SFRP1;TGFBR2;PCP4;LMO3;CD34;MEF2C;TMEM100;SRF;CSF3;OLFM1;IL6ST;PLA2G2A;FERMT2;ECT2;ZEB1;PKDCC;WWTR1;TGFB1I1;EZH2;FGFR1;IGF1;HGF;ID2;BOC;NRCAM;FBN2;RRAS;IL6R;GLIPR2
GO:0048251,elastic fiber assembly (GO:0048251),8,5,0.551667912,9.063423645,7.25E-05,0.006471757,11117;4629;10516;4239;7148,TNXB;MFAP4;FBLN5;EMILIN1;MYH11
GO:0000022,mitotic spindle elongation (GO:0000022),8,5,0.551667912,9.063423645,7.25E-05,0.006471757,9212;24137;29127;9493;9055,KIF4A;KIF23;PRC1;AURKB;RACGAP1
GO:0051256,mitotic spindle midzone assembly (GO:0051256),8,5,0.551667912,9.063423645,7.25E-05,0.006471757,9212;24137;29127;9493;9055,KIF4A;KIF23;PRC1;AURKB;RACGAP1
GO:0071407,cellular response to organic cyclic compound (GO:0071407),148,24,10.20585638,2.351591,7.33E-05,0.006471757,5244;65010;9472;111;108;5138;358;6696;4208;7226;6263;120892;10411;6422;477;672;641;3488;6347;8013;5888;1958;2099;7035,ATP1A2;NR4A3;ADCY5;AQP1;PDE2A;SFRP1;EGR1;SLC26A6;LRRK2;MEF2C;BLM;SPP1;BRCA1;RAD51;RYR3;CCL2;RAPGEF3;AKAP6;TRPM2;TFPI;ABCB4;ESR1;IGFBP5;ADCY2
GO:0006259,DNA metabolic process (GO:0006259),276,37,19.03254297,1.944038695,7.54E-05,0.006471757,4907;983;7153;1111;4171;81620;10721;1763;2237;8317;2175;116028;990;672;8914;9401;5427;7298;10535;641;4173;55388;23594;4998;8318;9156;5888;11169;8438;7516;7832;10635;29089;3070;3149;3838;29128,XRCC2;RECQL4;HMGB3;TIMELESS;ORC1;RAD54L;POLQ;MCM2;DNA2;RNASEH2A;EXO1;BLM;UHRF1;CDC6;TOP2A;CDC45;CDC7;KPNA2;WDHD1;FANCA;BRCA1;RAD51AP1;MCM10;UBE2T;RAD51;ORC6;CDT1;CDK1;MCM4;CHEK1;FEN1;POLE2;TYMS;BTG2;HELLS;RMI2;NT5E
GO:0010881,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),17,7,1.172294313,5.971196755,7.64E-05,0.006471757,1756;775;287;6262;6546;477;845,ATP1A2;ANK2;CASQ2;DMD;RYR2;SLC8A1;CACNA1C
GO:0000076,DNA replication checkpoint signaling (GO:0000076),17,7,1.172294313,5.971196755,7.64E-05,0.006471757,63967;81620;1763;990;8914;4998;8318,TIMELESS;ORC1;CLSPN;DNA2;CDC6;CDC45;CDT1
GO:2000146,negative regulation of cell motility (GO:2000146),113,20,7.79230926,2.566633245,8.31E-05,0.006933538,7168;388;4804;10395;104;9353;7122;6781;6910;6422;225689;6376;4286;3488;25932;9863;8434;2192;89795;127435,CLDN5;SFRP1;NGFR;RHOB;RECK;SLIT2;PODN;CX3CL1;NAV3;TPM1;MAGI2;DLC1;MAPK15;MITF;FBLN1;CLIC4;ADARB1;STC1;TBX5;IGFBP5
GO:0006027,glycosaminoglycan catabolic process (GO:0006027),56,13,3.861675386,3.366414497,8.61E-05,0.007088741,375790;10082;6383;60495;2247;3373;10894;1634;1464;4958;4969;5549;3161,OGN;PRELP;HPSE2;LYVE1;FGF2;DCN;HYAL1;HMMR;SDC2;OMD;AGRN;CSPG4;GPC6
GO:0045765,regulation of angiogenesis (GO:0045765),200,29,13.79169781,2.102714286,1.11E-04,0.009046233,388;1116;3569;9723;358;947;5579;11117;7122;8742;5740;1944;4881;2247;493;10411;6422;2627;3373;57381;672;9314;1634;64094;9510;6237;641700;5176;126393,HSPB6;CLDN5;RHOJ;IL6;ADAMTS1;AQP1;PRKCB;SFRP1;CD34;NPR1;FGF2;KLF4;ECSCR;GATA6;DCN;BRCA1;HYAL1;SEMA3E;RHOB;SMOC2;PTGIS;RAPGEF3;EMILIN1;TNFSF12;ATP2B4;RRAS;CHI3L1;EFNA3;SERPINF1
GO:0060307,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),18,7,1.241252803,5.639463602,1.18E-04,0.009308467,23704;3757;287;6330;6324;781;6640,ANK2;KCNH2;SCN4B;SCN1B;CACNA2D1;KCNE4;SNTA1
GO:0010863,positive regulation of phospholipase C activity (GO:0010863),43,11,2.965215028,3.709680376,1.18E-04,0.009308467,3815;395;1909;4915;627;6401;1902;2247;5156;2260;2099,ARHGAP6;FGF2;LPAR1;BDNF;FGFR1;EDNRA;SELE;KIT;ESR1;NTRK2;PDGFRA
GO:1901992,positive regulation of mitotic cell cycle phase transition (GO:1901992),58,13,3.999592364,3.250331238,1.26E-04,0.009866588,11065;983;891;9700;3373;993;8317;995;51514;9787;113130;9510;894,ADAMTS1;CDCA5;UBE2C;DTL;CDC7;CDC25C;HYAL1;CCNB1;CDK1;DLGAP5;CCND2;CDC25A;ESPL1
GO:0007519,skeletal muscle tissue development (GO:0007519),37,10,2.551464094,3.919318333,1.46E-04,0.011225296,6840;58;51804;857;4208;1959;6495;6943;11149;64091,TCF21;MEF2C;CAV1;BVES;POPDC2;SIX4;ACTA1;EGR2;SVIL;SIX1
GO:2000258,negative regulation of protein activation cascade (GO:2000258),9,5,0.620626401,8.056376574,1.54E-04,0.0114215,2;7035;2157;2159;2161,F10;A2M;F8;TFPI;F12
GO:0048557,embryonic digestive tract morphogenesis (GO:0048557),9,5,0.620626401,8.056376574,1.54E-04,0.0114215,2294;6943;5156;3398;348093,TCF21;FOXF1;RBPMS2;ID2;PDGFRA
GO:0051382,kinetochore assembly (GO:0051382),9,5,0.620626401,8.056376574,1.54E-04,0.0114215,1062;1063;387103;9787;1058,CENPF;CENPA;DLGAP5;CENPE;CENPW
GO:0010604,positive regulation of macromolecule metabolic process (GO:0010604),383,46,26.4111013,1.741691855,1.61E-04,0.011816257,2934;2252;58;70;6622;4915;6401;3479;284;2621;3624;3569;5138;9464;947;4208;140628;11117;7122;1191;4609;2053;287;10439;2048;10365;2247;10891;57419;1869;22943;11149;55022;4286;7037;672;1958;9314;9863;3398;90865;27303;1789;59;8736;72,KLF2;CLDN5;IL6;ACTG2;ANK2;GATA5;PDE2A;SLC24A3;MYOM1;IL33;CD34;EGR1;FGF2;MEF2C;KLF4;ACTC1;GSN;ACTA2;CLU;INHBA;GAS6;FGF7;PID1;BRCA1;OLFM1;PPARGC1A;RBMS3;HAND2;EPHX2;BVES;MAGI2;E2F1;EMILIN1;IGF1;DNMT3B;SELE;ACTA1;ID2;MITF;TFRC;NTRK2;EPHB2;MYC;ANGPT1;DKK1;SNCA
GO:0002040,sprouting angiogenesis (GO:0002040),52,12,3.585841429,3.346494884,1.70E-04,0.012080525,55742;284;9723;6722;9353;1960;2247;3164;144455;79733;8434;84870,NR4A1;EGR3;FGF2;RSPO3;SRF;SEMA3E;RECK;E2F7;SLIT2;PARVA;E2F8;ANGPT1
GO:0086002,cardiac muscle cell action potential involved in contraction (GO:0086002),31,9,2.13771316,4.210106468,1.72E-04,0.012080525,23704;3757;775;287;6330;6324;781;6262;6640,ANK2;KCNH2;SCN4B;SCN1B;RYR2;CACNA2D1;KCNE4;CACNA1C;SNTA1
GO:0032465,regulation of cytokinesis (GO:0032465),84,16,5.792513078,2.762186254,1.73E-04,0.012080525,6840;1894;9928;11113;6790;9212;5347;29127;9493;10733;990;90293;10112;144455;79733;9055,AURKA;KIF14;KIF20A;CDC6;PLK1;E2F7;KIF23;PRC1;CIT;AURKB;ECT2;PLK4;RACGAP1;KLHL13;SVIL;E2F8
GO:0010232,vascular transport (GO:0010232),84,16,5.792513078,2.762186254,1.73E-04,0.012080525,489;6573;8884;6581;8671;493;57419;3177;6517;3953;6515;5243;477;10060;482;7037,ATP1A2;SLC2A4;SLC24A3;ATP1B2;SLC5A6;SLC22A3;SLC19A1;ABCC9;LEPR;SLC4A4;ABCB1;ATP2A3;SLC2A3;ATP2B4;TFRC;SLC29A2
GO:0031570,DNA integrity checkpoint signaling (GO:0031570),38,10,2.620422583,3.816178377,1.86E-04,0.012677201,63967;1111;81620;1763;1869;83990;990;8914;29980;8318,TIMELESS;CLSPN;DNA2;CDC6;CDC45;BRIP1;CDT1;CHEK1;DONSON;E2F1
GO:0006270,DNA replication initiation (GO:0006270),38,10,2.620422583,3.816178377,1.86E-04,0.012677201,4171;81620;8317;990;5427;4173;55388;23594;4998;8318,ORC1;MCM2;CDC6;CDC45;CDC7;MCM10;ORC6;CDT1;MCM4;POLE2
GO:0000086,G2/M transition of mitotic cell cycle (GO:0000086),129,21,8.895645085,2.360705694,1.92E-04,0.012934996,5577;79866;983;6790;5347;891;6502;9833;10763;5243;993;890;995;283807;10733;23194;9088;2305;9133;4751;4660,AURKA;FOXM1;PPP1R12B;NEK2;BORA;MELK;CDC25C;PLK1;CCNB2;CCNB1;CDK1;NES;PKMYT1;PLK4;CDC25A;SKP2;CCNA2;PRKAR2B;FBXL22;FBXL7;ABCB1
GO:0000082,G1/S transition of mitotic cell cycle (GO:0000082),85,16,5.861471567,2.729689945,2.00E-04,0.01332602,3624;4609;81620;6241;993;8317;1033;1869;9134;898;1978;1104;990;7298;4998;8318,ORC1;CCNE1;INHBA;CDC6;CDC45;CDC7;CCNE2;CDT1;CDC25A;RCC1;RRM2;E2F1;CDKN3;TYMS;EIF4EBP1;MYC
GO:0044839,cell cycle G2/M phase transition (GO:0044839),130,21,8.964603574,2.342546419,2.14E-04,0.014128508,5577;79866;983;6790;5347;891;6502;9833;10763;5243;993;890;995;283807;10733;23194;9088;2305;9133;4751;4660,AURKA;FOXM1;PPP1R12B;NEK2;BORA;MELK;CDC25C;PLK1;CCNB2;CCNB1;CDK1;NES;PKMYT1;PLK4;CDC25A;SKP2;CCNA2;PRKAR2B;FBXL22;FBXL7;ABCB1
GO:0060538,skeletal muscle organ development (GO:0060538),32,9,2.206671649,4.07854064,2.24E-04,0.014659476,6840;51804;857;84976;4208;6495;6943;11149;64091,TCF21;MEF2C;CAV1;BVES;POPDC2;SIX4;SVIL;SIX1;DISP1
GO:0051056,regulation of small GTPase mediated signal transduction (GO:0051056),140,22,9.654188464,2.278803659,2.30E-04,0.014689743,399;388;84952;5881;395;10395;83478;1894;29127;9353;5649;57381;2305;2;79658;90627;9824;55789;80728;55843;9754;57569,RHOJ;A2M;ARHGAP6;ARHGAP39;FOXM1;RELN;STARD13;STARD8;CGNL1;RHOB;SLIT2;DEPDC1B;RAC3;ARHGAP20;ARHGAP11A;ECT2;ARHGAP15;RACGAP1;ARHGAP10;DLC1;ARHGAP24;RHOH
GO:0150104,transport across blood-brain barrier (GO:0150104),86,16,5.930430056,2.697949364,2.30E-04,0.014689743,489;6573;8884;6581;8671;493;57419;3177;6517;3953;6515;5243;477;10060;482;7037,ATP1A2;SLC2A4;SLC24A3;ATP1B2;SLC5A6;SLC22A3;SLC19A1;ABCC9;LEPR;SLC4A4;ABCB1;ATP2A3;SLC2A3;ATP2B4;TFRC;SLC29A2
GO:0001934,positive regulation of protein phosphorylation (GO:0001934),368,44,25.37672396,1.73387235,2.45E-04,0.015391299,23043;2252;6622;6366;2690;1116;4915;627;3479;284;2621;3690;3624;3625;3569;3570;857;5347;1062;5649;2247;656;653;493;120892;10411;3953;51422;3678;6376;3082;7037;5168;718;1440;7804;146433;57161;1464;25999;11030;7272;894;80310,IL6;RELN;FGF2;BMP5;LRRK2;IL34;INHBA;GAS6;TTK;FGF7;CSF3;CAV1;PLK1;CX3CL1;CENPE;GHR;CCND2;BDNF;RBPMS;C3;LRP8;RAPGEF3;BMP8B;LEPR;PDGFD;IGF1;HGF;PRKAG2;INHBB;CCL21;ATP2B4;CLIP3;ITGA5;PELI2;ENPP2;TFRC;TNIK;CSPG4;NTRK2;ITGB3;IL6R;CHI3L1;ANGPT1;SNCA
GO:0006941,striated muscle contraction (GO:0006941),54,12,3.723758408,3.222550629,2.49E-04,0.015391299,7168;7139;1756;3757;1837;6330;6324;6262;6546;477;845;92241,ATP1A2;CASQ2;RCSD1;KCNH2;SCN4B;DMD;DTNA;TPM1;TNNT2;SCN1B;RYR2;SLC8A1
GO:0007076,mitotic chromosome condensation (GO:0007076),26,8,1.792920715,4.461993179,2.53E-04,0.015391299,983;5347;891;113130;54892;64151;23397;51203,NCAPH;CDCA5;PLK1;CCNB1;CDK1;NCAPG2;NCAPG;NUSAP1
GO:0086010,membrane depolarization during action potential (GO:0086010),26,8,1.792920715,4.461993179,2.53E-04,0.015391299,8912;6332;3757;775;6330;6324;6546;477,ATP1A2;SCN7A;CACNA1H;KCNH2;SCN4B;SCN1B;SLC8A1;CACNA1C
GO:0030071,regulation of mitotic metaphase/anaphase transition (GO:0030071),26,8,1.792920715,4.461993179,2.53E-04,0.015391299,11065;5347;891;1062;9700;990;1843;9787,DUSP1;UBE2C;CDC6;PLK1;CCNB1;DLGAP5;CENPE;ESPL1
GO:0043066,negative regulation of apoptotic process (GO:0043066),482,54,33.23799171,1.624646894,2.75E-04,0.016512619,2316;6622;4804;4915;627;3479;284;2621;9928;51804;3569;857;2869;358;983;4085;5347;79625;1511;3071;596;4208;2537;4609;1960;6495;10891;4776;6422;4929;5563;5166;2627;3678;6376;3082;23017;22943;23542;4680;1048;7037;332;6347;3572;558;9314;1410;85480;330;6491;79658;894;26471,PDK4;FAIM2;IL6;CTSG;NR4A2;CRYAB;AQP1;EGR3;SFRP1;KIF14;MEF2C;KLF4;STIL;GATA6;NGFR;GAS6;BIRC5;TSLP;CAV1;PLK1;PPARGC1A;CDK1;IL6ST;FLNA;CX3CL1;CCND2;BCL2;BDNF;CCL2;MAD2L1;AXL;NDNF;SIX4;GRK5;ARHGAP10;IGF1;HGF;BIRC3;NCKAP1L;NFATC4;MAPK8IP2;CEACAM6;ITGA5;CEACAM5;SIX1;TFRC;NTRK2;IFI6;MYC;ANGPT1;DKK1;PRKAA2;SNCA;NUPR1
GO:0032147,activation of protein kinase activity (GO:0032147),114,19,7.861267749,2.416912972,2.79E-04,0.016608203,23043;111;196883;154;108;1894;2690;1116;5577;79866;3479;150;22974;63967;284;7048;2621;9928;3690,ADCY5;TGFBR2;KIF14;CLSPN;GAS6;BORA;TPX2;ADCY4;GHR;ECT2;PRKAR2B;ADRA2A;IGF1;ADRB2;TNIK;ITGB3;CHI3L1;ANGPT1;ADCY2
GO:1902622,regulation of neutrophil migration (GO:1902622),10,5,0.68958489,7.250738916,2.90E-04,0.016620635,399;83700;3071;10562;683,JAM3;NCKAP1L;OLFM4;BST1;RHOH
GO:0051988,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),10,5,0.68958489,7.250738916,2.90E-04,0.016620635,1894;891;29127;4751;10615,SPAG5;NEK2;CCNB1;ECT2;RACGAP1
GO:1903115,regulation of actin filament-based movement (GO:1903115),10,5,0.68958489,7.250738916,2.90E-04,0.016620635,5144;5142;287;5350;6781,ANK2;PDE4B;PLN;PDE4D;STC1
GO:0071415,cellular response to purine-containing compound (GO:0071415),10,5,0.68958489,7.250738916,2.90E-04,0.016620635,6262;6546;7226;6263;845,CASQ2;RYR3;TRPM2;RYR2;SLC8A1
GO:0071503,response to heparin (GO:0071503),6,4,0.413750934,9.667651888,3.01E-04,0.017086225,338328;9353;6422;1958,GPIHBP1;SFRP1;EGR1;SLIT2
GO:0033623,regulation of integrin activation (GO:0033623),15,6,1.034377335,5.800591133,3.09E-04,0.017176199,9928;5734;83700;10979;54922;6403,KIF14;JAM3;FERMT2;SELP;PTGER4;RASIP1
GO:0048546,digestive tract morphogenesis (GO:0048546),15,6,1.034377335,5.800591133,3.09E-04,0.017176199,2294;64321;6943;5156;3398;348093,TCF21;FOXF1;SOX17;RBPMS2;ID2;PDGFRA
GO:0000724,double-strand break repair via homologous recombination (GO:0000724),97,17,6.688973436,2.541496115,3.13E-04,0.017235224,4171;10721;2237;8317;672;9401;641;4173;8318;5888;8438;7516;10635;675;51659;84296;4796,XRCC2;RECQL4;TONSL;RAD54L;POLQ;MCM2;BLM;CDC45;CDC7;BRCA1;RAD51AP1;RAD51;MCM4;GINS4;BRCA2;FEN1;GINS2
GO:0045860,positive regulation of protein kinase activity (GO:0045860),153,23,10.55064882,2.17996072,3.25E-04,0.017778284,23043;154;6622;6366;1894;79866;150;22974;63967;7048;2621;9928;3690;3570;1062;1191;5649;51422;22943;7804;1958;146433;2146,TGFBR2;RELN;EGR1;KIF14;IL34;CLSPN;CLU;GAS6;BORA;TPX2;CENPE;ECT2;LRP8;EZH2;ADRA2A;PRKAG2;CCL21;ADRB2;TNIK;ITGB3;IL6R;DKK1;SNCA
GO:0010882,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),21,7,1.44812827,4.833825944,3.58E-04,0.019212615,1756;775;287;6262;6546;477;845,ATP1A2;ANK2;CASQ2;DMD;RYR2;SLC8A1;CACNA1C
GO:0014902,myotube differentiation (GO:0014902),21,7,1.44812827,4.833825944,3.58E-04,0.019212615,8912;3479;51804;4208;170689;11096;58494,JAM2;MEF2C;CACNA1H;ADAMTS15;SIX4;ADAMTS5;IGF1
GO:0008285,negative regulation of cell population proliferation (GO:0008285),375,44,25.85943339,1.701506732,3.71E-04,0.019726426,10395;3624;3569;2172;104;6196;563;4609;6659;347;8864;7049;653;6910;7483;6422;2627;93649;1033;1869;990;3489;3488;7832;9314;9863;144455;83595;4920;25959;9510;11095;4969;863;4345;2192;10290;26471;1028;85004;127435;4330;7041;138151,IL6;OGN;MYOCD;ADAMTS1;SFRP1;BMP5;TGFBR3;SOX4;KLF4;PER2;GATA6;ADAMTS8;INHBA;NACC2;CDC6;E2F7;RERG;PODN;IGFBP6;RPS6KA2;KANK2;MAGI2;E2F1;TGFB1I1;CBFA2T3;CDKN3;SPEG;CD200;DLC1;CDKN1C;APOD;MN1;WNT9A;FBLN1;BTG2;SOX7;ROR2;ADARB1;FABP6;MYC;TBX5;IGFBP5;NUPR1;AZGP1
GO:0048660,regulation of smooth muscle cell proliferation (GO:0048660),49,11,3.378965962,3.255433799,4.07E-04,0.021474308,3479;3569;3570;2006;347;6376;3488;8013;3398;348093;4969,NR4A3;IL6;OGN;RBPMS2;CX3CL1;IGF1;ELN;ID2;APOD;IL6R;IGFBP5
GO:0007088,regulation of mitotic nuclear division (GO:0007088),57,12,3.930633875,3.052942702,4.23E-04,0.022134677,79866;3479;6790;891;1111;1104;995;9088;4751;1843;51203;4288,DUSP1;AURKA;NEK2;BORA;CDC25C;CCNB1;MKI67;NUSAP1;PKMYT1;RCC1;CHEK1;IGF1
GO:0034394,protein localization to cell surface (GO:0034394),28,8,1.930837693,4.143279381,4.46E-04,0.022871396,2316;2252;284;338328;83700;287;10516;79608,GPIHBP1;ANK2;FBLN5;FGF7;JAM3;RIC3;FLNA;ANGPT1
GO:1901019,regulation of calcium ion transmembrane transporter activity (GO:1901019),28,8,1.930837693,4.143279381,4.46E-04,0.022871396,1756;150;5144;783;785;287;5350;57158,ANK2;PLN;JPH2;PDE4D;DMD;CACNB2;ADRA2A;CACNB4
GO:0097553,calcium ion transmembrane import into cytosol (GO:0097553),42,10,2.896256539,3.452732817,4.49E-04,0.022871396,6366;2247;2906;781;493;6262;6546;7226;6263;3708,ITPR1;FGF2;RYR3;GRIN2D;TRPM2;CCL21;ATP2B4;RYR2;CACNA2D1;SLC8A1
GO:2000811,negative regulation of anoikis (GO:2000811),16,6,1.103335824,5.438054187,4.65E-04,0.02326443,857;596;5166;3678;4680;1048,PDK4;CAV1;BCL2;CEACAM6;ITGA5;CEACAM5
GO:0010965,regulation of mitotic sister chromatid separation (GO:0010965),16,6,1.103335824,5.438054187,4.65E-04,0.02326443,11065;9232;5347;1062;990;10460,UBE2C;CDC6;PLK1;CENPE;TACC3;PTTG1
GO:0030261,chromosome condensation (GO:0030261),35,9,2.413547116,3.728951443,4.68E-04,0.02326443,983;5347;891;7153;113130;54892;64151;23397;51203,NCAPH;CDCA5;TOP2A;PLK1;CCNB1;CDK1;NCAPG2;NCAPG;NUSAP1
GO:0022411,cellular component disassembly (GO:0022411),66,13,4.551260276,2.856351694,4.90E-04,0.023954029,2934;80274;1511;4322;4312;4320;4321;170689;7092;11096;9507;2;7177,MMP11;A2M;CTSG;TPSAB1;GSN;ADAMTS15;MMP13;TLL1;ADAMTS5;SCUBE1;MMP1;MMP12;ADAMTS4
GO:0022617,extracellular matrix disassembly (GO:0022617),66,13,4.551260276,2.856351694,4.90E-04,0.023954029,2934;80274;1511;4322;4312;4320;4321;170689;7092;11096;9507;2;7177,MMP11;A2M;CTSG;TPSAB1;GSN;ADAMTS15;MMP13;TLL1;ADAMTS5;SCUBE1;MMP1;MMP12;ADAMTS4
GO:0045444,fat cell differentiation (GO:0045444),58,12,3.999592364,3.000305758,5.01E-04,0.024144237,3625;8864;3164;1959;63976;10891;4929;55022;8013;9314;79689;25999,NR4A1;NR4A3;NR4A2;KLF4;PER2;PID1;PPARGC1A;STEAP4;EGR2;INHBB;CLIP3;PRDM16
GO:0060055,angiogenesis involved in wound healing (GO:0060055),11,5,0.758543379,6.591580833,5.02E-04,0.024144237,3690;4162;6722;79625;947,CD34;SRF;NDNF;MCAM;ITGB3
GO:0030239,myofibril assembly (GO:0030239),43,10,2.965215028,3.372436705,5.49E-04,0.026208521,7168;25802;7111;70;7139;1465;9172;51804;5239;5156,PGM5;LMOD1;TMOD1;MYOM2;ACTC1;CSRP1;TPM1;SIX4;TNNT2;PDGFRA
GO:0050678,regulation of epithelial cell proliferation (GO:0050678),93,16,6.41313948,2.494877907,5.75E-04,0.027204893,7538;2252;3479;284;51804;4609;2247;3164;7049;653;6422;3373;8013;29128;26471;1028,NR4A1;NR4A3;ZFP36;SFRP1;FGF2;BMP5;TGFBR3;FGF7;UHRF1;HYAL1;SIX4;IGF1;CDKN1C;MYC;ANGPT1;NUPR1
GO:1904705,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),36,9,2.482505605,3.625369458,5.87E-04,0.02729717,7168;3479;4208;2247;3488;5592;8013;9510;1264,NR4A3;CNN1;ADAMTS1;FGF2;MEF2C;TPM1;PRKG1;IGF1;IGFBP5
GO:0001706,endoderm formation (GO:0001706),36,9,2.482505605,3.625369458,5.87E-04,0.02729717,3624;64321;3678;3679;1847;1843;1294;1301;83595,DUSP1;SOX17;COL11A1;INHBA;ITGA7;ITGA5;DUSP5;COL7A1;SOX7
GO:1903508,positive regulation of nucleic acid-templated transcription (GO:1903508),509,55,35.09987092,1.56695733,5.90E-04,0.02729717,2252;3757;3479;3624;51804;3569;9464;6663;6696;4208;4609;7704;2294;6659;58476;322;4781;1316;9759;2535;10365;2247;64321;1959;6495;63976;10891;6910;6422;8324;2627;93649;1869;2305;4286;672;641;7942;2353;1958;2099;9314;3398;4602;675;6886;59;84913;84722;1028;7041;23090;29028;253738;9586,KLF2;FOXF1;IL6;SOX17;MYOCD;ZBTB16;SOX10;SFRP1;FOXM1;FOS;EGR1;FGF2;SOX4;MEF2C;KLF4;GATA6;ACTA2;INHBA;BLM;SPP1;FGF7;BRCA1;PPARGC1A;HAND2;KCNH2;TP53INP2;TFEB;APBB1;FZD7;KLF6;BRCA2;ATOH8;E2F1;TGFB1I1;ATAD2;SIX4;EBF3;IGF1;FZD2;ID2;HDAC4;CREB5;EGR2;CDKN1C;NFIB;MITF;ESR1;SIX1;PSRC1;PRDM16;MYB;MYC;TAL1;ZNF423;TBX5
GO:0045944,positive regulation of transcription by RNA polymerase II (GO:0045944),906,88,62.47639106,1.408532063,6.08E-04,0.027908881,375790;4804;3479;3624;3569;9464;6722;4208;140628;4609;64651;114548;2294;6659;322;4781;1316;9759;4223;10365;2247;3164;64321;56963;653;4093;1959;6495;6943;10891;6910;5308;7472;4929;2627;93649;23414;6376;3082;1869;2305;55022;4286;4321;8061;672;9787;8013;7942;467;2353;3726;1440;1958;3663;2099;9314;1634;4602;90865;26586;144455;79733;29128;1870;25937;7025;5241;7067;6886;5187;9839;84913;28999;133522;4072;29028;4784;5178;9079;2118;84969;3727;4605;4774;23764;5013;3131,NR4A1;PER1;KLF2;NR4A3;TCF21;FOXF1;CSRNP1;IL6;SOX17;HLF;MYOCD;NR4A2;PGR;GATA5;OTX1;JUND;IL33;PEG3;FOXM1;FOS;EGR1;FGF2;BMP5;SOX4;LDB2;MEF2C;KLF4;SRF;GATA6;INHBA;NGFR;UHRF1;DCN;PID1;CSF3;BRCA1;MYBL2;ZEB2;PPARGC1A;E2F7;HAND2;TFEB;NR2F1;NFIX;DLGAP5;APBB1;CX3CL1;ATF3;KLF6;ATOH8;E2F1;WWTR1;MAFF;ATAD2;SMAD9;THRA;IGF1;HGF;WNT2;AGRN;NFIA;CKAP2;HDAC4;MEOX2;EGR2;NFIB;ETV4;NLRP3;MITF;E2F2;JUNB;ESR1;SIX1;PPARGC1B;TOX2;IRF5;E2F8;MYB;KLF15;MYC;ZFPM2;MMP12;EPCAM;FOSL1;TAL1;RGMA;TBX5;PITX2
GO:0032870,cellular response to hormone stimulus (GO:0032870),76,14,5.240845166,2.671324864,6.16E-04,0.028064982,8912;2690;150;857;10267;4208;9353;6586;6422;477;8013;687;10865;7035,KLF9;ATP1A2;NR4A3;SLIT3;SFRP1;MEF2C;RAMP1;CAV1;CACNA1H;SLIT2;GHR;ADRA2A;TFPI;ARID5A
GO:0016525,negative regulation of angiogenesis (GO:0016525),85,15,5.861471567,2.559084323,6.41E-04,0.028460725,9723;56999;11117;7122;1944;4881;10365;493;9314;1634;1870;9510;90993;641700;5176,KLF2;CLDN5;ADAMTS1;NPR1;KLF4;ECSCR;DCN;SEMA3E;EMILIN1;CREB3L1;ATP2B4;E2F2;ADAMTS9;EFNA3;SERPINF1
GO:0045893,"positive regulation of transcription, DNA-templated (GO:0045893)",1170,109,80.68143216,1.350992379,6.48E-04,0.028460725,375790;2252;3757;3479;3624;51804;3569;9464;6663;6696;6722;4208;140628;1111;4609;64651;7704;114548;2294;6659;58476;322;4781;1316;9759;2535;4223;10365;2247;3164;64321;56963;653;1959;6495;6943;63976;10891;6910;5308;6422;7472;8324;4929;2627;93649;23414;6376;3082;1869;2305;55022;4286;4321;8061;672;641;8013;7942;467;2353;3726;1440;1958;3663;2099;9314;3398;1634;4602;55038;90865;26586;144455;79733;29128;675;1870;25937;7025;5241;7067;6886;5187;59;9839;84913;28999;133522;84722;1028;7041;4072;23090;29028;4784;5178;9079;2118;253738;9586;387496;84969;3727;4605;4774;23764;5013;3131,NR4A1;PER1;KLF2;NR4A3;TCF21;FOXF1;CSRNP1;IL6;SOX17;HLF;MYOCD;ZBTB16;NR4A2;PGR;GATA5;SOX10;RASL11A;OTX1;JUND;SFRP1;IL33;PEG3;FOXM1;FOS;EGR1;FGF2;BMP5;SOX4;LDB2;MEF2C;KLF4;SRF;GATA6;ACTA2;INHBA;BLM;SPP1;FGF7;UHRF1;DCN;PID1;CSF3;BRCA1;MYBL2;ZEB2;PPARGC1A;E2F7;HAND2;KCNH2;TP53INP2;TFEB;NR2F1;NFIX;APBB1;CX3CL1;ATF3;CDCA4;FZD7;KLF6;BRCA2;CHEK1;ATOH8;E2F1;WWTR1;TGFB1I1;MAFF;ATAD2;SIX4;EBF3;THRA;IGF1;HGF;FZD2;WNT2;AGRN;NFIA;ID2;CKAP2;HDAC4;MEOX2;CREB5;EGR2;CDKN1C;NFIB;ETV4;NLRP3;MITF;E2F2;JUNB;ESR1;SIX1;PPARGC1B;PSRC1;TOX2;IRF5;PRDM16;E2F8;MYB;KLF15;MYC;ZFPM2;MMP12;EPCAM;FOSL1;TAL1;ZNF423;RGMA;TBX5;PITX2
GO:0032060,bleb assembly (GO:0032060),7,4,0.482709423,8.286558761,6.65E-04,0.028460725,5376;4638;2012;2014,MYLK;PMP22;EMP3;EMP1
GO:2000669,negative regulation of dendritic cell apoptotic process (GO:2000669),7,4,0.482709423,8.286558761,6.65E-04,0.028460725,6366;2621;6387;558,CXCL12;GAS6;AXL;CCL21
GO:0071313,cellular response to caffeine (GO:0071313),7,4,0.482709423,8.286558761,6.65E-04,0.028460725,6262;6546;6263;845,CASQ2;RYR3;RYR2;SLC8A1
GO:0031000,response to caffeine (GO:0031000),7,4,0.482709423,8.286558761,6.65E-04,0.028460725,6262;6546;6263;845,CASQ2;RYR3;RYR2;SLC8A1
GO:0044818,mitotic G2/M transition checkpoint (GO:0044818),44,10,3.034173517,3.295790416,6.68E-04,0.028460725,63967;983;5347;1111;990;672;29980;641;4998;51514,ORC1;CLSPN;DTL;BLM;CDC6;BRCA1;PLK1;CDK1;CHEK1;DONSON
GO:1902751,positive regulation of cell cycle G2/M phase transition (GO:1902751),23,7,1.586045248,4.413493253,6.68E-04,0.028460725,983;891;993;8317;995;51514;79915,ATAD5;DTL;CDC7;CDC25C;CCNB1;CDK1;CDC25A
GO:0086064,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),17,6,1.172294313,5.118168647,6.77E-04,0.028460725,775;6910;6262;6546;477;482,ATP1A2;ATP1B2;RYR2;SLC8A1;CACNA1C;TBX5
GO:0055023,positive regulation of cardiac muscle tissue growth (GO:0055023),17,6,1.172294313,5.118168647,6.77E-04,0.028460725,9472;3479;4208;2247;7049;23414,FGF2;TGFBR3;MEF2C;AKAP6;IGF1;ZFPM2
GO:0051983,regulation of chromosome segregation (GO:0051983),17,6,1.172294313,5.118168647,6.77E-04,0.028460725,9212;11004;699;116028;990;4288,KIF2C;CDC6;BUB1;MKI67;AURKB;RMI2
GO:0030336,negative regulation of cell migration (GO:0030336),142,21,9.792105442,2.14458475,7.24E-04,0.030209929,7168;388;4804;10395;104;9353;7122;2247;6781;6910;6422;225689;6376;482;4286;3488;25932;9863;8434;89795;127435,CLDN5;ATP1B2;SFRP1;FGF2;NGFR;RHOB;RECK;SLIT2;PODN;CX3CL1;NAV3;TPM1;MAGI2;DLC1;MAPK15;MITF;CLIC4;ADARB1;STC1;TBX5;IGFBP5
GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),133,20,9.171479041,2.180673358,7.74E-04,0.032006347,3815;2252;2690;3479;284;2621;3690;3569;3570;5649;3678;3082;5168;9021;3572;1440;7804;146433;85480;1464,IL6;RELN;IL34;GAS6;FGF7;TSLP;CSF3;IL6ST;GHR;SOCS3;LRP8;IGF1;HGF;KIT;ITGA5;ENPP2;CSPG4;ITGB3;IL6R;ANGPT1
GO:0071345,cellular response to cytokine stimulus (GO:0071345),480,52,33.10007473,1.570993432,7.77E-04,0.032006347,7538;65010;1901;3815;9472;6366;2690;1116;2621;3569;3570;5138;1511;596;2920;4609;5740;6387;2247;6422;3953;3373;6376;3082;55022;81792;4312;672;1843;2162;332;6347;9021;11213;2353;163351;58985;3726;6935;3590;3572;1440;4692;1052;7804;1958;146433;3977;558;3663;4882;64388,DUSP1;IL6;CTSG;ZFP36;GREM2;PDE2A;SFRP1;FOS;EGR1;FGF2;SLC26A6;IL34;CXCL12;GAS6;BIRC5;PID1;CSF3;BRCA1;HYAL1;F13A1;IL6ST;S1PR1;CX3CL1;GHR;PTGIS;SOCS3;BCL2;CCL2;AXL;LRP8;ZEB1;AKAP6;CXCL2;LIFR;LEPR;HGF;IL11RA;KIT;IRAK3;NDN;IL22RA1;NPR2;CEBPD;CCL21;JUNB;MMP1;GBP6;IL6R;CHI3L1;IRF5;MYC;ADAMTS12
GO:1902893,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),45,10,3.103132006,3.222550629,8.06E-04,0.032323761,4804;6722;4781;2247;4776;8061;2353;1958;9314;84913,FOS;EGR1;FGF2;KLF4;SRF;NGFR;ATOH8;NFIB;NFATC4;FOSL1
GO:0090257,regulation of muscle system process (GO:0090257),12,5,0.827501868,6.04228243,8.12E-04,0.032323761,7168;309;477;4660;10398,ATP1A2;MYL9;PPP1R12B;ANXA6;TPM1
GO:0043116,negative regulation of vascular permeability (GO:0043116),12,5,0.827501868,6.04228243,8.12E-04,0.032323761,284;5138;10979;9353;7122,CLDN5;PDE2A;SLIT2;FERMT2;ANGPT1
GO:0007077,mitotic nuclear membrane disassembly (GO:0007077),12,5,0.827501868,6.04228243,8.12E-04,0.032323761,983;5347;891;5579;9133,PRKCB;PLK1;CCNB2;CCNB1;CDK1
GO:0051315,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),12,5,0.827501868,6.04228243,8.12E-04,0.032323761,11004;1062;81620;83540;10403,KIF2C;NUF2;CDT1;NDC80;CENPE
GO:0085029,extracellular matrix assembly (GO:0085029),24,7,1.655003737,4.229597701,8.88E-04,0.035063576,2621;11117;4629;10516;2824;4239;7148,TNXB;MFAP4;FBLN5;GAS6;EMILIN1;MYH11;GPM6B
GO:0043268,positive regulation of potassium ion transport (GO:0043268),38,9,2.620422583,3.434560539,8.97E-04,0.035063576,2316;9472;3757;150;3779;287;3778;3782;2273,FHL1;ANK2;KCNMB1;KCNN3;KCNMA1;FLNA;KCNH2;AKAP6;ADRA2A
GO:0097435,supramolecular fiber organization (GO:0097435),346,40,23.8596372,1.676471426,8.98E-04,0.035063576,2934;7169;7168;10435;399;388;25802;84952;7111;65108;390;70;5881;1674;6622;9928;5239;81930;11004;11117;11076;4629;2258;10516;7092;4239;347240;1294;7373;1286;1292;81578;1288;1805;1301;25999;3925;7148;51673;146909,TNXB;COL14A1;MFAP4;PGM5;TPPP;DES;LMOD1;COL11A1;TMOD1;KIF18B;CDC42EP2;KIF14;KIF2C;ACTC1;TPPP3;DPT;GSN;FBLN5;KIF18A;CGNL1;KIF24;FGF13;RHOB;RAC3;TPM2;COL21A1;COL4A4;TPM1;TLL1;EMILIN1;COL6A2;STMN1;MYH11;CLIP3;MARCKSL1;COL7A1;COL4A6;RND3;RHOH;SNCA
GO:0072359,circulatory system development (GO:0072359),125,19,8.619811128,2.204224631,9.08E-04,0.035197337,8572;7048;9464;6722;4208;2294;775;6659;9260;64321;5463;6943;6910;23414;11149;3398;27295;64091;11155,TCF21;FOXF1;SOX17;LDB3;TGFBR2;SOX4;MEF2C;SRF;PDLIM4;PDLIM3;HAND2;BVES;POPDC2;ID2;POU6F1;ZFPM2;CACNA1C;TBX5;PDLIM7
GO:0010976,positive regulation of neuron projection development (GO:0010976),88,15,6.068347034,2.471842812,9.33E-04,0.03593467,23242;4915;627;79625;2042;6324;5649;653;6376;482;7804;9863;9760;4920;4919,ATP1B2;RELN;BMP5;EPHA3;CX3CL1;BDNF;ROR1;NDNF;LRP8;MAGI2;SCN1B;NTRK2;TOX;ROR2;COBL
GO:0007019,microtubule depolymerization (GO:0007019),18,6,1.241252803,4.833825944,9.57E-04,0.036399921,9928;81930;11004;347240;3925;146909,KIF18B;KIF14;KIF2C;KIF18A;KIF24;STMN1
GO:0071312,cellular response to alkaloid (GO:0071312),18,6,1.241252803,4.833825944,9.57E-04,0.036399921,6262;6546;6263;845;641;5888,CASQ2;BLM;RAD51;RYR3;RYR2;SLC8A1
GO:0048661,positive regulation of smooth muscle cell proliferation (GO:0048661),46,10,3.172090495,3.152495181,9.67E-04,0.036572997,3479;3569;3570;2247;6376;3488;8013;3398;348093;9510,NR4A3;IL6;ADAMTS1;FGF2;RBPMS2;CX3CL1;IGF1;ID2;IL6R;IGFBP5
GO:0030308,negative regulation of cell growth (GO:0030308),126,19,8.688769618,2.186730784,0.001001321,0.037202291,5167;3624;56920;9353;6586;322;4881;64321;6422;4487;3373;2258;2273;64061;84722;65078;147906;58189;85004,SOX17;FHL1;SLIT3;WFDC1;SFRP1;SEMA3G;NPR1;INHBA;HYAL1;FGF13;RTN4R;RERG;DACT3;SLIT2;APBB1;TSPYL2;MSX1;PSRC1;ENPP1
GO:0050808,synapse organization (GO:0050808),126,19,8.688769618,2.186730784,0.001001321,0.037202291,375790;6622;627;9723;10082;783;785;9379;9378;3897;4897;120892;6376;22943;145581;94030;5789;23024;80728,ARHGAP39;LRRK2;NRXN1;LRFN5;PDZRN3;SEMA3E;CX3CL1;L1CAM;BDNF;CACNB2;NRXN2;AGRN;NRCAM;CACNB4;PTPRD;LRRC4B;DKK1;SNCA;GPC6
GO:0051592,response to calcium ion (GO:0051592),107,17,7.378558326,2.303973114,0.001002624,0.037202291,7139;1894;857;3779;4208;6262;7226;6263;7220;83849;23208;5563;845;3778;3707;25932;10235,KCNMB1;RASGRP2;CASQ2;MEF2C;CAV1;KCNMA1;RYR3;ECT2;TRPM2;ITPKB;TNNT2;TRPC1;RYR2;SYT15;CLIC4;SYT11;PRKAA2
GO:1903829,positive regulation of cellular protein localization (GO:1903829),71,13,4.896052721,2.655200167,0.001011516,0.037301993,4804;10979;983;5347;4130;81620;10403;23208;5563;7037;79608;51512;25937,NGFR;PLK1;GTSE1;CDT1;CDK1;NDC80;RIC3;FERMT2;WWTR1;MAP1A;TFRC;SYT11;PRKAA2
GO:0051283,negative regulation of sequestering of calcium ion (GO:0051283),25,7,1.723962226,4.060413793,0.001160411,0.04201947,6366;309;2247;6262;7226;6263;3708,ITPR1;FGF2;ANXA6;RYR3;TRPM2;CCL21;RYR2
GO:0043271,negative regulation of ion transport (GO:0043271),25,7,1.723962226,4.060413793,0.001160411,0.04201947,6622;150;5350;6781;23208;845;2824,CASQ2;PLN;ADRA2A;GPM6B;SYT11;STC1;SNCA
GO:0019933,cAMP-mediated signaling (GO:0019933),25,7,1.723962226,4.060413793,0.001160411,0.04201947,9472;10486;108;5138;5144;27115;10411,PDE2A;PDE4D;PDE7B;RAPGEF3;AKAP6;CAP2;ADCY2
GO:0032956,regulation of actin cytoskeleton organization (GO:0032956),90,15,6.206264013,2.416912972,0.001183272,0.04259069,11170;399;388;390;5881;10395;9723;2042;7226;10411;5156;2824;10391;683;128239,FAM107A;IQGAP3;EPHA3;SEMA3E;RHOB;RAC3;RAPGEF3;TRPM2;DLC1;GPM6B;CORO2B;PDGFRA;BST1;RND3;RHOH
GO:0042327,positive regulation of phosphorylation (GO:0042327),252,31,17.37753924,1.783911956,0.001216182,0.043018397,23043;3815;2252;4915;3479;284;2621;3690;3071;2048;2045;2042;8671;2247;120892;8324;5563;3953;5156;3082;7037;718;2260;146433;558;57161;25999;4920;4919;5210;894,FGF2;LRRK2;EPHA3;IL34;GAS6;FGF7;PFKFB4;EPHA7;CCND2;FZD7;AXL;ROR1;C3;LEPR;FGFR1;SLC4A4;IGF1;HGF;NCKAP1L;KIT;CLIP3;PELI2;TFRC;TNIK;NTRK2;ITGB3;PDGFRA;EPHB2;ROR2;ANGPT1;PRKAA2
GO:0071900,regulation of protein serine/threonine kinase activity (GO:0071900),109,17,7.516475304,2.261698378,0.001238402,0.043018397,154;6622;891;6546;993;1033;890;9134;898;995;9088;9133;990;641;2146;9077;894,CCNE1;BLM;CDC6;CDC25C;CCNE2;CCNB2;CCNB1;PKMYT1;CCND2;CDC25A;CCNA2;EZH2;CDKN3;DIRAS3;ADRB2;SLC8A1;SNCA
GO:0055119,relaxation of cardiac muscle (GO:0055119),13,5,0.896460357,5.577491474,0.001244931,0.043018397,2934;5350;6546;477;5997,ATP1A2;RGS2;GSN;PLN;SLC8A1
GO:0060306,regulation of membrane repolarization (GO:0060306),13,5,0.896460357,5.577491474,0.001244931,0.043018397,9472;3757;857;781;845,CASQ2;CAV1;KCNH2;AKAP6;CACNA2D1
GO:0071872,cellular response to epinephrine stimulus (GO:0071872),8,4,0.551667912,7.250738916,0.001256639,0.043018397,6622;5142;493;6262,PDE4B;ATP2B4;RYR2;SNCA
GO:0071871,response to epinephrine (GO:0071871),8,4,0.551667912,7.250738916,0.001256639,0.043018397,6622;5142;493;6262,PDE4B;ATP2B4;RYR2;SNCA
GO:0014829,vascular associated smooth muscle contraction (GO:0014829),8,4,0.551667912,7.250738916,0.001256639,0.043018397,1909;1910;6546;59,EDNRB;ACTA2;EDNRA;SLC8A1
GO:1902099,regulation of metaphase/anaphase transition of cell cycle (GO:1902099),8,4,0.551667912,7.250738916,0.001256639,0.043018397,11065;5347;1062;990,UBE2C;CDC6;PLK1;CENPE
GO:0010948,negative regulation of cell cycle process (GO:0010948),64,12,4.413343298,2.719027094,0.001259564,0.043018397,9212;1111;9700;6241;8317;1869;4751;672;5888;2146;144455;79733,NEK2;CDC7;BRCA1;RAD51;E2F7;AURKB;CHEK1;RRM2;E2F1;EZH2;ESPL1;E2F8
GO:0007399,nervous system development (GO:0007399),445,48,30.68652762,1.56420435,0.001334736,0.045328243,2934;65108;1894;627;1902;3624;8642;6663;5376;4359;4884;9379;9378;4208;7704;1910;3897;152330;6285;4897;2048;9638;2674;2676;5649;9759;2247;1959;10763;5050;7472;2258;79633;2824;79094;9201;558;6491;1808;25937;9839;284403;57716;23114;89795;9079;146713;2256,ZBTB16;RBFOX3;SOX10;EDNRB;RELN;FGF2;LDB2;MEF2C;NRXN1;GSN;STIL;INHBA;GFRA3;PMP22;ZEB2;FGF13;NES;LPAR1;ECT2;MPZ;L1CAM;BDNF;GFRA1;WDR62;NAV3;NFASC;AXL;WWTR1;DCLK1;CNTN4;PAFAH1B3;NRXN2;WNT2;HDAC4;NRCAM;EGR2;DPYSL2;S100B;GPM6B;DCHS1;NPTX1;MARCKSL1;FEZ1;PRX;FAT4;EPHB2;CHAC1;FGF11
GO:0097306,cellular response to alcohol (GO:0097306),48,10,3.310007473,3.021141215,0.001369348,0.046242415,111;108;5737;5734;1066;6422;672;641;687;5888,KLF9;ADCY5;PTGFR;SFRP1;BLM;BRCA1;RAD51;CES1;PTGER4;ADCY2
GO:1903670,regulation of sprouting angiogenesis (GO:1903670),33,8,2.275630138,3.515509778,0.001463399,0.048869405,56999;10365;2247;3678;57381;9314;1870;90993,KLF2;RHOJ;FGF2;KLF4;CREB3L1;E2F2;ITGA5;ADAMTS9
GO:0007095,mitotic G2 DNA damage checkpoint signaling (GO:0007095),33,8,2.275630138,3.515509778,0.001463399,0.048869405,63967;983;5347;1111;672;29980;641;51514,CLSPN;DTL;BLM;BRCA1;PLK1;CDK1;CHEK1;DONSON
GO:0051783,regulation of nuclear division (GO:0051783),20,6,1.379169781,4.35044335,0.001773403,0.05793437,79866;1104;995;9088;4751;4288,NEK2;BORA;CDC25C;MKI67;PKMYT1;RCC1
GO:2000209,regulation of anoikis (GO:2000209),20,6,1.379169781,4.35044335,0.001773403,0.05793437,857;596;5166;3678;4680;1048,PDK4;CAV1;BCL2;CEACAM6;ITGA5;CEACAM5
GO:0048566,embryonic digestive tract development (GO:0048566),20,6,1.379169781,4.35044335,0.001773403,0.05793437,2294;6943;5156;3398;91461;348093,TCF21;FOXF1;RBPMS2;PKDCC;ID2;PDGFRA
GO:0010971,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),20,6,1.379169781,4.35044335,0.001773403,0.05793437,983;891;993;8317;995;51514,DTL;CDC7;CDC25C;CCNB1;CDK1;CDC25A
GO:0042692,muscle cell differentiation (GO:0042692),34,8,2.344588627,3.412112431,0.001799742,0.058117038,1756;4208;2627;93649;11149;64091;23345;10290,MYOCD;MEF2C;GATA6;SYNE1;DMD;BVES;POPDC2;SPEG
GO:1902895,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),34,8,2.344588627,3.412112431,0.001799742,0.058117038,4804;6722;2247;8061;2353;1958;9314;84913,FOS;EGR1;FGF2;KLF4;SRF;NGFR;ATOH8;FOSL1
GO:0014912,negative regulation of smooth muscle cell migration (GO:0014912),14,5,0.965418846,5.179099226,0.001827337,0.058117038,7168;4208;9353;3488;5592,MEF2C;SLIT2;TPM1;PRKG1;IGFBP5
GO:0090075,relaxation of muscle (GO:0090075),14,5,0.965418846,5.179099226,0.001827337,0.058117038,2934;5350;6546;477;5997,ATP1A2;RGS2;GSN;PLN;SLC8A1
GO:0051081,nuclear membrane disassembly (GO:0051081),14,5,0.965418846,5.179099226,0.001827337,0.058117038,983;5347;891;5579;9133,PRKCB;PLK1;CCNB2;CCNB1;CDK1
GO:0043153,entrainment of circadian clock by photoperiod (GO:0043153),27,7,1.861879204,3.759642401,0.001899107,0.060081746,8864;1408;283807;3398;8863;5187;9099,PER1;CRY2;PER2;USP2;PER3;FBXL22;ID2
GO:0061098,positive regulation of protein tyrosine kinase activity (GO:0061098),42,9,2.896256539,3.107459536,0.001913628,0.060224188,4915;627;150;2621;5649;1839;7804;146433;374,RELN;IL34;GAS6;BDNF;LRP8;ADRA2A;HBEGF;NTRK2;AREG
GO:0010717,regulation of epithelial to mesenchymal transition (GO:0010717),76,13,5.240845166,2.480515945,0.001932539,0.060502548,7048;3569;10979;10439;2042;653;6910;6422;10252;2146;25937;7041;152007,IL6;SPRY1;SFRP1;TGFBR2;BMP5;EPHA3;OLFM1;FERMT2;WWTR1;TGFB1I1;EZH2;GLIPR2;TBX5
GO:0051258,protein polymerization (GO:0051258),59,11,4.068550853,2.703665359,0.002079722,0.06477311,2934;11170;23242;81624;8522;395;11065;11076;845;2258;51673,FAM107A;TPPP;ARHGAP6;CASQ2;TPPP3;GSN;UBE2C;GAS7;FGF13;DIAPH3;COBL
GO:0045019,negative regulation of nitric oxide biosynthetic process (GO:0045019),9,4,0.620626401,6.445101259,0.002138823,0.06559422,857;947;5740;493,CD34;CAV1;PTGIS;ATP2B4
GO:1904406,negative regulation of nitric oxide metabolic process (GO:1904406),9,4,0.620626401,6.445101259,0.002138823,0.06559422,857;947;5740;493,CD34;CAV1;PTGIS;ATP2B4
GO:0045601,regulation of endothelial cell differentiation (GO:0045601),9,4,0.620626401,6.445101259,0.002138823,0.06559422,55273;6935;84913;81575,APOLD1;TMEM100;ATOH8;ZEB1
GO:0014068,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),77,13,5.309803655,2.448301452,0.002181604,0.06656662,3815;4915;3479;2247;6403;5156;3082;2260;1440;1634;4920;4919;80310,FGF2;DCN;CSF3;SELP;ROR1;FGFR1;PDGFD;IGF1;HGF;KIT;NTRK2;PDGFRA;ROR2
GO:0019935,cyclic-nucleotide-mediated signaling (GO:0019935),35,8,2.413547116,3.314623505,0.002194241,0.066614065,9472;10486;108;5138;5144;358;27115;10411,AQP1;PDE2A;PDE4D;PDE7B;RAPGEF3;AKAP6;CAP2;ADCY2
GO:0006816,calcium ion transport (GO:0006816),115,17,7.930226238,2.143696723,0.002245081,0.067814978,8912;489;2621;857;10267;783;775;287;781;493;57419;6262;6546;7226;6263;3708;7220,ANK2;SLC24A3;ITPR1;RAMP1;GAS6;CAV1;CACNA1H;RYR3;TRPM2;CACNB2;ATP2A3;TRPC1;ATP2B4;RYR2;CACNA2D1;SLC8A1;CACNA1C
GO:0045669,positive regulation of osteoblast differentiation (GO:0045669),43,9,2.965215028,3.035193035,0.002274755,0.068367764,3479;3569;3570;10979;4208;2201;3082;3572;25937,IL6;MEF2C;IL6ST;FERMT2;WWTR1;IGF1;HGF;FBN2;IL6R
GO:0006937,regulation of muscle contraction (GO:0006937),28,7,1.930837693,3.625369458,0.002383578,0.069891146,7168;857;309;477;4660;10398;1264,ATP1A2;CNN1;MYL9;PPP1R12B;ANXA6;CAV1;TPM1
GO:0060401,cytosolic calcium ion transport (GO:0060401),28,7,1.930837693,3.625369458,0.002383578,0.069891146,489;775;781;79085;6262;57158;6546,JPH2;SLC25A23;ATP2A3;RYR2;CACNA2D1;SLC8A1;CACNA1C
GO:1902305,regulation of sodium ion transmembrane transport (GO:1902305),28,7,1.930837693,3.625369458,0.002383578,0.069891146,6330;6324;493;6640;5348;7871;53826,FXYD1;FXYD6;SCN4B;SLMAP;SCN1B;ATP2B4;SNTA1
GO:0048146,positive regulation of fibroblast proliferation (GO:0048146),28,7,1.930837693,3.625369458,0.002383578,0.069891146,3479;2621;358;4609;7472;5156;1869,AQP1;GAS6;E2F1;IGF1;WNT2;PDGFRA;MYC
GO:0009648,photoperiodism (GO:0009648),28,7,1.930837693,3.625369458,0.002383578,0.069891146,8864;1408;283807;3398;8863;5187;9099,PER1;CRY2;PER2;USP2;PER3;FBXL22;ID2
GO:0031400,negative regulation of protein modification process (GO:0031400),78,13,5.378762144,2.416912972,0.002456461,0.070922844,1756;9353;11076;2048;493;120892;5563;6640;91663;55022;5348;25937;2192,FXYD1;TPPP;LRRK2;MYADM;PID1;SLIT2;DMD;WWTR1;ATP2B4;FBLN1;EPHB2;SNTA1;PRKAA2
GO:0045664,regulation of neuron differentiation (GO:0045664),78,13,5.378762144,2.416912972,0.002456461,0.070922844,1894;627;4208;152330;4897;6495;120892;22943;2260;274;6935;3398;5121,PCP4;LRRK2;MEF2C;BIN1;ECT2;BDNF;ZEB1;CNTN4;FGFR1;ID2;NRCAM;SIX1;DKK1
GO:0060326,cell chemotaxis (GO:0060326),69,12,4.758135743,2.521996145,0.002462254,0.070922844,55742;3815;6366;1902;185;6387;1960;3164;5156;6376;3082;1839,NR4A1;AGTR1;EGR3;CXCL12;CX3CL1;LPAR1;HGF;KIT;HBEGF;CCL21;PDGFRA;PARVA
GO:0045766,positive regulation of angiogenesis (GO:0045766),116,17,7.999184727,2.125216579,0.002465958,0.070922844,388;1116;358;947;5579;8742;5740;2247;10411;2627;3373;3678;672;9314;64094;6237;126393,HSPB6;AQP1;PRKCB;CD34;FGF2;KLF4;GATA6;BRCA1;HYAL1;RHOB;SMOC2;PTGIS;RAPGEF3;TNFSF12;ITGA5;RRAS;CHI3L1
GO:2000147,positive regulation of cell motility (GO:2000147),220,27,15.17086759,1.779726825,0.002519452,0.072116318,3815;11170;6366;3479;150;857;10979;54437;9723;7869;56920;4638;2048;9423;59352;6387;5156;3082;1839;91663;4680;51512;2159;4920;117581;131578;80310,F10;FAM107A;SEMA5B;SEMA3G;MYLK;TWIST2;CXCL12;MYADM;CAV1;GTSE1;SEMA3E;FERMT2;SEMA3B;ADRA2A;PDGFD;IGF1;HGF;KIT;HBEGF;CCL21;NTN1;CEACAM6;LGR6;PDGFRA;LRRC15;EPHB2;ROR2
GO:1900274,regulation of phospholipase C activity (GO:1900274),15,5,1.034377335,4.833825944,0.002586702,0.073690358,3815;2247;5156;2260;2099,FGF2;FGFR1;KIT;ESR1;PDGFRA
GO:0000122,negative regulation of transcription by RNA polymerase II (GO:0000122),677,66,46.68489707,1.413733437,0.002616167,0.074178217,7538;6622;857;5138;6663;9212;5347;6722;4208;4609;7704;1428;1910;322;4781;9759;10365;8864;5463;6943;63976;4776;4929;1408;2627;23414;1869;2305;22943;4286;8013;467;6935;3090;2099;10865;9314;3398;4602;2146;90865;1789;144455;79733;29128;7025;7067;8863;5187;9099;9839;25959;138151;93986;3400;122953;2354;4784;1390;5178;221895;93166;23492;23466;84733;9079,PER1;KLF2;FOSB;NR4A3;TCF21;ZBTB16;NR4A2;ZFP36;SOX10;PDE2A;CBX2;EDNRB;HIC1;IL33;CBX7;PEG3;FOXM1;CRY2;CRYM;LDB2;MEF2C;KLF4;PER2;SRF;GATA6;NACC2;UHRF1;PRDM6;CAV1;PLK1;ZEB2;CREM;USP2;E2F7;NR2F1;NFIX;APBB1;ATF3;KANK2;AURKB;JDP2;ZEB1;PER3;E2F1;EZH2;JAZF1;THRA;ID4;DNMT3B;ID2;HDAC4;NFIB;NFATC4;MITF;ARID5A;POU6F1;ESR1;FOXP2;PRDM16;E2F8;MYB;MYC;ZFPM2;CBX6;DKK1;SNCA
GO:0055117,regulation of cardiac muscle contraction (GO:0055117),36,8,2.482505605,3.222550629,0.002653548,0.074803909,5144;5142;287;5350;6781;6262;6546;5997,RGS2;ANK2;PDE4B;PLN;PDE4D;RYR2;SLC8A1;STC1
GO:0051781,positive regulation of cell division (GO:0051781),44,9,3.034173517,2.966211375,0.002688013,0.074803909,6840;1894;9928;11113;9212;29127;9493;990;6886,KIF14;CDC6;KIF23;CIT;AURKB;ECT2;RACGAP1;SVIL;TAL1
GO:0090307,mitotic spindle assembly (GO:0090307),44,9,3.034173517,2.966211375,0.002688013,0.074803909,2316;22974;9212;24137;29127;9493;3832;3833;9055,KIF4A;TPX2;KIF11;KIF23;KIFC1;FLNA;PRC1;AURKB;RACGAP1
GO:0022008,neurogenesis (GO:0022008),44,9,3.034173517,2.966211375,0.002688013,0.074803909,1902;11113;51804;8642;6495;7472;79633;79094;284403,CIT;LPAR1;WDR62;SIX4;WNT2;DCHS1;SIX1;FAT4;CHAC1
GO:0010811,positive regulation of cell-substrate adhesion (GO:0010811),70,12,4.827094232,2.485967628,0.002789444,0.07655803,2316;5881;6366;10979;79625;6422;6376;55679;91663;10562;285613;2199,SFRP1;LIMS2;MYADM;FLNA;RAC3;CX3CL1;FERMT2;FBLN2;NDNF;RELL2;CCL21;OLFM4
GO:1901215,negative regulation of neuron death (GO:1901215),98,15,6.757931925,2.219613954,0.00282316,0.07655803,6622;4915;627;9928;51804;79625;947;596;4208;6495;10891;4776;120892;6347;4345,CD34;KIF14;LRRK2;MEF2C;PPARGC1A;BCL2;BDNF;CCL2;NDNF;SIX4;CD200;NFATC4;SIX1;NTRK2;SNCA
GO:0051480,regulation of cytosolic calcium ion concentration (GO:0051480),148,20,10.20585638,1.959659167,0.002893174,0.07655803,111;1909;1902;857;5737;5733;5734;185;624;775;5350;493;6262;6546;7220;477;5156;2099;6869;623,ATP1A2;ADCY5;AGTR1;PTGFR;PLN;BDKRB2;TACR1;BDKRB1;CAV1;LPAR1;EDNRA;TRPC1;ATP2B4;PTGER3;ESR1;RYR2;PDGFRA;SLC8A1;PTGER4;CACNA1C
GO:0043569,negative regulation of insulin-like growth factor receptor signaling pathway (GO:0043569),5,3,0.344792445,8.7008867,0.00294209,0.07655803,653;3488;8483,BMP5;CILP;IGFBP5
GO:1904995,negative regulation of leukocyte adhesion to vascular endothelial cell (GO:1904995),5,3,0.344792445,8.7008867,0.00294209,0.07655803,6366;6387;9314,KLF4;CXCL12;CCL21
GO:0035701,hematopoietic stem cell migration (GO:0035701),5,3,0.344792445,8.7008867,0.00294209,0.07655803,2621;83700;58494,JAM2;GAS6;JAM3
GO:0045578,negative regulation of B cell differentiation (GO:0045578),5,3,0.344792445,8.7008867,0.00294209,0.07655803,3624;6422;3398,SFRP1;INHBA;ID2
GO:0070120,ciliary neurotrophic factor-mediated signaling pathway (GO:0070120),5,3,0.344792445,8.7008867,0.00294209,0.07655803,3570;3572;3977,IL6ST;LIFR;IL6R
GO:0071504,cellular response to heparin (GO:0071504),5,3,0.344792445,8.7008867,0.00294209,0.07655803,9353;6422;1958,SFRP1;EGR1;SLIT2
GO:1901228,positive regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901228),5,3,0.344792445,8.7008867,0.00294209,0.07655803,6722;140628;93649,MYOCD;GATA5;SRF
GO:2000267,"negative regulation of blood coagulation, intrinsic pathway (GO:2000267)",5,3,0.344792445,8.7008867,0.00294209,0.07655803,2;2157;2161,A2M;F8;F12
GO:2000266,"regulation of blood coagulation, intrinsic pathway (GO:2000266)",5,3,0.344792445,8.7008867,0.00294209,0.07655803,2;2157;2161,A2M;F8;F12
GO:1904904,regulation of endothelial cell-matrix adhesion via fibronectin (GO:1904904),5,3,0.344792445,8.7008867,0.00294209,0.07655803,4680;4321;6237,CEACAM6;RRAS;MMP12
GO:0060707,trophoblast giant cell differentiation (GO:0060707),5,3,0.344792445,8.7008867,0.00294209,0.07655803,10733;144455;79733,E2F7;PLK4;E2F8
GO:1905150,regulation of voltage-gated sodium channel activity (GO:1905150),5,3,0.344792445,8.7008867,0.00294209,0.07655803,2258;2256;7871,FGF13;SLMAP;FGF11
GO:0040001,establishment of mitotic spindle localization (GO:0040001),29,7,1.999796182,3.500356718,0.00295787,0.076636873,4085;5347;9700;10403;1058;51203;89958,SAPCD2;CENPA;PLK1;NDC80;NUSAP1;MAD2L1;ESPL1
GO:2001257,regulation of cation channel activity (GO:2001257),89,14,6.137305523,2.281131344,0.002975375,0.076759569,1756;5144;1740;783;785;4208;287;5649;57158;3755;2258;23542;2256;7871,ANK2;RELN;MEF2C;DLG2;FGF13;JPH2;PDE4D;DMD;CACNB2;KCNG1;SLMAP;CACNB4;MAPK8IP2;FGF11
GO:0001558,regulation of cell growth (GO:0001558),212,26,14.61919967,1.77848313,0.003024929,0.077545912,5167;11170;9472;9928;3624;185;26153;596;9353;6586;322;4881;64321;6422;4487;3373;7037;10235;8425;2273;64061;84722;147906;58189;85004;8643,FAM107A;SOX17;FHL1;AGTR1;SLIT3;WFDC1;SFRP1;NPR1;RASGRP2;KIF14;INHBA;KIF26A;HYAL1;RERG;LTBP4;DACT3;SLIT2;APBB1;BCL2;TSPYL2;MSX1;AKAP6;TFRC;PSRC1;ENPP1;PTCH2
GO:0030031,cell projection assembly (GO:0030031),22,6,1.517086759,3.9549485,0.003031657,0.077545912,2934;55742;399;5881;3071;57381,RHOJ;GSN;RAC3;NCKAP1L;PARVA;RHOH
GO:0051495,positive regulation of cytoskeleton organization (GO:0051495),80,13,5.516679122,2.356490148,0.003091436,0.078739928,1073;10435;25802;6366;3071;10763;6376;10733;274;1440;10615;11346;171024,SYNPO2;LMOD1;CDC42EP2;SPAG5;BIN1;CSF3;CFL2;SYNPO;NES;CX3CL1;PLK4;NCKAP1L;CCL21
GO:2000045,regulation of G1/S transition of mitotic cell cycle (GO:2000045),71,12,4.896052721,2.450954,0.003151057,0.079584041,11170;9928;3373;1869;6347;9314;3398;144455;25959;9510;2273;894,FAM107A;FHL1;ADAMTS1;KIF14;KLF4;HYAL1;E2F7;KANK2;CCND2;CCL2;E2F1;ID2
GO:0043524,negative regulation of neuron apoptotic process (GO:0043524),71,12,4.896052721,2.450954,0.003151057,0.079584041,4915;627;9928;51804;79625;596;4208;6495;10891;4776;6376;6347,KIF14;MEF2C;PPARGC1A;CX3CL1;BCL2;BDNF;CCL2;NDNF;SIX4;NFATC4;SIX1;NTRK2
GO:0032467,positive regulation of cytokinesis (GO:0032467),37,8,2.551464094,3.135454666,0.003184617,0.079761397,6840;1894;9928;11113;9212;29127;9493;990,KIF14;CDC6;KIF23;CIT;AURKB;ECT2;RACGAP1;SVIL
GO:0001755,neural crest cell migration (GO:0001755),37,8,2.551464094,3.135454666,0.003184617,0.079761397,309;6663;54437;55698;9723;7869;56920;5308,SOX10;SEMA5B;SEMA3G;ANXA6;SEMA3E;SEMA3B;RADIL;PITX2
GO:0006261,DNA-dependent DNA replication (GO:0006261),129,18,8.895645085,2.023462023,0.003233832,0.080657955,4171;81620;1763;8317;990;9401;5427;641;4173;55388;23594;4998;8318;5888;11169;51659;9837;84296,RECQL4;GINS1;ORC1;MCM2;DNA2;BLM;CDC6;CDC45;CDC7;WDHD1;MCM10;RAD51;ORC6;CDT1;MCM4;GINS4;POLE2;GINS2
GO:1903236,regulation of leukocyte tethering or rolling (GO:1903236),10,4,0.68958489,5.800591133,0.003371153,0.083049183,6366;6401;6387;6403,CXCL12;SELP;SELE;CCL21
GO:0002686,negative regulation of leukocyte migration (GO:0002686),10,4,0.68958489,5.800591133,0.003371153,0.083049183,9353;11117;653;4345,BMP5;SLIT2;EMILIN1;CD200
GO:1902969,mitotic DNA replication (GO:1902969),10,4,0.68958489,5.800591133,0.003371153,0.083049183,4171;4173;8318;9837,GINS1;MCM2;CDC45;MCM4
GO:0007160,cell-matrix adhesion (GO:0007160),100,15,6.895848903,2.175221675,0.003443338,0.084481248,10395;6366;3690;10580;10979;947;56999;11117;3897;8516;10516;10894;3679;81792;8910,LYVE1;ITGA8;SORBS1;CD34;FBLN5;FERMT2;L1CAM;ITGA7;EMILIN1;DLC1;CCL21;ITGB3;SGCE;ADAMTS9;ADAMTS12
GO:0051897,positive regulation of protein kinase B signaling (GO:0051897),161,21,11.10231673,1.891497109,0.003541356,0.085555311,3815;2252;6366;1116;284;2621;10979;2247;5156;6376;3082;1839;2260;1440;558;2099;9365;374;2159;9542;388121,F10;NRG2;TNFAIP8L3;FGF2;GAS6;FGF7;CSF3;CX3CL1;FERMT2;AXL;FGFR1;HGF;KIT;HBEGF;CCL21;ESR1;KL;CHI3L1;PDGFRA;ANGPT1;AREG
GO:0086009,membrane repolarization (GO:0086009),16,5,1.103335824,4.531711823,0.003551073,0.085555311,23704;3757;3752;477;482,ATP1A2;ATP1B2;KCNH2;KCND3;KCNE4
GO:0014003,oligodendrocyte development (GO:0014003),16,5,1.103335824,4.531711823,0.003551073,0.085555311,6663;5354;11076;56978;118738,PLP1;TPPP;SOX10;PRDM8;ZNF488
GO:0006268,DNA unwinding involved in DNA replication (GO:0006268),16,5,1.103335824,4.531711823,0.003551073,0.085555311,4171;9401;641;4173;5888,RECQL4;MCM2;BLM;RAD51;MCM4
GO:0044843,cell cycle G1/S phase transition (GO:0044843),63,11,4.344384809,2.532004066,0.003558281,0.085555311,3624;4609;993;8317;1033;1869;890;9134;898;1978;1104,CCNE1;INHBA;CDC7;CCNE2;CDC25A;CCNA2;RCC1;E2F1;CDKN3;EIF4EBP1;MYC
GO:0010605,negative regulation of macromolecule metabolic process (GO:0010605),193,24,13.30898838,1.80329258,0.003583004,0.085806512,3479;9464;6790;947;4208;140628;11117;7122;10439;2247;493;57419;6422;5563;91663;2099;9314;8483;3398;27303;5241;90993;84913;83643,CLDN5;PGR;GATA5;AURKA;SLC24A3;SFRP1;CD34;FGF2;MEF2C;KLF4;MYADM;OLFM1;RBMS3;HAND2;CCDC3;ATOH8;EMILIN1;CILP;IGF1;ID2;CREB3L1;ATP2B4;ESR1;PRKAA2
GO:0030890,positive regulation of B cell proliferation (GO:0030890),30,7,2.068754671,3.383678161,0.00363229,0.086299194,3071;596;4208;2048;1880;7037;683,MEF2C;GPR183;BCL2;NCKAP1L;TFRC;EPHB2;BST1
GO:0030030,cell projection organization (GO:0030030),30,7,2.068754671,3.383678161,0.00363229,0.086299194,2934;55742;399;5881;3071;57381;482,RHOJ;ATP1B2;GSN;RAC3;NCKAP1L;PARVA;RHOH
GO:0051966,"regulation of synaptic transmission, glutamatergic (GO:0051966)",46,9,3.172090495,2.837245663,0.003691443,0.087359309,9378;4208;5649;120892;477;23542;6347;2899;57616,ATP1A2;RELN;LRRK2;MEF2C;GRIK3;NRXN1;CCL2;MAPK8IP2;TSHZ3
GO:0033275,actin-myosin filament sliding (GO:0033275),38,8,2.620422583,3.052942702,0.003794679,0.088754155,7169;7168;58;7111;70;1674;7139;1756,DES;TMOD1;ACTC1;TPM2;DMD;TPM1;ACTA1;TNNT2
GO:0030049,muscle filament sliding (GO:0030049),38,8,2.620422583,3.052942702,0.003794679,0.088754155,7169;7168;58;7111;70;1674;7139;1756,DES;TMOD1;ACTC1;TPM2;DMD;TPM1;ACTA1;TNNT2
GO:0003281,ventricular septum development (GO:0003281),38,8,2.620422583,3.052942702,0.003794679,0.088754155,7048;5138;9353;6586;6659;7049;6910;23414,SLIT3;PDE2A;TGFBR2;TGFBR3;SOX4;SLIT2;ZFPM2;TBX5
GO:1904018,positive regulation of vasculature development (GO:1904018),102,15,7.033765881,2.132570269,0.004171041,0.09717878,388;1116;358;947;5579;8742;5740;2247;10411;2627;3373;672;64094;6237;126393,HSPB6;AQP1;PRKCB;CD34;FGF2;GATA6;BRCA1;HYAL1;RHOB;SMOC2;PTGIS;RAPGEF3;TNFSF12;RRAS;CHI3L1
GO:0060429,epithelium development (GO:0060429),122,17,8.412935661,2.020697731,0.004205009,0.097591918,6663;983;947;1066;3853;4223;64321;6495;6943;6910;7472;2627;8914;6491;6876;25959;4222,TCF21;SOX17;MEOX1;SOX10;CD34;TIMELESS;STIL;GATA6;TAGLN;CDK1;KANK2;WNT2;MEOX2;CES1;SIX1;TBX5;KRT6A
GO:0043410,positive regulation of MAPK cascade (GO:0043410),273,31,18.8256675,1.646687959,0.004228421,0.097757847,3815;154;6366;1116;4915;1902;3479;150;284;2621;3569;10979;9464;1880;2247;120892;5156;6376;6347;5590;2260;146433;57161;2146;5320;4920;4919;388121;80310;152007;148252,IL6;TNFAIP8L3;FGF2;LRRK2;IL34;GAS6;HAND2;PLA2G2A;GPR183;CX3CL1;FERMT2;LPAR1;CCL2;ROR1;EZH2;FGFR1;ADRA2A;PDGFD;IGF1;KIT;CCL21;DIRAS1;PELI2;ADRB2;NTRK2;GLIPR2;CHI3L1;PDGFRA;ROR2;PRKCZ;ANGPT1
GO:0051963,regulation of synapse assembly (GO:0051963),47,9,3.241048984,2.776878734,0.004292375,0.098856197,6622;627;10082;9378;4208;2048;145581;94030;5789,MEF2C;NRXN1;LRFN5;BDNF;PTPRD;EPHB2;LRRC4B;SNCA;GPC6
GO:0009967,positive regulation of signal transduction (GO:0009967),251,29,17.30858075,1.67546955,0.004341196,0.099598966,2316;627;3479;2621;3690;10580;3569;9378;5579;5740;59352;5649;66000;10365;120892;6422;6517;3678;55679;718;5590;3572;558;85480;64094;4330;55885;84870;55789,KLF2;IL6;SLC2A4;PRKCB;SFRP1;SORBS1;RELN;LMO3;RSPO3;LRRK2;NRXN1;LIMS2;GAS6;TSLP;SMOC2;IL6ST;FLNA;DEPDC1B;PTGIS;BDNF;AXL;C3;IGF1;ITGA5;MN1;LGR6;TMEM108;ITGB3;PRKCZ
GO:1901655,cellular response to ketone (GO:1901655),39,8,2.689381072,2.974662119,0.004491203,0.102259928,111;108;5737;5734;358;6696;6422;687,KLF9;ADCY5;AQP1;PTGFR;SFRP1;SPP1;PTGER4;ADCY2
GO:0007096,regulation of exit from mitosis (GO:0007096),39,8,2.689381072,2.974662119,0.004491203,0.102259928,11065;991;701;4085;4751;9735;54443;113130,KNTC1;CDCA5;UBE2C;NEK2;CDC20;BUB1B;ANLN;MAD2L1
GO:0006977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",56,10,3.861675386,2.589549613,0.00452348,0.102606183,983;6790;891;6659;1869;995;7832;144455;79733;51512,AURKA;SOX4;CDC25C;GTSE1;CCNB1;E2F7;CDK1;E2F1;BTG2;E2F8
GO:0006954,inflammatory response (GO:0006954),230,27,15.86045248,1.702347398,0.004672458,0.105587012,3815;6366;1116;6401;3569;11343;5737;5733;5734;80274;2350;8639;185;2920;114548;624;8605;9759;4776;3373;6376;6347;2353;1036;12;6869;5806,IL6;AOC3;MGLL;AGTR1;PTGFR;PLA2G4C;FOS;CDO1;BDKRB2;TACR1;HYAL1;SERPINA3;PTX3;CX3CL1;FOLR2;CCL2;CXCL2;SELE;HDAC4;KIT;SCUBE1;NFATC4;NLRP3;CCL21;PTGER3;CHI3L1;PTGER4
GO:0007188,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),165,21,11.37815069,1.845642633,0.00473015,0.105680145,1901;9630;111;196883;154;108;1902;150;2774;5737;5745;10267;5733;5734;165140;9590;5138;7434;2781;2775;2869,ADCY5;VIPR2;OXER1;PDE2A;PTH1R;PTGFR;RAMP1;GNAL;ADCY4;S1PR1;GNAO1;LPAR1;AKAP12;GRK5;ADRA2A;GNA14;GNAZ;PTGER3;ADRB2;PTGER4;ADCY2
GO:0071459,"protein localization to chromosome, centromeric region (GO:0071459)",17,5,1.172294313,4.265140539,0.004748573,0.105680145,983;9212;1058;7272;27085,TTK;CENPA;CDK1;AURKB;MTBP
GO:0071870,cellular response to catecholamine stimulus (GO:0071870),24,6,1.655003737,3.625369458,0.004858486,0.105680145,6622;5142;493;6262;120892;8013,NR4A3;PDE4B;LRRK2;ATP2B4;RYR2;SNCA
GO:0010518,positive regulation of phospholipase activity (GO:0010518),24,6,1.655003737,3.625369458,0.004858486,0.105680145,3815;185;2247;5156;2260;2099,AGTR1;FGF2;FGFR1;KIT;ESR1;PDGFRA
GO:0010611,regulation of cardiac muscle hypertrophy (GO:0010611),24,6,1.655003737,3.625369458,0.004858486,0.105680145,3479;9464;29995;8013;3572;5997,NR4A3;RGS2;HAND2;IL6ST;IGF1;LMCD1
GO:0030097,hemopoiesis (GO:0030097),94,14,6.482097969,2.159794571,0.004938419,0.105680145,3815;7048;3624;947;7704;9833;7049;6422;7482;9760;8076;6886;6237;219790,ZBTB16;SFRP1;TGFBR2;CD34;TGFBR3;INHBA;MELK;WNT2B;MFAP5;KIT;RRAS;TOX;RTKN2;TAL1
GO:0043549,regulation of kinase activity (GO:0043549),94,14,6.482097969,2.159794571,0.004938419,0.105680145,3815;1894;4915;2048;2045;2042;5156;2260;558;4920;4919;64061;1028;9079,LDB2;EPHA3;EPHA7;ECT2;TSPYL2;AXL;ROR1;FGFR1;KIT;CDKN1C;NTRK2;PDGFRA;EPHB2;ROR2
GO:0002576,platelet degranulation (GO:0002576),124,17,8.550852639,1.988105832,0.00497092,0.105680145,2316;3479;2621;3690;1191;6403;3082;2;6812;2162;7123;22927;1675;2157;12;22915;5099,CFD;CLEC3B;A2M;MMRN1;CLU;GAS6;F13A1;SERPINA3;FLNA;SELP;IGF1;HGF;F8;HABP4;ITGB3;PCDH7;STXBP1
GO:0034695,response to prostaglandin E (GO:0034695),11,4,0.758543379,5.273264666,0.005010621,0.105680145,6366;5734;7049;6422,SFRP1;TGFBR3;CCL21;PTGER4
GO:1901380,negative regulation of potassium ion transmembrane transport (GO:1901380),11,4,0.758543379,5.273264666,0.005010621,0.105680145,3757;857;845;274,CASQ2;BIN1;CAV1;KCNH2
GO:0042310,vasoconstriction (GO:0042310),11,4,0.758543379,5.273264666,0.005010621,0.105680145,1909;1910;6546;59,EDNRB;ACTA2;EDNRA;SLC8A1
GO:0051900,regulation of mitochondrial depolarization (GO:0051900),11,4,0.758543379,5.273264666,0.005010621,0.105680145,596;2537;120892;1634,LRRK2;DCN;BCL2;IFI6
GO:0090128,regulation of synapse maturation (GO:0090128),11,4,0.758543379,5.273264666,0.005010621,0.105680145,22899;991;9378;5649,RELN;NRXN1;CDC20;ARHGEF15
GO:2000668,regulation of dendritic cell apoptotic process (GO:2000668),11,4,0.758543379,5.273264666,0.005010621,0.105680145,6366;2621;6387;558,CXCL12;GAS6;AXL;CCL21
GO:1903170,negative regulation of calcium ion transmembrane transport (GO:1903170),11,4,0.758543379,5.273264666,0.005010621,0.105680145,150;5350;477;274,ATP1A2;PLN;BIN1;ADRA2A
GO:2000105,positive regulation of DNA-dependent DNA replication (GO:2000105),11,4,0.758543379,5.273264666,0.005010621,0.105680145,81620;8317;144455;79733,CDC7;E2F7;CDT1;E2F8
GO:1903671,negative regulation of sprouting angiogenesis (GO:1903671),11,4,0.758543379,5.273264666,0.005010621,0.105680145,56999;10365;1870;90993,KLF2;CREB3L1;E2F2;ADAMTS9
GO:2000725,regulation of cardiac muscle cell differentiation (GO:2000725),11,4,0.758543379,5.273264666,0.005010621,0.105680145,4208;8324;93649;22943,MYOCD;MEF2C;FZD7;DKK1
GO:0048048,embryonic eye morphogenesis (GO:0048048),11,4,0.758543379,5.273264666,0.005010621,0.105680145,2201;2202;8076;4237,MFAP5;EFEMP1;FBN2;MFAP2
GO:0010628,positive regulation of gene expression (GO:0010628),476,48,32.82424078,1.462333899,0.005093617,0.107054997,221662;2934;2252;58;70;4915;3479;150;284;2621;3624;3569;5734;5138;9464;947;4208;140628;11117;7122;1191;4609;2053;287;6659;10439;2048;2247;10891;57419;1869;22943;55022;4286;7037;672;1958;29923;9314;22927;3398;90865;27303;1789;59;8736;72;23034,CLDN5;IL6;RBM24;ACTG2;ANK2;GATA5;PDE2A;SLC24A3;MYOM1;IL33;CD34;EGR1;FGF2;SOX4;MEF2C;KLF4;ACTC1;GSN;ACTA2;CLU;INHBA;GAS6;FGF7;PID1;BRCA1;OLFM1;PPARGC1A;RBMS3;HAND2;SAMD4A;EPHX2;E2F1;EMILIN1;ADRA2A;IGF1;DNMT3B;ACTA1;ID2;HABP4;MITF;HILPDA;TFRC;NTRK2;PTGER4;EPHB2;MYC;ANGPT1;DKK1
GO:0030500,regulation of bone mineralization (GO:0030500),57,10,3.930633875,2.544118918,0.005155019,0.107593131,5167;1901;166929;4208;6546;2201;2824;9636;9365;91461,MEF2C;S1PR1;PKDCC;ISG15;GPM6B;FBN2;KL;SLC8A1;SGMS2;ENPP1
GO:1901890,positive regulation of cell junction assembly (GO:1901890),57,10,3.930633875,2.544118918,0.005155019,0.107593131,627;857;10979;9378;7122;2048;6910;6422;94030;5789,CLDN5;SFRP1;NRXN1;CAV1;FERMT2;BDNF;PTPRD;EPHB2;LRRC4B;TBX5
GO:2000649,regulation of sodium ion transmembrane transporter activity (GO:2000649),40,8,2.758339561,2.900295567,0.00528186,0.109229205,1756;6330;6324;2258;5348;2256;7871;53826,FXYD1;FXYD6;FGF13;SCN4B;DMD;SLMAP;SCN1B;FGF11
GO:0045778,positive regulation of ossification (GO:0045778),40,8,2.758339561,2.900295567,0.00528186,0.109229205,4208;7704;6546;2201;2824;9636;9365;91461,ZBTB16;MEF2C;PKDCC;ISG15;GPM6B;FBN2;KL;SLC8A1
GO:0071363,cellular response to growth factor stimulus (GO:0071363),156,20,10.75752429,1.859163825,0.005298386,0.109229205,7538;4915;7048;5138;79625;4208;1960;3164;4093;55273;6422;7472;3373;3082;81792;6347;9314;7123;8483;9863,CLEC3B;NR4A1;ZFP36;PDE2A;EGR3;SFRP1;TGFBR2;MEF2C;KLF4;TMEM100;HYAL1;CCL2;NDNF;MAGI2;CILP;SMAD9;HGF;WNT2;NTRK2;ADAMTS12
GO:0048662,negative regulation of smooth muscle cell proliferation (GO:0048662),32,7,2.206671649,3.172198276,0.005324265,0.109229205,7168;4208;347;3488;5592;4969;1264,CNN1;OGN;MEF2C;TPM1;PRKG1;APOD;IGFBP5
GO:0070839,metal ion export (GO:0070839),32,7,2.206671649,3.172198276,0.005324265,0.109229205,23704;3757;8671;493;3752;477;482,ATP1A2;ATP1B2;KCNH2;KCND3;SLC4A4;ATP2B4;KCNE4
GO:0031325,positive regulation of cellular metabolic process (GO:0031325),105,15,7.240641348,2.07163969,0.005493302,0.109668856,32;6622;6401;284;7048;3624;341;983;891;185;11149;55022;9314;9863;29128,AGTR1;TGFBR2;KLF4;INHBA;UHRF1;PID1;CCNB1;ACACB;CDK1;BVES;MAGI2;SELE;APOC1;ANGPT1;SNCA
GO:0007346,regulation of mitotic cell cycle (GO:0007346),178,22,12.27461105,1.792317485,0.005536606,0.109668856,79866;11065;991;701;983;4085;5347;891;1978;1104;995;9088;4751;9787;7832;6886;9099;64094;1028;1164;1163;4288,UBE2C;NEK2;BORA;CDC20;CDC25C;PLK1;BUB1B;USP2;CCNB1;CDK1;SMOC2;CKS2;MKI67;DLGAP5;PKMYT1;CKS1B;RCC1;MAD2L1;CDKN1C;EIF4EBP1;BTG2;TAL1
GO:0031032,actomyosin structure organization (GO:0031032),76,12,5.240845166,2.289707026,0.005568702,0.109668856,7168;25802;7111;70;7139;1465;10580;11113;257019;9172;51804;5239,PGM5;LMOD1;TMOD1;MYOM2;SORBS1;ACTC1;CSRP1;CIT;FRMD3;TPM1;SIX4;TNNT2
GO:0051302,regulation of cell division (GO:0051302),76,12,5.240845166,2.289707026,0.005568702,0.109668856,6790;9212;5347;4609;10733;641;23594;90293;10112;6886;146909;9055,AURKA;KIF18B;BLM;KIF20A;PLK1;ORC6;PRC1;AURKB;PLK4;KLHL13;MYC;TAL1
GO:0002692,negative regulation of cellular extravasation (GO:0002692),6,3,0.413750934,7.250738916,0.005582876,0.109668856,6366;5734;6387,CXCL12;CCL21;PTGER4
GO:1901897,regulation of relaxation of cardiac muscle (GO:1901897),6,3,0.413750934,7.250738916,0.005582876,0.109668856,5144;5142;5350,PDE4B;PLN;PDE4D
GO:2000169,regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),6,3,0.413750934,7.250738916,0.005582876,0.109668856,1756;493;6640,DMD;ATP2B4;SNTA1
GO:0110110,positive regulation of animal organ morphogenesis (GO:0110110),6,3,0.413750934,7.250738916,0.005582876,0.109668856,51804;947;6495,CD34;SIX4;SIX1
GO:0032494,response to peptidoglycan (GO:0032494),6,3,0.413750934,7.250738916,0.005582876,0.109668856,3569;11213;3663,IL6;IRAK3;IRF5
GO:0032466,negative regulation of cytokinesis (GO:0032466),6,3,0.413750934,7.250738916,0.005582876,0.109668856,9212;144455;79733,E2F7;AURKB;E2F8
GO:0003211,cardiac ventricle formation (GO:0003211),6,3,0.413750934,7.250738916,0.005582876,0.109668856,4208;6659;6910,SOX4;MEF2C;TBX5
GO:1902949,positive regulation of tau-protein kinase activity (GO:1902949),6,3,0.413750934,7.250738916,0.005582876,0.109668856,1191;22943;1958,EGR1;CLU;DKK1
GO:0061469,regulation of type B pancreatic cell proliferation (GO:0061469),6,3,0.413750934,7.250738916,0.005582876,0.109668856,3164;8013;26471,NR4A1;NR4A3;NUPR1
GO:0045926,negative regulation of growth (GO:0045926),126,17,8.688769618,1.956548596,0.005847194,0.114486908,5167;3624;9353;6586;322;4881;64321;6422;4487;3373;4499;2273;64061;84722;147906;58189;85004,SOX17;FHL1;SLIT3;WFDC1;SFRP1;NPR1;MT1M;INHBA;HYAL1;RERG;DACT3;SLIT2;APBB1;TSPYL2;MSX1;PSRC1;ENPP1
GO:0051347,positive regulation of transferase activity (GO:0051347),147,19,10.13689789,1.874340672,0.005928709,0.115706063,3815;4915;9212;5347;4609;2048;2045;2042;5156;225689;4751;2260;558;9314;4920;4919;4345;79075;25849,KLF4;EPHA3;NEK2;EPHA7;PLK1;AURKB;AXL;ROR1;PARM1;FGFR1;CD200;KIT;MAPK15;NTRK2;DSCC1;PDGFRA;EPHB2;ROR2;MYC
GO:0010629,negative regulation of gene expression (GO:0010629),314,34,21.65296555,1.570223714,0.005951282,0.115731893,7538;3479;5734;9464;6790;947;4208;140628;11117;7122;10439;2247;493;57419;23208;6422;5563;91663;7298;3488;7832;2099;9314;8483;3398;3070;2146;27303;1789;5241;90993;84913;23034;83643,CLDN5;ZFP36;PGR;GATA5;AURKA;SLC24A3;SFRP1;CD34;FGF2;MEF2C;KLF4;MYADM;OLFM1;RBMS3;HAND2;CCDC3;SAMD4A;ATOH8;EMILIN1;CILP;EZH2;IGF1;DNMT3B;ID2;CREB3L1;TYMS;ATP2B4;ESR1;BTG2;HELLS;PTGER4;SYT11;PRKAA2;IGFBP5
GO:0071902,positive regulation of protein serine/threonine kinase activity (GO:0071902),106,15,7.309599837,2.05209592,0.006002618,0.115731893,3815;154;6622;150;10979;2247;493;120892;2260;146433;2146;84722;894;80310;148252,FGF2;LRRK2;IL34;CCND2;FERMT2;EZH2;FGFR1;ADRA2A;PDGFD;KIT;ATP2B4;DIRAS1;ADRB2;PSRC1;SNCA
GO:0015980,energy derivation by oxidation of organic compounds (GO:0015980),25,6,1.723962226,3.48035468,0.006026299,0.115731893,84701;4609;10891;3953;55022;8013,NR4A3;PID1;PPARGC1A;COX4I2;LEPR;MYC
GO:0003229,ventricular cardiac muscle tissue development (GO:0003229),25,6,1.723962226,3.48035468,0.006026299,0.115731893,7168;7139;56999;7049;6910;3398,TGFBR3;TPM1;ID2;TNNT2;ADAMTS9;TBX5
GO:0007422,peripheral nervous system development (GO:0007422),25,6,1.723962226,3.48035468,0.006026299,0.115731893,627;6663;5376;2676;1959;23114,SOX10;GFRA3;PMP22;BDNF;NFASC;EGR2
GO:0002042,cell migration involved in sprouting angiogenesis (GO:0002042),18,5,1.241252803,4.028188287,0.006206956,0.116593797,6722;9353;1960;2247;3164,NR4A1;EGR3;FGF2;SRF;SLIT2
GO:1904063,negative regulation of cation transmembrane transport (GO:1904063),18,5,1.241252803,4.028188287,0.006206956,0.116593797,3757;857;8501;477;274,ATP1A2;BIN1;CAV1;KCNH2;SLC43A1
GO:0010613,positive regulation of cardiac muscle hypertrophy (GO:0010613),18,5,1.241252803,4.028188287,0.006206956,0.116593797,9472;3479;9464;8013;3572,NR4A3;HAND2;IL6ST;AKAP6;IGF1
GO:0086005,ventricular cardiac muscle cell action potential (GO:0086005),18,5,1.241252803,4.028188287,0.006206956,0.116593797,23704;3757;287;6262;6640,ANK2;KCNH2;RYR2;KCNE4;SNTA1
GO:1905606,regulation of presynapse assembly (GO:1905606),18,5,1.241252803,4.028188287,0.006206956,0.116593797,6622;10082;145581;94030;5789,LRFN5;PTPRD;LRRC4B;SNCA;GPC6
GO:0099174,regulation of presynapse organization (GO:0099174),18,5,1.241252803,4.028188287,0.006206956,0.116593797,6622;10082;145581;94030;5789,LRFN5;PTPRD;LRRC4B;SNCA;GPC6
GO:1905562,regulation of vascular endothelial cell proliferation (GO:1905562),18,5,1.241252803,4.028188287,0.006206956,0.116593797,4208;2247;10000;6347;2260,FGF2;MEF2C;CCL2;FGFR1;AKT3
GO:0070372,regulation of ERK1 and ERK2 cascade (GO:0070372),235,27,16.20524492,1.66612724,0.00622835,0.116631186,6366;1116;4915;284;2621;10979;9464;11117;2048;2045;1880;2247;7049;10252;5156;6376;6347;5590;5320;4920;4919;6237;388121;2192;55885;80310;152007,SPRY1;TNFAIP8L3;LMO3;FGF2;TGFBR3;GAS6;EPHA7;HAND2;PLA2G2A;GPR183;CX3CL1;FERMT2;CCL2;ROR1;EMILIN1;PDGFD;CCL21;FBLN1;RRAS;NTRK2;GLIPR2;CHI3L1;PDGFRA;EPHB2;ROR2;PRKCZ;ANGPT1
GO:1903580,positive regulation of ATP metabolic process (GO:1903580),33,7,2.275630138,3.076071055,0.006363729,0.118796194,3479;8671;10891;5563;55022;5210;26471,PFKFB4;PID1;PPARGC1A;SLC4A4;IGF1;PRKAA2;NUPR1
GO:0001764,neuron migration (GO:0001764),50,9,3.447924451,2.61026601,0.006560139,0.121706784,4915;79625;4208;4131;4897;5649;4929;2258;2260,NR4A2;RELN;MEF2C;FGF13;NDNF;FGFR1;MAP1B;NRCAM;NTRK2
GO:0008154,actin polymerization or depolymerization (GO:0008154),50,9,3.447924451,2.61026601,0.006560139,0.121706784,2934;11170;6840;1073;11034;23242;81624;8522;395,FAM107A;ARHGAP6;GSN;GAS7;CFL2;DSTN;SVIL;DIAPH3;COBL
GO:0044773,mitotic DNA damage checkpoint signaling (GO:0044773),59,10,4.068550853,2.457877599,0.00662374,0.122508614,63967;983;5347;1111;672;29980;641;51514;2177;146956,CLSPN;EME1;DTL;BLM;BRCA1;PLK1;CDK1;CHEK1;DONSON;FANCD2
GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),170,21,11.72294313,1.791359026,0.006662881,0.122854526,6401;7048;57863;8642;10082;4359;140628;5010;7122;3897;152330;57549;91624;23022;6403;145581;79633;94030;5789;4680;1048,CLDN5;GATA5;CADM3;TGFBR2;LRFN5;NEXN;PALLD;MPZ;SELP;L1CAM;CNTN4;SELE;CLDN11;CEACAM6;CEACAM5;DCHS1;PTPRD;FAT4;IGSF9;LRRC4B;GPC6
GO:0051240,positive regulation of multicellular organismal process (GO:0051240),341,36,23.51484476,1.530947806,0.007065263,0.127260168,154;2690;150;7048;2621;3624;3625;51804;3569;6319;2167;857;5734;10979;140628;7704;10439;4881;8864;2247;6495;63976;10891;6910;3953;7037;29923;2146;90865;25937;7067;4237;133522;7041;152007;2118,IL6;ZBTB16;GATA5;IL33;TGFBR2;NPR1;FGF2;PER2;INHBA;GAS6;CAV1;OLFM1;PPARGC1A;GHR;FERMT2;SCD;WWTR1;TGFB1I1;EZH2;LEPR;SIX4;ADRA2A;THRA;ETV4;INHBB;HILPDA;FABP4;ADRB2;SIX1;TFRC;PPARGC1B;GLIPR2;PRDM16;PTGER4;TBX5;MFAP2
GO:0030318,melanocyte differentiation (GO:0030318),12,4,0.827501868,4.833825944,0.007109935,0.127260168,5167;3815;4208;4286,MEF2C;KIT;MITF;ENPP1
GO:0007413,axonal fasciculation (GO:0007413),12,4,0.827501868,4.833825944,0.007109935,0.127260168,152330;4897;2048;2042,EPHA3;CNTN4;NRCAM;EPHB2
GO:0098911,regulation of ventricular cardiac muscle cell action potential (GO:0098911),12,4,0.827501868,4.833825944,0.007109935,0.127260168,857;775;6262;274,BIN1;CAV1;RYR2;CACNA1C
GO:0051282,regulation of sequestering of calcium ion (GO:0051282),12,4,0.827501868,4.833825944,0.007109935,0.127260168,309;287;6262;845,ANK2;CASQ2;ANXA6;RYR2
GO:2000107,negative regulation of leukocyte apoptotic process (GO:2000107),12,4,0.827501868,4.833825944,0.007109935,0.127260168,6366;2621;6387;558,CXCL12;GAS6;AXL;CCL21
GO:0007063,regulation of sister chromatid cohesion (GO:0007063),12,4,0.827501868,4.833825944,0.007109935,0.127260168,9700;2237;699;113130,CDCA5;BUB1;FEN1;ESPL1
GO:1903083,protein localization to condensed chromosome (GO:1903083),12,4,0.827501868,4.833825944,0.007109935,0.127260168,983;9212;7272;27085,TTK;CDK1;AURKB;MTBP
GO:0051145,smooth muscle cell differentiation (GO:0051145),12,4,0.827501868,4.833825944,0.007109935,0.127260168,4208;1910;2627;93649,MYOCD;EDNRB;MEF2C;GATA6
GO:0007167,enzyme linked receptor protein signaling pathway (GO:0007167),139,18,9.585229975,1.877889216,0.007135975,0.127260168,3815;4915;627;624;2048;2045;2042;4881;5156;5789;2260;3572;3977;558;4882;4920;4919;9068,ANGPTL1;NPR1;EPHA3;BDKRB2;EPHA7;IL6ST;BDNF;AXL;ROR1;LIFR;FGFR1;KIT;NPR2;NTRK2;PTPRD;PDGFRA;EPHB2;ROR2
GO:0043523,regulation of neuron apoptotic process (GO:0043523),98,14,6.757931925,2.07163969,0.00716771,0.127260168,4915;627;9928;51804;79625;596;4208;2045;6495;10891;4776;23017;6347;26471,FAIM2;KIF14;MEF2C;EPHA7;PPARGC1A;BCL2;BDNF;CCL2;NDNF;SIX4;NFATC4;SIX1;NTRK2;NUPR1
GO:0007157,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),42,8,2.896256539,2.762186254,0.007177042,0.127260168,6401;57863;8642;6403;79633;5789;4680;1048,CADM3;SELP;SELE;CEACAM6;CEACAM5;DCHS1;PTPRD;FAT4
GO:0010718,positive regulation of epithelial to mesenchymal transition (GO:0010718),42,8,2.896256539,2.762186254,0.007177042,0.127260168,7048;3569;10979;10439;2146;25937;7041;152007,IL6;TGFBR2;OLFM1;FERMT2;WWTR1;TGFB1I1;EZH2;GLIPR2
GO:0042060,wound healing (GO:0042060),69,11,4.758135743,2.311829799,0.00723649,0.127936888,7168;3479;3690;309;6722;3853;2247;23208;8324;5156;4321,FGF2;SRF;ANXA6;FZD7;TPM1;IGF1;ITGB3;PDGFRA;MMP12;SYT11;KRT6A
GO:1902531,regulation of intracellular signal transduction (GO:1902531),437,44,30.13485971,1.460103031,0.00731045,0.128865434,23043;399;388;5881;395;9472;10395;83478;1894;4915;5577;22974;9590;5138;983;6790;9212;29127;1111;1763;9104;120892;5563;51422;57381;2;83990;116028;672;641;9156;330;79658;90627;9099;8395;6237;683;9824;55789;80728;55843;9754;57569,RHOJ;A2M;ARHGAP6;PDE2A;AURKA;ARHGAP39;RGN;LRRK2;STARD13;STARD8;DNA2;EXO1;BLM;BRCA1;TPX2;USP2;RHOB;BRIP1;CDK1;DEPDC1B;RAC3;ARHGAP20;ARHGAP11A;AURKB;ECT2;PIP5K1B;AKAP12;PRKAR2B;CHEK1;AKAP6;ARHGAP15;RACGAP1;ARHGAP10;BIRC3;PRKAG2;DLC1;ARHGAP24;TNIK;RRAS;NTRK2;RMI2;BST1;PRKAA2;RHOH
GO:0035690,cellular response to drug (GO:0035690),26,6,1.792920715,3.346494884,0.007385827,0.129813463,3757;2621;5142;4208;4609;7037,PDE4B;MEF2C;GAS6;KCNH2;TFRC;MYC
GO:0007193,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),60,10,4.137509342,2.416912972,0.007470241,0.130512756,2316;111;196883;108;1902;150;2774;165140;9590;5138,ADCY5;OXER1;PDE2A;GNAL;ADCY4;FLNA;LPAR1;AKAP12;ADRA2A;ADCY2
GO:0032233,positive regulation of actin filament bundle assembly (GO:0032233),51,9,3.51688294,2.559084323,0.00749075,0.130512756,7168;22899;1902;10979;10411;6422;6376;11346;171024,SYNPO2;SFRP1;ARHGEF15;SYNPO;CX3CL1;FERMT2;LPAR1;RAPGEF3;TPM1
GO:0008015,blood circulation (GO:0008015),51,9,3.51688294,2.559084323,0.00749075,0.130512756,70;185;2006;624;6387;4881;4223;5350;6444,AGTR1;NPR1;ACTC1;PLN;CXCL12;BDKRB2;ELN;MEOX2;SGCD
GO:0045892,"negative regulation of transcription, DNA-templated (GO:0045892)",938,84,64.68306271,1.298639806,0.007585474,0.13178117,7538;2316;6622;2621;51804;857;5138;6663;9212;5347;4208;4609;7704;1428;1910;322;9759;7089;10365;8864;5463;1063;6943;63976;6422;4929;1408;2627;23414;1869;2305;22943;4286;672;8914;332;8013;467;6935;3090;2099;10865;9314;1410;3398;4602;2146;90865;1789;144455;79733;29128;7025;7067;83595;8863;5187;9099;9839;25959;90993;84913;863;57616;1028;862;117581;138151;93986;56849;23090;3400;55635;122953;2354;4784;1390;5178;221895;93166;23492;23466;84733;9079,PER1;KLF2;FOSB;NR4A3;TCF21;ZBTB16;NR4A2;CRYAB;ZFP36;SOX10;PDE2A;CBX2;EDNRB;HIC1;SFRP1;IL33;CBX7;PEG3;FOXM1;CRY2;CRYM;LDB2;MEF2C;KLF4;PER2;TIMELESS;TWIST2;GATA6;CENPF;GAS6;NACC2;UHRF1;BIRC5;PRDM6;CAV1;BRCA1;PLK1;ZEB2;CREM;TCEAL7;USP2;E2F7;DEPDC1;FLNA;NR2F1;NFIX;APBB1;ATF3;KANK2;AURKB;JDP2;ATOH8;ZEB1;PER3;E2F1;EZH2;JAZF1;SIX4;CBFA2T3;THRA;ID4;DNMT3B;ID2;HDAC4;CDKN1C;CREB3L1;MITF;ARID5A;POU6F1;ESR1;FOXP2;SOX7;TSHZ3;RUNX1T1;PRDM16;E2F8;MYB;MYC;TLE2;ZFPM2;CBX6;DKK1;ZNF423;SNCA
GO:1902905,positive regulation of supramolecular fiber organization (GO:1902905),89,13,6.137305523,2.118193391,0.007795454,0.135038829,1073;10435;25802;6366;3071;1191;6376;274;1440;84722;89795;11346;171024,SYNPO2;LMOD1;CDC42EP2;CLU;BIN1;CSF3;CFL2;SYNPO;CX3CL1;NAV3;NCKAP1L;CCL21;PSRC1
GO:0043069,negative regulation of programmed cell death (GO:0043069),379,39,26.13526734,1.492236505,0.007889669,0.135047104,2316;6622;4804;3479;284;2621;9928;51804;3569;2869;358;983;4085;5347;3071;596;2537;4609;1960;6422;5563;2627;6376;3082;23017;22943;1048;7037;332;3572;558;1410;85480;330;6491;79658;25959;894;26471,FAIM2;IL6;CRYAB;AQP1;EGR3;SFRP1;KIF14;STIL;GATA6;NGFR;GAS6;BIRC5;TSLP;PLK1;CDK1;IL6ST;FLNA;CX3CL1;KANK2;CCND2;BCL2;MAD2L1;AXL;SIX4;GRK5;ARHGAP10;IGF1;HGF;BIRC3;NCKAP1L;CEACAM5;TFRC;IFI6;MYC;ANGPT1;DKK1;PRKAA2;SNCA;NUPR1
GO:0086003,cardiac muscle cell contraction (GO:0086003),19,5,1.310211292,3.816178377,0.007953198,0.135047104,2934;775;6330;6324;781,GSN;SCN4B;SCN1B;CACNA2D1;CACNA1C
GO:0010827,regulation of glucose transmembrane transport (GO:0010827),19,5,1.310211292,3.816178377,0.007953198,0.135047104,5579;51422;718;8013;25999,NR4A3;PRKCB;C3;PRKAG2;CLIP3
GO:0006112,energy reserve metabolic process (GO:0006112),19,5,1.310211292,3.816178377,0.007953198,0.135047104,4609;3953;51422;55022;5837,PYGM;PID1;LEPR;PRKAG2;MYC
GO:0150077,regulation of neuroinflammatory response (GO:0150077),19,5,1.310211292,3.816178377,0.007953198,0.135047104,3479;3569;90865;4345;26471,IL6;IL33;IGF1;CD200;NUPR1
GO:0043567,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),19,5,1.310211292,3.816178377,0.007953198,0.135047104,3479;653;3489;3488;8483,BMP5;IGFBP6;CILP;IGF1;IGFBP5
GO:0051154,negative regulation of striated muscle cell differentiation (GO:0051154),19,5,1.310211292,3.816178377,0.007953198,0.135047104,627;9759;8324;22943;1048,FZD7;BDNF;HDAC4;CEACAM5;DKK1
GO:0010810,regulation of cell-substrate adhesion (GO:0010810),43,8,2.965215028,2.697949364,0.008297564,0.14049763,79625;8324;6376;91663;10391;683;285613;2199,MYADM;CX3CL1;FZD7;FBLN2;NDNF;RELL2;CORO2B;BST1
GO:2000573,positive regulation of DNA biosynthetic process (GO:2000573),61,10,4.206467831,2.377291448,0.008397849,0.141174109,9212;4609;2247;225689;3082;4751;9314;64094;79075;25849,FGF2;KLF4;NEK2;SMOC2;AURKB;PARM1;HGF;MAPK15;DSCC1;MYC
GO:0045598,regulation of fat cell differentiation (GO:0045598),80,12,5.516679122,2.175221675,0.008407974,0.141174109,5167;7538;3569;10979;7704;6422;23414;1869;3398;25937;862;55885,IL6;ZBTB16;ZFP36;SFRP1;LMO3;FERMT2;E2F1;WWTR1;ID2;RUNX1T1;ZFPM2;ENPP1
GO:0045786,negative regulation of cell cycle (GO:0045786),80,12,5.516679122,2.175221675,0.008407974,0.141174109,388;3624;4085;5347;6196;3164;93649;1843;7832;64061;26471;1028,NR4A1;DUSP1;MYOCD;INHBA;PLK1;RHOB;RPS6KA2;TSPYL2;MAD2L1;CDKN1C;BTG2;NUPR1
GO:0051248,negative regulation of protein metabolic process (GO:0051248),52,9,3.585841429,2.509871163,0.008518798,0.141846249,2316;3690;3625;4085;1191;1910;11213;1410;5806,CRYAB;EDNRB;CLU;FLNA;PTX3;MAD2L1;IRAK3;INHBB;ITGB3
GO:0051279,regulation of release of sequestered calcium ion into cytosol (GO:0051279),52,9,3.585841429,2.509871163,0.008518798,0.141846249,1756;9472;6622;5144;287;57158;7220;845;6376,ANK2;CASQ2;JPH2;CX3CL1;PDE4D;DMD;AKAP6;TRPC1;SNCA
GO:0006275,regulation of DNA replication (GO:0006275),52,9,3.585841429,2.509871163,0.008518798,0.141846249,81620;1763;890;990;641;64061;79075;79915;157570,ATAD5;DNA2;BLM;CDC6;CDT1;TSPYL2;ESCO2;CCNA2;DSCC1
GO:0051896,regulation of protein kinase B signaling (GO:0051896),207,24,14.27440723,1.681330763,0.008555374,0.142061743,3815;2252;6366;1116;4915;284;2621;10979;2247;5156;6376;3082;1839;2260;1440;558;2099;9365;9863;374;2159;9542;6237;388121,F10;NRG2;TNFAIP8L3;FGF2;GAS6;FGF7;CSF3;CX3CL1;FERMT2;AXL;MAGI2;FGFR1;HGF;KIT;HBEGF;CCL21;ESR1;RRAS;NTRK2;KL;CHI3L1;PDGFRA;ANGPT1;AREG
GO:0071248,cellular response to metal ion (GO:0071248),131,17,9.033562063,1.881871169,0.00859535,0.142332363,8912;6622;1894;358;1740;4208;7226;6263;83849;23208;120892;5563;4499;2353;3707;25932;10235,AQP1;FOS;RASGRP2;LRRK2;MEF2C;DLG2;MT1M;CACNA1H;RYR3;ECT2;TRPM2;ITPKB;SYT15;CLIC4;SYT11;PRKAA2;SNCA
GO:0097746,blood vessel diameter maintenance (GO:0097746),35,7,2.413547116,2.900295567,0.008885171,0.146727363,1909;185;624;1910;4881;10365;8864,KLF2;AGTR1;EDNRB;NPR1;PER2;BDKRB2;EDNRA
GO:0051209,release of sequestered calcium ion into cytosol (GO:0051209),27,6,1.861879204,3.222550629,0.008953461,0.14686167,6366;2247;6262;7226;6263;3708,ITPR1;FGF2;RYR3;TRPM2;CCL21;RYR2
GO:1904427,positive regulation of calcium ion transmembrane transport (GO:1904427),27,6,1.861879204,3.222550629,0.008953461,0.14686167,9472;6622;783;287;7220;6376,ANK2;CX3CL1;AKAP6;CACNB2;TRPC1;SNCA
GO:1902904,negative regulation of supramolecular fiber organization (GO:1902904),71,11,4.896052721,2.246707833,0.0089666,0.14686167,6622;22974;9353;11117;1191;2258;91663;1410;25999;3925;89795,CRYAB;CLU;MYADM;TPX2;FGF13;SLIT2;NAV3;EMILIN1;STMN1;CLIP3;SNCA
GO:0086016,AV node cell action potential (GO:0086016),7,3,0.482709423,6.214919071,0.009271595,0.148222226,783;775;6330,SCN4B;CACNB2;CACNA1C
GO:2000322,regulation of glucocorticoid receptor signaling pathway (GO:2000322),7,3,0.482709423,6.214919071,0.009271595,0.148222226,1408;5187;55885,PER1;LMO3;CRY2
GO:0061042,vascular wound healing (GO:0061042),7,3,0.482709423,6.214919071,0.009271595,0.148222226,4162;79625;947,CD34;NDNF;MCAM
GO:0045620,negative regulation of lymphocyte differentiation (GO:0045620),7,3,0.482709423,6.214919071,0.009271595,0.148222226,3624;6422;3398,SFRP1;INHBA;ID2
GO:1905278,positive regulation of epithelial tube formation (GO:1905278),7,3,0.482709423,6.214919071,0.009271595,0.148222226,51804;2247;6495,FGF2;SIX4;SIX1
GO:0032754,positive regulation of interleukin-5 production (GO:0032754),7,3,0.482709423,6.214919071,0.009271595,0.148222226,5144;5590;85480,TSLP;PDE4D;PRKCZ
GO:0051150,regulation of smooth muscle cell differentiation (GO:0051150),7,3,0.482709423,6.214919071,0.009271595,0.148222226,6722;93649;348093,MYOCD;SRF;RBPMS2
GO:0070344,regulation of fat cell proliferation (GO:0070344),7,3,0.482709423,6.214919071,0.009271595,0.148222226,8864;1869;55022,PER2;PID1;E2F1
GO:0006957,"complement activation, alternative pathway (GO:0006957)",7,3,0.482709423,6.214919071,0.009271595,0.148222226,718;1675;5199,CFD;CFP;C3
GO:1901381,positive regulation of potassium ion transmembrane transport (GO:1901381),44,8,3.034173517,2.636632333,0.009544131,0.151771886,2316;9472;3757;3779;287;3778;482;3782,ANK2;KCNMB1;ATP1B2;KCNN3;KCNMA1;FLNA;KCNH2;AKAP6
GO:0048754,branching morphogenesis of an epithelial tube (GO:0048754),44,8,3.034173517,2.636632333,0.009544131,0.151771886,7048;9723;9353;4609;2247;54922;6495;6943,TCF21;TGFBR2;FGF2;SEMA3E;SLIT2;SIX1;RASIP1;MYC
GO:0071310,cellular response to organic substance (GO:0071310),122,16,8.412935661,1.901833158,0.009608951,0.152100266,9472;8912;2690;150;7048;10267;9353;6586;120892;6422;55022;3488;6347;1440;9314;7123,CLEC3B;SLIT3;SFRP1;TGFBR2;LRRK2;KLF4;RAMP1;PID1;CSF3;CACNA1H;SLIT2;GHR;CCL2;AKAP6;ADRA2A;IGFBP5
GO:0010649,regulation of cell communication by electrical coupling (GO:0010649),13,4,0.896460357,4.461993179,0.009716603,0.152100266,857;5144;6546;845,CASQ2;CAV1;PDE4D;SLC8A1
GO:0043267,negative regulation of potassium ion transport (GO:0043267),13,4,0.896460357,4.461993179,0.009716603,0.152100266,3757;857;845;274,CASQ2;BIN1;CAV1;KCNH2
GO:1903206,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),13,4,0.896460357,4.461993179,0.009716603,0.152100266,5831;120892;3082;8013,NR4A3;LRRK2;PYCR1;HGF
GO:0150079,negative regulation of neuroinflammatory response (GO:0150079),13,4,0.896460357,4.461993179,0.009716603,0.152100266,3479;23208;6376;4345,CX3CL1;IGF1;CD200;SYT11
GO:0090266,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),13,4,0.896460357,4.461993179,0.009716603,0.152100266,4085;891;10403;1843,DUSP1;CCNB1;NDC80;MAD2L1
GO:0051493,regulation of cytoskeleton organization (GO:0051493),112,15,7.723350771,1.94216221,0.009910676,0.154727313,11170;399;388;390;5881;10395;11076;2042;91624;5563;2824;25932;10391;683;128239,FAM107A;TPPP;IQGAP3;EPHA3;NEXN;RHOB;RAC3;DLC1;GPM6B;CORO2B;CLIC4;BST1;PRKAA2;RND3;RHOH
GO:0006468,protein phosphorylation (GO:0006468),494,48,34.06549358,1.409050478,0.009996439,0.154727313,23043;3815;4915;63967;7048;2621;11113;2869;983;6790;9212;5347;1511;6196;5579;660;1111;9833;2048;2042;5649;7049;120892;2202;5563;5166;5156;51422;225689;8317;890;898;10733;4751;10000;9535;332;6347;9201;30811;11213;5590;5592;2260;91461;7272;388228;55351,PDK4;CTSG;BMX;PRKCB;AURKA;TGFBR2;RELN;TGFBR3;LRRK2;EPHA3;CLSPN;CCNE1;GAS6;NEK2;TTK;BIRC5;CDC7;MELK;PLK1;CDK1;RPS6KA2;CIT;AURKB;PLK4;CCL2;CCNA2;CHEK1;SBK1;STK32B;PKDCC;DCLK1;FGFR1;GRK5;PRKG1;PRKAG2;KIT;IRAK3;EFEMP1;MAPK15;TNIK;NTRK2;AKT3;PDGFRA;EPHB2;GMFG;PRKCZ;PRKAA2;HUNK
GO:0006940,regulation of smooth muscle contraction (GO:0006940),20,5,1.379169781,3.625369458,0.01001313,0.154727313,154;857;6722;93649;1264,CNN1;MYOCD;SRF;CAV1;ADRB2
GO:0010738,regulation of protein kinase A signaling (GO:0010738),20,5,1.379169781,3.625369458,0.01001313,0.154727313,9472;154;5577;9590;120892,LRRK2;AKAP12;PRKAR2B;AKAP6;ADRB2
GO:0002673,regulation of acute inflammatory response (GO:0002673),20,5,1.379169781,3.625369458,0.01001313,0.154727313,3569;388125;114548;3572;2161,IL6;IL6ST;C2CD4B;NLRP3;F12
GO:0044344,cellular response to fibroblast growth factor stimulus (GO:0044344),92,13,6.344180991,2.049121868,0.010242485,0.15786559,7538;2252;79625;23768;1960;2247;3164;6422;3373;6347;2260;9365;79801,NR4A1;ZFP36;EGR3;SFRP1;FGF2;FGF7;HYAL1;CCL2;NDNF;FGFR1;SHCBP1;KL;FLRT2
GO:0050679,positive regulation of epithelial cell proliferation (GO:0050679),123,16,8.48189415,1.8863711,0.010361714,0.158503591,2252;3479;3690;4609;8742;1960;2247;3164;653;6422;8324;3373;4321;10000;8013;374,NR4A1;NR4A3;EGR3;SFRP1;FGF2;BMP5;FGF7;HYAL1;FZD7;IGF1;TNFSF12;ITGB3;AKT3;MYC;MMP12;AREG
GO:0045599,negative regulation of fat cell differentiation (GO:0045599),36,7,2.482505605,2.819731801,0.010389355,0.158503591,5167;3569;10979;23414;1869;25937;862,IL6;FERMT2;E2F1;WWTR1;RUNX1T1;ZFPM2;ENPP1
GO:0030278,regulation of ossification (GO:0030278),36,7,2.482505605,2.819731801,0.010389355,0.158503591,5167;1901;166929;4208;7704;6422;22943,ZBTB16;SFRP1;MEF2C;S1PR1;DKK1;SGMS2;ENPP1
GO:0030501,positive regulation of bone mineralization (GO:0030501),36,7,2.482505605,2.819731801,0.010389355,0.158503591,4208;6546;2201;2824;9636;9365;91461,MEF2C;PKDCC;ISG15;GPM6B;FBN2;KL;SLC8A1
GO:0030335,positive regulation of cell migration (GO:0030335),268,29,18.48087506,1.569189765,0.010603855,0.160670849,3815;11170;3479;150;857;10979;54437;9723;7869;56920;3071;4638;2048;59352;6387;5156;3373;3082;1839;91663;4680;5168;51512;2159;4920;117581;131578;80310;152007,F10;FAM107A;SEMA5B;SEMA3G;MYLK;TWIST2;CXCL12;MYADM;CAV1;GTSE1;HYAL1;SEMA3E;FERMT2;SEMA3B;ADRA2A;PDGFD;IGF1;HGF;NCKAP1L;KIT;HBEGF;CEACAM6;ENPP2;LGR6;GLIPR2;PDGFRA;LRRC15;EPHB2;ROR2
GO:0051130,positive regulation of cellular component organization (GO:0051130),113,15,7.79230926,1.924974934,0.010722619,0.160670849,5244;10435;6622;991;9378;1191;11076;81620;5649;10411;3373;4312;7037;25999;6886,TPPP;RELN;CDC42EP2;NRXN1;CLU;CDC20;HYAL1;CDT1;RAPGEF3;CLIP3;ABCB4;MMP1;TFRC;TAL1;SNCA
GO:0033674,positive regulation of kinase activity (GO:0033674),113,15,7.79230926,1.924974934,0.010722619,0.160670849,3815;6366;4915;2621;1062;2048;2045;2042;5649;5156;51422;2260;558;4920;4919,RELN;EPHA3;GAS6;EPHA7;CENPE;AXL;ROR1;FGFR1;PRKAG2;KIT;CCL21;NTRK2;PDGFRA;EPHB2;ROR2
GO:0051965,positive regulation of synapse assembly (GO:0051965),28,6,1.930837693,3.107459536,0.010745247,0.160670849,375790;627;9378;2048;94030;5789,NRXN1;BDNF;AGRN;PTPRD;EPHB2;LRRC4B
GO:0043113,receptor clustering (GO:0043113),28,6,1.930837693,3.107459536,0.010745247,0.160670849,375790;2316;1740;9379;9378;9863,NRXN1;DLG2;FLNA;MAGI2;NRXN2;AGRN
GO:1901654,response to ketone (GO:1901654),28,6,1.930837693,3.107459536,0.010745247,0.160670849,5244;6366;857;9353;6586;7049,SLIT3;TGFBR3;CAV1;SLIT2;CCL21;ABCB4
GO:0071354,cellular response to interleukin-6 (GO:0071354),28,6,1.930837693,3.107459536,0.010745247,0.160670849,3569;3570;5740;55022;9021;3572,IL6;PID1;IL6ST;PTGIS;SOCS3;IL6R
GO:0060412,ventricular septum morphogenesis (GO:0060412),28,6,1.930837693,3.107459536,0.010745247,0.160670849,7048;9353;6586;6659;7049;23414,SLIT3;TGFBR2;TGFBR3;SOX4;SLIT2;ZFPM2
GO:0048699,generation of neurons (GO:0048699),200,23,13.79169781,1.667669951,0.010875389,0.161257925,4915;11113;51804;79625;29127;4208;4131;4897;5649;2535;8864;6495;7483;7472;8324;4929;7482;2258;6376;5789;2260;7732;84913,NR4A2;RELN;MEF2C;PER2;FGF13;RNF112;CX3CL1;CIT;FZD7;ATOH8;NDNF;WNT2B;SIX4;RACGAP1;FGFR1;FZD2;WNT2;MAP1B;NRCAM;WNT9A;SIX1;NTRK2;PTPRD
GO:1901379,regulation of potassium ion transmembrane transport (GO:1901379),54,9,3.723758408,2.416912972,0.010891818,0.161257925,2316;9472;3757;857;3779;3778;274;3782;2273,FHL1;KCNMB1;BIN1;KCNN3;CAV1;KCNMA1;FLNA;KCNH2;AKAP6
GO:0001960,negative regulation of cytokine-mediated signaling pathway (GO:0001960),54,9,3.723758408,2.416912972,0.010891818,0.161257925,2621;3569;9353;6586;10293;9636;11213;83643;11274,IL6;SLIT3;GAS6;TRAIP;SLIT2;USP18;CCDC3;IRAK3;ISG15
GO:0002920,regulation of humoral immune response (GO:0002920),54,9,3.723758408,2.416912972,0.010891818,0.161257925,1191;2627;718;5199;715;716;3078;3075;730,C7;CFP;GATA6;CLU;C3;CFHR1;C1R;CFH;C1S
GO:0006281,DNA repair (GO:0006281),292,31,20.1358788,1.539540455,0.010964099,0.161929232,983;1111;10293;322;10721;1763;2237;9319;2175;83990;116028;672;8914;9401;5427;10535;641;9156;5888;11169;8438;7516;7832;10635;29089;113130;3838;675;2177;55215;146956,XRCC2;RECQL4;FANCI;TIMELESS;RAD54L;POLQ;EME1;CDCA5;DNA2;RNASEH2A;EXO1;BLM;TRIP13;KPNA2;WDHD1;FANCA;BRCA1;TRAIP;RAD51AP1;UBE2T;RAD51;BRIP1;CDK1;APBB1;BRCA2;CHEK1;FEN1;POLE2;FANCD2;BTG2;RMI2
GO:0032970,regulation of actin filament-based process (GO:0032970),73,11,5.033969699,2.185154194,0.011000044,0.162061919,11170;399;388;390;5881;10395;2042;2824;10391;683;128239,FAM107A;IQGAP3;EPHA3;RHOB;RAC3;DLC1;GPM6B;CORO2B;BST1;RND3;RHOH
GO:0042326,negative regulation of phosphorylation (GO:0042326),83,12,5.723554589,2.096599205,0.011196231,0.16414767,3624;9353;2048;9759;120892;91663;55022;25937;863;2192;26471;1028,LRRK2;INHBA;MYADM;PID1;SLIT2;WWTR1;CBFA2T3;HDAC4;CDKN1C;FBLN1;EPHB2;NUPR1
GO:1902749,regulation of cell cycle G2/M phase transition (GO:1902749),83,12,5.723554589,2.096599205,0.011196231,0.16414767,5577;22974;9928;983;6790;5347;1063;10733;4751;51512;3161;79915,ATAD5;AURKA;KIF14;CENPF;NEK2;PLK1;GTSE1;TPX2;CDK1;HMMR;PLK4;PRKAR2B
GO:0045596,negative regulation of cell differentiation (GO:0045596),190,22,13.10211292,1.679118486,0.011649004,0.170370227,5167;3690;3569;857;10979;7704;152330;653;6910;2202;7483;6422;10252;93649;23414;1869;81792;3398;4602;25937;862;117581,IL6;MYOCD;ZBTB16;SPRY1;SFRP1;BMP5;TWIST2;CAV1;FERMT2;E2F1;WWTR1;CNTN4;ID2;EFEMP1;WNT9A;ITGB3;RUNX1T1;MYB;ZFPM2;TBX5;ENPP1;ADAMTS12
GO:0031328,positive regulation of cellular biosynthetic process (GO:0031328),179,21,12.34356954,1.701290695,0.011745935,0.170955967,6622;6366;3479;10580;3569;5745;1191;4609;6659;81620;1763;10365;2247;10891;3082;1958;9314;9839;64094;23034;79915,KLF2;IL6;PTH1R;ATAD5;SORBS1;EGR1;FGF2;SOX4;KLF4;CLU;DNA2;ZEB2;PPARGC1A;CDT1;SMOC2;SAMD4A;IGF1;HGF;CCL21;MYC;SNCA
GO:0045055,regulated exocytosis (GO:0045055),179,21,12.34356954,1.701290695,0.011745935,0.170955967,2316;6622;3479;2621;3690;26154;1191;6403;83849;23208;3082;2;6812;2162;7123;22927;1675;2157;12;22915;5099,CFD;CLEC3B;A2M;MMRN1;CLU;GAS6;F13A1;SERPINA3;FLNA;SELP;IGF1;HGF;F8;HABP4;ABCA12;SYT15;ITGB3;PCDH7;SYT11;STXBP1;SNCA
GO:0006875,cellular metal ion homeostasis (GO:0006875),104,14,7.171682859,1.952122016,0.011937586,0.173325671,489;857;5745;287;6387;6781;493;9104;57419;6262;6546;477;3778;482,ATP1A2;ANK2;PTH1R;SLC24A3;ATP1B2;RGN;CXCL12;CAV1;KCNMA1;ATP2A3;ATP2B4;RYR2;SLC8A1;STC1
GO:0070507,regulation of microtubule cytoskeleton organization (GO:0070507),37,7,2.551464094,2.743522833,0.012070461,0.173577848,11170;11076;2042;5563;3925;220134;221150,FAM107A;TPPP;EPHA3;SKA1;SKA3;STMN1;PRKAA2
GO:2000273,positive regulation of signaling receptor activity (GO:2000273),37,7,2.551464094,2.743522833,0.012070461,0.173577848,154;150;2048;5649;1839;6347;374,RELN;CCL2;ADRA2A;HBEGF;ADRB2;EPHB2;AREG
GO:2000134,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),37,7,2.551464094,2.743522833,0.012070461,0.173577848,11170;6347;9314;144455;25959;2273;138151,FAM107A;FHL1;KLF4;NACC2;E2F7;KANK2;CCL2
GO:0051928,positive regulation of calcium ion transport (GO:0051928),37,7,2.551464094,2.743522833,0.012070461,0.173577848,857;783;4638;287;6387;6781;6347,ANK2;MYLK;CXCL12;CAV1;CCL2;CACNB2;STC1
GO:0051492,regulation of stress fiber assembly (GO:0051492),74,11,5.102928188,2.155625083,0.012140451,0.173752975,7168;84952;395;10395;22899;1902;5734;10979;10411;6422;3925,ARHGAP6;SFRP1;CGNL1;ARHGEF15;FERMT2;LPAR1;RAPGEF3;TPM1;STMN1;DLC1;PTGER4
GO:0030330,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",74,11,5.102928188,2.155625083,0.012140451,0.173752975,983;6790;891;6659;1869;995;2305;7832;144455;79733;51512,AURKA;FOXM1;SOX4;CDC25C;GTSE1;CCNB1;E2F7;CDK1;E2F1;BTG2;E2F8
GO:2000177,regulation of neural precursor cell proliferation (GO:2000177),21,5,1.44812827,3.452732817,0.012411117,0.175040459,10763;120892;79801;3398;9760,LRRK2;NES;ID2;SHCBP1;TOX
GO:1904707,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),21,5,1.44812827,3.452732817,0.012411117,0.175040459,3479;2247;3488;8013;9510,NR4A3;ADAMTS1;FGF2;IGF1;IGFBP5
GO:1904666,regulation of ubiquitin protein ligase activity (GO:1904666),21,5,1.44812827,3.452732817,0.012411117,0.175040459,11065;991;4085;5347;9532,UBE2C;CDC20;PLK1;BAG2;MAD2L1
GO:0052652,cyclic purine nucleotide metabolic process (GO:0052652),21,5,1.44812827,3.452732817,0.012411117,0.175040459,111;196883;108;4881;4882,ADCY5;NPR1;ADCY4;NPR2;ADCY2
GO:0060043,regulation of cardiac muscle cell proliferation (GO:0060043),21,5,1.44812827,3.452732817,0.012411117,0.175040459,4208;2247;7049;6910;23414,FGF2;TGFBR3;MEF2C;ZFPM2;TBX5
GO:0030888,regulation of B cell proliferation (GO:0030888),46,8,3.172090495,2.521996145,0.012447627,0.175040459,3071;596;4208;2048;933;1880;7037;683,MEF2C;GPR183;CD22;BCL2;NCKAP1L;TFRC;EPHB2;BST1
GO:0048145,regulation of fibroblast proliferation (GO:0048145),46,8,3.172090495,2.521996145,0.012447627,0.175040459,3479;2621;358;4609;6422;7472;5156;1869,AQP1;SFRP1;GAS6;E2F1;IGF1;WNT2;PDGFRA;MYC
GO:0007204,positive regulation of cytosolic calcium ion concentration (GO:0007204),147,18,10.13689789,1.775691163,0.01246337,0.175040459,111;1909;1902;857;5737;5733;5734;185;624;775;781;6262;57158;6546;5156;2099;6869;623,ADCY5;AGTR1;PTGFR;BDKRB2;TACR1;BDKRB1;CAV1;JPH2;LPAR1;EDNRA;PTGER3;ESR1;RYR2;CACNA2D1;PDGFRA;SLC8A1;PTGER4;CACNA1C
GO:0030041,actin filament polymerization (GO:0030041),29,6,1.999796182,3.000305758,0.012776737,0.176253883,2934;11170;23242;81624;8522;395,FAM107A;ARHGAP6;GSN;GAS7;DIAPH3;COBL
GO:0010001,glial cell differentiation (GO:0010001),29,6,1.999796182,3.000305758,0.012776737,0.176253883,6663;11076;6659;4781;5649;1959,TPPP;SOX10;RELN;SOX4;EGR2;NFIB
GO:0010560,positive regulation of glycoprotein biosynthetic process (GO:0010560),14,4,0.965418846,4.143279381,0.01287231,0.176253883,6366;3479;10267;90865,IL33;RAMP1;IGF1;CCL21
GO:0034764,positive regulation of transmembrane transport (GO:0034764),14,4,0.965418846,4.143279381,0.01287231,0.176253883,65010;718;8013;25999,NR4A3;SLC26A6;C3;CLIP3
GO:0098703,calcium ion import across plasma membrane (GO:0098703),14,4,0.965418846,4.143279381,0.01287231,0.176253883,781;493;6546;7226,TRPM2;ATP2B4;CACNA2D1;SLC8A1
GO:0046058,cAMP metabolic process (GO:0046058),14,4,0.965418846,4.143279381,0.01287231,0.176253883,111;196883;108;5144,ADCY5;ADCY4;PDE4D;ADCY2
GO:2000479,regulation of cAMP-dependent protein kinase activity (GO:2000479),14,4,0.965418846,4.143279381,0.01287231,0.176253883,154;5577;493;11142,PRKAR2B;PKIG;ATP2B4;ADRB2
GO:0003214,cardiac left ventricle morphogenesis (GO:0003214),14,4,0.965418846,4.143279381,0.01287231,0.176253883,7048;2294;6910;6262,FOXF1;TGFBR2;RYR2;TBX5
GO:0060045,positive regulation of cardiac muscle cell proliferation (GO:0060045),14,4,0.965418846,4.143279381,0.01287231,0.176253883,4208;2247;7049;23414,FGF2;TGFBR3;MEF2C;ZFPM2
GO:0099560,synaptic membrane adhesion (GO:0099560),14,4,0.965418846,4.143279381,0.01287231,0.176253883,10082;145581;94030;5789,LRFN5;PTPRD;LRRC4B;GPC6
GO:0034501,protein localization to kinetochore (GO:0034501),14,4,0.965418846,4.143279381,0.01287231,0.176253883,983;9212;7272;27085,TTK;CDK1;AURKB;MTBP
GO:0031571,mitotic G1 DNA damage checkpoint signaling (GO:0031571),65,10,4.482301787,2.23099659,0.013016511,0.177823296,983;6790;891;6659;1869;995;7832;144455;79733;51512,AURKA;SOX4;CDC25C;GTSE1;CCNB1;E2F7;CDK1;E2F1;BTG2;E2F8
GO:0070555,response to interleukin-1 (GO:0070555),85,12,5.861471567,2.047267459,0.01341796,0.18289197,6622;6366;1116;6401;5740;9759;6422;3373;6376;81792;6347;11213,SFRP1;HYAL1;CX3CL1;PTGIS;CCL2;SELE;HDAC4;IRAK3;CCL21;CHI3L1;SNCA;ADAMTS12
GO:0010646,regulation of cell communication (GO:0010646),38,7,2.620422583,2.671324864,0.013939186,0.185610302,11343;2869;287;6262;6546;845;64061,MGLL;ANK2;CASQ2;TSPYL2;GRK5;RYR2;SLC8A1
GO:0070317,negative regulation of G0 to G1 transition (GO:0070317),38,7,2.620422583,2.671324864,0.013939186,0.185610302,1111;6241;8317;1869;672;5888;2146,CDC7;BRCA1;RAD51;CHEK1;RRM2;E2F1;EZH2
GO:0010596,negative regulation of endothelial cell migration (GO:0010596),38,7,2.620422583,2.671324864,0.013939186,0.185610302,4208;56999;9353;2247;6781;493;1634,FGF2;MEF2C;DCN;SLIT2;ATP2B4;ADAMTS9;STC1
GO:0014066,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),106,14,7.309599837,1.915289525,0.013983031,0.185610302,3815;4915;3479;2247;6403;5156;3082;2260;1440;1634;4920;4919;8395;80310,FGF2;DCN;CSF3;SELP;PIP5K1B;ROR1;FGFR1;PDGFD;IGF1;HGF;KIT;NTRK2;PDGFRA;ROR2
GO:0071679,commissural neuron axon guidance (GO:0071679),8,3,0.551667912,5.438054187,0.014080569,0.185610302,2048;4781;4684,NCAM1;NFIB;EPHB2
GO:0014866,skeletal myofibril assembly (GO:0014866),8,3,0.551667912,5.438054187,0.014080569,0.185610302,58;70;4629,ACTC1;ACTA1;MYH11
GO:0090494,dopamine uptake (GO:0090494),8,3,0.551667912,5.438054187,0.014080569,0.185610302,6622;6581;225689,SLC22A3;MAPK15;SNCA
GO:0035313,"wound healing, spreading of epidermal cells (GO:0035313)",8,3,0.551667912,5.438054187,0.014080569,0.185610302,83478;3678;4321,ARHGAP24;ITGA5;MMP12
GO:1904754,positive regulation of vascular associated smooth muscle cell migration (GO:1904754),8,3,0.551667912,5.438054187,0.014080569,0.185610302,3488;8013;9510,NR4A3;ADAMTS1;IGFBP5
GO:2000553,positive regulation of T-helper 2 cell cytokine production (GO:2000553),8,3,0.551667912,5.438054187,0.014080569,0.185610302,3569;114548;5590,IL6;NLRP3;PRKCZ
GO:0033622,integrin activation (GO:0033622),8,3,0.551667912,5.438054187,0.014080569,0.185610302,10979;6387;6376,CXCL12;CX3CL1;FERMT2
GO:0060973,cell migration involved in heart development (GO:0060973),8,3,0.551667912,5.438054187,0.014080569,0.185610302,8642;6910;5308,DCHS1;TBX5;PITX2
GO:0044070,regulation of anion transport (GO:0044070),8,3,0.551667912,5.438054187,0.014080569,0.185610302,1066;6781;5243,ABCB1;CES1;STC1
GO:0097106,postsynaptic density organization (GO:0097106),8,3,0.551667912,5.438054187,0.014080569,0.185610302,9379;9378;66000,NRXN1;NRXN2;TMEM108
GO:0048478,replication fork protection (GO:0048478),8,3,0.551667912,5.438054187,0.014080569,0.185610302,8914;29980;641,TIMELESS;BLM;DONSON
GO:0031346,positive regulation of cell projection organization (GO:0031346),117,15,8.068143216,1.859163825,0.014505238,0.190789904,4804;4915;627;79625;9353;2042;6324;5649;6376;482;5789;9863;9760;4920;4919,ATP1B2;RELN;EPHA3;NGFR;SLIT2;CX3CL1;BDNF;ROR1;NDNF;MAGI2;SCN1B;NTRK2;PTPRD;TOX;ROR2
GO:1901214,regulation of neuron death (GO:1901214),86,12,5.930430056,2.023462023,0.014647701,0.192243078,6622;9928;947;4208;1191;10891;120892;23017;22943;2353;1958;4345,FAIM2;CD34;FOS;EGR1;KIF14;LRRK2;MEF2C;CLU;PPARGC1A;CD200;DKK1;SNCA
GO:2000181,negative regulation of blood vessel morphogenesis (GO:2000181),76,11,5.240845166,2.098898107,0.01468864,0.192360381,9723;11117;7122;1944;4881;493;9314;1634;9510;641700;5176,CLDN5;ADAMTS1;NPR1;KLF4;ECSCR;DCN;SEMA3E;EMILIN1;ATP2B4;EFNA3;SERPINF1
GO:0071396,cellular response to lipid (GO:0071396),217,24,14.96399212,1.603850083,0.014785392,0.1932065,7538;5244;111;108;3569;358;6696;1511;5142;4208;2920;114548;2042;7483;6422;7472;8324;5166;477;55022;6347;558;2099;7035,PDK4;ATP1A2;IL6;CTSG;ADCY5;ZFP36;AQP1;SFRP1;PDE4B;MEF2C;EPHA3;SPP1;PID1;FZD7;CCL2;AXL;CXCL2;WNT2;NLRP3;TFPI;ABCB4;ESR1;WNT9A;ADCY2
GO:0010557,positive regulation of macromolecule biosynthetic process (GO:0010557),128,16,8.826686596,1.812684729,0.014850723,0.193639258,6366;3479;10580;3569;4609;6659;81620;1763;2247;3082;6347;9314;90865;64094;23034;79915,IL6;ATAD5;IL33;SORBS1;FGF2;SOX4;KLF4;DNA2;CDT1;SMOC2;SAMD4A;CCL2;IGF1;HGF;CCL21;MYC
GO:0035633,maintenance of blood-brain barrier (GO:0035633),30,6,2.068754671,2.900295567,0.015062849,0.19555677,1756;3569;83700;7122;3908;58494,CLDN5;IL6;JAM2;LAMA2;JAM3;DMD
GO:0034113,heterotypic cell-cell adhesion (GO:0034113),30,6,2.068754671,2.900295567,0.015062849,0.19555677,55742;3690;83700;3678;3679;4345,JAM3;ITGA7;CD200;ITGA5;ITGB3;PARVA
GO:0033044,regulation of chromosome organization (GO:0033044),22,5,1.517086759,3.295790416,0.015169782,0.195677162,4609;81620;699;116028;80119,BUB1;CDT1;PIF1;RMI2;MYC
GO:0010883,regulation of lipid storage (GO:0010883),22,5,1.517086759,3.295790416,0.015169782,0.195677162,3690;3569;718;29923;4232,IL6;MEST;C3;HILPDA;ITGB3
GO:0007093,mitotic cell cycle checkpoint signaling (GO:0007093),22,5,1.517086759,3.295790416,0.015169782,0.195677162,701;9212;1111;11130;699,BUB1;BUB1B;AURKB;CHEK1;ZWINT
GO:0055074,calcium ion homeostasis (GO:0055074),97,13,6.688973436,1.943497029,0.015604091,0.200419216,6622;489;857;5745;287;6387;6781;493;9104;57419;6262;57158;6546,ANK2;PTH1R;SLC24A3;RGN;CXCL12;CAV1;JPH2;ATP2A3;ATP2B4;RYR2;SLC8A1;STC1;SNCA
GO:0043405,regulation of MAP kinase activity (GO:0043405),97,13,6.688973436,1.943497029,0.015604091,0.200419216,3815;150;2247;120892;10252;1843;11213;2260;146433;2146;5997;80310;148252,DUSP1;RGS2;SPRY1;FGF2;LRRK2;IL34;EZH2;FGFR1;ADRA2A;PDGFD;KIT;IRAK3;DIRAS1
GO:0032273,positive regulation of protein polymerization (GO:0032273),67,10,4.620218765,2.164399676,0.015939228,0.202541975,10435;25802;6366;3071;11076;274;1440;84722;51673;89795,TPPP;LMOD1;CDC42EP2;TPPP3;BIN1;CSF3;NAV3;NCKAP1L;CCL21;PSRC1
GO:0034446,substrate adhesion-dependent cell spreading (GO:0034446),48,8,3.310007473,2.416912972,0.015951215,0.202541975,55742;9928;3690;10979;55698;8516;10319;11149,ITGA8;KIF14;LAMC3;FERMT2;BVES;ITGB3;PARVA;RADIL
GO:0070588,calcium ion transmembrane transport (GO:0070588),87,12,5.999388545,2.000203839,0.01596115,0.202541975,489;2621;775;2906;781;79085;493;57419;6546;7226;6263;7220,SLC24A3;GAS6;RYR3;SLC25A23;GRIN2D;TRPM2;ATP2A3;TRPC1;ATP2B4;CACNA2D1;SLC8A1;CACNA1C
GO:0048565,digestive tract development (GO:0048565),39,7,2.689381072,2.602829355,0.016005932,0.202541975,3815;23242;140628;2294;1910;2627;91461,FOXF1;GATA5;EDNRB;GATA6;PKDCC;KIT;COBL
GO:0031297,replication fork processing (GO:0031297),39,7,2.689381072,2.602829355,0.016005932,0.202541975,10293;1763;641;5888;675;146956;4796,TONSL;EME1;DNA2;BLM;TRAIP;RAD51;BRCA2
GO:2001259,positive regulation of cation channel activity (GO:2001259),39,7,2.689381072,2.602829355,0.016005932,0.202541975,9472;154;287;2048;5649;57158;6347,ANK2;RELN;JPH2;CCL2;AKAP6;ADRB2;EPHB2
GO:0006310,DNA recombination (GO:0006310),39,7,2.689381072,2.602829355,0.016005932,0.202541975,9401;641;9156;5888;8438;7516;3149,XRCC2;RECQL4;HMGB3;RAD54L;EXO1;BLM;RAD51
GO:0098659,inorganic cation import across plasma membrane (GO:0098659),77,11,5.309803655,2.07163969,0.016104411,0.202541975,3757;781;493;6546;7226;477;10060;482;84561;84679;285195,ATP1A2;SLC9A9;ATP1B2;SLC12A8;KCNH2;ABCC9;TRPM2;ATP2B4;CACNA2D1;SLC8A1;SLC9A7
GO:0071901,negative regulation of protein serine/threonine kinase activity (GO:0071901),77,11,5.309803655,2.07163969,0.016104411,0.202541975,5577;5347;54922;6546;10252;93649;1843;11213;11142;5997;1028,DUSP1;RGS2;MYOCD;SPRY1;PLK1;PRKAR2B;PKIG;IRAK3;CDKN1C;SLC8A1;RASIP1
GO:0007015,actin filament organization (GO:0007015),151,18,10.41273184,1.728652987,0.016106316,0.202541975,2316;2934;6840;11034;23242;7169;7168;10435;399;388;58;25802;84952;7111;65108;390;70;5881,LMOD1;TMOD1;CDC42EP2;ACTC1;GSN;CGNL1;RHOB;FLNA;RAC3;TPM2;TPM1;DSTN;ACTA1;SVIL;MARCKSL1;RND3;RHOH;COBL
GO:0043031,negative regulation of macrophage activation (GO:0043031),15,4,1.034377335,3.867060755,0.016612531,0.205468978,23208;6376;145581;4345,LRFN5;CX3CL1;CD200;SYT11
GO:0035994,response to muscle stretch (GO:0035994),15,4,1.034377335,3.867060755,0.016612531,0.205468978,2934;1756;6262;6546,GSN;DMD;RYR2;SLC8A1
GO:1902656,calcium ion import into cytosol (GO:1902656),15,4,1.034377335,3.867060755,0.016612531,0.205468978,781;493;6546;7226,TRPM2;ATP2B4;CACNA2D1;SLC8A1
GO:0007520,myoblast fusion (GO:0007520),15,4,1.034377335,3.867060755,0.016612531,0.205468978,8912;170689;11096;58494,JAM2;CACNA1H;ADAMTS15;ADAMTS5
GO:0002675,positive regulation of acute inflammatory response (GO:0002675),15,4,1.034377335,3.867060755,0.016612531,0.205468978,3569;388125;5733;3572,IL6;IL6ST;C2CD4B;PTGER3
GO:0060760,positive regulation of response to cytokine stimulus (GO:0060760),15,4,1.034377335,3.867060755,0.016612531,0.205468978,2621;558;85480;100130733,LRRC70;GAS6;TSLP;AXL
GO:0048701,embryonic cranial skeleton morphogenesis (GO:0048701),15,4,1.034377335,3.867060755,0.016612531,0.205468978,7048;6495;5156;25902,TGFBR2;MTHFD1L;SIX1;PDGFRA
GO:0007492,endoderm development (GO:0007492),15,4,1.034377335,3.867060755,0.016612531,0.205468978,64321;1847;1843;83595,DUSP1;SOX17;DUSP5;SOX7
GO:0010594,regulation of endothelial cell migration (GO:0010594),88,12,6.068347034,1.97747425,0.017361637,0.213854097,388;284;3690;56999;9353;2247;6781;57381;1634;64094;84913;6237,RHOJ;FGF2;DCN;RHOB;SLIT2;SMOC2;ATOH8;RRAS;ITGB3;ADAMTS9;ANGPT1;STC1
GO:0050729,positive regulation of inflammatory response (GO:0050729),88,12,6.068347034,1.97747425,0.017361637,0.213854097,6622;3569;388125;5734;5138;185;6376;3572;85480;90865;5320;26471,IL6;AGTR1;PDE2A;IL33;TSLP;IL6ST;PLA2G2A;CX3CL1;C2CD4B;PTGER4;SNCA;NUPR1
GO:0018108,peptidyl-tyrosine phosphorylation (GO:0018108),68,10,4.689177254,2.132570269,0.017570926,0.214807791,3815;2690;660;2048;2042;5649;2202;5156;2260;91461,BMX;RELN;EPHA3;GHR;PKDCC;FGFR1;KIT;EFEMP1;PDGFRA;EPHB2
GO:0060070,canonical Wnt signaling pathway (GO:0060070),68,10,4.689177254,2.132570269,0.017570926,0.214807791,857;2535;120892;7483;6422;7472;8324;4929;7482;85458,NR4A2;SFRP1;LRRK2;CAV1;DIXDC1;FZD7;WNT2B;FZD2;WNT2;WNT9A
GO:0071320,cellular response to cAMP (GO:0071320),31,6,2.13771316,2.806737645,0.017617741,0.214807791,65010;9472;5138;358;10411;3488,AQP1;PDE2A;SLC26A6;RAPGEF3;AKAP6;IGFBP5
GO:0032715,negative regulation of interleukin-6 production (GO:0032715),31,6,2.13771316,2.806737645,0.017617741,0.214807791,2621;3071;23208;6376;11213;4345,GAS6;CX3CL1;NCKAP1L;CD200;IRAK3;SYT11
GO:0048638,regulation of developmental growth (GO:0048638),31,6,2.13771316,2.806737645,0.017617741,0.214807791,2690;3479;51804;10439;4897;6495,OLFM1;GHR;SIX4;IGF1;NRCAM;SIX1
GO:0009895,negative regulation of catabolic process (GO:0009895),49,8,3.378965962,2.367588218,0.01794738,0.218384015,2316;150;341;4085;9759;11213;863;26471,FLNA;MAD2L1;ADRA2A;CBFA2T3;HDAC4;IRAK3;APOC1;NUPR1
GO:0045428,regulation of nitric oxide biosynthetic process (GO:0045428),40,7,2.758339561,2.537758621,0.018280735,0.221004126,857;947;1191;5740;10365;493;9314,KLF2;CD34;KLF4;CLU;CAV1;PTGIS;ATP2B4
GO:0044273,sulfur compound catabolic process (GO:0044273),40,7,2.758339561,2.537758621,0.018280735,0.221004126,3373;79094;1634;1464;4958;4969;5549,OGN;PRELP;DCN;HYAL1;OMD;CSPG4;CHAC1
GO:0030195,negative regulation of blood coagulation (GO:0030195),40,7,2.758339561,2.537758621,0.018280735,0.221004126,947;5156;2;7035;2157;2159;2161,F10;A2M;CD34;F8;TFPI;PDGFRA;F12
GO:0043534,blood vessel endothelial cell migration (GO:0043534),23,5,1.586045248,3.152495181,0.018309775,0.221004126,6722;9353;1960;2247;3164,NR4A1;EGR3;FGF2;SRF;SLIT2
GO:1901990,regulation of mitotic cell cycle phase transition (GO:1901990),187,21,12.89523745,1.628508206,0.018515326,0.223037329,5577;22974;9928;11065;991;701;983;4085;6790;5347;891;1062;1063;1869;10733;4751;9735;990;54443;3398;3161,AURKA;KNTC1;KIF14;CENPF;UBE2C;NEK2;CDC6;CDC20;PLK1;TPX2;BUB1B;CCNB1;CDK1;CENPE;HMMR;PLK4;PRKAR2B;ANLN;MAD2L1;E2F1;ID2
GO:0014070,response to organic cyclic compound (GO:0014070),59,9,4.068550853,2.212089839,0.018959437,0.227930357,5244;6696;7226;120892;6422;3488;6347;2099;85315,SFRP1;LRRK2;SPP1;CCL2;TRPM2;PAQR8;ABCB4;ESR1;IGFBP5
GO:0043406,positive regulation of MAP kinase activity (GO:0043406),69,10,4.758135743,2.101663454,0.019322525,0.231369917,3815;150;2247;120892;22943;2260;146433;2146;80310;148252,FGF2;LRRK2;IL34;EZH2;FGFR1;ADRA2A;PDGFD;KIT;DIRAS1;DKK1
GO:0071277,cellular response to calcium ion (GO:0071277),69,10,4.758135743,2.101663454,0.019322525,0.231369917,1894;4208;7226;6263;83849;23208;5563;3707;25932;10235,RASGRP2;MEF2C;RYR3;ECT2;TRPM2;ITPKB;SYT15;CLIC4;SYT11;PRKAA2
GO:0043087,regulation of GTPase activity (GO:0043087),188,21,12.96419594,1.619845928,0.019540437,0.233514044,375790;6366;5909;1894;4915;10979;2042;54922;120892;10411;6422;6376;11149;6347;5592;132864;10235;2146;65078;9824;55843,SFRP1;RASGRP2;LRRK2;EPHA3;RTN4R;CPEB2;ARHGAP11A;CX3CL1;FERMT2;ECT2;CCL2;BVES;RAPGEF3;EZH2;ARHGAP15;RAP1GAP;PRKG1;AGRN;CCL21;NTRK2;RASIP1
GO:0070252,actin-mediated cell contraction (GO:0070252),9,3,0.620626401,4.833825944,0.020051441,0.235994594,2934;55742;70,ACTC1;GSN;PARVA
GO:0060575,intestinal epithelial cell differentiation (GO:0060575),9,3,0.620626401,4.833825944,0.020051441,0.235994594,140628;2627;3572,GATA5;GATA6;IL6ST
GO:0090129,positive regulation of synapse maturation (GO:0090129),9,3,0.620626401,4.833825944,0.020051441,0.235994594,991;9378;5649,RELN;NRXN1;CDC20
GO:0002691,regulation of cellular extravasation (GO:0002691),9,3,0.620626401,4.833825944,0.020051441,0.235994594,83700;10562;683,JAM3;OLFM4;BST1
GO:0098883,synapse pruning (GO:0098883),9,3,0.620626401,4.833825944,0.020051441,0.235994594,6376;22943;718,CX3CL1;C3;DKK1
GO:0046602,regulation of mitotic centrosome separation (GO:0046602),9,3,0.620626401,4.833825944,0.020051441,0.235994594,3832;1111;4751,NEK2;KIF11;CHEK1
GO:1901617,organic hydroxy compound biosynthetic process (GO:1901617),50,8,3.447924451,2.320236453,0.020116379,0.235994594,1593;9023;51302;8309;8864;51422;6713;1717,ACOX2;PER2;CH25H;CYP39A1;PRKAG2;DHCR7;CYP27A1;SQLE
GO:0030449,regulation of complement activation (GO:0030449),50,8,3.447924451,2.320236453,0.020116379,0.235994594,1191;718;5199;715;716;3078;3075;730,C7;CFP;CLU;C3;CFHR1;C1R;CFH;C1S
GO:0043408,regulation of MAPK cascade (GO:0043408),166,19,11.44710918,1.659807704,0.020272104,0.235994594,23043;3815;154;4915;1902;3479;150;3569;857;2045;2247;7049;6376;1843;2260;57161;4920;4919;6237,DUSP1;IL6;FGF2;TGFBR3;EPHA7;CAV1;CX3CL1;LPAR1;ROR1;FGFR1;ADRA2A;IGF1;KIT;PELI2;ADRB2;TNIK;RRAS;NTRK2;ROR2
GO:0051899,membrane depolarization (GO:0051899),32,6,2.206671649,2.719027094,0.020454697,0.235994594,8912;6332;3757;857;785;6324,SCN7A;CAV1;CACNA1H;KCNH2;CACNB4;SCN1B
GO:0007202,activation of phospholipase C activity (GO:0007202),32,6,2.206671649,2.719027094,0.020454697,0.235994594,395;1909;4915;627;6401;1902,ARHGAP6;LPAR1;BDNF;EDNRA;SELE;NTRK2
GO:0090049,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),32,6,2.206671649,2.719027094,0.020454697,0.235994594,4223;2247;57381;10000;9314;90627,RHOJ;FGF2;STARD13;KLF4;MEOX2;AKT3
GO:0001889,liver development (GO:0001889),32,6,2.206671649,2.719027094,0.020454697,0.235994594,23242;3569;6790;7049;144455;79733,IL6;AURKA;TGFBR3;E2F7;E2F8;COBL
GO:0001953,negative regulation of cell-matrix adhesion (GO:0001953),32,6,2.206671649,2.719027094,0.020454697,0.235994594,11170;395;10395;9723;347;4321,FAM107A;ARHGAP6;SEMA3E;DLC1;APOD;MMP12
GO:0031326,regulation of cellular biosynthetic process (GO:0031326),32,6,2.206671649,2.719027094,0.020454697,0.235994594,1066;5563;5166;51422;4286;718,PDK4;C3;PRKAG2;CES1;MITF;PRKAA2
GO:2000310,regulation of NMDA receptor activity (GO:2000310),32,6,2.206671649,2.719027094,0.020454697,0.235994594,1740;4208;2048;5649;23542;6347,RELN;MEF2C;DLG2;CCL2;MAPK8IP2;EPHB2
GO:0031111,negative regulation of microtubule polymerization or depolymerization (GO:0031111),32,6,2.206671649,2.719027094,0.020454697,0.235994594,6622;22974;2258;25999;3925;89795,TPX2;FGF13;NAV3;STMN1;CLIP3;SNCA
GO:0033144,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),32,6,2.206671649,2.719027094,0.020454697,0.235994594,6943;6422;1408;672;5187;25959,PER1;TCF21;SFRP1;CRY2;BRCA1;KANK2
GO:1904064,positive regulation of cation transmembrane transport (GO:1904064),41,7,2.82729805,2.475862069,0.020773198,0.237790059,2316;9472;3757;3779;287;3778;3782,ANK2;KCNMB1;KCNN3;KCNMA1;FLNA;KCNH2;AKAP6
GO:0070316,regulation of G0 to G1 transition (GO:0070316),41,7,2.82729805,2.475862069,0.020773198,0.237790059,1111;6241;8317;1869;672;5888;2146,CDC7;BRCA1;RAD51;CHEK1;RRM2;E2F1;EZH2
GO:0070169,positive regulation of biomineral tissue development (GO:0070169),41,7,2.82729805,2.475862069,0.020773198,0.237790059,4208;6546;2201;2824;9636;9365;91461,MEF2C;PKDCC;ISG15;GPM6B;FBN2;KL;SLC8A1
GO:0046320,regulation of fatty acid oxidation (GO:0046320),16,4,1.103335824,3.625369458,0.02096635,0.237790059,10891;5166;51422;8013,PDK4;NR4A3;PPARGC1A;PRKAG2
GO:0007158,neuron cell-cell adhesion (GO:0007158),16,4,1.103335824,3.625369458,0.02096635,0.237790059,9379;9378;152330;9369,NRXN1;CNTN4;NRXN2;NRXN3
GO:0150118,negative regulation of cell-substrate junction organization (GO:0150118),16,4,1.103335824,3.625369458,0.02096635,0.237790059,11170;395;10395;347,FAM107A;ARHGAP6;DLC1;APOD
GO:0051895,negative regulation of focal adhesion assembly (GO:0051895),16,4,1.103335824,3.625369458,0.02096635,0.237790059,11170;395;10395;347,FAM107A;ARHGAP6;DLC1;APOD
GO:1904706,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),16,4,1.103335824,3.625369458,0.02096635,0.237790059,7168;4208;5592;1264,CNN1;MEF2C;TPM1;PRKG1
GO:0070593,dendrite self-avoidance (GO:0070593),16,4,1.103335824,3.625369458,0.02096635,0.237790059,152330;57549;91624;23022,NEXN;PALLD;CNTN4;IGSF9
GO:1901701,cellular response to oxygen-containing compound (GO:1901701),320,32,22.06671649,1.450147783,0.021840587,0.245491345,7538;5244;65010;7168;9472;3569;5138;358;1511;5142;4208;2920;9353;114548;2042;493;6263;10411;7483;6422;7472;8324;5166;5156;55022;3488;6347;8013;2353;1958;558;2099,PDK4;NR4A3;IL6;CTSG;ZFP36;AQP1;PDE2A;SFRP1;FOS;EGR1;PDE4B;SLC26A6;MEF2C;EPHA3;PID1;SLIT2;RYR3;FZD7;CCL2;AXL;RAPGEF3;TPM1;AKAP6;CXCL2;WNT2;NLRP3;ATP2B4;ABCB4;ESR1;WNT9A;PDGFRA;IGFBP5
GO:0007528,neuromuscular junction development (GO:0007528),24,5,1.655003737,3.021141215,0.021849587,0.245491345,375790;783;785;120892;23024,LRRK2;PDZRN3;CACNB2;AGRN;CACNB4
GO:0000132,establishment of mitotic spindle orientation (GO:0000132),24,5,1.655003737,3.021141215,0.021849587,0.245491345,4085;5347;10403;1058;89958,SAPCD2;CENPA;PLK1;NDC80;MAD2L1
GO:0055013,cardiac muscle cell development (GO:0055013),24,5,1.655003737,3.021141215,0.021849587,0.245491345,70;6546;4629;5156;8470,ACTC1;SORBS2;MYH11;PDGFRA;SLC8A1
GO:0055075,potassium ion homeostasis (GO:0055075),24,5,1.655003737,3.021141215,0.021849587,0.245491345,3757;477;3778;482;84561,ATP1A2;ATP1B2;SLC12A8;KCNMA1;KCNH2
GO:0044089,positive regulation of cellular component biogenesis (GO:0044089),91,12,6.275222502,1.912282791,0.022118245,0.247584306,10435;11117;1191;11076;81620;3373;6376;4312;7037;6886;11346;171024,SYNPO2;TPPP;CDC42EP2;CLU;HYAL1;CDT1;SYNPO;CX3CL1;EMILIN1;MMP1;TFRC;TAL1
GO:0019216,regulation of lipid metabolic process (GO:0019216),91,12,6.275222502,1.912282791,0.022118245,0.247584306,32;6319;857;341;51422;3398;6713;1717;12;388121;83643;114898,TNFAIP8L3;C1QTNF2;CAV1;ACACB;SERPINA3;CCDC3;SCD;ID2;PRKAG2;DHCR7;APOC1;SQLE
GO:0019722,calcium-mediated signaling (GO:0019722),102,13,7.033765881,1.848227567,0.022876242,0.255118901,6401;5737;185;775;287;1910;6262;6546;7226;6403;1827;10231;120892,RCAN2;AGTR1;ANK2;EDNRB;PTGFR;LRRK2;RCAN1;SELP;TRPM2;SELE;RYR2;SLC8A1;CACNA1C
GO:0071417,cellular response to organonitrogen compound (GO:0071417),102,13,7.033765881,1.848227567,0.022876242,0.255118901,65010;9472;5138;358;4208;9353;7226;6263;10411;6422;672;3488;1958,AQP1;PDE2A;SFRP1;EGR1;SLC26A6;MEF2C;BRCA1;SLIT2;RYR3;RAPGEF3;AKAP6;TRPM2;IGFBP5
GO:0001933,negative regulation of protein phosphorylation (GO:0001933),146,17,10.0679394,1.688528241,0.023347345,0.259890542,5167;1756;6622;857;5144;9353;11117;2048;120892;6422;51422;22943;91663;55022;5590;25937;2192,SFRP1;LRRK2;MYADM;PID1;CAV1;SLIT2;PDE4D;DMD;EMILIN1;WWTR1;PRKAG2;FBLN1;EPHB2;PRKCZ;DKK1;SNCA;ENPP1
GO:0050853,B cell receptor signaling pathway (GO:0050853),33,6,2.275630138,2.636632333,0.023586023,0.261096842,3071;5579;974;660;596;4208,BMX;PRKCB;MEF2C;BCL2;CD79B;NCKAP1L
GO:0055001,muscle cell development (GO:0055001),33,6,2.275630138,2.636632333,0.023586023,0.261096842,1756;3479;287;6546;4629;274,ANK2;BIN1;DMD;IGF1;MYH11;SLC8A1
GO:0035065,regulation of histone acetylation (GO:0035065),33,6,2.275630138,2.636632333,0.023586023,0.261096842,6622;1111;10891;10411;93649;672,MYOCD;BRCA1;PPARGC1A;CHEK1;RAPGEF3;SNCA
GO:0001932,regulation of protein phosphorylation (GO:0001932),263,27,18.13608261,1.488744873,0.024734919,0.273311756,23043;2252;1894;4915;284;2621;3690;9353;2048;2045;2247;120892;3953;3082;91663;55022;7037;718;467;146433;57161;25999;25937;2192;64061;894;683,FGF2;LRRK2;IL34;GAS6;MYADM;FGF7;PID1;EPHA7;SLIT2;ATF3;CCND2;ECT2;TSPYL2;C3;WWTR1;LEPR;HGF;CLIP3;PELI2;FBLN1;TFRC;TNIK;NTRK2;ITGB3;EPHB2;ANGPT1;BST1
GO:0043254,regulation of protein-containing complex assembly (GO:0043254),114,14,7.861267749,1.780883243,0.02496226,0.274737495,2934;10435;1191;11076;81620;6403;225689;4312;7037;6812;5590;1410;55355;6886,TPPP;CRYAB;CDC42EP2;GSN;HJURP;CLU;CDT1;SELP;MAPK15;MMP1;TFRC;PRKCZ;TAL1;STXBP1
GO:0031333,negative regulation of protein-containing complex assembly (GO:0031333),52,8,3.585841429,2.23099659,0.025001066,0.274737495,9928;5734;83700;1191;22943;5590;1410;7067,CRYAB;KIF14;CLU;JAM3;THRA;PTGER4;PRKCZ;DKK1
GO:0001667,ameboidal-type cell migration (GO:0001667),52,8,3.585841429,2.23099659,0.025001066,0.274737495,309;6663;154810;54437;55698;9723;7869;56920,SOX10;SEMA5B;SEMA3G;ANXA6;SEMA3E;SEMA3B;AMOTL1;RADIL
GO:0032091,negative regulation of protein binding (GO:0032091),72,10,4.96501121,2.014094143,0.025342731,0.277477511,154;489;857;6790;9212;10763;120892;22943;3078;9532,AURKA;LRRK2;CAV1;NES;BAG2;AURKB;CFHR1;ATP2A3;ADRB2;DKK1
GO:0000904,cell morphogenesis involved in differentiation (GO:0000904),72,10,4.96501121,2.014094143,0.025342731,0.277477511,55742;9928;3690;10979;55698;4208;5649;8516;10319;11149,ITGA8;RELN;KIF14;MEF2C;LAMC3;FERMT2;BVES;ITGB3;PARVA;RADIL
GO:0090022,regulation of neutrophil chemotaxis (GO:0090022),25,5,1.723962226,2.900295567,0.025805409,0.278534955,6366;83700;3071;9353;683,SLIT2;JAM3;NCKAP1L;CCL21;BST1
GO:0031114,regulation of microtubule depolymerization (GO:0031114),25,5,1.723962226,2.900295567,0.025805409,0.278534955,22974;4130;4131;2258;89795,TPX2;FGF13;NAV3;MAP1B;MAP1A
GO:0098901,regulation of cardiac muscle cell action potential (GO:0098901),25,5,1.723962226,2.900295567,0.025805409,0.278534955,857;775;287;6262;2258,ANK2;CAV1;FGF13;RYR2;CACNA1C
GO:0060314,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),25,5,1.723962226,2.900295567,0.025805409,0.278534955,1756;9472;5144;57158;845,CASQ2;JPH2;PDE4D;DMD;AKAP6
GO:1902430,negative regulation of amyloid-beta formation (GO:1902430),17,4,1.172294313,3.412112431,0.025956435,0.278534955,4915;3479;1191;274,CLU;BIN1;IGF1;NTRK2
GO:0014911,positive regulation of smooth muscle cell migration (GO:0014911),17,4,1.172294313,3.412112431,0.025956435,0.278534955,3479;3488;8013;9510,NR4A3;ADAMTS1;IGF1;IGFBP5
GO:0010959,regulation of metal ion transport (GO:0010959),17,4,1.172294313,3.412112431,0.025956435,0.278534955,596;287;5350;781,ANK2;PLN;BCL2;CACNA2D1
GO:0014742,positive regulation of muscle hypertrophy (GO:0014742),17,4,1.172294313,3.412112431,0.025956435,0.278534955,3479;9464;8013;3572,NR4A3;HAND2;IL6ST;IGF1
GO:1903579,negative regulation of ATP metabolic process (GO:1903579),17,4,1.172294313,3.412112431,0.025956435,0.278534955,9759;55022;863;26471,PID1;CBFA2T3;HDAC4;NUPR1
GO:0034199,activation of protein kinase A activity (GO:0034199),17,4,1.172294313,3.412112431,0.025956435,0.278534955,111;196883;108;5577,ADCY5;ADCY4;PRKAR2B;ADCY2
GO:0034097,response to cytokine (GO:0034097),148,17,10.20585638,1.665710292,0.026258377,0.278534955,9472;6622;1116;6401;3570;6722;596;9759;6403;55022;9636;11213;3572;1440;3977;3899;7079,AFF3;SRF;PID1;CSF3;IL6ST;BCL2;SELP;AKAP6;LIFR;TIMP4;SELE;HDAC4;IRAK3;ISG15;IL6R;CHI3L1;SNCA
GO:0010389,regulation of G2/M transition of mitotic cell cycle (GO:0010389),148,17,10.20585638,1.665710292,0.026258377,0.278534955,5577;22974;9928;983;6790;5347;891;1063;993;8317;995;10733;23194;4751;51514;3161;2273,FHL1;AURKA;KIF14;CENPF;DTL;NEK2;CDC7;CDC25C;PLK1;TPX2;CCNB1;CDK1;HMMR;PLK4;CDC25A;PRKAR2B;FBXL7
GO:0071375,cellular response to peptide hormone stimulus (GO:0071375),104,13,7.171682859,1.812684729,0.026398389,0.278534955,5167;111;196883;108;5577;3625;10580;857;3164;4929;6517;8013;132864,NR4A1;NR4A3;NR4A2;ADCY5;SLC2A4;SORBS1;CAV1;ADCY4;CPEB2;PRKAR2B;INHBB;ENPP1;ADCY2
GO:0050796,regulation of insulin secretion (GO:0050796),104,13,7.171682859,1.812684729,0.026398389,0.278534955,111;150;3625;3569;26154;775;6659;8864;4826;3708;10411;6422;25924,IL6;ADCY5;ITPR1;SFRP1;MYRIP;SOX4;PER2;NNAT;RAPGEF3;ADRA2A;ABCA12;INHBB;CACNA1C
GO:0045005,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),43,7,2.965215028,2.360705694,0.026446986,0.278534955,10293;8914;29980;641;5888;146956;4796,TIMELESS;TONSL;EME1;BLM;TRAIP;RAD51;DONSON
GO:0070374,positive regulation of ERK1 and ERK2 cascade (GO:0070374),171,19,11.79190162,1.611275315,0.026707506,0.278534955,6366;1116;4915;284;2621;10979;9464;1880;2247;5156;6376;6347;5590;5320;4920;4919;388121;80310;152007,TNFAIP8L3;FGF2;GAS6;HAND2;PLA2G2A;GPR183;CX3CL1;FERMT2;CCL2;ROR1;PDGFD;CCL21;NTRK2;GLIPR2;CHI3L1;PDGFRA;ROR2;PRKCZ;ANGPT1
GO:0031145,anaphase-promoting complex-dependent catabolic process (GO:0031145),83,11,5.723554589,1.921882604,0.026828681,0.278534955,11065;991;701;983;4085;6790;9212;9232;5347;891;6502,AURKA;UBE2C;CDC20;PLK1;BUB1B;CCNB1;CDK1;AURKB;SKP2;MAD2L1;PTTG1
GO:0051973,positive regulation of telomerase activity (GO:0051973),34,6,2.344588627,2.559084323,0.02702296,0.278534955,9212;4609;225689;4751;9314;25849,KLF4;NEK2;AURKB;PARM1;MAPK15;MYC
GO:0043537,negative regulation of blood vessel endothelial cell migration (GO:0043537),34,6,2.344588627,2.559084323,0.02702296,0.278534955,4208;4223;2247;493;9314;90627,FGF2;STARD13;MEF2C;KLF4;MEOX2;ATP2B4
GO:0060562,epithelial tube morphogenesis (GO:0060562),34,6,2.344588627,2.559084323,0.02702296,0.278534955,388;4208;9353;54922;64321;6262,SOX17;MEF2C;RHOB;SLIT2;RYR2;RASIP1
GO:0021953,central nervous system neuron differentiation (GO:0021953),34,6,2.344588627,2.559084323,0.02702296,0.278534955,4915;6659;7472;4929;23017;9760,FAIM2;NR4A2;SOX4;WNT2;NTRK2;TOX
GO:0009650,UV protection (GO:0009650),10,3,0.68958489,4.35044335,0.027200136,0.278534955,2237;4239;51435,MFAP4;FEN1;SCARA3
GO:2000756,regulation of peptidyl-lysine acetylation (GO:2000756),10,3,0.68958489,4.35044335,0.027200136,0.278534955,5563;93649;28999,MYOCD;KLF15;PRKAA2
GO:0071379,cellular response to prostaglandin stimulus (GO:0071379),10,3,0.68958489,4.35044335,0.027200136,0.278534955,5737;5734;6422,PTGFR;SFRP1;PTGER4
GO:0106030,neuron projection fasciculation (GO:0106030),10,3,0.68958489,4.35044335,0.027200136,0.278534955,152330;4897;2048,CNTN4;NRCAM;EPHB2
GO:0045820,negative regulation of glycolytic process (GO:0045820),10,3,0.68958489,4.35044335,0.027200136,0.278534955,9759;863;26471,CBFA2T3;HDAC4;NUPR1
GO:1900543,negative regulation of purine nucleotide metabolic process (GO:1900543),10,3,0.68958489,4.35044335,0.027200136,0.278534955,9759;863;26471,CBFA2T3;HDAC4;NUPR1
GO:1901841,regulation of high voltage-gated calcium channel activity (GO:1901841),10,3,0.68958489,4.35044335,0.027200136,0.278534955,783;5142;781,PDE4B;CACNB2;CACNA2D1
GO:0006171,cAMP biosynthetic process (GO:0006171),10,3,0.68958489,4.35044335,0.027200136,0.278534955,111;196883;108,ADCY5;ADCY4;ADCY2
GO:2000757,negative regulation of peptidyl-lysine acetylation (GO:2000757),10,3,0.68958489,4.35044335,0.027200136,0.278534955,6622;672;28999,BRCA1;KLF15;SNCA
GO:0035493,SNARE complex assembly (GO:0035493),10,3,0.68958489,4.35044335,0.027200136,0.278534955,6622;6812;29091,STXBP6;STXBP1;SNCA
GO:1900120,regulation of receptor binding (GO:1900120),10,3,0.68958489,4.35044335,0.027200136,0.278534955,489;627;64388,GREM2;BDNF;ATP2A3
GO:0010559,regulation of glycoprotein biosynthetic process (GO:0010559),10,3,0.68958489,4.35044335,0.027200136,0.278534955,6366;3479;64168,NECAB1;IGF1;CCL21
GO:1902947,regulation of tau-protein kinase activity (GO:1902947),10,3,0.68958489,4.35044335,0.027200136,0.278534955,1191;22943;1958,EGR1;CLU;DKK1
GO:0033314,mitotic DNA replication checkpoint signaling (GO:0033314),10,3,0.68958489,4.35044335,0.027200136,0.278534955,63967;990;4998,ORC1;CLSPN;CDC6
GO:0030949,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),10,3,0.68958489,4.35044335,0.027200136,0.278534955,3690;5579;3678,PRKCB;ITGA5;ITGB3
GO:0001867,"complement activation, lectin pathway (GO:0001867)",10,3,0.68958489,4.35044335,0.027200136,0.278534955,4239;78989;5648,MFAP4;MASP1;COLEC11
GO:2001214,positive regulation of vasculogenesis (GO:2001214),10,3,0.68958489,4.35044335,0.027200136,0.278534955,947;55273;6237,CD34;TMEM100;RRAS
GO:0050871,positive regulation of B cell activation (GO:0050871),53,8,3.654799918,2.188902314,0.027730068,0.282517696,3569;3071;596;4208;2048;1880;7037;683,IL6;MEF2C;GPR183;BCL2;NCKAP1L;TFRC;EPHB2;BST1
GO:0048738,cardiac muscle tissue development (GO:0048738),53,8,3.654799918,2.188902314,0.027730068,0.282517696,70;56999;140628;6444;653;2627;4487;93649,MYOCD;GATA5;BMP5;ACTC1;GATA6;MSX1;SGCD;ADAMTS9
GO:0002697,regulation of immune effector process (GO:0002697),53,8,3.654799918,2.188902314,0.027730068,0.282517696,1191;718;5199;715;716;3078;3075;730,C7;CFP;CLU;C3;CFHR1;C1R;CFH;C1S
GO:0031532,actin cytoskeleton reorganization (GO:0031532),63,9,4.344384809,2.07163969,0.027999102,0.284303338,2316;2934;55742;23043;8572;1901;3815;2252;221981,GSN;PDLIM4;FGF7;FLNA;S1PR1;KIT;TNIK;THSD7A;PARVA
GO:0072657,protein localization to membrane (GO:0072657),195,21,13.44690536,1.561697613,0.027999929,0.284303338,375790;2316;23043;2621;857;10267;10979;26154;1740;783;9379;9378;287;2258;91663;6812;9863;30846;254887;92162;7871,ANK2;TMEM88;NRXN1;RAMP1;DLG2;GAS6;MYADM;CAV1;FGF13;EHD2;FLNA;FERMT2;MAGI2;CACNB2;NRXN2;SLMAP;AGRN;ABCA12;ZDHHC23;TNIK;STXBP1
GO:0006302,double-strand break repair (GO:0006302),161,18,11.10231673,1.621283236,0.0288386,0.29232517,322;10721;1763;2237;9319;83990;672;9401;641;5888;7516;10635;113130;3838;675;146956;4796;25900,XRCC2;RECQL4;TONSL;POLQ;EME1;CDCA5;DNA2;BLM;TRIP13;KPNA2;BRCA1;RAD51AP1;RAD51;BRIP1;APBB1;IFFO1;BRCA2;FEN1
GO:0034109,homotypic cell-cell adhesion (GO:0034109),44,7,3.034173517,2.307053292,0.029644824,0.299487455,2316;3690;1465;5156;1048;6812;10398,MYL9;FLNA;CSRP1;CEACAM5;ITGB3;PDGFRA;STXBP1
GO:0003208,cardiac ventricle morphogenesis (GO:0003208),44,7,3.034173517,2.307053292,0.029644824,0.299487455,7168;7139;7048;4208;2294;6659;7049,FOXF1;TGFBR2;TGFBR3;SOX4;MEF2C;TPM1;TNNT2
GO:0032392,DNA geometric change (GO:0032392),26,5,1.792920715,2.788745737,0.030191024,0.299964046,1763;80119;9401;641;3149,RECQL4;HMGB3;DNA2;BLM;PIF1
GO:0051155,positive regulation of striated muscle cell differentiation (GO:0051155),26,5,1.792920715,2.788745737,0.030191024,0.299964046,221662;9472;3479;4208;93649,MYOCD;RBM24;MEF2C;AKAP6;IGF1
GO:1900087,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),26,5,1.792920715,2.788745737,0.030191024,0.299964046,3373;990;9510;894;27085,ADAMTS1;CDC6;HYAL1;CCND2;MTBP
GO:0001885,endothelial cell development (GO:0001885),26,5,1.792920715,2.788745737,0.030191024,0.299964046,5138;5144;6781;10411;91663,PDE2A;MYADM;PDE4D;RAPGEF3;STC1
GO:0043010,camera-type eye development (GO:0043010),26,5,1.792920715,2.788745737,0.030191024,0.299964046,775;10763;2201;2202;5308,NES;EFEMP1;FBN2;CACNA1C;PITX2
GO:0032272,negative regulation of protein polymerization (GO:0032272),26,5,1.792920715,2.788745737,0.030191024,0.299964046,6622;9353;91663;25999;3925,MYADM;SLIT2;STMN1;CLIP3;SNCA
GO:0032330,regulation of chondrocyte differentiation (GO:0032330),26,5,1.792920715,2.788745737,0.030191024,0.299964046,7704;2202;7483;81792;91461,ZBTB16;PKDCC;EFEMP1;WNT9A;ADAMTS12
GO:1901016,regulation of potassium ion transmembrane transporter activity (GO:1901016),26,5,1.792920715,2.788745737,0.030191024,0.299964046,287;845;3755;482;2273,FHL1;ANK2;ATP1B2;CASQ2;KCNG1
GO:0031641,regulation of myelination (GO:0031641),26,5,1.792920715,2.788745737,0.030191024,0.299964046,9928;11076;1959;58494;163175,LGI4;TPPP;JAM2;KIF14;EGR2
GO:0021782,glial cell development (GO:0021782),26,5,1.792920715,2.788745737,0.030191024,0.299964046,6663;11076;6659;56978;118738,TPPP;SOX10;SOX4;PRDM8;ZNF488
GO:0051893,regulation of focal adhesion assembly (GO:0051893),54,8,3.723758408,2.148367086,0.03065846,0.303265849,11170;395;10395;10979;2042;347;6422;2824,FAM107A;ARHGAP6;SFRP1;EPHA3;FERMT2;DLC1;GPM6B;APOD
GO:0070301,cellular response to hydrogen peroxide (GO:0070301),35,6,2.413547116,2.485967628,0.030775606,0.303265849,388;1894;3569;358;7226;7732,IL6;AQP1;RHOB;RNF112;ECT2;TRPM2
GO:0060541,respiratory system development (GO:0060541),35,6,2.413547116,2.485967628,0.030775606,0.303265849,2252;1116;84976;2294;2247;6943,TCF21;FOXF1;FGF2;FGF7;CHI3L1;DISP1
GO:1902807,negative regulation of cell cycle G1/S phase transition (GO:1902807),35,6,2.413547116,2.485967628,0.030775606,0.303265849,11170;6347;9314;144455;25959;2273,FAM107A;FHL1;KLF4;E2F7;KANK2;CCL2
GO:0046580,negative regulation of Ras protein signal transduction (GO:0046580),35,6,2.413547116,2.485967628,0.030775606,0.303265849,10395;83478;2048;54922;10252;3925,SPRY1;STMN1;DLC1;ARHGAP24;EPHB2;RASIP1
GO:1902532,negative regulation of intracellular signal transduction (GO:1902532),197,21,13.58482234,1.545842815,0.030863466,0.30363387,399;84952;11113;857;1608;5138;5144;596;9353;114548;933;493;3708;5563;91663;1843;2099;9863;5187;219790;7957,PER1;DUSP1;PDE2A;ITPR1;MYADM;CGNL1;CAV1;SLIT2;CIT;PDE4D;CD22;BCL2;MAGI2;NLRP3;ATP2B4;ESR1;DGKG;RTKN2;PRKAA2;RHOH;EPM2A
GO:0051100,negative regulation of binding (GO:0051100),85,11,5.861471567,1.876661837,0.031342287,0.304394957,857;6790;9212;5350;10763;120892;1869;22943;22927;3078;9532,AURKA;LRRK2;PLN;CAV1;NES;BAG2;AURKB;E2F1;CFHR1;HABP4;DKK1
GO:0071385,cellular response to glucocorticoid stimulus (GO:0071385),18,4,1.241252803,3.222550629,0.031599144,0.304394957,7538;11170;358;687,FAM107A;KLF9;ZFP36;AQP1
GO:0045577,regulation of B cell differentiation (GO:0045577),18,4,1.241252803,3.222550629,0.031599144,0.304394957,3624;3071;6422;3398,SFRP1;INHBA;ID2;NCKAP1L
GO:0070102,interleukin-6-mediated signaling pathway (GO:0070102),18,4,1.241252803,3.222550629,0.031599144,0.304394957,3569;3570;9021;3572,IL6;IL6ST;SOCS3;IL6R
GO:0050901,leukocyte tethering or rolling (GO:0050901),18,4,1.241252803,3.222550629,0.031599144,0.304394957,6401;6403;58494;50512,JAM2;SELP;SELE;PODXL2
GO:0003254,regulation of membrane depolarization (GO:0003254),18,4,1.241252803,3.222550629,0.031599144,0.304394957,6324;6910;120892;2273,FHL1;LRRK2;SCN1B;TBX5
GO:0051968,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",18,4,1.241252803,3.222550629,0.031599144,0.304394957,9378;5649;6347;57616,RELN;NRXN1;CCL2;TSHZ3
GO:0019217,regulation of fatty acid metabolic process (GO:0019217),18,4,1.241252803,3.222550629,0.031599144,0.304394957,857;5563;5166;51422,PDK4;CAV1;PRKAG2;PRKAA2
GO:0090224,regulation of spindle organization (GO:0090224),18,4,1.241252803,3.222550629,0.031599144,0.304394957,79866;22974;10460;84722,BORA;TPX2;TACC3;PSRC1
GO:0045687,positive regulation of glial cell differentiation (GO:0045687),18,4,1.241252803,3.222550629,0.031599144,0.304394957,1959;274;146433;3398,IL34;BIN1;ID2;EGR2
GO:0030214,hyaluronan catabolic process (GO:0030214),18,4,1.241252803,3.222550629,0.031599144,0.304394957,2247;3373;10894;3161,LYVE1;FGF2;HYAL1;HMMR
GO:0022616,DNA strand elongation (GO:0022616),18,4,1.241252803,3.222550629,0.031599144,0.304394957,4173;51659;9837;84296,GINS1;MCM4;GINS4;GINS2
GO:0006271,DNA strand elongation involved in DNA replication (GO:0006271),18,4,1.241252803,3.222550629,0.031599144,0.304394957,4173;51659;9837;84296,GINS1;MCM4;GINS4;GINS2
GO:0009966,regulation of signal transduction (GO:0009966),198,21,13.65378083,1.538035528,0.032375202,0.311371744,11343;2869;26153;1191;4684;66000;120892;6376;23542;3489;3488;3977;2099;25937;64061;5997;683;84870;2788;8786;8490,RGS2;MGLL;GNG7;NCAM1;RSPO3;LRRK2;RGS5;CLU;KIF26A;IGFBP6;CX3CL1;TSPYL2;LIFR;WWTR1;GRK5;MAPK8IP2;RGS11;ESR1;TMEM108;BST1;IGFBP5
GO:0001508,action potential (GO:0001508),45,7,3.103132006,2.255785441,0.033093247,0.317262372,1756;23704;9472;8912;9630;6332;3757,SCN7A;CACNA1H;KCNH2;DMD;AKAP6;GNA14;KCNE4
GO:0014032,neural crest cell development (GO:0014032),45,7,3.103132006,2.255785441,0.033093247,0.317262372,309;6663;54437;55698;9723;7869;56920,SOX10;SEMA5B;SEMA3G;ANXA6;SEMA3E;SEMA3B;RADIL
GO:0045787,positive regulation of cell cycle (GO:0045787),65,9,4.482301787,2.007896931,0.033499783,0.320648403,891;1111;1978;6886;9099;64094;84722;894;26471,USP2;CCNB1;SMOC2;CCND2;CHEK1;EIF4EBP1;PSRC1;TAL1;NUPR1
GO:0018212,peptidyl-tyrosine modification (GO:0018212),55,8,3.792716897,2.109305867,0.033791962,0.322048205,3815;2048;2042;5649;2202;5156;2260;91461,RELN;EPHA3;PKDCC;FGFR1;KIT;EFEMP1;PDGFRA;EPHB2
GO:0007266,Rho protein signal transduction (GO:0007266),55,8,3.792716897,2.109305867,0.033791962,0.322048205,10435;388;395;4804;150;185;9423;57381,RHOJ;AGTR1;ARHGAP6;CDC42EP2;NGFR;RHOB;ADRA2A;NTN1
GO:0070527,platelet aggregation (GO:0070527),36,6,2.482505605,2.416912972,0.034852856,0.322048205,2316;3690;1465;5156;6812;10398,MYL9;FLNA;CSRP1;ITGB3;PDGFRA;STXBP1
GO:1900026,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),36,6,2.482505605,2.416912972,0.034852856,0.322048205,2316;5881;10979;55679;91663;10562,LIMS2;MYADM;FLNA;RAC3;FERMT2;OLFM4
GO:0002028,regulation of sodium ion transport (GO:0002028),36,6,2.482505605,2.416912972,0.034852856,0.322048205,6330;6324;493;6640;5187;7871,PER1;SCN4B;SLMAP;SCN1B;ATP2B4;SNTA1
GO:0007190,activation of adenylate cyclase activity (GO:0007190),36,6,2.482505605,2.416912972,0.034852856,0.322048205,10486;111;196883;154;108;1909,ADCY5;ADCY4;CAP2;EDNRA;ADRB2;ADCY2
GO:1902806,regulation of cell cycle G1/S phase transition (GO:1902806),36,6,2.482505605,2.416912972,0.034852856,0.322048205,9928;493;1869;3398;2146;4330,KIF14;E2F1;EZH2;ID2;ATP2B4;MN1
GO:0051384,response to glucocorticoid (GO:0051384),27,5,1.861879204,2.685458858,0.035017743,0.322048205,7538;11170;3569;9353;6586,FAM107A;IL6;ZFP36;SLIT3;SLIT2
GO:0098815,modulation of excitatory postsynaptic potential (GO:0098815),27,5,1.861879204,2.685458858,0.035017743,0.322048205,9378;5649;66000;120892;5590,RELN;LRRK2;NRXN1;TMEM108;PRKCZ
GO:0030193,regulation of blood coagulation (GO:0030193),27,5,1.861879204,2.685458858,0.035017743,0.322048205,857;947;2048;7035;2161,CD34;CAV1;TFPI;EPHB2;F12
GO:0042886,amide transport (GO:0042886),27,5,1.861879204,2.685458858,0.035017743,0.322048205,6573;84976;26154;2350;8884,SLC5A6;SLC19A1;FOLR2;ABCA12;DISP1
GO:0045931,positive regulation of mitotic cell cycle (GO:0045931),27,5,1.861879204,2.685458858,0.035017743,0.322048205,891;1978;6886;9099;64094,USP2;CCNB1;SMOC2;EIF4EBP1;TAL1
GO:0019371,cyclooxygenase pathway (GO:0019371),11,3,0.758543379,3.9549485,0.035521204,0.322048205,5730;5740;5742,PTGS1;PTGDS;PTGIS
GO:0062099,negative regulation of programmed necrotic cell death (GO:0062099),11,3,0.758543379,3.9549485,0.035521204,0.322048205,291;330;26471,BIRC3;SLC25A4;NUPR1
GO:0006853,carnitine shuttle (GO:0006853),11,3,0.758543379,3.9549485,0.035521204,0.322048205,32;5563;51422,ACACB;PRKAG2;PRKAA2
GO:0030042,actin filament depolymerization (GO:0030042),11,3,0.758543379,3.9549485,0.035521204,0.322048205,2934;1073;11034,GSN;CFL2;DSTN
GO:1900006,positive regulation of dendrite development (GO:1900006),11,3,0.758543379,3.9549485,0.035521204,0.322048205,23242;653;7804,BMP5;LRP8;COBL
GO:0014904,myotube cell development (GO:0014904),11,3,0.758543379,3.9549485,0.035521204,0.322048205,58;3479;6495,IGF1;ACTA1;SIX1
GO:1902514,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),11,3,0.758543379,3.9549485,0.035521204,0.322048205,783;781;274,BIN1;CACNB2;CACNA2D1
GO:0150078,positive regulation of neuroinflammatory response (GO:0150078),11,3,0.758543379,3.9549485,0.035521204,0.322048205,3569;90865;26471,IL6;IL33;NUPR1
GO:0010517,regulation of phospholipase activity (GO:0010517),11,3,0.758543379,3.9549485,0.035521204,0.322048205,6622;2260;5997,RGS2;FGFR1;SNCA
GO:2000551,regulation of T-helper 2 cell cytokine production (GO:2000551),11,3,0.758543379,3.9549485,0.035521204,0.322048205,3569;114548;5590,IL6;NLRP3;PRKCZ
GO:0045741,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),11,3,0.758543379,3.9549485,0.035521204,0.322048205,150;1839;374,ADRA2A;HBEGF;AREG
GO:0072075,metanephric mesenchyme development (GO:0072075),11,3,0.758543379,3.9549485,0.035521204,0.322048205,51804;6495;6943,TCF21;SIX4;SIX1
GO:0071636,positive regulation of transforming growth factor beta production (GO:0071636),11,3,0.758543379,3.9549485,0.035521204,0.322048205,947;2627;4345,CD34;GATA6;CD200
GO:0048484,enteric nervous system development (GO:0048484),11,3,0.758543379,3.9549485,0.035521204,0.322048205,6663;26153;1910,SOX10;EDNRB;KIF26A
GO:0022010,central nervous system myelination (GO:0022010),11,3,0.758543379,3.9549485,0.035521204,0.322048205,6663;5354;1191,PLP1;SOX10;CLU
GO:0002065,columnar/cuboidal epithelial cell differentiation (GO:0002065),11,3,0.758543379,3.9549485,0.035521204,0.322048205,140628;6659;2627,GATA5;SOX4;GATA6
GO:2000615,regulation of histone H3-K9 acetylation (GO:2000615),11,3,0.758543379,3.9549485,0.035521204,0.322048205,1111;10411;672,BRCA1;CHEK1;RAPGEF3
GO:0033260,nuclear DNA replication (GO:0033260),11,3,0.758543379,3.9549485,0.035521204,0.322048205,4171;29980;4173,MCM2;MCM4;DONSON
GO:0001325,formation of extrachromosomal circular DNA (GO:0001325),11,3,0.758543379,3.9549485,0.035521204,0.322048205,1763;641;9156,DNA2;EXO1;BLM
GO:0090656,t-circle formation (GO:0090656),11,3,0.758543379,3.9549485,0.035521204,0.322048205,1763;641;9156,DNA2;EXO1;BLM
GO:0090737,telomere maintenance via telomere trimming (GO:0090737),11,3,0.758543379,3.9549485,0.035521204,0.322048205,1763;641;9156,DNA2;EXO1;BLM
GO:2000052,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),11,3,0.758543379,3.9549485,0.035521204,0.322048205,6422;22943;84870,SFRP1;RSPO3;DKK1
GO:0051570,regulation of histone H3-K9 methylation (GO:0051570),11,3,0.758543379,3.9549485,0.035521204,0.322048205,672;4602;1789,BRCA1;DNMT3B;MYB
GO:0048568,embryonic organ development (GO:0048568),66,9,4.551260276,1.97747425,0.036511956,0.330532176,3815;23242;7048;64321;10763;7732;6491;91461;6886,SOX17;TGFBR2;STIL;RNF112;NES;PKDCC;KIT;TAL1;COBL
GO:0007010,cytoskeleton organization (GO:0007010),120,14,8.275018683,1.69183908,0.036668564,0.33113475,23043;7168;399;388;390;5881;81624;1674;23022;6347;274;1808;79658;7694,DES;BIN1;RHOB;RAC3;PALLD;CCL2;TPM1;ZNF135;ARHGAP10;DPYSL2;TNIK;DIAPH3;RND3;RHOH
GO:0051972,regulation of telomerase activity (GO:0051972),46,7,3.172090495,2.206746627,0.036798871,0.33113475,9212;4609;225689;4751;80119;9314;25849,KLF4;NEK2;AURKB;PIF1;PARM1;MAPK15;MYC
GO:0010569,regulation of double-strand break repair via homologous recombination (GO:0010569),46,7,3.172090495,2.206746627,0.036798871,0.33113475,1111;10721;116028;8914;5888;10635;55010,TIMELESS;POLQ;RAD51AP1;RAD51;PARPBP;CHEK1;RMI2
GO:1900180,regulation of protein localization to nucleus (GO:1900180),46,7,3.172090495,2.206746627,0.036798871,0.33113475,4804;10979;983;5347;7037;51512;25937,NGFR;PLK1;GTSE1;CDK1;FERMT2;WWTR1;TFRC
GO:0033135,regulation of peptidyl-serine phosphorylation (GO:0033135),98,12,6.757931925,1.775691163,0.036858589,0.331176351,1756;6622;627;2621;3569;857;5144;493;10411;22943;7037;1440,IL6;GAS6;CSF3;CAV1;PDE4D;DMD;BDNF;RAPGEF3;ATP2B4;TFRC;DKK1;SNCA
GO:0034622,cellular protein-containing complex assembly (GO:0034622),166,18,11.44710918,1.572449404,0.037500374,0.335066658,1756;154;6622;284;1062;1191;1063;845;23542;6812;29091;274;1346;387103;54443;23149;9787;1058,COX7A1;CASQ2;CENPF;CLU;BIN1;CENPA;DLGAP5;CENPE;DMD;ANLN;MAPK8IP2;ADRB2;FCHO1;STXBP6;ANGPT1;CENPW;STXBP1;SNCA
GO:0060079,excitatory postsynaptic potential (GO:0060079),19,4,1.310211292,3.052942702,0.037904729,0.335066658,4208;2906;120892;23542,LRRK2;MEF2C;GRIN2D;MAPK8IP2
GO:1902992,negative regulation of amyloid precursor protein catabolic process (GO:1902992),19,4,1.310211292,3.052942702,0.037904729,0.335066658,4915;3479;1191;274,CLU;BIN1;IGF1;NTRK2
GO:0048592,eye morphogenesis (GO:0048592),19,4,1.310211292,3.052942702,0.037904729,0.335066658,2201;2202;8076;4237,MFAP5;EFEMP1;FBN2;MFAP2
GO:0061756,leukocyte adhesion to vascular endothelial cell (GO:0061756),19,4,1.310211292,3.052942702,0.037904729,0.335066658,6401;6403;58494;50512,JAM2;SELP;SELE;PODXL2
GO:0051926,negative regulation of calcium ion transport (GO:0051926),19,4,1.310211292,3.052942702,0.037904729,0.335066658,150;5350;6781;477,ATP1A2;PLN;ADRA2A;STC1
GO:0071377,cellular response to glucagon stimulus (GO:0071377),19,4,1.310211292,3.052942702,0.037904729,0.335066658,111;196883;108;5577,ADCY5;ADCY4;PRKAR2B;ADCY2
GO:0003181,atrioventricular valve morphogenesis (GO:0003181),19,4,1.310211292,3.052942702,0.037904729,0.335066658,7048;6586;6659;10439,SLIT3;TGFBR2;SOX4;OLFM1
GO:0001658,branching involved in ureteric bud morphogenesis (GO:0001658),19,4,1.310211292,3.052942702,0.037904729,0.335066658,4609;2247;6495;6943,TCF21;FGF2;SIX1;MYC
GO:0051146,striated muscle cell differentiation (GO:0051146),19,4,1.310211292,3.052942702,0.037904729,0.335066658,4208;93649;11149;64091,MYOCD;MEF2C;BVES;POPDC2
GO:0060675,ureteric bud morphogenesis (GO:0060675),19,4,1.310211292,3.052942702,0.037904729,0.335066658,4609;2247;6495;6943,TCF21;FGF2;SIX1;MYC
GO:2001234,negative regulation of apoptotic signaling pathway (GO:2001234),77,10,5.309803655,1.883308809,0.038184136,0.337040887,627;3479;596;1191;4929;6376;3082;23542;219790;255027,NR4A2;CLU;CX3CL1;BCL2;BDNF;IGF1;HGF;MAPK8IP2;RTKN2;MPV17L
GO:0030001,metal ion transport (GO:0030001),88,11,6.068347034,1.812684729,0.039087123,0.338220825,489;857;10267;775;781;6262;6546;7226;6263;3708;7220,ITPR1;RAMP1;CAV1;RYR3;TRPM2;ATP2A3;TRPC1;RYR2;CACNA2D1;SLC8A1;CACNA1C
GO:2001239,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),28,5,1.930837693,2.589549613,0.040294373,0.338220825,3624;596;2537;2260;2070,INHBA;BCL2;FGFR1;IFI6;EYA4
GO:0031110,regulation of microtubule polymerization or depolymerization (GO:0031110),28,5,1.930837693,2.589549613,0.040294373,0.338220825,4130;4131;3925;220134;221150,SKA1;SKA3;STMN1;MAP1B;MAP1A
GO:0070509,calcium ion import (GO:0070509),28,5,1.930837693,2.589549613,0.040294373,0.338220825,8912;783;775;79085;6546,CACNA1H;SLC25A23;CACNB2;SLC8A1;CACNA1C
GO:0043552,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),28,5,1.930837693,2.589549613,0.040294373,0.338220825,3815;6366;2247;5156;388121,TNFAIP8L3;FGF2;KIT;CCL21;PDGFRA
GO:0050848,regulation of calcium-mediated signaling (GO:0050848),28,5,1.930837693,2.589549613,0.040294373,0.338220825,933;9104;3708;120892;683,ITPR1;RGN;LRRK2;CD22;BST1
GO:0045214,sarcomere organization (GO:0045214),28,5,1.930837693,2.589549613,0.040294373,0.338220825,7168;7139;1465;9172;51804,MYOM2;CSRP1;TPM1;SIX4;TNNT2
GO:0070884,regulation of calcineurin-NFAT signaling cascade (GO:0070884),28,5,1.930837693,2.589549613,0.040294373,0.338220825,9472;3479;493;1827;29995,RCAN1;AKAP6;IGF1;LMCD1;ATP2B4
GO:0001501,skeletal system development (GO:0001501),156,17,10.75752429,1.580289251,0.040670996,0.338220825,1116;3479;5745;5734;7704;6659;656;653;6781;3373;7092;9507;4148;2260;91461;5549;5307,ZBTB16;PRELP;PTH1R;BMP5;SOX4;HYAL1;TLL1;BMP8B;MATN3;PKDCC;FGFR1;IGF1;PITX1;CHI3L1;PTGER4;ADAMTS4;STC1
GO:2000377,regulation of reactive oxygen species metabolic process (GO:2000377),57,8,3.930633875,2.035295134,0.040695026,0.338220825,6622;7048;185;2305;55022;672;83875;683,AGTR1;TGFBR2;FOXM1;BCO2;PID1;BRCA1;BST1;SNCA
GO:0072001,renal system development (GO:0072001),57,8,3.930633875,2.035295134,0.040695026,0.338220825,185;2294;64321;1063;6495;6943;93649;8516,TCF21;FOXF1;SOX17;MYOCD;ITGA8;AGTR1;CENPF;SIX1
GO:1901216,positive regulation of neuron death (GO:1901216),47,7,3.241048984,2.159794571,0.040767586,0.338220825,6622;1191;2045;22943;2353;1958;26471,FOS;EGR1;CLU;EPHA7;DKK1;SNCA;NUPR1
GO:0030838,positive regulation of actin filament polymerization (GO:0030838),47,7,3.241048984,2.159794571,0.040767586,0.338220825,2934;10435;25802;6366;3071;274;1440,LMOD1;CDC42EP2;GSN;BIN1;CSF3;NCKAP1L;CCL21
GO:0006538,glutamate catabolic process (GO:0006538),5,2,0.344792445,5.800591133,0.041299964,0.338220825,137872;2571,ADHFE1;GAD1
GO:0032277,negative regulation of gonadotropin secretion (GO:0032277),5,2,0.344792445,5.800591133,0.041299964,0.338220825,3624;3625,INHBA;INHBB
GO:0035385,Roundabout signaling pathway (GO:0035385),5,2,0.344792445,5.800591133,0.041299964,0.338220825,9353;6586,SLIT3;SLIT2
GO:0051152,positive regulation of smooth muscle cell differentiation (GO:0051152),5,2,0.344792445,5.800591133,0.041299964,0.338220825,3815;93649,MYOCD;KIT
GO:1990416,cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),5,2,0.344792445,5.800591133,0.041299964,0.338220825,4915;66000,NTRK2;TMEM108
GO:0098735,positive regulation of the force of heart contraction (GO:0098735),5,2,0.344792445,5.800591133,0.041299964,0.338220825,6262;6546,RYR2;SLC8A1
GO:0086045,membrane depolarization during AV node cell action potential (GO:0086045),5,2,0.344792445,5.800591133,0.041299964,0.338220825,783;775,CACNB2;CACNA1C
GO:0042749,regulation of circadian sleep/wake cycle (GO:0042749),5,2,0.344792445,5.800591133,0.041299964,0.338220825,5730;8863,PTGDS;PER3
GO:0045986,negative regulation of smooth muscle contraction (GO:0045986),5,2,0.344792445,5.800591133,0.041299964,0.338220825,154;3778,KCNMA1;ADRB2
GO:2000969,positive regulation of AMPA receptor activity (GO:2000969),5,2,0.344792445,5.800591133,0.041299964,0.338220825,154;5649,RELN;ADRB2
GO:2000481,positive regulation of cAMP-dependent protein kinase activity (GO:2000481),5,2,0.344792445,5.800591133,0.041299964,0.338220825,154;493,ATP2B4;ADRB2
GO:0014820,tonic smooth muscle contraction (GO:0014820),5,2,0.344792445,5.800591133,0.041299964,0.338220825,1909;4638,MYLK;EDNRA
GO:1904428,negative regulation of tubulin deacetylation (GO:1904428),5,2,0.344792445,5.800591133,0.041299964,0.338220825,11076;5563,TPPP;PRKAA2
GO:0035542,regulation of SNARE complex assembly (GO:0035542),5,2,0.344792445,5.800591133,0.041299964,0.338220825,6622;6812,STXBP1;SNCA
GO:1905563,negative regulation of vascular endothelial cell proliferation (GO:1905563),5,2,0.344792445,5.800591133,0.041299964,0.338220825,4208;6347,MEF2C;CCL2
GO:1903020,positive regulation of glycoprotein metabolic process (GO:1903020),5,2,0.344792445,5.800591133,0.041299964,0.338220825,6366;3479,IGF1;CCL21
GO:0034694,response to prostaglandin (GO:0034694),5,2,0.344792445,5.800591133,0.041299964,0.338220825,6366;7049,TGFBR3;CCL21
GO:1903975,regulation of glial cell migration (GO:1903975),5,2,0.344792445,5.800591133,0.041299964,0.338220825,1880;482,ATP1B2;GPR183
GO:1903238,positive regulation of leukocyte tethering or rolling (GO:1903238),5,2,0.344792445,5.800591133,0.041299964,0.338220825,6401;6403,SELP;SELE
GO:0030202,heparin metabolic process (GO:0030202),5,2,0.344792445,5.800591133,0.041299964,0.338220825,284;55790,CSGALNACT1;ANGPT1
GO:0071295,cellular response to vitamin (GO:0071295),5,2,0.344792445,5.800591133,0.041299964,0.338220825,2621;6422,SFRP1;GAS6
GO:0046813,receptor-mediated virion attachment to host cell (GO:0046813),5,2,0.344792445,5.800591133,0.041299964,0.338220825,2621;131578,GAS6;LRRC15
GO:0032823,regulation of natural killer cell differentiation (GO:0032823),5,2,0.344792445,5.800591133,0.041299964,0.338220825,2621;558,GAS6;AXL
GO:0090521,glomerular visceral epithelial cell migration (GO:0090521),5,2,0.344792445,5.800591133,0.041299964,0.338220825,54443;25959,KANK2;ANLN
GO:2001015,negative regulation of skeletal muscle cell differentiation (GO:2001015),5,2,0.344792445,5.800591133,0.041299964,0.338220825,51804;93649,MYOCD;SIX4
GO:0060539,diaphragm development (GO:0060539),5,2,0.344792445,5.800591133,0.041299964,0.338220825,84976;6943,TCF21;DISP1
GO:0072524,pyridine-containing compound metabolic process (GO:0072524),5,2,0.344792445,5.800591133,0.041299964,0.338220825,23498;316,HAAO;AOX1
GO:0071655,regulation of granulocyte colony-stimulating factor production (GO:0071655),5,2,0.344792445,5.800591133,0.041299964,0.338220825,947;85480,CD34;TSLP
GO:0038026,reelin-mediated signaling pathway (GO:0038026),5,2,0.344792445,5.800591133,0.041299964,0.338220825,5649;7804,RELN;LRP8
GO:0097119,postsynaptic density protein 95 clustering (GO:0097119),5,2,0.344792445,5.800591133,0.041299964,0.338220825,9379;9378,NRXN1;NRXN2
GO:0002087,regulation of respiratory gaseous exchange by nervous system process (GO:0002087),5,2,0.344792445,5.800591133,0.041299964,0.338220825,477;57616,ATP1A2;TSHZ3
GO:0046645,positive regulation of gamma-delta T cell activation (GO:0046645),5,2,0.344792445,5.800591133,0.041299964,0.338220825,3071;6659,SOX4;NCKAP1L
GO:0070562,regulation of vitamin D receptor signaling pathway (GO:0070562),5,2,0.344792445,5.800591133,0.041299964,0.338220825,25959;4330,KANK2;MN1
GO:0120193,tight junction organization (GO:0120193),5,2,0.344792445,5.800591133,0.041299964,0.338220825,5010;7122,CLDN5;CLDN11
GO:0035360,positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),5,2,0.344792445,5.800591133,0.041299964,0.338220825,5740;55885,LMO3;PTGIS
GO:1902547,regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547),5,2,0.344792445,5.800591133,0.041299964,0.338220825,493;81792,ATP2B4;ADAMTS12
GO:0060993,kidney morphogenesis (GO:0060993),5,2,0.344792445,5.800591133,0.041299964,0.338220825,6659;120892,LRRK2;SOX4
GO:2000405,negative regulation of T cell migration (GO:2000405),5,2,0.344792445,5.800591133,0.041299964,0.338220825,347;4345,CD200;APOD
GO:0003164,His-Purkinje system development (GO:0003164),5,2,0.344792445,5.800591133,0.041299964,0.338220825,6910;3398,ID2;TBX5
GO:0045003,double-strand break repair via synthesis-dependent strand annealing (GO:0045003),5,2,0.344792445,5.800591133,0.041299964,0.338220825,5888;8438,RAD54L;RAD51
GO:0030111,regulation of Wnt signaling pathway (GO:0030111),111,13,7.654392282,1.698371278,0.041869466,0.342418178,59352;120892;6422;8324;22943;3090;2099;83595;147906;23500;147495;84870;55789,HIC1;SFRP1;RSPO3;LRRK2;DACT3;DEPDC1B;FZD7;ESR1;APCDD1;LGR6;SOX7;DAAM2;DKK1
GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),89,11,6.137305523,1.792317485,0.041940728,0.342534938,6622;4804;2621;358;2537;4609;114548;2045;3082;9314;83595,AQP1;KLF4;NGFR;GAS6;EPHA7;HGF;NLRP3;SOX7;IFI6;MYC;SNCA
GO:1900182,positive regulation of protein localization to nucleus (GO:1900182),68,9,4.689177254,1.919313243,0.043080549,0.347268567,2316;4804;1894;10979;983;5347;7037;51512;25937,NGFR;PLK1;GTSE1;CDK1;FLNA;FERMT2;ECT2;WWTR1;TFRC
GO:0051591,response to cAMP (GO:0051591),38,6,2.620422583,2.289707026,0.044010446,0.347268567,65010;9472;5138;358;10411;3488,AQP1;PDE2A;SLC26A6;RAPGEF3;AKAP6;IGFBP5
GO:0030516,regulation of axon extension (GO:0030516),38,6,2.620422583,2.289707026,0.044010446,0.347268567,56920;10439;3897;4897;9423;65078,SEMA3G;OLFM1;RTN4R;L1CAM;NRCAM;NTN1
GO:0000165,MAPK cascade (GO:0000165),302,29,20.82546369,1.392526017,0.044042283,0.347268567,7538;23043;3815;2252;3479;284;5734;983;1740;6712;4208;4609;2674;2676;4684;2247;120892;5156;2258;3082;1839;1847;6347;2260;9365;1326;374;9542;8437,ZFP36;NRG2;NCAM1;FGF2;LRRK2;MEF2C;DLG2;GFRA3;FGF7;FGF13;CDK1;GFRA1;CCL2;MAP3K8;FGFR1;IGF1;HGF;KIT;HBEGF;DUSP5;TNIK;KL;PDGFRA;PTGER4;RASAL1;MYC;SPTBN2;ANGPT1;AREG
GO:0000725,recombinational repair (GO:0000725),79,10,5.447720633,1.835630105,0.044392226,0.347268567,10721;2237;672;9401;641;5888;7516;10635;675;4796,XRCC2;RECQL4;TONSL;POLQ;BLM;BRCA1;RAD51AP1;RAD51;BRCA2;FEN1
GO:0051924,regulation of calcium ion transport (GO:0051924),58,8,3.999592364,2.000203839,0.044473795,0.347268567,150;783;596;4638;287;5350;6781;781,ANK2;MYLK;PLN;BCL2;CACNB2;ADRA2A;CACNA2D1;STC1
GO:0060393,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),58,8,3.999592364,2.000203839,0.044473795,0.347268567,3624;3625;11117;656;653;22943;11030;7272,BMP5;INHBA;TTK;RBPMS;EMILIN1;BMP8B;INHBB;DKK1
GO:0050727,regulation of inflammatory response (GO:0050727),205,21,14.13649025,1.485517241,0.04454832,0.347268567,6622;6401;3569;11343;5734;5138;185;114548;5740;6376;145581;81792;27293;9314;85480;330;90865;5320;4345;11274;683,IL6;MGLL;AGTR1;PDE2A;IL33;KLF4;LRFN5;TSLP;USP18;PLA2G2A;CX3CL1;PTGIS;BIRC3;SELE;CD200;NLRP3;PTGER4;BST1;SNCA;SMPDL3B;ADAMTS12
GO:2000758,positive regulation of peptidyl-lysine acetylation (GO:2000758),20,4,1.379169781,2.900295567,0.044877629,0.347268567,6659;10891;5563;672,SOX4;BRCA1;PPARGC1A;PRKAA2
GO:2000404,regulation of T cell migration (GO:2000404),20,4,1.379169781,2.900295567,0.044877629,0.347268567,6366;6387;347;4345,CXCL12;CD200;CCL21;APOD
GO:0010954,positive regulation of protein processing (GO:0010954),20,4,1.379169781,2.900295567,0.044877629,0.347268567,2934;7123;2161;9532,CLEC3B;GSN;BAG2;F12
GO:0051058,negative regulation of small GTPase mediated signal transduction (GO:0051058),20,4,1.379169781,2.900295567,0.044877629,0.347268567,84952;9353;2048;10252,SPRY1;CGNL1;SLIT2;EPHB2
GO:0045621,positive regulation of lymphocyte differentiation (GO:0045621),20,4,1.379169781,2.900295567,0.044877629,0.347268567,399;2621;3071;558,GAS6;AXL;NCKAP1L;RHOH
GO:0030004,cellular monovalent inorganic cation homeostasis (GO:0030004),20,4,1.379169781,2.900295567,0.044877629,0.347268567,6546;477;3778;482,ATP1A2;ATP1B2;KCNMA1;SLC8A1
GO:0006760,folic acid-containing compound metabolic process (GO:0006760),20,4,1.379169781,2.900295567,0.044877629,0.347268567,6573;2350;25902;8836,SLC19A1;MTHFD1L;FOLR2;GGH
GO:0048709,oligodendrocyte differentiation (GO:0048709),20,4,1.379169781,2.900295567,0.044877629,0.347268567,6663;11076;56978;118738,TPPP;SOX10;PRDM8;ZNF488
GO:0048843,negative regulation of axon extension involved in axon guidance (GO:0048843),20,4,1.379169781,2.900295567,0.044877629,0.347268567,54437;9723;7869;56920,SEMA5B;SEMA3G;SEMA3E;SEMA3B
GO:0040036,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),20,4,1.379169781,2.900295567,0.044877629,0.347268567,2247;10252;64094;90993,SPRY1;FGF2;SMOC2;CREB3L1
GO:0030851,granulocyte differentiation (GO:0030851),20,4,1.379169781,2.900295567,0.044877629,0.347268567,1869;1440;6886;863,CSF3;E2F1;CBFA2T3;TAL1
GO:0051276,chromosome organization (GO:0051276),101,12,6.964807392,1.722947861,0.044923218,0.347268567,7153;4609;81620;83540;10403;387103;64946;2146;29943;26240;2669;55143,GEM;CDCA8;NUF2;TOP2A;CENPH;CDT1;NDC80;EZH2;FAM50B;PADI1;MYC;CENPW
GO:0010829,negative regulation of glucose transmembrane transport (GO:0010829),12,3,0.827501868,3.625369458,0.044991628,0.347268567,5167;5579;55022,PRKCB;PID1;ENPP1
GO:0045822,negative regulation of heart contraction (GO:0045822),12,3,0.827501868,3.625369458,0.044991628,0.347268567,5144;5350;477,ATP1A2;PLN;PDE4D
GO:1905209,positive regulation of cardiocyte differentiation (GO:1905209),12,3,0.827501868,3.625369458,0.044991628,0.347268567,4208;6910;93649,MYOCD;MEF2C;TBX5
GO:0006069,ethanol oxidation (GO:0006069),12,3,0.827501868,3.625369458,0.044991628,0.347268567,125;126;217,ADH1B;ALDH2;ADH1C
GO:0001504,neurotransmitter uptake (GO:0001504),12,3,0.827501868,3.625369458,0.044991628,0.347268567,6581;3177;477,ATP1A2;SLC22A3;SLC29A2
GO:0055123,digestive system development (GO:0055123),12,3,0.827501868,3.625369458,0.044991628,0.347268567,3815;23242;2294,FOXF1;KIT;COBL
GO:1901844,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),12,3,0.827501868,3.625369458,0.044991628,0.347268567,857;5144;6910,CAV1;PDE4D;TBX5
GO:1902307,positive regulation of sodium ion transmembrane transport (GO:1902307),12,3,0.827501868,3.625369458,0.044991628,0.347268567,1756;482;5348,FXYD1;ATP1B2;DMD
GO:0090280,positive regulation of calcium ion import (GO:0090280),12,3,0.827501868,3.625369458,0.044991628,0.347268567,6387;6781;6347,CXCL12;CCL2;STC1
GO:0031115,negative regulation of microtubule polymerization (GO:0031115),12,3,0.827501868,3.625369458,0.044991628,0.347268567,6622;25999;3925,STMN1;CLIP3;SNCA
GO:1902548,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),12,3,0.827501868,3.625369458,0.044991628,0.347268567,493;81792;1634,DCN;ATP2B4;ADAMTS12
GO:0048710,regulation of astrocyte differentiation (GO:0048710),12,3,0.827501868,3.625369458,0.044991628,0.347268567,3569;274;3398,IL6;BIN1;ID2
GO:0046068,cGMP metabolic process (GO:0046068),12,3,0.827501868,3.625369458,0.044991628,0.347268567,5138;4881;4882,PDE2A;NPR1;NPR2
GO:0071498,cellular response to fluid shear stress (GO:0071498),12,3,0.827501868,3.625369458,0.044991628,0.347268567,4208;10365;9314,KLF2;MEF2C;KLF4
GO:0042340,keratan sulfate catabolic process (GO:0042340),12,3,0.827501868,3.625369458,0.044991628,0.347268567,4958;4969;5549,OGN;PRELP;OMD
GO:0015669,gas transport (GO:0015669),12,3,0.827501868,3.625369458,0.044991628,0.347268567,358;4609;114757,AQP1;CYGB;MYC
GO:0002003,angiotensin maturation (GO:0002003),12,3,0.827501868,3.625369458,0.044991628,0.347268567,1066;1359;1511,CTSG;CPA3;CES1
GO:0002002,regulation of angiotensin levels in blood (GO:0002002),12,3,0.827501868,3.625369458,0.044991628,0.347268567,1066;1359;1511,CTSG;CPA3;CES1
GO:1904668,positive regulation of ubiquitin protein ligase activity (GO:1904668),12,3,0.827501868,3.625369458,0.044991628,0.347268567,11065;991;5347,UBE2C;CDC20;PLK1
GO:0000075,cell cycle checkpoint signaling (GO:0000075),12,3,0.827501868,3.625369458,0.044991628,0.347268567,701;11130;699,BUB1;BUB1B;ZWINT
GO:0045930,negative regulation of mitotic cell cycle (GO:0045930),48,7,3.310007473,2.114798851,0.045004527,0.347268567,701;4085;1111;11130;699;7832;1028,BUB1;BUB1B;CHEK1;MAD2L1;ZWINT;CDKN1C;BTG2
GO:0045807,positive regulation of endocytosis (GO:0045807),48,7,3.310007473,2.114798851,0.045004527,0.347268567,6622;6366;3071;1191;718;558;25999,CLU;AXL;C3;NCKAP1L;CCL21;CLIP3;SNCA
GO:0042552,myelination (GO:0042552),48,7,3.310007473,2.114798851,0.045004527,0.347268567,6663;5354;5376;4359;11076;163175;23114,LGI4;PLP1;TPPP;SOX10;PMP22;MPZ;NFASC
GO:0006874,cellular calcium ion homeostasis (GO:0006874),135,15,9.309396019,1.611275315,0.045318166,0.349240379,489;857;5745;309;596;287;6387;5350;6781;493;9104;57419;6262;6546;7220,ANK2;PTH1R;SLC24A3;RGN;PLN;CXCL12;ANXA6;CAV1;BCL2;ATP2A3;TRPC1;ATP2B4;RYR2;SLC8A1;STC1
GO:0042304,regulation of fatty acid biosynthetic process (GO:0042304),29,5,1.999796182,2.500254799,0.046027214,0.354250425,341;5563;5166;51422;672,PDK4;BRCA1;PRKAG2;APOC1;PRKAA2
GO:0036294,cellular response to decreased oxygen levels (GO:0036294),69,9,4.758135743,1.891497109,0.046644253,0.358082506,358;205;79625;4609;5740;6422;2627;132864;29923,AQP1;SFRP1;GATA6;CPEB2;PTGIS;NDNF;HILPDA;MYC;AK4
GO:0033500,carbohydrate homeostasis (GO:0033500),69,9,4.758135743,1.891497109,0.046644253,0.358082506,4804;150;3569;6659;5563;1408;6517;3953;5166,PDK4;IL6;SLC2A4;CRY2;SOX4;NGFR;LEPR;ADRA2A;PRKAA2
GO:0043409,negative regulation of MAPK cascade (GO:0043409),91,11,6.275222502,1.752925892,0.048072222,0.368574138,857;11117;4609;2048;10252;2305;1843;11213;2192;5997;55885,DUSP1;RGS2;SPRY1;FOXM1;LMO3;CAV1;EMILIN1;IRAK3;FBLN1;EPHB2;MYC
GO:0042531,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),59,8,4.068550853,1.966302079,0.048476048,0.371196843,3815;2690;3479;3569;3570;9021;3572;85480,IL6;TSLP;IL6ST;GHR;SOCS3;IGF1;KIT;IL6R
GO:0032412,regulation of ion transmembrane transporter activity (GO:0032412),39,6,2.689381072,2.23099659,0.049102176,0.375512948,287;6330;6324;5348;2273;53826,FXYD1;FHL1;ANK2;FXYD6;SCN4B;SCN1B
GO:0071560,cellular response to transforming growth factor beta stimulus (GO:0071560),114,13,7.861267749,1.653677297,0.050135697,0.382929703,7048;5138;10979;4208;7122;7049;4093;6422;7472;5590;2353;7123;8483,CLEC3B;CLDN5;PDE2A;SFRP1;TGFBR2;FOS;TGFBR3;MEF2C;FERMT2;CILP;SMAD9;WNT2;PRKCZ
GO:0006110,regulation of glycolytic process (GO:0006110),70,9,4.827094232,1.864475721,0.050398517,0.383961329,3479;9759;8671;5563;51422;5210;23225;863;26471,PFKFB4;CBFA2T3;SLC4A4;IGF1;PRKAG2;HDAC4;NUP210;PRKAA2;NUPR1
GO:0001822,kidney development (GO:0001822),70,9,4.827094232,1.864475721,0.050398517,0.383961329,185;7704;6659;64321;1063;6495;6943;8516;25959,TCF21;SOX17;ZBTB16;ITGA8;AGTR1;SOX4;CENPF;KANK2;SIX1
GO:0016055,Wnt signaling pathway (GO:0016055),92,11,6.344180991,1.73387235,0.051354922,0.390752451,5881;10979;2535;120892;7483;6422;7472;8324;4929;7482;85458,NR4A2;SFRP1;LRRK2;DIXDC1;RAC3;FERMT2;FZD7;WNT2B;FZD2;WNT2;WNT9A
GO:0051091,positive regulation of DNA-binding transcription factor activity (GO:0051091),245,24,16.89482981,1.420552931,0.051902045,0.391660713,3815;3569;857;6722;5579;1191;114548;5649;9759;2535;10891;7472;93649;6376;7037;11213;5590;1440;7804;2099;4919;219790;4345;133522,IL6;MYOCD;PRKCB;RELN;SRF;CLU;CSF3;CAV1;PPARGC1A;CX3CL1;ROR1;LRP8;FZD2;WNT2;HDAC4;CD200;KIT;IRAK3;NLRP3;ESR1;TFRC;PPARGC1B;PRKCZ;RTKN2
GO:0097305,response to alcohol (GO:0097305),30,5,2.068754671,2.416912972,0.052220087,0.391660713,6366;7048;9353;6586;7049,SLIT3;TGFBR2;TGFBR3;SLIT2;CCL21
GO:0045332,phospholipid translocation (GO:0045332),30,5,2.068754671,2.416912972,0.052220087,0.391660713,5244;5243;79895;57198;57088,ATP8B4;PLSCR4;ABCB1;ABCB4;ATP8B2
GO:0051294,establishment of spindle orientation (GO:0051294),30,5,2.068754671,2.416912972,0.052220087,0.391660713,4085;5347;10403;1058;89958,SAPCD2;CENPA;PLK1;NDC80;MAD2L1
GO:0090218,positive regulation of lipid kinase activity (GO:0090218),30,5,2.068754671,2.416912972,0.052220087,0.391660713,3815;6366;2247;5156;388121,TNFAIP8L3;FGF2;KIT;CCL21;PDGFRA
GO:0030323,respiratory tube development (GO:0030323),30,5,2.068754671,2.416912972,0.052220087,0.391660713,2252;1116;2294;2247;6943,TCF21;FOXF1;FGF2;FGF7;CHI3L1
GO:0030204,chondroitin sulfate metabolic process (GO:0030204),30,5,2.068754671,2.416912972,0.052220087,0.391660713,55790;79625;3373;1634;1464,CSGALNACT1;DCN;HYAL1;NDNF;CSPG4
GO:0045821,positive regulation of glycolytic process (GO:0045821),21,4,1.44812827,2.762186254,0.052516808,0.391660713,3479;8671;5563;5210,PFKFB4;SLC4A4;IGF1;PRKAA2
GO:1900544,positive regulation of purine nucleotide metabolic process (GO:1900544),21,4,1.44812827,2.762186254,0.052516808,0.391660713,3479;8671;5563;5210,PFKFB4;SLC4A4;IGF1;PRKAA2
GO:0035590,purinergic nucleotide receptor signaling pathway (GO:0035590),21,4,1.44812827,2.762186254,0.052516808,0.391660713,4907;1511;114548;718,CTSG;C3;NLRP3;NT5E
GO:0038179,neurotrophin signaling pathway (GO:0038179),21,4,1.44812827,2.762186254,0.052516808,0.391660713,4804;4915;627;9863,NGFR;BDNF;MAGI2;NTRK2
GO:0035584,calcium-mediated signaling using intracellular calcium source (GO:0035584),21,4,1.44812827,2.762186254,0.052516808,0.391660713,5737;6262;7226;6403,PTGFR;SELP;TRPM2;RYR2
GO:0033137,negative regulation of peptidyl-serine phosphorylation (GO:0033137),21,4,1.44812827,2.762186254,0.052516808,0.391660713,1756;857;5144;22943,CAV1;PDE4D;DMD;DKK1
GO:0048483,autonomic nervous system development (GO:0048483),21,4,1.44812827,2.762186254,0.052516808,0.391660713,6663;26153;6659;1910,SOX10;EDNRB;SOX4;KIF26A
GO:0033762,response to glucagon (GO:0033762),21,4,1.44812827,2.762186254,0.052516808,0.391660713,111;196883;108;5577,ADCY5;ADCY4;PRKAR2B;ADCY2
GO:0060291,long-term synaptic potentiation (GO:0060291),21,4,1.44812827,2.762186254,0.052516808,0.391660713,2906;4776;5590;57616,GRIN2D;NFATC4;TSHZ3;PRKCZ
GO:0048585,negative regulation of response to stimulus (GO:0048585),60,8,4.137509342,1.933530378,0.052705141,0.392092327,150;947;26153;9353;1191;10000;9314;127943,CD34;KLF4;CLU;KIF26A;SLIT2;ADRA2A;AKT3;FCRLB
GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),60,8,4.137509342,1.933530378,0.052705141,0.392092327,57863;3897;152330;57549;91624;23022;4680;1048,CADM3;NEXN;PALLD;L1CAM;CNTN4;CEACAM6;CEACAM5;IGSF9
GO:0016239,positive regulation of macroautophagy (GO:0016239),50,7,3.447924451,2.030206897,0.05429972,0.399104146,154;291;5563;26353;1634;7957;79443,DCN;HSPB8;FYCO1;ADRB2;SLC25A4;PRKAA2;EPM2A
GO:0043270,positive regulation of ion transport (GO:0043270),50,7,3.447924451,2.030206897,0.05429972,0.399104146,150;783;4638;287;6330;6324;2273,FHL1;ANK2;MYLK;SCN4B;CACNB2;ADRA2A;SCN1B
GO:0010770,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),50,7,3.447924451,2.030206897,0.05429972,0.399104146,2316;5881;10979;55679;91663;5789;10562,LIMS2;MYADM;FLNA;RAC3;FERMT2;OLFM4;PTPRD
GO:0090303,positive regulation of wound healing (GO:0090303),40,6,2.758339561,2.175221675,0.054541253,0.399104146,150;10979;4638;1839;64094;2161,MYLK;SMOC2;FERMT2;ADRA2A;HBEGF;F12
GO:0010634,positive regulation of epithelial cell migration (GO:0010634),93,11,6.41313948,1.715228561,0.054785148,0.399104146,2252;388;284;3690;2247;3373;5168;64094;84913;6237;152007,FGF2;FGF7;HYAL1;RHOB;SMOC2;ATOH8;ENPP2;RRAS;ITGB3;GLIPR2;ANGPT1
GO:0045667,regulation of osteoblast differentiation (GO:0045667),82,10,5.6545961,1.768472906,0.054930547,0.399104146,3479;3569;3570;10979;4208;2201;3082;3572;25937;117581,IL6;MEF2C;TWIST2;IL6ST;FERMT2;WWTR1;IGF1;HGF;FBN2;IL6R
GO:0071676,negative regulation of mononuclear cell migration (GO:0071676),13,3,0.896460357,3.346494884,0.055574135,0.399104146,9353;653;1843,DUSP1;BMP5;SLIT2
GO:0035627,ceramide transport (GO:0035627),13,3,0.896460357,3.346494884,0.055574135,0.399104146,5244;26154;5243,ABCB1;ABCA12;ABCB4
GO:0032370,positive regulation of lipid transport (GO:0032370),13,3,0.896460357,3.346494884,0.055574135,0.399104146,5244;26154;6696,SPP1;ABCA12;ABCB4
GO:0086014,atrial cardiac muscle cell action potential (GO:0086014),13,3,0.896460357,3.346494884,0.055574135,0.399104146,783;775;287,ANK2;CACNB2;CACNA1C
GO:0035162,embryonic hemopoiesis (GO:0035162),13,3,0.896460357,3.346494884,0.055574135,0.399104146,3815;7048;6886,TGFBR2;KIT;TAL1
GO:0106058,positive regulation of calcineurin-mediated signaling (GO:0106058),13,3,0.896460357,3.346494884,0.055574135,0.399104146,9472;3479;29995,AKAP6;IGF1;LMCD1
GO:0070886,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),13,3,0.896460357,3.346494884,0.055574135,0.399104146,9472;3479;29995,AKAP6;IGF1;LMCD1
GO:0005513,detection of calcium ion (GO:0005513),13,3,0.896460357,3.346494884,0.055574135,0.399104146,3779;6262;845,KCNMB1;CASQ2;RYR2
GO:0030007,cellular potassium ion homeostasis (GO:0030007),13,3,0.896460357,3.346494884,0.055574135,0.399104146,477;3778;482,ATP1A2;ATP1B2;KCNMA1
GO:0070741,response to interleukin-6 (GO:0070741),13,3,0.896460357,3.346494884,0.055574135,0.399104146,1116;5740;55022,PID1;PTGIS;CHI3L1
GO:0010832,negative regulation of myotube differentiation (GO:0010832),13,3,0.896460357,3.346494884,0.055574135,0.399104146,627;9759;1048,BDNF;HDAC4;CEACAM5
GO:1905564,positive regulation of vascular endothelial cell proliferation (GO:1905564),13,3,0.896460357,3.346494884,0.055574135,0.399104146,2247;10000;2260,FGF2;FGFR1;AKT3
GO:1902902,negative regulation of autophagosome assembly (GO:1902902),13,3,0.896460357,3.346494884,0.055574135,0.399104146,9638;120892;26471,LRRK2;FEZ1;NUPR1
GO:0044774,mitotic DNA integrity checkpoint signaling (GO:0044774),13,3,0.896460357,3.346494884,0.055574135,0.399104146,63967;990;4998,ORC1;CLSPN;CDC6
GO:0045940,positive regulation of steroid metabolic process (GO:0045940),13,3,0.896460357,3.346494884,0.055574135,0.399104146,341;1066;185,AGTR1;CES1;APOC1
GO:0009205,purine ribonucleoside triphosphate metabolic process (GO:0009205),13,3,0.896460357,3.346494884,0.055574135,0.399104146,205;51715;120892,LRRK2;RAB23;AK4
GO:0032674,regulation of interleukin-5 production (GO:0032674),13,3,0.896460357,3.346494884,0.055574135,0.399104146,5144;5590;85480,TSLP;PDE4D;PRKCZ
GO:0030207,chondroitin sulfate catabolic process (GO:0030207),13,3,0.896460357,3.346494884,0.055574135,0.399104146,3373;1634;1464,DCN;HYAL1;CSPG4
GO:2000104,negative regulation of DNA-dependent DNA replication (GO:2000104),13,3,0.896460357,3.346494884,0.055574135,0.399104146,8914;29980;641,TIMELESS;BLM;DONSON
GO:0036376,sodium ion export across plasma membrane (GO:0036376),13,3,0.896460357,3.346494884,0.055574135,0.399104146,8671;477;482,ATP1A2;ATP1B2;SLC4A4
GO:0048812,neuron projection morphogenesis (GO:0048812),139,15,9.585229975,1.56490768,0.055975924,0.399104146,23043;8522;627;6383;4130;3071;152330;322;6285;4131;4897;2048;120892;23542;9201,LRRK2;GAS7;APBB1;SDC2;BDNF;DCLK1;CNTN4;NCKAP1L;MAP1B;NRCAM;MAP1A;MAPK8IP2;S100B;TNIK;EPHB2
GO:0034645,cellular macromolecule biosynthetic process (GO:0034645),310,29,21.3771316,1.356589862,0.058003434,0.399104146,63967;3624;983;1111;4171;1763;2237;4929;8317;1869;374393;83990;116028;990;80119;672;8914;9401;29980;5427;7298;10535;641;4173;55388;23594;4998;8318;9156,NR4A2;RECQL4;TIMELESS;ORC1;CLSPN;INHBA;MCM2;DNA2;RNASEH2A;EXO1;BLM;CDC6;CDC45;CDC7;BRCA1;FAM111B;MCM10;ORC6;BRIP1;CDK1;MCM4;PIF1;CHEK1;FEN1;DONSON;POLE2;E2F1;TYMS;RMI2
GO:0050680,negative regulation of epithelial cell proliferation (GO:0050680),72,9,4.96501121,1.812684729,0.058489459,0.399104146,857;4781;7049;6422;687;675;84913;26471;1028,KLF9;SFRP1;TGFBR3;CAV1;BRCA2;ATOH8;CDKN1C;NFIB;NUPR1
GO:0006026,aminoglycan catabolic process (GO:0006026),31,5,2.13771316,2.338948038,0.058874384,0.399104146,375790;1116;10082;6383;60495,HPSE2;SDC2;AGRN;CHI3L1;GPC6
GO:0043266,regulation of potassium ion transport (GO:0043266),31,5,2.13771316,2.338948038,0.058874384,0.399104146,3757;150;287;845;2273,FHL1;ANK2;CASQ2;KCNH2;ADRA2A
GO:0003091,renal water homeostasis (GO:0003091),31,5,2.13771316,2.338948038,0.058874384,0.399104146,111;196883;108;5577;358,ADCY5;AQP1;ADCY4;PRKAR2B;ADCY2
GO:0017158,regulation of calcium ion-dependent exocytosis (GO:0017158),31,5,2.13771316,2.338948038,0.058874384,0.399104146,8912;150;83849;23208;6812,CACNA1H;ADRA2A;SYT15;SYT11;STXBP1
GO:0000077,DNA damage checkpoint signaling (GO:0000077),31,5,2.13771316,2.338948038,0.058874384,0.399104146,63967;1111;1869;83990;29980,CLSPN;BRIP1;CHEK1;DONSON;E2F1
GO:0030517,negative regulation of axon extension (GO:0030517),31,5,2.13771316,2.338948038,0.058874384,0.399104146,54437;9723;7869;56920;65078,SEMA5B;SEMA3G;SEMA3E;RTN4R;SEMA3B
GO:1990778,protein localization to cell periphery (GO:1990778),140,15,9.654188464,1.553729768,0.058888322,0.399104146,2316;23043;2621;857;10267;26154;783;287;2258;91663;6812;30846;254887;92162;7871,ANK2;TMEM88;RAMP1;GAS6;MYADM;CAV1;FGF13;EHD2;FLNA;CACNB2;SLMAP;ABCA12;ZDHHC23;TNIK;STXBP1
GO:0007265,Ras protein signal transduction (GO:0007265),140,15,9.654188464,1.553729768,0.058888322,0.399104146,10435;399;388;395;4804;3479;150;185;9423;2247;10411;890;10235;6237;85004,AGTR1;ARHGAP6;CDC42EP2;RASGRP2;FGF2;NGFR;RHOB;RERG;CCNA2;RAPGEF3;ADRA2A;IGF1;NTN1;RRAS;RHOH
GO:1902172,regulation of keratinocyte apoptotic process (GO:1902172),6,2,0.413750934,4.833825944,0.059158508,0.399104146,7538;2934,ZFP36;GSN
GO:0097011,cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),6,2,0.413750934,4.833825944,0.059158508,0.399104146,7538;4882,ZFP36;NPR2
GO:0097012,response to granulocyte macrophage colony-stimulating factor (GO:0097012),6,2,0.413750934,4.833825944,0.059158508,0.399104146,7538;4882,ZFP36;NPR2
GO:0071474,cellular hyperosmotic response (GO:0071474),6,2,0.413750934,4.833825944,0.059158508,0.399104146,358;92241,AQP1;RCSD1
GO:0007171,activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171),6,2,0.413750934,4.833825944,0.059158508,0.399104146,154;284,ADRB2;ANGPT1
GO:1901078,negative regulation of relaxation of muscle (GO:1901078),6,2,0.413750934,4.833825944,0.059158508,0.399104146,5144;5142,PDE4B;PDE4D
GO:0051481,negative regulation of cytosolic calcium ion concentration (GO:0051481),6,2,0.413750934,4.833825944,0.059158508,0.399104146,6546;477,ATP1A2;SLC8A1
GO:0051454,intracellular pH elevation (GO:0051454),6,2,0.413750934,4.833825944,0.059158508,0.399104146,65010;596,SLC26A6;BCL2
GO:0070365,hepatocyte differentiation (GO:0070365),6,2,0.413750934,4.833825944,0.059158508,0.399104146,144455;79733,E2F7;E2F8
GO:1901879,regulation of protein depolymerization (GO:1901879),6,2,0.413750934,4.833825944,0.059158508,0.399104146,4130;4131,MAP1B;MAP1A
GO:0001996,positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),6,2,0.413750934,4.833825944,0.059158508,0.399104146,7168;5144,PDE4D;TPM1
GO:0030240,skeletal muscle thin filament assembly (GO:0030240),6,2,0.413750934,4.833825944,0.059158508,0.399104146,58;70,ACTC1;ACTA1
GO:1901098,positive regulation of autophagosome maturation (GO:1901098),6,2,0.413750934,4.833825944,0.059158508,0.399104146,154;79443,FYCO1;ADRB2
GO:0070100,negative regulation of chemokine-mediated signaling pathway (GO:0070100),6,2,0.413750934,4.833825944,0.059158508,0.399104146,9353;6586,SLIT3;SLIT2
GO:0035754,B cell chemotaxis (GO:0035754),6,2,0.413750934,4.833825944,0.059158508,0.399104146,2621;9023,GAS6;CH25H
GO:0019530,taurine metabolic process (GO:0019530),6,2,0.413750934,4.833825944,0.059158508,0.399104146,2690;1036,CDO1;GHR
GO:1903997,positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),6,2,0.413750934,4.833825944,0.059158508,0.399104146,4915;627,BDNF;NTRK2
GO:0045630,positive regulation of T-helper 2 cell differentiation (GO:0045630),6,2,0.413750934,4.833825944,0.059158508,0.399104146,114548;5590,NLRP3;PRKCZ
GO:2000323,negative regulation of glucocorticoid receptor signaling pathway (GO:2000323),6,2,0.413750934,4.833825944,0.059158508,0.399104146,1408;5187,PER1;CRY2
GO:0070303,negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),6,2,0.413750934,4.833825944,0.059158508,0.399104146,4609;2305,FOXM1;MYC
GO:0072012,glomerulus vasculature development (GO:0072012),6,2,0.413750934,4.833825944,0.059158508,0.399104146,284;947,CD34;ANGPT1
GO:0033292,T-tubule organization (GO:0033292),6,2,0.413750934,4.833825944,0.059158508,0.399104146,287;274,ANK2;BIN1
GO:1903598,positive regulation of gap junction assembly (GO:1903598),6,2,0.413750934,4.833825944,0.059158508,0.399104146,857;6910,CAV1;TBX5
GO:0010667,negative regulation of cardiac muscle cell apoptotic process (GO:0010667),6,2,0.413750934,4.833825944,0.059158508,0.399104146,9464;26471,HAND2;NUPR1
GO:0098596,imitative learning (GO:0098596),6,2,0.413750934,4.833825944,0.059158508,0.399104146,9379;9378,NRXN1;NRXN2
GO:0042297,vocal learning (GO:0042297),6,2,0.413750934,4.833825944,0.059158508,0.399104146,9379;9378,NRXN1;NRXN2
GO:0090027,negative regulation of monocyte chemotaxis (GO:0090027),6,2,0.413750934,4.833825944,0.059158508,0.399104146,9353;1843,DUSP1;SLIT2
GO:0070601,centromeric sister chromatid cohesion (GO:0070601),6,2,0.413750934,4.833825944,0.059158508,0.399104146,701;699,BUB1;BUB1B
GO:0033047,regulation of mitotic sister chromatid segregation (GO:0033047),6,2,0.413750934,4.833825944,0.059158508,0.399104146,891;1843,DUSP1;CCNB1
GO:1903504,regulation of mitotic spindle checkpoint (GO:1903504),6,2,0.413750934,4.833825944,0.059158508,0.399104146,891;1843,DUSP1;CCNB1
GO:0070345,negative regulation of fat cell proliferation (GO:0070345),6,2,0.413750934,4.833825944,0.059158508,0.399104146,8864;1869,PER2;E2F1
GO:2000726,negative regulation of cardiac muscle cell differentiation (GO:2000726),6,2,0.413750934,4.833825944,0.059158508,0.399104146,8324;22943,FZD7;DKK1
GO:0021795,cerebral cortex cell migration (GO:0021795),6,2,0.413750934,4.833825944,0.059158508,0.399104146,5649;2258,RELN;FGF13
GO:0022029,telencephalon cell migration (GO:0022029),6,2,0.413750934,4.833825944,0.059158508,0.399104146,120892;2258,LRRK2;FGF13
GO:0097107,postsynaptic density assembly (GO:0097107),6,2,0.413750934,4.833825944,0.059158508,0.399104146,9379;9378,NRXN1;NRXN2
GO:0120040,regulation of macrophage proliferation (GO:0120040),6,2,0.413750934,4.833825944,0.059158508,0.399104146,146433;90865,IL33;IL34
GO:0150146,cell junction disassembly (GO:0150146),6,2,0.413750934,4.833825944,0.059158508,0.399104146,6376;22943,CX3CL1;DKK1
GO:0090322,regulation of superoxide metabolic process (GO:0090322),6,2,0.413750934,4.833825944,0.059158508,0.399104146,10516;683,FBLN5;BST1
GO:1902043,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),6,2,0.413750934,4.833825944,0.059158508,0.399104146,6422;467,SFRP1;ATF3
GO:1902975,mitotic DNA replication initiation (GO:1902975),6,2,0.413750934,4.833825944,0.059158508,0.399104146,4171;4173,MCM2;MCM4
GO:1902315,nuclear cell cycle DNA replication initiation (GO:1902315),6,2,0.413750934,4.833825944,0.059158508,0.399104146,4171;4173,MCM2;MCM4
GO:0051573,negative regulation of histone H3-K9 methylation (GO:0051573),6,2,0.413750934,4.833825944,0.059158508,0.399104146,672;1789,BRCA1;DNMT3B
GO:0010756,positive regulation of plasminogen activation (GO:0010756),6,2,0.413750934,4.833825944,0.059158508,0.399104146,7123;2161,CLEC3B;F12
GO:0006677,glycosylceramide metabolic process (GO:0006677),6,2,0.413750934,4.833825944,0.059158508,0.399104146,30815;256435,ST6GALNAC6;ST6GALNAC3
GO:2000096,"positive regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000096)",6,2,0.413750934,4.833825944,0.059158508,0.399104146,22943;84870,RSPO3;DKK1
GO:0010216,maintenance of DNA methylation (GO:0010216),6,2,0.413750934,4.833825944,0.059158508,0.399104146,3070;29128,UHRF1;HELLS
GO:0048017,inositol lipid-mediated signaling (GO:0048017),51,7,3.51688294,1.990398918,0.059364281,0.399595401,3479;5156;2260;5334;84812;388121;5332,TNFAIP8L3;PLCD4;PLCB4;FGFR1;PLCL1;IGF1;PDGFRA
GO:1900024,regulation of substrate adhesion-dependent cell spreading (GO:1900024),51,7,3.51688294,1.990398918,0.059364281,0.399595401,2316;5881;10979;55679;91663;2192;10562,LIMS2;MYADM;FLNA;RAC3;FERMT2;OLFM4;FBLN1
GO:0031334,positive regulation of protein-containing complex assembly (GO:0031334),117,13,8.068143216,1.611275315,0.05945968,0.399789863,10435;6622;10979;1191;11076;81620;54922;4312;7037;9636;2099;6886;51673,TPPP;CDC42EP2;TPPP3;CLU;CDT1;FERMT2;ISG15;MMP1;ESR1;TFRC;RASIP1;TAL1;SNCA
GO:0010631,epithelial cell migration (GO:0010631),41,6,2.82729805,2.122167488,0.060330063,0.404736616,3815;8742;54443;90627;9839;25959,STARD13;ZEB2;KANK2;ANLN;TNFSF12;KIT
GO:0051881,regulation of mitochondrial membrane potential (GO:0051881),41,6,2.82729805,2.122167488,0.060330063,0.404736616,5831;596;120892;55022;83875;79845,LRRK2;PYCR1;BCO2;PID1;RNF122;BCL2
GO:0070371,ERK1 and ERK2 cascade (GO:0070371),22,4,1.517086759,2.636632333,0.060816148,0.405733477,3479;5734;983;4609,CDK1;IGF1;PTGER4;MYC
GO:0045761,regulation of adenylate cyclase activity (GO:0045761),22,4,1.517086759,2.636632333,0.060816148,0.405733477,10486;775;1910;5064,EDNRB;CAP2;PALM;CACNA1C
GO:1901385,regulation of voltage-gated calcium channel activity (GO:1901385),22,4,1.517086759,2.636632333,0.060816148,0.405733477,1756;783;785;5142,PDE4B;DMD;CACNB2;CACNB4
GO:1990090,cellular response to nerve growth factor stimulus (GO:1990090),22,4,1.517086759,2.636632333,0.060816148,0.405733477,4915;627;66000;9863,BDNF;MAGI2;NTRK2;TMEM108
GO:1901021,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),22,4,1.517086759,2.636632333,0.060816148,0.405733477,9472;287;6262;57158,ANK2;JPH2;AKAP6;RYR2
GO:2000113,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),542,47,37.37550105,1.257508225,0.061022175,0.406656647,5167;2621;51804;7704;9759;7089;8864;1063;63976;6422;1408;2627;23414;1869;2305;990;672;8914;7298;3488;332;6935;7832;10865;9314;1410;3398;4602;2146;7067;83595;5187;90993;84913;863;64061;57616;1028;862;117581;138151;23034;93986;56849;23090;3400;55635,PER1;ZBTB16;CRYAB;SFRP1;FOXM1;CRY2;KLF4;PER2;TIMELESS;TWIST2;GATA6;CENPF;GAS6;NACC2;CDC6;BIRC5;BRCA1;TCEAL7;DEPDC1;SAMD4A;TSPYL2;ATOH8;ZEB1;E2F1;EZH2;SIX4;CBFA2T3;THRA;ID4;ID2;HDAC4;CDKN1C;CREB3L1;TYMS;ARID5A;FOXP2;BTG2;SOX7;TSHZ3;RUNX1T1;PRDM16;MYB;TLE2;ZFPM2;ZNF423;IGFBP5;ENPP1
GO:0051054,positive regulation of DNA metabolic process (GO:0051054),62,8,4.27542632,1.87115843,0.061854635,0.41174774,4609;2247;3082;672;5888;9760;64094;2070,FGF2;BRCA1;RAD51;SMOC2;HGF;TOX;EYA4;MYC
GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),118,13,8.137101705,1.597620439,0.062810005,0.417644847,1901;111;196883;154;108;1902;150;2774;5737;5745;10267;5733;5734,ADCY5;PTH1R;PTGFR;RAMP1;GNAL;ADCY4;S1PR1;LPAR1;ADRA2A;PTGER3;ADRB2;PTGER4;ADCY2
GO:0031327,negative regulation of cellular biosynthetic process (GO:0031327),52,7,3.585841429,1.952122016,0.06470967,0.429326519,857;341;947;5740;493;672;255027,CD34;CAV1;BRCA1;PTGIS;ATP2B4;APOC1;MPV17L
GO:0051216,cartilage development (GO:0051216),52,7,3.585841429,1.952122016,0.06470967,0.429326519,1116;4208;7704;4781;2247;7482;3373,ZBTB16;FGF2;MEF2C;HYAL1;WNT2B;NFIB;CHI3L1
GO:0050922,negative regulation of chemotaxis (GO:0050922),32,5,2.206671649,2.265855911,0.065989141,0.430767531,54437;9723;7869;56920;9353,SEMA5B;SEMA3G;SEMA3E;SLIT2;SEMA3B
GO:0010828,positive regulation of glucose transmembrane transport (GO:0010828),32,5,2.206671649,2.265855911,0.065989141,0.430767531,3479;10580;718;8013;25999,NR4A3;SORBS1;C3;IGF1;CLIP3
GO:0055008,cardiac muscle tissue morphogenesis (GO:0055008),32,5,2.206671649,2.265855911,0.065989141,0.430767531,1901;7168;70;7139;7049,TGFBR3;ACTC1;S1PR1;TPM1;TNNT2
GO:0032733,positive regulation of interleukin-10 production (GO:0032733),32,5,2.206671649,2.265855911,0.065989141,0.430767531,3569;947;9636;5590;85480,IL6;CD34;TSLP;ISG15;PRKCZ
GO:0003180,aortic valve morphogenesis (GO:0003180),32,5,2.206671649,2.265855911,0.065989141,0.430767531,2006;140628;9353;11117;6586,SLIT3;GATA5;SLIT2;EMILIN1;ELN
GO:0035987,endodermal cell differentiation (GO:0035987),32,5,2.206671649,2.265855911,0.065989141,0.430767531,3624;3678;3679;1294;1301,COL11A1;INHBA;ITGA7;ITGA5;COL7A1
GO:0032781,positive regulation of ATPase activity (GO:0032781),42,6,2.896256539,2.07163969,0.066469668,0.430767531,7168;7139;9104;6262;482;29128,ATP1B2;RGN;UHRF1;TPM1;TNNT2;RYR2
GO:0045666,positive regulation of neuron differentiation (GO:0045666),42,6,2.896256539,2.07163969,0.066469668,0.430767531,1894;4208;4897;2260;6935;5121,PCP4;MEF2C;ECT2;ZEB1;FGFR1;NRCAM
GO:0002548,monocyte chemotaxis (GO:0002548),42,6,2.896256539,2.07163969,0.066469668,0.430767531,6366;3569;3570;2350;6376;6347,IL6;CX3CL1;FOLR2;CCL2;CCL21;IL6R
GO:0034614,cellular response to reactive oxygen species (GO:0034614),63,8,4.344384809,1.841457503,0.066779076,0.430767531,7168;388;1894;3569;358;7226;5156;2353,IL6;AQP1;FOS;RHOB;ECT2;TPM1;TRPM2;PDGFRA
GO:0042113,B cell activation (GO:0042113),85,10,5.861471567,1.706056216,0.066995942,0.430767531,3815;5579;974;596;4208;2048;933;1316;1880;9759,PRKCB;MEF2C;GPR183;CD22;BCL2;KLF6;CD79B;HDAC4;KIT;EPHB2
GO:0042593,glucose homeostasis (GO:0042593),85,10,5.861471567,1.706056216,0.066995942,0.430767531,4804;150;3569;6659;10891;5563;1408;6517;3953;5166,PDK4;IL6;SLC2A4;CRY2;SOX4;NGFR;PPARGC1A;LEPR;ADRA2A;PRKAA2
GO:0006890,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",85,10,5.861471567,1.706056216,0.066995942,0.430767531,24137;29127;9493;81930;11004;1062;3832;56992;26153;51226,KIF2C;KIF4A;KIF15;KIF26A;KIF18A;KIF11;KIF23;CENPE;RACGAP1;COPZ2
GO:1990868,response to chemokine (GO:1990868),14,3,0.965418846,3.107459536,0.067220087,0.430767531,6366;6387;1843,DUSP1;CXCL12;CCL21
GO:2001044,regulation of integrin-mediated signaling pathway (GO:2001044),14,3,0.965418846,3.107459536,0.067220087,0.430767531,2316;55679;683,LIMS2;FLNA;BST1
GO:2000403,positive regulation of lymphocyte migration (GO:2000403),14,3,0.965418846,3.107459536,0.067220087,0.430767531,6366;6387;58494,JAM2;CXCL12;CCL21
GO:0090051,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),14,3,0.965418846,3.107459536,0.067220087,0.430767531,4223;9314;90627,STARD13;KLF4;MEOX2
GO:0045624,positive regulation of T-helper cell differentiation (GO:0045624),14,3,0.965418846,3.107459536,0.067220087,0.430767531,114548;5590;4602,NLRP3;MYB;PRKCZ
GO:0001541,ovarian follicle development (GO:0001541),14,3,0.965418846,3.107459536,0.067220087,0.430767531,3815;3624;3625,INHBA;KIT;INHBB
GO:0055002,striated muscle cell development (GO:0055002),14,3,0.965418846,3.107459536,0.067220087,0.430767531,25802;7111;5239,PGM5;LMOD1;TMOD1
GO:2001212,regulation of vasculogenesis (GO:2001212),14,3,0.965418846,3.107459536,0.067220087,0.430767531,947;55273;6237,CD34;TMEM100;RRAS
GO:0086011,membrane repolarization during action potential (GO:0086011),14,3,0.965418846,3.107459536,0.067220087,0.430767531,23704;3757;3752,KCNH2;KCND3;KCNE4
GO:0097623,potassium ion export across plasma membrane (GO:0097623),14,3,0.965418846,3.107459536,0.067220087,0.430767531,23704;3757;3752,KCNH2;KCND3;KCNE4
GO:0050866,negative regulation of cell activation (GO:0050866),14,3,0.965418846,3.107459536,0.067220087,0.430767531,11117;5156;4345,EMILIN1;CD200;PDGFRA
GO:0042311,vasodilation (GO:0042311),14,3,0.965418846,3.107459536,0.067220087,0.430767531,154;10365;3778,KLF2;KCNMA1;ADRB2
GO:1902894,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),14,3,0.965418846,3.107459536,0.067220087,0.430767531,6722;4781;4776,SRF;NFIB;NFATC4
GO:0002830,positive regulation of type 2 immune response (GO:0002830),14,3,0.965418846,3.107459536,0.067220087,0.430767531,3569;114548;5590,IL6;NLRP3;PRKCZ
GO:0042093,T-helper cell differentiation (GO:0042093),14,3,0.965418846,3.107459536,0.067220087,0.430767531,3569;5734;1880,IL6;GPR183;PTGER4
GO:0061037,negative regulation of cartilage development (GO:0061037),14,3,0.965418846,3.107459536,0.067220087,0.430767531,2202;7483;81792,EFEMP1;WNT9A;ADAMTS12
GO:1903978,regulation of microglial cell activation (GO:1903978),14,3,0.965418846,3.107459536,0.067220087,0.430767531,3569;23208;6376,IL6;CX3CL1;SYT11
GO:0035581,sequestering of extracellular ligand from receptor (GO:0035581),14,3,0.965418846,3.107459536,0.067220087,0.430767531,2201;91851;64388,GREM2;CHRDL1;FBN2
GO:0040037,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),14,3,0.965418846,3.107459536,0.067220087,0.430767531,2247;10252;90993,SPRY1;FGF2;CREB3L1
GO:0001959,regulation of cytokine-mediated signaling pathway (GO:0001959),74,9,5.102928188,1.76369325,0.067371088,0.431275409,2621;9021;11213;3977;558;85480;330;25999;11274,GAS6;TSLP;USP18;SOCS3;AXL;LIFR;BIRC3;IRAK3;CLIP3
GO:2000145,regulation of cell motility (GO:2000145),131,14,9.033562063,1.549776257,0.067482035,0.431526074,2316;2252;388;6366;9928;154810;9423;91624;2247;1839;5168;9542;2192;9079,NRG2;FGF2;KIF14;LDB2;FGF7;NEXN;RHOB;FLNA;AMOTL1;HBEGF;CCL21;NTN1;FBLN1;ENPP2
GO:0007417,central nervous system development (GO:0007417),265,25,18.27399959,1.368063946,0.068606846,0.437956213,2934;65108;7048;6663;4884;7704;11076;6659;152330;6285;4897;2045;4781;5649;347;2906;4826;1959;54510;5463;10763;5050;4929;718;9201,ZBTB16;TPPP;NR4A2;SOX10;TGFBR2;RELN;SOX4;GSN;NNAT;EPHA7;NES;GRIN2D;C3;DCLK1;CNTN4;PAFAH1B3;NRCAM;EGR2;NFIB;S100B;APOD;POU6F1;PCDH18;NPTX1;MARCKSL1
GO:0001818,negative regulation of cytokine production (GO:0001818),179,18,12.34356954,1.458249168,0.068633298,0.437956213,7538;2621;3624;3625;3569;5734;947;3071;347;23208;6376;9636;11213;558;9314;284297;4345;89795,IL6;ZFP36;CD34;KLF4;INHBA;GAS6;CX3CL1;NAV3;AXL;SSC5D;NCKAP1L;CD200;IRAK3;INHBB;ISG15;APOD;PTGER4;SYT11
GO:0045744,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),23,4,1.586045248,2.521996145,0.069764858,0.441427957,6622;3925;5997;9737,RGS2;GPRASP1;STMN1;SNCA
GO:0034204,lipid translocation (GO:0034204),23,4,1.586045248,2.521996145,0.069764858,0.441427957,5244;5243;79895;57198,ATP8B4;ABCB1;ABCB4;ATP8B2
GO:1904037,positive regulation of epithelial cell apoptotic process (GO:1904037),23,4,1.586045248,2.521996145,0.069764858,0.441427957,2934;3569;6347;641700,IL6;GSN;ECSCR;CCL2
GO:0030947,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),23,4,1.586045248,2.521996145,0.069764858,0.441427957,3690;5579;11117;3678,PRKCB;EMILIN1;ITGA5;ITGB3
GO:0048675,axon extension (GO:0048675),23,4,1.586045248,2.521996145,0.069764858,0.441427957,54437;9353;6586;4131,SLIT3;SEMA5B;SLIT2;MAP1B
GO:1903169,regulation of calcium ion transmembrane transport (GO:1903169),23,4,1.586045248,2.521996145,0.069764858,0.441427957,287;781;477;845,ATP1A2;ANK2;CASQ2;CACNA2D1
GO:0010875,positive regulation of cholesterol efflux (GO:0010875),23,4,1.586045248,2.521996145,0.069764858,0.441427957,857;10351;26154;1066,ABCA8;CAV1;CES1;ABCA12
GO:0030212,hyaluronan metabolic process (GO:0030212),23,4,1.586045248,2.521996145,0.069764858,0.441427957,2247;3373;10894;3161,LYVE1;FGF2;HYAL1;HMMR
GO:0006024,glycosaminoglycan biosynthetic process (GO:0006024),97,11,6.688973436,1.644497486,0.070016511,0.442089544,375790;284;55790;10082;6383;3373;1634;1464;4958;4969;5549,CSGALNACT1;OGN;PRELP;DCN;HYAL1;SDC2;OMD;AGRN;CSPG4;ANGPT1;GPC6
GO:0120162,positive regulation of cold-induced thermogenesis (GO:0120162),97,11,6.688973436,1.644497486,0.070016511,0.442089544,154;6319;2167;857;8864;63976;10891;3953;7067;4237;133522,PER2;CAV1;PPARGC1A;SCD;LEPR;THRA;FABP4;ADRB2;PPARGC1B;PRDM16;MFAP2
GO:0015698,inorganic anion transport (GO:0015698),53,7,3.654799918,1.915289525,0.070337001,0.442718022,5167;65010;29127;25932;203859;5348;80727,FXYD1;TTYH3;SLC26A6;ANO5;RACGAP1;CLIC4;ENPP1
GO:0003007,heart morphogenesis (GO:0003007),53,7,3.654799918,1.915289525,0.070337001,0.442718022,70;10395;10439;23768;7049;64321;6262,SOX17;TGFBR3;ACTC1;OLFM1;DLC1;RYR2;FLRT2
GO:2000117,negative regulation of cysteine-type endopeptidase activity (GO:2000117),53,7,3.654799918,1.915289525,0.070337001,0.442718022,6622;4804;2621;358;2537;3082;9314,AQP1;KLF4;NGFR;GAS6;HGF;IFI6;SNCA
GO:0016101,diterpenoid metabolic process (GO:0016101),64,8,4.413343298,1.812684729,0.071938424,0.452324129,375790;338328;10082;6383;7804;5947;125;83875,ADH1B;GPIHBP1;BCO2;SDC2;LRP8;AGRN;RBP1;GPC6
GO:0050671,positive regulation of lymphocyte proliferation (GO:0050671),75,9,5.171886677,1.74017734,0.072112269,0.452470613,3569;3071;596;4208;2048;1880;7037;3572;683,IL6;MEF2C;IL6ST;GPR183;BCL2;NCKAP1L;TFRC;EPHB2;BST1
GO:0048667,cell morphogenesis involved in neuron differentiation (GO:0048667),75,9,5.171886677,1.74017734,0.072112269,0.452470613,6383;4130;4208;152330;322;6285;4131;4897;23542,MEF2C;APBB1;SDC2;CNTN4;MAP1B;NRCAM;MAP1A;MAPK8IP2;S100B
GO:0099643,signal release from synapse (GO:0099643),43,6,2.965215028,2.023462023,0.072959833,0.454219915,6622;2571;9379;9378;6812;5799,NRXN1;PTPRN2;NRXN2;GAD1;STXBP1;SNCA
GO:0050772,positive regulation of axonogenesis (GO:0050772),43,6,2.965215028,2.023462023,0.072959833,0.454219915,4804;4915;627;9353;3897;9423,NGFR;SLIT2;L1CAM;BDNF;NTN1;NTRK2
GO:0001954,positive regulation of cell-matrix adhesion (GO:0001954),43,6,2.965215028,2.023462023,0.072959833,0.454219915,6366;10979;6422;6376;4680;6237,SFRP1;CX3CL1;FERMT2;CCL21;CEACAM6;RRAS
GO:0032376,positive regulation of cholesterol transport (GO:0032376),33,5,2.275630138,2.197193611,0.073561126,0.454219915,5244;857;10351;26154;1066,ABCA8;CAV1;CES1;ABCA12;ABCB4
GO:0001570,vasculogenesis (GO:0001570),33,5,2.275630138,2.197193611,0.073561126,0.454219915,7048;857;7049;54922;64321,SOX17;TGFBR2;TGFBR3;CAV1;RASIP1
GO:0000018,regulation of DNA recombination (GO:0000018),33,5,2.275630138,2.197193611,0.073561126,0.454219915,1111;641;5888;10635;3838,BLM;KPNA2;RAD51AP1;RAD51;CHEK1
GO:0019886,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),98,11,6.757931925,1.6277169,0.074208892,0.454219915,24137;29127;9493;81930;11004;1062;3832;56992;8722;6712;26153,KIF2C;KIF4A;KIF15;KIF26A;KIF18A;KIF11;KIF23;CENPE;RACGAP1;CTSF;SPTBN2
GO:0002495,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),98,11,6.757931925,1.6277169,0.074208892,0.454219915,24137;29127;9493;81930;11004;1062;3832;56992;8722;6712;26153,KIF2C;KIF4A;KIF15;KIF26A;KIF18A;KIF11;KIF23;CENPE;RACGAP1;CTSF;SPTBN2
GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),133,14,9.171479041,1.526471351,0.07451479,0.454219915,7048;3624;3625;10979;7122;7049;656;56963;653;4093;55273;5590;2353;7041,CLDN5;TGFBR2;FOS;BMP5;TGFBR3;TMEM100;INHBA;FERMT2;BMP8B;TGFB1I1;SMAD9;INHBB;PRKCZ;RGMA
GO:0035725,sodium ion transmembrane transport (GO:0035725),87,10,5.999388545,1.666836532,0.07590966,0.454219915,6332;6330;6324;8671;57419;6546;477;482;84679;285195,ATP1A2;SCN7A;SLC9A9;SLC24A3;ATP1B2;SCN4B;SLC4A4;SCN1B;SLC8A1;SLC9A7
GO:0034612,response to tumor necrosis factor (GO:0034612),110,12,7.585433793,1.5819794,0.076172705,0.454219915,7538;6366;1116;6401;6422;3373;6376;55022;81792;672;6347;3899,AFF3;ZFP36;SFRP1;PID1;BRCA1;HYAL1;CX3CL1;CCL2;SELE;CCL21;CHI3L1;ADAMTS12
GO:0036297,interstrand cross-link repair (GO:0036297),54,7,3.723758408,1.879821201,0.076246571,0.454219915,2175;5888;10635;29089;2177;55215;146956,FANCI;EME1;FANCA;RAD51AP1;UBE2T;RAD51;FANCD2
GO:1903507,negative regulation of nucleic acid-templated transcription (GO:1903507),460,40,31.72090495,1.260998072,0.076340209,0.454219915,2621;51804;7704;9759;7089;8864;1063;63976;6422;1408;2627;23414;1869;2305;672;8914;332;6935;10865;9314;1410;3398;4602;2146;7067;83595;5187;90993;84913;863;57616;1028;862;117581;138151;93986;56849;23090;3400;55635,PER1;ZBTB16;CRYAB;SFRP1;FOXM1;CRY2;KLF4;PER2;TIMELESS;TWIST2;GATA6;CENPF;GAS6;NACC2;BIRC5;BRCA1;TCEAL7;DEPDC1;ATOH8;ZEB1;E2F1;EZH2;SIX4;CBFA2T3;THRA;ID4;ID2;HDAC4;CDKN1C;CREB3L1;ARID5A;FOXP2;SOX7;TSHZ3;RUNX1T1;PRDM16;MYB;TLE2;ZFPM2;ZNF423
GO:0006813,potassium ion transport (GO:0006813),122,13,8.412935661,1.545239441,0.077454954,0.454219915,3757;358;3779;3777;57419;3752;477;10060;3755;3778;84679;285195;3782,ATP1A2;SLC9A9;AQP1;KCNMB1;SLC24A3;KCNN3;KCNK3;KCNMA1;KCNH2;ABCC9;KCND3;KCNG1;SLC9A7
GO:0042981,regulation of apoptotic process (GO:0042981),738,61,50.8913649,1.198631637,0.07864398,0.454219915,2316;388;6622;4804;1894;3479;284;2621;9928;51804;3569;2869;358;983;4085;5347;6502;6196;3071;596;4208;9353;7153;1191;2537;4609;9833;6659;10439;322;1960;6422;5563;2627;3778;6376;3082;1869;23017;22943;1048;7037;332;274;3572;7804;558;3663;1410;85480;330;6491;25999;79658;54507;894;26471;79845;10562;4616;10687,FAIM2;IL6;CRYAB;AQP1;EGR3;SFRP1;KIF14;SOX4;MEF2C;STIL;GATA6;CLU;NGFR;GAS6;BIN1;ADAMTSL4;TOP2A;BIRC5;TSLP;MELK;OLFM1;PLK1;KCNMA1;RHOB;SLIT2;CDK1;IL6ST;FLNA;RPS6KA2;APBB1;CX3CL1;RNF122;CCND2;ECT2;BCL2;SKP2;MAD2L1;AXL;LRP8;E2F1;SIX4;GRK5;ARHGAP10;IGF1;HGF;BIRC3;NCKAP1L;GADD45B;OLFM4;CLIP3;CEACAM5;TFRC;IRF5;IFI6;MYC;ANGPT1;DKK1;PRKAA2;SNCA;NUPR1;PNMA2
GO:0060216,definitive hemopoiesis (GO:0060216),7,2,0.482709423,4.143279381,0.079113274,0.454219915,7049;8076,TGFBR3;MFAP5
GO:0044806,G-quadruplex DNA unwinding (GO:0044806),7,2,0.482709423,4.143279381,0.079113274,0.454219915,1763;641,DNA2;BLM
GO:2000766,negative regulation of cytoplasmic translation (GO:2000766),7,2,0.482709423,4.143279381,0.079113274,0.454219915,221662;132864,RBM24;CPEB2
GO:0006972,hyperosmotic response (GO:0006972),7,2,0.482709423,4.143279381,0.079113274,0.454219915,358;92241,AQP1;RCSD1
GO:0007217,tachykinin receptor signaling pathway (GO:0007217),7,2,0.482709423,4.143279381,0.079113274,0.454219915,2869;6869,TACR1;GRK5
GO:0071380,cellular response to prostaglandin E stimulus (GO:0071380),7,2,0.482709423,4.143279381,0.079113274,0.454219915,5734;6422,SFRP1;PTGER4
GO:2001046,positive regulation of integrin-mediated signaling pathway (GO:2001046),7,2,0.482709423,4.143279381,0.079113274,0.454219915,2316;55679,LIMS2;FLNA
GO:0014909,smooth muscle cell migration (GO:0014909),7,2,0.482709423,4.143279381,0.079113274,0.454219915,55742;3690,ITGB3;PARVA
GO:0098976,excitatory chemical synaptic transmission (GO:0098976),7,2,0.482709423,4.143279381,0.079113274,0.454219915,8572;2906,PDLIM4;GRIN2D
GO:1905065,positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),7,2,0.482709423,4.143279381,0.079113274,0.454219915,3815;93649,MYOCD;KIT
GO:0051660,establishment of centrosome localization (GO:0051660),7,2,0.482709423,4.143279381,0.079113274,0.454219915,4085;117583,MAD2L1;PARD3B
GO:0010919,regulation of inositol phosphate biosynthetic process (GO:0010919),7,2,0.482709423,4.143279381,0.079113274,0.454219915,6622;5745,PTH1R;SNCA
GO:0032488,Cdc42 protein signal transduction (GO:0032488),7,2,0.482709423,4.143279381,0.079113274,0.454219915,9423;57381,RHOJ;NTN1
GO:0031915,positive regulation of synaptic plasticity (GO:0031915),7,2,0.482709423,4.143279381,0.079113274,0.454219915,991;2048,CDC20;EPHB2
GO:0038166,angiotensin-activated signaling pathway (GO:0038166),7,2,0.482709423,4.143279381,0.079113274,0.454219915,857;185,AGTR1;CAV1
GO:0060371,regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371),7,2,0.482709423,4.143279381,0.079113274,0.454219915,6324;6910,SCN1B;TBX5
GO:0014842,regulation of skeletal muscle satellite cell proliferation (GO:0014842),7,2,0.482709423,4.143279381,0.079113274,0.454219915,284;2247,FGF2;ANGPT1
GO:0090043,regulation of tubulin deacetylation (GO:0090043),7,2,0.482709423,4.143279381,0.079113274,0.454219915,11076;5563,TPPP;PRKAA2
GO:0090493,catecholamine uptake (GO:0090493),7,2,0.482709423,4.143279381,0.079113274,0.454219915,6581;225689,SLC22A3;MAPK15
GO:0015872,dopamine transport (GO:0015872),7,2,0.482709423,4.143279381,0.079113274,0.454219915,6581;225689,SLC22A3;MAPK15
GO:2000544,regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544),7,2,0.482709423,4.143279381,0.079113274,0.454219915,2247;2260,FGF2;FGFR1
GO:1903995,regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),7,2,0.482709423,4.143279381,0.079113274,0.454219915,4915;627,BDNF;NTRK2
GO:1905208,negative regulation of cardiocyte differentiation (GO:1905208),7,2,0.482709423,4.143279381,0.079113274,0.454219915,8324;22943,FZD7;DKK1
GO:0046850,regulation of bone remodeling (GO:0046850),7,2,0.482709423,4.143279381,0.079113274,0.454219915,6422;3953,SFRP1;LEPR
GO:0033604,negative regulation of catecholamine secretion (GO:0033604),7,2,0.482709423,4.143279381,0.079113274,0.454219915,150;23208,ADRA2A;SYT11
GO:2000535,regulation of entry of bacterium into host cell (GO:2000535),7,2,0.482709423,4.143279381,0.079113274,0.454219915,857;3853,CAV1;KRT6A
GO:0003190,atrioventricular valve formation (GO:0003190),7,2,0.482709423,4.143279381,0.079113274,0.454219915,8642;10439,OLFM1;DCHS1
GO:0033005,positive regulation of mast cell activation (GO:0033005),7,2,0.482709423,4.143279381,0.079113274,0.454219915,8013;85480,NR4A3;TSLP
GO:0072189,ureter development (GO:0072189),7,2,0.482709423,4.143279381,0.079113274,0.454219915,2294;64321,FOXF1;SOX17
GO:0003357,noradrenergic neuron differentiation (GO:0003357),7,2,0.482709423,4.143279381,0.079113274,0.454219915,9464;6659,SOX4;HAND2
GO:0090267,positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),7,2,0.482709423,4.143279381,0.079113274,0.454219915,4085;10403,NDC80;MAD2L1
GO:0090232,positive regulation of spindle checkpoint (GO:0090232),7,2,0.482709423,4.143279381,0.079113274,0.454219915,4085;10403,NDC80;MAD2L1
GO:0071499,cellular response to laminar fluid shear stress (GO:0071499),7,2,0.482709423,4.143279381,0.079113274,0.454219915,10365;9314,KLF2;KLF4
GO:0032291,axon ensheathment in central nervous system (GO:0032291),7,2,0.482709423,4.143279381,0.079113274,0.454219915,6663;5354,PLP1;SOX10
GO:0003256,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),7,2,0.482709423,4.143279381,0.079113274,0.454219915,6722;93649,MYOCD;SRF
GO:0006600,creatine metabolic process (GO:0006600),7,2,0.482709423,4.143279381,0.079113274,0.454219915,2593;1152,CKB;GAMT
GO:1901387,positive regulation of voltage-gated calcium channel activity (GO:1901387),7,2,0.482709423,4.143279381,0.079113274,0.454219915,783;781,CACNB2;CACNA2D1
GO:0044065,regulation of respiratory system process (GO:0044065),7,2,0.482709423,4.143279381,0.079113274,0.454219915,477;57616,ATP1A2;TSHZ3
GO:1903979,negative regulation of microglial cell activation (GO:1903979),7,2,0.482709423,4.143279381,0.079113274,0.454219915,23208;6376,CX3CL1;SYT11
GO:2000727,positive regulation of cardiac muscle cell differentiation (GO:2000727),7,2,0.482709423,4.143279381,0.079113274,0.454219915,4208;93649,MYOCD;MEF2C
GO:1901894,regulation of ATPase-coupled calcium transmembrane transporter activity (GO:1901894),7,2,0.482709423,4.143279381,0.079113274,0.454219915,5350;6262,PLN;RYR2
GO:0015671,oxygen transport (GO:0015671),7,2,0.482709423,4.143279381,0.079113274,0.454219915,4609;114757,CYGB;MYC
GO:1904590,negative regulation of protein import (GO:1904590),7,2,0.482709423,4.143279381,0.079113274,0.454219915,51715;347,RAB23;APOD
GO:0042308,negative regulation of protein import into nucleus (GO:0042308),7,2,0.482709423,4.143279381,0.079113274,0.454219915,51715;347,RAB23;APOD
GO:0086036,regulation of cardiac muscle cell membrane potential (GO:0086036),7,2,0.482709423,4.143279381,0.079113274,0.454219915,5350;5348,FXYD1;PLN
GO:0032387,negative regulation of intracellular transport (GO:0032387),7,2,0.482709423,4.143279381,0.079113274,0.454219915,5350;1410,CRYAB;PLN
GO:1902746,regulation of lens fiber cell differentiation (GO:1902746),7,2,0.482709423,4.143279381,0.079113274,0.454219915,2247;10252,SPRY1;FGF2
GO:0031935,regulation of chromatin silencing (GO:0031935),7,2,0.482709423,4.143279381,0.079113274,0.454219915,8318;29028,CDC45;ATAD2
GO:0045913,positive regulation of carbohydrate metabolic process (GO:0045913),24,4,1.655003737,2.416912972,0.079347912,0.454219915,3479;8671;5563;5210,PFKFB4;SLC4A4;IGF1;PRKAA2
GO:0030279,negative regulation of ossification (GO:0030279),24,4,1.655003737,2.416912972,0.079347912,0.454219915,5167;4208;6422;22943,SFRP1;MEF2C;DKK1;ENPP1
GO:0010837,regulation of keratinocyte proliferation (GO:0010837),24,4,1.655003737,2.416912972,0.079347912,0.454219915,7538;2252;687;374,KLF9;ZFP36;FGF7;AREG
GO:0099565,"chemical synaptic transmission, postsynaptic (GO:0099565)",24,4,1.655003737,2.416912972,0.079347912,0.454219915,4208;2906;120892;23542,LRRK2;MEF2C;GRIN2D;MAPK8IP2
GO:0050805,negative regulation of synaptic transmission (GO:0050805),24,4,1.655003737,2.416912972,0.079347912,0.454219915,23208;120892;6812;2899,LRRK2;GRIK3;SYT11;STXBP1
GO:0044319,"wound healing, spreading of cells (GO:0044319)",24,4,1.655003737,2.416912972,0.079347912,0.454219915,2316;83478;3678;4321,FLNA;ARHGAP24;ITGA5;MMP12
GO:0055007,cardiac muscle cell differentiation (GO:0055007),24,4,1.655003737,2.416912972,0.079347912,0.454219915,4208;6546;4629;93649,MYOCD;MEF2C;MYH11;SLC8A1
GO:0048841,regulation of axon extension involved in axon guidance (GO:0048841),24,4,1.655003737,2.416912972,0.079347912,0.454219915,54437;9723;7869;56920,SEMA5B;SEMA3G;SEMA3E;SEMA3B
GO:0051497,negative regulation of stress fiber assembly (GO:0051497),24,4,1.655003737,2.416912972,0.079347912,0.454219915,84952;395;10395;3925,ARHGAP6;CGNL1;STMN1;DLC1
GO:0032768,regulation of monooxygenase activity (GO:0032768),24,4,1.655003737,2.416912972,0.079347912,0.454219915,6622;857;114757;115677,NOSTRIN;CAV1;CYGB;SNCA
GO:0045833,negative regulation of lipid metabolic process (GO:0045833),24,4,1.655003737,2.416912972,0.079347912,0.454219915,150;341;347;83643,CCDC3;ADRA2A;APOD;APOC1
GO:0097028,dendritic cell differentiation (GO:0097028),24,4,1.655003737,2.416912972,0.079347912,0.454219915,7048;2621;7226;558,TGFBR2;GAS6;AXL;TRPM2
GO:0007269,neurotransmitter secretion (GO:0007269),44,6,3.034173517,1.97747425,0.079799045,0.454219915,6622;2571;9379;9378;6812;5799,NRXN1;PTPRN2;NRXN2;GAD1;STXBP1;SNCA
GO:1904645,response to amyloid-beta (GO:1904645),44,6,3.034173517,1.97747425,0.079799045,0.454219915,154;4804;3479;4322;781;4321,NGFR;MMP13;IGF1;ADRB2;CACNA2D1;MMP12
GO:0051496,positive regulation of stress fiber assembly (GO:0051496),44,6,3.034173517,1.97747425,0.079799045,0.454219915,7168;22899;1902;10979;10411;6422,SFRP1;ARHGEF15;FERMT2;LPAR1;RAPGEF3;TPM1
GO:0048260,positive regulation of receptor-mediated endocytosis (GO:0048260),44,6,3.034173517,1.97747425,0.079799045,0.454219915,6366;6401;284;1191;718;9863,CLU;C3;MAGI2;SELE;CCL21;ANGPT1
GO:0055065,metal ion homeostasis (GO:0055065),44,6,3.034173517,1.97747425,0.079799045,0.454219915,3757;6622;857;57158;6546;84561,SLC12A8;CAV1;JPH2;KCNH2;SLC8A1;SNCA
GO:0048247,lymphocyte chemotaxis (GO:0048247),44,6,3.034173517,1.97747425,0.079799045,0.454219915,6366;2621;1880;9023;6376;6347,GAS6;GPR183;CX3CL1;CH25H;CCL2;CCL21
GO:0046457,prostanoid biosynthetic process (GO:0046457),15,3,1.034377335,2.900295567,0.079871976,0.454219915,5730;5740;5742,PTGS1;PTGDS;PTGIS
GO:0070207,protein homotrimerization (GO:0070207),15,3,1.034377335,2.900295567,0.079871976,0.454219915,84976;286133;79689,SCARA5;STEAP4;DISP1
GO:0070206,protein trimerization (GO:0070206),15,3,1.034377335,2.900295567,0.079871976,0.454219915,84976;286133;79689,SCARA5;STEAP4;DISP1
GO:0048011,neurotrophin TRK receptor signaling pathway (GO:0048011),15,3,1.034377335,2.900295567,0.079871976,0.454219915,4804;4915;627,NGFR;BDNF;NTRK2
GO:0051571,positive regulation of histone H3-K4 methylation (GO:0051571),15,3,1.034377335,2.900295567,0.079871976,0.454219915,672;4602;1789,BRCA1;DNMT3B;MYB
GO:0032331,negative regulation of chondrocyte differentiation (GO:0032331),15,3,1.034377335,2.900295567,0.079871976,0.454219915,2202;7483;81792,EFEMP1;WNT9A;ADAMTS12
GO:1903715,regulation of aerobic respiration (GO:1903715),15,3,1.034377335,2.900295567,0.079871976,0.454219915,205;1346;863,COX7A1;CBFA2T3;AK4
GO:0043401,steroid hormone mediated signaling pathway (GO:0043401),15,3,1.034377335,2.900295567,0.079871976,0.454219915,2099;5241;4306,PGR;NR3C2;ESR1
GO:0045649,regulation of macrophage differentiation (GO:0045649),15,3,1.034377335,2.900295567,0.079871976,0.454219915,3624;146433;3398,IL34;INHBA;ID2
GO:2001028,positive regulation of endothelial cell chemotaxis (GO:2001028),15,3,1.034377335,2.900295567,0.079871976,0.454219915,2247;2260;64094,FGF2;SMOC2;FGFR1
GO:2001169,regulation of ATP biosynthetic process (GO:2001169),15,3,1.034377335,2.900295567,0.079871976,0.454219915,205;10891;55022,PID1;PPARGC1A;AK4
GO:0046827,positive regulation of protein export from nucleus (GO:0046827),15,3,1.034377335,2.900295567,0.079871976,0.454219915,2621;10411;51512,GAS6;GTSE1;RAPGEF3
GO:2000050,regulation of non-canonical Wnt signaling pathway (GO:2000050),15,3,1.034377335,2.900295567,0.079871976,0.454219915,6422;23500;84870,SFRP1;RSPO3;DAAM2
GO:1903672,positive regulation of sprouting angiogenesis (GO:1903672),15,3,1.034377335,2.900295567,0.079871976,0.454219915,2247;3678;9314,FGF2;KLF4;ITGA5
GO:0046039,GTP metabolic process (GO:0046039),15,3,1.034377335,2.900295567,0.079871976,0.454219915,205;51715;120892,LRRK2;RAB23;AK4
GO:0070932,histone H3 deacetylation (GO:0070932),15,3,1.034377335,2.900295567,0.079871976,0.454219915,9759;8864;5187,PER1;PER2;HDAC4
GO:0050651,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),15,3,1.034377335,2.900295567,0.079871976,0.454219915,55790;1634;1464,CSGALNACT1;DCN;CSPG4
GO:0006883,cellular sodium ion homeostasis (GO:0006883),15,3,1.034377335,2.900295567,0.079871976,0.454219915,6546;477;482,ATP1A2;ATP1B2;SLC8A1
GO:0072503,cellular divalent inorganic cation homeostasis (GO:0072503),111,12,7.654392282,1.567727333,0.080330673,0.456396671,489;857;5745;287;6387;6781;493;9104;57419;6262;6546;4499,ANK2;PTH1R;SLC24A3;RGN;MT1M;CXCL12;CAV1;ATP2A3;ATP2B4;RYR2;SLC8A1;STC1
GO:0010823,negative regulation of mitochondrion organization (GO:0010823),34,5,2.344588627,2.132570269,0.081584948,0.461410459,3479;1191;3082;7037;255027,CLU;IGF1;HGF;TFRC;MPV17L
GO:0055010,ventricular cardiac muscle tissue morphogenesis (GO:0055010),34,5,2.344588627,2.132570269,0.081584948,0.461410459,7168;7139;7049;6262;23414,TGFBR3;TPM1;TNNT2;RYR2;ZFPM2
GO:0010524,positive regulation of calcium ion transport into cytosol (GO:0010524),34,5,2.344588627,2.132570269,0.081584948,0.461410459,9472;6622;857;7220;6376,CAV1;CX3CL1;AKAP6;TRPC1;SNCA
GO:0051281,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),34,5,2.344588627,2.132570269,0.081584948,0.461410459,9472;6622;57158;7220;6376,JPH2;CX3CL1;AKAP6;TRPC1;SNCA
GO:0031175,neuron projection development (GO:0031175),171,17,11.79190162,1.441667387,0.081596959,0.461410459,23043;8522;627;3569;5354;3071;3897;152330;2048;66000;120892;2824;9201;7832;3925;114787;10129,PLP1;IL6;LRRK2;GPRIN1;GAS7;L1CAM;BDNF;DCLK1;CNTN4;STMN1;NCKAP1L;GPM6B;BTG2;TNIK;TMEM108;EPHB2;FRY
GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),55,7,3.792716897,1.845642633,0.082437868,0.465727465,6622;4804;2621;358;2537;3082;9314,AQP1;KLF4;NGFR;GAS6;HGF;IFI6;SNCA
GO:0072659,protein localization to plasma membrane (GO:0072659),136,14,9.378354508,1.492799189,0.085930137,0.48500099,2316;23043;2621;10267;26154;783;287;2258;91663;6812;30846;254887;92162;7871,ANK2;TMEM88;RAMP1;GAS6;MYADM;FGF13;EHD2;FLNA;CACNB2;SLMAP;ABCA12;ZDHHC23;TNIK;STXBP1
GO:0030218,erythrocyte differentiation (GO:0030218),45,6,3.103132006,1.933530378,0.086984552,0.489573169,3815;3624;3071;7049;3398;6886,TGFBR3;INHBA;ID2;NCKAP1L;KIT;TAL1
GO:0032720,negative regulation of tumor necrosis factor production (GO:0032720),45,6,3.103132006,1.933530378,0.086984552,0.489573169,3479;2621;947;23208;6376;11213,CD34;GAS6;CX3CL1;IGF1;IRAK3;SYT11
GO:0051962,positive regulation of nervous system development (GO:0051962),45,6,3.103132006,1.933530378,0.086984552,0.489573169,627;9378;2048;94030;5789;5176,NRXN1;BDNF;PTPRD;EPHB2;LRRC4B;SERPINF1
GO:0009893,positive regulation of metabolic process (GO:0009893),113,12,7.79230926,1.539979947,0.089068421,0.497527219,32;154;6319;2167;857;8864;63976;10891;3953;7067;4237;133522,PER2;CAV1;PPARGC1A;ACACB;SCD;LEPR;THRA;FABP4;ADRB2;PPARGC1B;PRDM16;MFAP2
GO:0010830,regulation of myotube differentiation (GO:0010830),25,4,1.723962226,2.320236453,0.089546484,0.497527219,221662;627;9759;1048,RBM24;BDNF;HDAC4;CEACAM5
GO:0071331,cellular response to hexose stimulus (GO:0071331),25,4,1.723962226,2.320236453,0.089546484,0.497527219,65010;2621;6659;5563,SLC26A6;SOX4;GAS6;PRKAA2
GO:0003148,outflow tract septum morphogenesis (GO:0003148),25,4,1.723962226,2.320236453,0.089546484,0.497527219,55742;7048;2627;23414,TGFBR2;GATA6;PARVA;ZFPM2
GO:1901889,negative regulation of cell junction assembly (GO:1901889),25,4,1.723962226,2.320236453,0.089546484,0.497527219,11170;395;10395;347,FAM107A;ARHGAP6;DLC1;APOD
GO:2000311,regulation of AMPA receptor activity (GO:2000311),25,4,1.723962226,2.320236453,0.089546484,0.497527219,154;4208;5649;23542,RELN;MEF2C;MAPK8IP2;ADRB2
GO:0045806,negative regulation of endocytosis (GO:0045806),25,4,1.723962226,2.320236453,0.089546484,0.497527219,857;341;2042;23208,EPHA3;CAV1;APOC1;SYT11
GO:0090279,regulation of calcium ion import (GO:0090279),25,4,1.723962226,2.320236453,0.089546484,0.497527219,6387;5350;6781;6347,PLN;CXCL12;CCL2;STC1
GO:0032414,positive regulation of ion transmembrane transporter activity (GO:0032414),25,4,1.723962226,2.320236453,0.089546484,0.497527219,1756;287;5243;482,ANK2;ATP1B2;DMD;ABCB1
GO:0072507,divalent inorganic cation homeostasis (GO:0072507),25,4,1.723962226,2.320236453,0.089546484,0.497527219,6622;857;57158;6546,CAV1;JPH2;SLC8A1;SNCA
GO:0010575,positive regulation of vascular endothelial growth factor production (GO:0010575),25,4,1.723962226,2.320236453,0.089546484,0.497527219,3569;672;718;3572,IL6;BRCA1;IL6ST;C3
GO:0060236,regulation of mitotic spindle organization (GO:0060236),35,5,2.413547116,2.07163969,0.090053172,0.497527219,79866;22974;5347;10460;84722,BORA;PLK1;TPX2;TACC3;PSRC1
GO:0051147,regulation of muscle cell differentiation (GO:0051147),35,5,2.413547116,2.07163969,0.090053172,0.497527219,6722;4208;93649;3398;91653,MYOCD;MEF2C;SRF;ID2;BOC
GO:0043627,response to estrogen (GO:0043627),35,5,2.413547116,2.07163969,0.090053172,0.497527219,857;6422;672;2099;10865,SFRP1;CAV1;BRCA1;ARID5A;ESR1
GO:0071526,semaphorin-plexin signaling pathway (GO:0071526),35,5,2.413547116,2.07163969,0.090053172,0.497527219,2316;54437;9723;7869;56920,SEMA5B;SEMA3G;SEMA3E;FLNA;SEMA3B
GO:0043551,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),35,5,2.413547116,2.07163969,0.090053172,0.497527219,3815;6366;2247;5156;388121,TNFAIP8L3;FGF2;KIT;CCL21;PDGFRA
GO:0030324,lung development (GO:0030324),35,5,2.413547116,2.07163969,0.090053172,0.497527219,2252;1116;2294;2247;6943,TCF21;FOXF1;FGF2;FGF7;CHI3L1
GO:0032886,regulation of microtubule-based process (GO:0032886),35,5,2.413547116,2.07163969,0.090053172,0.497527219,11170;6790;11076;2042;5563,FAM107A;TPPP;AURKA;EPHA3;PRKAA2
GO:0046890,regulation of lipid biosynthetic process (GO:0046890),35,5,2.413547116,2.07163969,0.090053172,0.497527219,10580;5563;5166;51422;718,PDK4;SORBS1;C3;PRKAG2;PRKAA2
GO:0099177,regulation of trans-synaptic signaling (GO:0099177),35,5,2.413547116,2.07163969,0.090053172,0.497527219,627;5649;7804;2901;2899,RELN;GRIK3;BDNF;LRP8;GRIK5
GO:0090100,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),90,10,6.206264013,1.611275315,0.090602064,0.500100096,3624;3625;656;653;9839;11030;7272;1028;7041;23090,BMP5;INHBA;TTK;ZEB2;RBPMS;BMP8B;TGFB1I1;CDKN1C;INHBB;ZNF423
GO:0050821,protein stabilization (GO:0050821),174,17,11.99877709,1.416811053,0.092194398,0.505447935,2316;55742;3479;338328;1191;287;6659;64321;10891;4487;482;1410;51512;8863;9099;9532;92162,GPIHBP1;SOX17;CRYAB;ANK2;ATP1B2;SOX4;TMEM88;CLU;GTSE1;PPARGC1A;USP2;FLNA;BAG2;MSX1;PER3;IGF1;PARVA
GO:0030182,neuron differentiation (GO:0030182),174,17,11.99877709,1.416811053,0.092194398,0.505447935,4915;3624;9464;6722;4208;6659;2535;5308;7483;7472;8324;4929;7482;5789;7732;3398;84913,NR4A2;SOX4;MEF2C;SRF;INHBA;HAND2;RNF112;FZD7;ATOH8;WNT2B;FZD2;WNT2;ID2;WNT9A;NTRK2;PTPRD;PITX2
GO:0098662,inorganic cation transmembrane transport (GO:0098662),274,25,18.89462599,1.323127539,0.092292156,0.505447935,8912;6332;3757;489;2621;3777;775;6330;6324;8671;493;57419;6546;7226;6263;7220;3752;477;10060;3755;286133;84679;285195;3782;9481,SCARA5;ATP1A2;SCN7A;SLC9A9;SLC24A3;GAS6;KCNN3;KCNK3;CACNA1H;KCNH2;RYR3;SCN4B;ABCC9;KCND3;TRPM2;SLC4A4;KCNG1;ATP2A3;TRPC1;SCN1B;ATP2B4;SLC8A1;CACNA1C;SLC25A27;SLC9A7
GO:0061564,axon development (GO:0061564),79,9,5.447720633,1.652067095,0.093094716,0.505447935,4130;5354;3897;152330;322;6285;4131;4897;2048,PLP1;APBB1;L1CAM;CNTN4;MAP1B;NRCAM;MAP1A;S100B;EPHB2
GO:0090288,negative regulation of cellular response to growth factor stimulus (GO:0090288),79,9,5.447720633,1.652067095,0.093094716,0.505447935,9353;11117;2247;4093;493;10252;81792;348093;90993,SPRY1;FGF2;SLIT2;RBPMS2;EMILIN1;SMAD9;CREB3L1;ATP2B4;ADAMTS12
GO:0070972,protein localization to endoplasmic reticulum (GO:0070972),16,3,1.103335824,2.719027094,0.093465582,0.505447935,287;6262;120892,ANK2;LRRK2;RYR2
GO:0048008,platelet-derived growth factor receptor signaling pathway (GO:0048008),16,3,1.103335824,2.719027094,0.093465582,0.505447935,5156;8013;80310,NR4A3;PDGFD;PDGFRA
GO:1904996,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),16,3,1.103335824,2.719027094,0.093465582,0.505447935,6401;3569;6403,IL6;SELP;SELE
GO:0008045,motor neuron axon guidance (GO:0008045),16,3,1.103335824,2.719027094,0.093465582,0.505447935,399;9353;9423,SLIT2;NTN1;RHOH
GO:0002082,regulation of oxidative phosphorylation (GO:0002082),16,3,1.103335824,2.719027094,0.093465582,0.505447935,205;1346;26471,COX7A1;AK4;NUPR1
GO:1900221,regulation of amyloid-beta clearance (GO:1900221),16,3,1.103335824,2.719027094,0.093465582,0.505447935,6722;1191;93649,MYOCD;SRF;CLU
GO:1903587,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),16,3,1.103335824,2.719027094,0.093465582,0.505447935,4804;185;2247,AGTR1;FGF2;NGFR
GO:0030857,negative regulation of epithelial cell differentiation (GO:0030857),16,3,1.103335824,2.719027094,0.093465582,0.505447935,857;10252;6935,SPRY1;CAV1;ZEB1
GO:0002407,dendritic cell chemotaxis (GO:0002407),16,3,1.103335824,2.719027094,0.093465582,0.505447935,6366;1880;7226,GPR183;TRPM2;CCL21
GO:0048245,eosinophil chemotaxis (GO:0048245),16,3,1.103335824,2.719027094,0.093465582,0.505447935,6366;6376;6347,CX3CL1;CCL2;CCL21
GO:0072677,eosinophil migration (GO:0072677),16,3,1.103335824,2.719027094,0.093465582,0.505447935,6366;6376;6347,CX3CL1;CCL2;CCL21
GO:1905508,protein localization to microtubule organizing center (GO:1905508),16,3,1.103335824,2.719027094,0.093465582,0.505447935,6491;29887;10615,SPAG5;STIL;SNX10
GO:0090201,negative regulation of release of cytochrome c from mitochondria (GO:0090201),16,3,1.103335824,2.719027094,0.093465582,0.505447935,3479;1191;3082,CLU;IGF1;HGF
GO:0008090,retrograde axonal transport (GO:0008090),16,3,1.103335824,2.719027094,0.093465582,0.505447935,4130;1740;66000,DLG2;MAP1A;TMEM108
GO:0046173,polyol biosynthetic process (GO:0046173),16,3,1.103335824,2.719027094,0.093465582,0.505447935,1593;2247;3707,FGF2;ITPKB;CYP27A1
GO:1902229,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),16,3,1.103335824,2.719027094,0.093465582,0.505447935,1191;6387;138151,CLU;CXCL12;NACC2
GO:0006688,glycosphingolipid biosynthetic process (GO:0006688),16,3,1.103335824,2.719027094,0.093465582,0.505447935,30815;6489;256435,ST6GALNAC6;ST8SIA1;ST6GALNAC3
GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),403,35,27.79027108,1.259433559,0.093504925,0.505447935,3815;2252;154;4804;2690;4915;627;3479;284;3690;10580;6383;3071;624;2048;2045;2042;1944;23768;2247;4776;5166;5156;3082;2260;8013;558;9365;79801;1288;3925;4920;4919;9068;80310,PDK4;NR4A3;ANGPTL1;SORBS1;FGF2;EPHA3;NGFR;BDKRB2;FGF7;EPHA7;GHR;SDC2;BDNF;AXL;ROR1;FGFR1;PDGFD;IGF1;HGF;STMN1;NCKAP1L;KIT;NFATC4;SHCBP1;ADRB2;NTRK2;ITGB3;KL;PDGFRA;EPHB2;ROR2;COL4A6;ANGPT1;FLRT2;EFNA3
GO:0042509,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),68,8,4.689177254,1.706056216,0.094929428,0.512133349,3815;2690;3479;3569;3570;9021;3572;85480,IL6;TSLP;IL6ST;GHR;SOCS3;IGF1;KIT;IL6R
GO:0002478,antigen processing and presentation of exogenous peptide antigen (GO:0002478),103,11,7.10272437,1.548701516,0.097516383,0.512133349,24137;29127;9493;81930;11004;1062;3832;56992;8722;6712;26153,KIF2C;KIF4A;KIF15;KIF26A;KIF18A;KIF11;KIF23;CENPE;RACGAP1;CTSF;SPTBN2
GO:0043393,regulation of protein binding (GO:0043393),115,12,7.930226238,1.513197687,0.098370075,0.512133349,857;6790;9212;5347;7122;9759;10763;120892;22943;1440;3078;9532,CLDN5;AURKA;LRRK2;CSF3;CAV1;PLK1;NES;BAG2;AURKB;CFHR1;HDAC4;DKK1
GO:0051128,regulation of cellular component organization (GO:0051128),139,14,9.585229975,1.460580501,0.098396264,0.512133349,11170;9928;6790;185;933;7037;11213;10235;55355;8425;58189;8643;11037;4288,FAM107A;AGTR1;WFDC1;AURKA;RASGRP2;KIF14;HJURP;LTBP4;MKI67;CD22;STON1;IRAK3;TFRC;PTCH2
GO:0031401,positive regulation of protein modification process (GO:0031401),213,20,14.68815816,1.361641111,0.098660221,0.512133349,23043;2252;10395;4915;284;2621;3690;10267;2247;120892;10411;3953;3082;7037;718;146433;57161;25999;894;157313,FGF2;LRRK2;RAMP1;IL34;GAS6;FGF7;CDCA2;CCND2;C3;RAPGEF3;LEPR;HGF;DLC1;CLIP3;PELI2;TFRC;TNIK;NTRK2;ITGB3;ANGPT1
GO:0051241,negative regulation of multicellular organismal process (GO:0051241),213,20,14.68815816,1.361641111,0.098660221,0.512133349,2621;5734;6722;4857;4208;4781;653;6781;6910;493;23208;6422;10252;93649;22943;11096;675;5334;5997;23090,RGS2;MYOCD;SPRY1;SFRP1;NOVA1;BMP5;MEF2C;SRF;GAS6;BRCA2;ADAMTS5;PLCL1;NFIB;ATP2B4;PTGER4;DKK1;SYT11;ZNF423;STC1;TBX5
GO:0045785,positive regulation of cell adhesion (GO:0045785),80,9,5.516679122,1.631416256,0.09884405,0.512133349,7168;5881;6366;79625;3071;6387;3373;285613;2199,CXCL12;HYAL1;RAC3;FBLN2;NDNF;TPM1;RELL2;NCKAP1L;CCL21
GO:0045840,positive regulation of mitotic nuclear division (GO:0045840),36,5,2.482505605,2.014094143,0.098956448,0.512133349,3479;6790;9700;9787;51203,AURKA;NUSAP1;DLGAP5;ESPL1;IGF1
GO:0051453,regulation of intracellular pH (GO:0051453),36,5,2.482505605,2.014094143,0.098956448,0.512133349,65010;8671;120892;84679;285195,SLC9A9;SLC26A6;LRRK2;SLC4A4;SLC9A7
GO:0003176,aortic valve development (GO:0003176),36,5,2.482505605,2.014094143,0.098956448,0.512133349,2006;140628;9353;11117;6586,SLIT3;GATA5;SLIT2;EMILIN1;ELN
GO:0070167,regulation of biomineral tissue development (GO:0070167),26,4,1.792920715,2.23099659,0.100338385,0.512133349,5167;1901;2621;166929,GAS6;S1PR1;SGMS2;ENPP1
GO:0005979,regulation of glycogen biosynthetic process (GO:0005979),26,4,1.792920715,2.23099659,0.100338385,0.512133349,5167;3479;10580;79660,SORBS1;IGF1;PPP1R3B;ENPP1
GO:0032231,regulation of actin filament bundle assembly (GO:0032231),26,4,1.792920715,2.23099659,0.100338385,0.512133349,5734;6376;11346;171024,SYNPO2;SYNPO;CX3CL1;PTGER4
GO:0010574,regulation of vascular endothelial growth factor production (GO:0010574),26,4,1.792920715,2.23099659,0.100338385,0.512133349,3569;672;718;3572,IL6;BRCA1;IL6ST;C3
GO:0035329,hippo signaling (GO:0035329),26,4,1.792920715,2.23099659,0.100338385,0.512133349,8642;154810;79633;25937,WWTR1;AMOTL1;DCHS1;FAT4
GO:0009308,amine metabolic process (GO:0009308),8,2,0.551667912,3.625369458,0.100790842,0.512133349,8639;11185,AOC3;INMT
GO:0046325,negative regulation of glucose import (GO:0046325),8,2,0.551667912,3.625369458,0.100790842,0.512133349,5167;55022,PID1;ENPP1
GO:1900119,positive regulation of execution phase of apoptosis (GO:1900119),8,2,0.551667912,3.625369458,0.100790842,0.512133349,10395;5740,PTGIS;DLC1
GO:0060159,regulation of dopamine receptor signaling pathway (GO:0060159),8,2,0.551667912,3.625369458,0.100790842,0.512133349,120892;5064,LRRK2;PALM
GO:0045628,regulation of T-helper 2 cell differentiation (GO:0045628),8,2,0.551667912,3.625369458,0.100790842,0.512133349,114548;5590,NLRP3;PRKCZ
GO:0002279,mast cell activation involved in immune response (GO:0002279),8,2,0.551667912,3.625369458,0.100790842,0.512133349,3815;8013,NR4A3;KIT
GO:0043303,mast cell degranulation (GO:0043303),8,2,0.551667912,3.625369458,0.100790842,0.512133349,3815;8013,NR4A3;KIT
GO:0045933,positive regulation of muscle contraction (GO:0045933),8,2,0.551667912,3.625369458,0.100790842,0.512133349,6722;93649,MYOCD;SRF
GO:0061387,regulation of extent of cell growth (GO:0061387),8,2,0.551667912,3.625369458,0.100790842,0.512133349,10439;4897,OLFM1;NRCAM
GO:0060054,positive regulation of epithelial cell proliferation involved in wound healing (GO:0060054),8,2,0.551667912,3.625369458,0.100790842,0.512133349,8324;4321,FZD7;MMP12
GO:0048846,axon extension involved in axon guidance (GO:0048846),8,2,0.551667912,3.625369458,0.100790842,0.512133349,9353;6586,SLIT3;SLIT2
GO:1902284,neuron projection extension involved in neuron projection guidance (GO:1902284),8,2,0.551667912,3.625369458,0.100790842,0.512133349,9353;6586,SLIT3;SLIT2
GO:0003300,cardiac muscle hypertrophy (GO:0003300),8,2,0.551667912,3.625369458,0.100790842,0.512133349,9759;6262,HDAC4;RYR2
GO:0098909,regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),8,2,0.551667912,3.625369458,0.100790842,0.512133349,857;2258,CAV1;FGF13
GO:0015884,folic acid transport (GO:0015884),8,2,0.551667912,3.625369458,0.100790842,0.512133349,6573;2350,SLC19A1;FOLR2
GO:0099625,ventricular cardiac muscle cell membrane repolarization (GO:0099625),8,2,0.551667912,3.625369458,0.100790842,0.512133349,3757;3752,KCNH2;KCND3
GO:0060316,positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),8,2,0.551667912,3.625369458,0.100790842,0.512133349,9472;57158,JPH2;AKAP6
GO:0035865,cellular response to potassium ion (GO:0035865),8,2,0.551667912,3.625369458,0.100790842,0.512133349,8912;1740,DLG2;CACNA1H
GO:0035864,response to potassium ion (GO:0035864),8,2,0.551667912,3.625369458,0.100790842,0.512133349,8912;1740,DLG2;CACNA1H
GO:0048536,spleen development (GO:0048536),8,2,0.551667912,3.625369458,0.100790842,0.512133349,6943;5308,TCF21;PITX2
GO:1900222,negative regulation of amyloid-beta clearance (GO:1900222),8,2,0.551667912,3.625369458,0.100790842,0.512133349,6722;93649,MYOCD;SRF
GO:0032769,negative regulation of monooxygenase activity (GO:0032769),8,2,0.551667912,3.625369458,0.100790842,0.512133349,6622;493,ATP2B4;SNCA
GO:0048670,regulation of collateral sprouting (GO:0048670),8,2,0.551667912,3.625369458,0.100790842,0.512133349,627;2258,FGF13;BDNF
GO:0098810,neurotransmitter reuptake (GO:0098810),8,2,0.551667912,3.625369458,0.100790842,0.512133349,6581;3177,SLC22A3;SLC29A2
GO:0070099,regulation of chemokine-mediated signaling pathway (GO:0070099),8,2,0.551667912,3.625369458,0.100790842,0.512133349,9353;6586,SLIT3;SLIT2
GO:2000510,positive regulation of dendritic cell chemotaxis (GO:2000510),8,2,0.551667912,3.625369458,0.100790842,0.512133349,6366;2621,GAS6;CCL21
GO:2000480,negative regulation of cAMP-dependent protein kinase activity (GO:2000480),8,2,0.551667912,3.625369458,0.100790842,0.512133349,5577;11142,PRKAR2B;PKIG
GO:1901032,negative regulation of response to reactive oxygen species (GO:1901032),8,2,0.551667912,3.625369458,0.100790842,0.512133349,5831;120892,LRRK2;PYCR1
GO:0034351,negative regulation of glial cell apoptotic process (GO:0034351),8,2,0.551667912,3.625369458,0.100790842,0.512133349,2621;6347,GAS6;CCL2
GO:0033194,response to hydroperoxide (GO:0033194),8,2,0.551667912,3.625369458,0.100790842,0.512133349,2878;7732,GPX3;RNF112
GO:0071493,cellular response to UV-B (GO:0071493),8,2,0.551667912,3.625369458,0.100790842,0.512133349,3373;4239,MFAP4;HYAL1
GO:0035457,cellular response to interferon-alpha (GO:0035457),8,2,0.551667912,3.625369458,0.100790842,0.512133349,2621;558,GAS6;AXL
GO:1904776,regulation of protein localization to cell cortex (GO:1904776),8,2,0.551667912,3.625369458,0.100790842,0.512133349,5347;89958,SAPCD2;PLK1
GO:0072074,kidney mesenchyme development (GO:0072074),8,2,0.551667912,3.625369458,0.100790842,0.512133349,51804;6495,SIX4;SIX1
GO:1905155,positive regulation of membrane invagination (GO:1905155),8,2,0.551667912,3.625369458,0.100790842,0.512133349,3071;718,C3;NCKAP1L
GO:0043372,"positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",8,2,0.551667912,3.625369458,0.100790842,0.512133349,3071;4602,NCKAP1L;MYB
GO:0050873,brown fat cell differentiation (GO:0050873),8,2,0.551667912,3.625369458,0.100790842,0.512133349,63976;10891,PPARGC1A;PRDM16
GO:0010664,negative regulation of striated muscle cell apoptotic process (GO:0010664),8,2,0.551667912,3.625369458,0.100790842,0.512133349,9464;26471,HAND2;NUPR1
GO:0038098,sequestering of BMP from receptor via BMP binding (GO:0038098),8,2,0.551667912,3.625369458,0.100790842,0.512133349,91851;64388,GREM2;CHRDL1
GO:2000427,positive regulation of apoptotic cell clearance (GO:2000427),8,2,0.551667912,3.625369458,0.100790842,0.512133349,718;6347,CCL2;C3
GO:0051177,meiotic sister chromatid cohesion (GO:0051177),8,2,0.551667912,3.625369458,0.100790842,0.512133349,701;699,BUB1;BUB1B
GO:0051984,positive regulation of chromosome segregation (GO:0051984),8,2,0.551667912,3.625369458,0.100790842,0.512133349,891;990,CDC6;CCNB1
GO:0048711,positive regulation of astrocyte differentiation (GO:0048711),8,2,0.551667912,3.625369458,0.100790842,0.512133349,274;3398,BIN1;ID2
GO:0099641,anterograde axonal protein transport (GO:0099641),8,2,0.551667912,3.625369458,0.100790842,0.512133349,4130;1740,DLG2;MAP1A
GO:0099640,axo-dendritic protein transport (GO:0099640),8,2,0.551667912,3.625369458,0.100790842,0.512133349,4130;1740,DLG2;MAP1A
GO:1905383,protein localization to presynapse (GO:1905383),8,2,0.551667912,3.625369458,0.100790842,0.512133349,4130;1740,DLG2;MAP1A
GO:0001779,natural killer cell differentiation (GO:0001779),8,2,0.551667912,3.625369458,0.100790842,0.512133349,558;9760,AXL;TOX
GO:1905522,negative regulation of macrophage migration (GO:1905522),8,2,0.551667912,3.625369458,0.100790842,0.512133349,11117;4345,EMILIN1;CD200
GO:2000425,regulation of apoptotic cell clearance (GO:2000425),8,2,0.551667912,3.625369458,0.100790842,0.512133349,718;6347,CCL2;C3
GO:2001251,negative regulation of chromosome organization (GO:2001251),8,2,0.551667912,3.625369458,0.100790842,0.512133349,7153;9700,TOP2A;ESPL1
GO:0006267,pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),8,2,0.551667912,3.625369458,0.100790842,0.512133349,4171;4173,MCM2;MCM4
GO:0006335,DNA replication-dependent nucleosome assembly (GO:0006335),8,2,0.551667912,3.625369458,0.100790842,0.512133349,8208;55723,CHAF1B;ASF1B
GO:0034723,DNA replication-dependent nucleosome organization (GO:0034723),8,2,0.551667912,3.625369458,0.100790842,0.512133349,8208;55723,CHAF1B;ASF1B
GO:0033689,negative regulation of osteoblast proliferation (GO:0033689),8,2,0.551667912,3.625369458,0.100790842,0.512133349,6422;4330,SFRP1;MN1
GO:0061820,telomeric D-loop disassembly (GO:0061820),8,2,0.551667912,3.625369458,0.100790842,0.512133349,9401;641,RECQL4;BLM
GO:0051148,negative regulation of muscle cell differentiation (GO:0051148),8,2,0.551667912,3.625369458,0.100790842,0.512133349,3398;348093,RBPMS2;ID2
GO:0030833,regulation of actin filament polymerization (GO:0030833),69,8,4.758135743,1.681330763,0.10126191,0.514092349,10435;25802;6366;3071;9353;91663;274;1440,LMOD1;CDC42EP2;BIN1;MYADM;CSF3;SLIT2;NCKAP1L;CCL21
GO:1903556,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),47,6,3.241048984,1.851252489,0.1023775,0.517570356,3479;2621;947;23208;6376;11213,CD34;GAS6;CX3CL1;IGF1;IRAK3;SYT11
GO:0031323,regulation of cellular metabolic process (GO:0031323),47,6,3.241048984,1.851252489,0.1023775,0.517570356,32;5166;2305;22943;55022;83875,PDK4;FOXM1;BCO2;PID1;ACACB;DKK1
GO:0061041,regulation of wound healing (GO:0061041),47,6,3.241048984,1.851252489,0.1023775,0.517570356,150;857;4638;2048;2247;1839,MYLK;FGF2;CAV1;ADRA2A;HBEGF;EPHB2
GO:0003143,embryonic heart tube morphogenesis (GO:0003143),47,6,3.241048984,1.851252489,0.1023775,0.517570356,7048;6722;4208;64321;6262;6491,SOX17;TGFBR2;MEF2C;SRF;STIL;RYR2
GO:0010862,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),47,6,3.241048984,1.851252489,0.1023775,0.517570356,3624;3625;656;653;11030;7272,BMP5;INHBA;TTK;RBPMS;BMP8B;INHBB
GO:0015914,phospholipid transport (GO:0015914),58,7,3.999592364,1.750178359,0.102685125,0.518689314,5244;341;26154;5243;79895;57198;388121,TNFAIP8L3;ATP8B4;ABCB1;ABCA12;ABCB4;APOC1;ATP8B2
GO:0120036,plasma membrane bounded cell projection organization (GO:0120036),128,13,8.826686596,1.472806342,0.10323057,0.521006683,7168;6366;3569;5354;3897;152330;66000;482;2824;7832;3925;114787;10129,PLP1;IL6;ATP1B2;GPRIN1;L1CAM;TPM1;CNTN4;STMN1;CCL21;GPM6B;BTG2;TMEM108;FRY
GO:0010975,regulation of neuron projection development (GO:0010975),165,16,11.37815069,1.406203911,0.105053499,0.529762233,4915;627;1902;79625;2042;6324;5649;120892;6376;482;9863;9760;4920;4919;65078;23413,ATP1B2;RELN;LRRK2;EPHA3;RTN4R;CX3CL1;LPAR1;BDNF;ROR1;NDNF;MAGI2;SCN1B;NCS1;NTRK2;TOX;ROR2
GO:0072337,modified amino acid transport (GO:0072337),17,3,1.172294313,2.559084323,0.107931828,0.536597712,6573;2350;8884,SLC5A6;SLC19A1;FOLR2
GO:2000648,positive regulation of stem cell proliferation (GO:2000648),17,3,1.172294313,2.559084323,0.107931828,0.536597712,10979;898;4072,CCNE1;FERMT2;EPCAM
GO:0002685,regulation of leukocyte migration (GO:0002685),17,3,1.172294313,2.559084323,0.107931828,0.536597712,399;3071;683,NCKAP1L;BST1;RHOH
GO:0009792,embryo development ending in birth or egg hatching (GO:0009792),17,3,1.172294313,2.559084323,0.107931828,0.536597712,672;2260;10742,RAI2;BRCA1;FGFR1
GO:0010460,positive regulation of heart rate (GO:0010460),17,3,1.172294313,2.559084323,0.107931828,0.536597712,7168;5144;6262,PDE4D;TPM1;RYR2
GO:0060415,muscle tissue morphogenesis (GO:0060415),17,3,1.172294313,2.559084323,0.107931828,0.536597712,70;4638;7049,MYLK;TGFBR3;ACTC1
GO:0001944,vasculature development (GO:0001944),17,3,1.172294313,2.559084323,0.107931828,0.536597712,2294;6943;5156,TCF21;FOXF1;PDGFRA
GO:0046676,negative regulation of insulin secretion (GO:0046676),17,3,1.172294313,2.559084323,0.107931828,0.536597712,150;3625;6422,SFRP1;ADRA2A;INHBB
GO:0032682,negative regulation of chemokine production (GO:0032682),17,3,1.172294313,2.559084323,0.107931828,0.536597712,3569;347;9314,IL6;KLF4;APOD
GO:0010804,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),17,3,1.172294313,2.559084323,0.107931828,0.536597712,2621;10293;83643,GAS6;TRAIP;CCDC3
GO:0045740,positive regulation of DNA replication (GO:0045740),17,3,1.172294313,2.559084323,0.107931828,0.536597712,81620;1763;79915,ATAD5;DNA2;CDT1
GO:0014074,response to purine-containing compound (GO:0014074),17,3,1.172294313,2.559084323,0.107931828,0.536597712,6262;7226;10060,ABCC9;TRPM2;RYR2
GO:0050810,regulation of steroid biosynthetic process (GO:0050810),17,3,1.172294313,2.559084323,0.107931828,0.536597712,1066;653;1958,EGR1;BMP5;CES1
GO:0072164,mesonephric tubule development (GO:0072164),17,3,1.172294313,2.559084323,0.107931828,0.536597712,9353;6495;6943,TCF21;SLIT2;SIX1
GO:1904355,positive regulation of telomere capping (GO:1904355),17,3,1.172294313,2.559084323,0.107931828,0.536597712,9212;225689;4751,NEK2;AURKB;MAPK15
GO:0032101,regulation of response to external stimulus (GO:0032101),129,13,8.895645085,1.461389239,0.107974063,0.536597712,6401;11343;857;185;2048;2627;5156;6376;81792;7804;330;11274;683,MGLL;AGTR1;GATA6;CAV1;USP18;CX3CL1;LRP8;BIRC3;SELE;PDGFRA;EPHB2;BST1;ADAMTS12
GO:0046324,regulation of glucose import (GO:0046324),37,5,2.551464094,1.959659167,0.108283651,0.536597712,5167;3479;10580;51422;55022,SORBS1;PID1;IGF1;PRKAG2;ENPP1
GO:1900744,regulation of p38MAPK cascade (GO:1900744),37,5,2.551464094,1.959659167,0.108283651,0.536597712,9464;1843;5187;4616;285613,PER1;DUSP1;HAND2;RELL2;GADD45B
GO:0001937,negative regulation of endothelial cell proliferation (GO:0001937),37,5,2.551464094,1.959659167,0.108283651,0.536597712,4804;857;4208;6347;84913,MEF2C;NGFR;CAV1;CCL2;ATOH8
GO:2000249,regulation of actin cytoskeleton reorganization (GO:2000249),37,5,2.551464094,1.959659167,0.108283651,0.536597712,9723;7226;10411;5156;1440,CSF3;SEMA3E;RAPGEF3;TRPM2;PDGFRA
GO:2001233,regulation of apoptotic signaling pathway (GO:2001233),37,5,2.551464094,1.959659167,0.108283651,0.536597712,627;596;4929;6376;23542,NR4A2;CX3CL1;BCL2;BDNF;MAPK8IP2
GO:0010507,negative regulation of autophagy (GO:0010507),59,7,4.068550853,1.720514319,0.1099825,0.544567388,6622;596;54922;120892;3953;3082;26471,LRRK2;BCL2;LEPR;HGF;RASIP1;SNCA;NUPR1
GO:0071479,cellular response to ionizing radiation (GO:0071479),48,6,3.310007473,1.812684729,0.110573639,0.54704374,388;1894;641;5888;10635;1410,CRYAB;BLM;RHOB;RAD51AP1;RAD51;ECT2
GO:1902533,positive regulation of intracellular signal transduction (GO:1902533),542,45,37.37550105,1.203997237,0.111119729,0.54929333,2316;3815;2252;154;6366;1894;1116;4915;1902;3479;150;284;2621;3569;857;10979;5579;596;6285;5649;2247;6403;5156;6376;3082;1839;7037;2260;1440;558;2099;9365;57161;330;1634;374;4306;2159;4920;4919;9542;219790;388121;26471;80310,F10;IL6;NRG2;TNFAIP8L3;PRKCB;RELN;FGF2;NR3C2;GAS6;FGF7;DCN;CSF3;CAV1;FLNA;CX3CL1;FERMT2;LPAR1;ECT2;BCL2;SELP;AXL;ROR1;FGFR1;ADRA2A;PDGFD;IGF1;HGF;BIRC3;KIT;HBEGF;CCL21;S100B;ESR1;PELI2;ADRB2;TFRC;NTRK2;KL;CHI3L1;PDGFRA;ROR2;ANGPT1;RTKN2;AREG;NUPR1
GO:0046627,negative regulation of insulin receptor signaling pathway (GO:0046627),27,4,1.861879204,2.148367086,0.111698497,0.549893255,5167;5579;55022;5590,PRKCB;PID1;PRKCZ;ENPP1
GO:0120033,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),27,4,1.861879204,2.148367086,0.111698497,0.549893255,83478;6366;5909;9353,SLIT2;RAP1GAP;ARHGAP24;CCL21
GO:0032232,negative regulation of actin filament bundle assembly (GO:0032232),27,4,1.861879204,2.148367086,0.111698497,0.549893255,84952;395;10395;3925,ARHGAP6;CGNL1;STMN1;DLC1
GO:0055067,monovalent inorganic cation homeostasis (GO:0055067),27,4,1.861879204,2.148367086,0.111698497,0.549893255,3757;5166;84561;84679,PDK4;SLC12A8;KCNH2;SLC9A7
GO:0006699,bile acid biosynthetic process (GO:0006699),27,4,1.861879204,2.148367086,0.111698497,0.549893255,1593;9023;51302;8309,ACOX2;CH25H;CYP39A1;CYP27A1
GO:0060548,negative regulation of cell death (GO:0060548),94,10,6.482097969,1.542710408,0.112656635,0.554156329,6622;10979;947;1191;6659;2247;10891;120892;25959;4345,CD34;FGF2;LRRK2;SOX4;CLU;PPARGC1A;KANK2;FERMT2;CD200;SNCA
GO:0018209,peptidyl-serine modification (GO:0018209),167,16,11.51606767,1.389363146,0.113533888,0.558014881,63967;7048;2621;983;6790;5347;79625;6196;5579;120892;8317;10000;5590;7272;388228;55351,PRKCB;AURKA;TGFBR2;LRRK2;CLSPN;GAS6;TTK;CDC7;PLK1;CDK1;RPS6KA2;SBK1;STK32B;NDNF;AKT3;PRKCZ
GO:0010212,response to ionizing radiation (GO:0010212),71,8,4.896052721,1.633969333,0.114615889,0.562413148,388;1894;4609;672;641;5888;10635;2177,BLM;BRCA1;RHOB;RAD51AP1;RAD51;ECT2;FANCD2;MYC
GO:0071773,cellular response to BMP stimulus (GO:0071773),71,8,4.896052721,1.633969333,0.114615889,0.562413148,7049;656;56963;653;4093;55273;6422;81792,SFRP1;BMP5;TGFBR3;TMEM100;BMP8B;SMAD9;RGMA;ADAMTS12
GO:0043065,positive regulation of apoptotic process (GO:0043065),307,27,21.17025613,1.275374272,0.114780845,0.562763182,388;6622;4804;10395;1894;3569;6196;9353;7153;1191;9833;5740;6659;10439;322;2045;6422;3778;1869;274;3663;25999;54507;26471;79845;4616;10687,IL6;SFRP1;SOX4;CLU;NGFR;BIN1;ADAMTSL4;TOP2A;MELK;EPHA7;OLFM1;KCNMA1;RHOB;SLIT2;RPS6KA2;APBB1;RNF122;PTGIS;ECT2;E2F1;DLC1;GADD45B;CLIP3;IRF5;SNCA;NUPR1;PNMA2
GO:0048666,neuron development (GO:0048666),143,14,9.861063931,1.419725102,0.116656739,0.570511805,4915;3569;6722;5354;4208;3897;152330;66000;2824;7832;3925;163175;114787;10129,LGI4;PLP1;IL6;MEF2C;SRF;GPRIN1;L1CAM;CNTN4;STMN1;GPM6B;BTG2;NTRK2;TMEM108;FRY
GO:0016126,sterol biosynthetic process (GO:0016126),38,5,2.620422583,1.908089188,0.118022015,0.570511805,1066;9023;51422;6713;1717,CH25H;PRKAG2;CES1;DHCR7;SQLE
GO:0006974,cellular response to DNA damage stimulus (GO:0006974),347,30,23.92859569,1.253730072,0.118093218,0.570511805,221662;983;596;7153;1111;4609;10293;322;10721;2237;225689;1869;2175;116028;672;8914;9401;5427;641;55388;9156;51514;5888;11169;8438;7516;7832;10635;3090;29089,RBM24;XRCC2;HIC1;RECQL4;TIMELESS;RAD54L;POLQ;DTL;EXO1;BLM;TOP2A;WDHD1;FANCA;BRCA1;TRAIP;RAD51AP1;MCM10;UBE2T;RAD51;CDK1;APBB1;BCL2;CHEK1;FEN1;POLE2;E2F1;MAPK15;BTG2;RMI2;MYC
GO:0010468,regulation of gene expression (GO:0010468),1073,84,73.99245873,1.135250828,0.118199714,0.570511805,2934;2252;399;58;70;4915;3479;284;2621;3624;3569;5138;9464;6790;947;4857;153579;4208;140628;11117;7122;1191;4609;2053;287;6659;10439;322;2048;9759;2247;64321;6495;10891;493;57419;6546;2202;6422;8324;5563;1869;22943;91663;55022;4286;7037;672;7942;1958;3090;2099;9314;8483;3398;4602;2146;90865;27303;1789;675;25937;5241;3899;83595;5187;59;90993;84913;56978;118738;133522;8736;72;57716;23090;83643;1390;5178;93166;4605;4774;55422;54796,PER1;CLDN5;IL6;SOX17;ACTG2;AFF3;ANK2;PGR;GATA5;PDE2A;HIC1;AURKA;SLC24A3;MYOM1;SFRP1;IL33;PEG3;NOVA1;CD34;EGR1;FGF2;SOX4;MEF2C;KLF4;ACTC1;GSN;ACTA2;CLU;INHBA;GAS6;MYADM;FGF7;PID1;PRDM6;BRCA1;MYBL2;OLFM1;CREM;PPARGC1A;RBMS3;HAND2;ZNF331;CCDC3;TFEB;APBB1;EPHX2;FZD7;BRCA2;ATOH8;E2F1;EMILIN1;CILP;WWTR1;EZH2;BTNL9;IGF1;DNMT3B;PRDM8;NFIA;ACTA1;ID2;HDAC4;EFEMP1;CREB3L1;MITF;ATP2B4;ESR1;SIX1;TFRC;PPARGC1B;NTRK2;BNC2;SOX7;PRX;SLC8A1;EPHB2;MYB;MYC;ANGPT1;DKK1;ZNF423;PRKAA2;RHOH;ZNF488
GO:1901987,regulation of cell cycle phase transition (GO:1901987),95,10,6.551056458,1.526471351,0.118604988,0.570511805,11065;991;701;983;4085;5347;891;493;51512;4330,UBE2C;CDC20;PLK1;GTSE1;BUB1B;CCNB1;CDK1;MAD2L1;ATP2B4;MN1
GO:0018105,peptidyl-serine phosphorylation (GO:0018105),156,15,10.75752429,1.394372869,0.119809605,0.570511805,63967;7048;2621;983;6790;5347;6196;5579;120892;8317;10000;5590;7272;388228;55351,PRKCB;AURKA;TGFBR2;LRRK2;CLSPN;GAS6;TTK;CDC7;PLK1;CDK1;RPS6KA2;SBK1;STK32B;AKT3;PRKCZ
GO:0034330,cell junction organization (GO:0034330),72,8,4.96501121,1.611275315,0.121631692,0.570511805,375790;2316;6622;10979;9723;3897;2318;55679,FLNC;LIMS2;SEMA3E;FLNA;FERMT2;L1CAM;AGRN;SNCA
GO:0045663,positive regulation of myoblast differentiation (GO:0045663),18,3,1.241252803,2.416912972,0.123198365,0.570511805,221662;4208;91653,RBM24;MEF2C;BOC
GO:2000463,positive regulation of excitatory postsynaptic potential (GO:2000463),18,3,1.241252803,2.416912972,0.123198365,0.570511805,9378;5649;5590,RELN;NRXN1;PRKCZ
GO:0098719,sodium ion import across plasma membrane (GO:0098719),18,3,1.241252803,2.416912972,0.123198365,0.570511805,6546;84679;285195,SLC9A9;SLC8A1;SLC9A7
GO:0036336,dendritic cell migration (GO:0036336),18,3,1.241252803,2.416912972,0.123198365,0.570511805,6366;1880;7226,GPR183;TRPM2;CCL21
GO:0090050,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),18,3,1.241252803,2.416912972,0.123198365,0.570511805,2247;57381;10000,RHOJ;FGF2;AKT3
GO:0042551,neuron maturation (GO:0042551),18,3,1.241252803,2.416912972,0.123198365,0.570511805,6376;718;163175,LGI4;CX3CL1;C3
GO:0051569,regulation of histone H3-K4 methylation (GO:0051569),18,3,1.241252803,2.416912972,0.123198365,0.570511805,672;4602;1789,BRCA1;DNMT3B;MYB
GO:0050918,positive chemotaxis (GO:0050918),18,3,1.241252803,2.416912972,0.123198365,0.570511805,2252;284;6376,FGF7;CX3CL1;ANGPT1
GO:2000042,negative regulation of double-strand break repair via homologous recombination (GO:2000042),18,3,1.241252803,2.416912972,0.123198365,0.570511805,10721;116028;55010,POLQ;PARPBP;RMI2
GO:0033630,positive regulation of cell adhesion mediated by integrin (GO:0033630),18,3,1.241252803,2.416912972,0.123198365,0.570511805,5881;6366;3071,RAC3;NCKAP1L;CCL21
GO:0090278,negative regulation of peptide hormone secretion (GO:0090278),18,3,1.241252803,2.416912972,0.123198365,0.570511805,150;3625;6422,SFRP1;ADRA2A;INHBB
GO:1902259,regulation of delayed rectifier potassium channel activity (GO:1902259),18,3,1.241252803,2.416912972,0.123198365,0.570511805,23704;9472;3755,AKAP6;KCNG1;KCNE4
GO:0032793,positive regulation of CREB transcription factor activity (GO:0032793),18,3,1.241252803,2.416912972,0.123198365,0.570511805,5649;7804;4345,RELN;LRP8;CD200
GO:0001836,release of cytochrome c from mitochondria (GO:0001836),18,3,1.241252803,2.416912972,0.123198365,0.570511805,596;1191;2537,CLU;BCL2;IFI6
GO:0035024,negative regulation of Rho protein signal transduction (GO:0035024),18,3,1.241252803,2.416912972,0.123198365,0.570511805,10395;54922;3925,STMN1;DLC1;RASIP1
GO:0071539,protein localization to centrosome (GO:0071539),18,3,1.241252803,2.416912972,0.123198365,0.570511805,6491;29887;10615,SPAG5;STIL;SNX10
GO:0035050,embryonic heart tube development (GO:0035050),18,3,1.241252803,2.416912972,0.123198365,0.570511805,64321;6262;5308,SOX17;RYR2;PITX2
GO:0046599,regulation of centriole replication (GO:0046599),18,3,1.241252803,2.416912972,0.123198365,0.570511805,10733;672;6491,STIL;BRCA1;PLK4
GO:0006516,glycoprotein catabolic process (GO:0006516),18,3,1.241252803,2.416912972,0.123198365,0.570511805,56999;81792;4321,ADAMTS9;MMP12;ADAMTS12
GO:1900077,negative regulation of cellular response to insulin stimulus (GO:1900077),28,4,1.930837693,2.07163969,0.123599184,0.570511805,5167;5579;55022;5590,PRKCB;PID1;PRKCZ;ENPP1
GO:1901020,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),28,4,1.930837693,2.07163969,0.123599184,0.570511805,150;5350;477;845,ATP1A2;CASQ2;PLN;ADRA2A
GO:0050771,negative regulation of axonogenesis (GO:0050771),28,4,1.930837693,2.07163969,0.123599184,0.570511805,4804;56920;2258;65078,SEMA3G;NGFR;FGF13;RTN4R
GO:2000278,regulation of DNA biosynthetic process (GO:2000278),28,4,1.930837693,2.07163969,0.123599184,0.570511805,4609;2247;3082;64094,FGF2;SMOC2;HGF;MYC
GO:0030098,lymphocyte differentiation (GO:0030098),84,9,5.792513078,1.553729768,0.123822474,0.570511805,3815;399;974;6659;1316;9759;3953;558;9760,SOX4;KLF6;AXL;LEPR;CD79B;HDAC4;KIT;TOX;RHOH
GO:0051788,response to misfolded protein (GO:0051788),9,2,0.620626401,3.222550629,0.123859242,0.570511805,1191;2161,CLU;F12
GO:0032026,response to magnesium ion (GO:0032026),9,2,0.620626401,3.222550629,0.123859242,0.570511805,6622;6263,RYR3;SNCA
GO:0060546,negative regulation of necroptotic process (GO:0060546),9,2,0.620626401,3.222550629,0.123859242,0.570511805,291;330,BIRC3;SLC25A4
GO:0022898,regulation of transmembrane transporter activity (GO:0022898),9,2,0.620626401,3.222550629,0.123859242,0.570511805,6622;596,BCL2;SNCA
GO:0045161,neuronal ion channel clustering (GO:0045161),9,2,0.620626401,3.222550629,0.123859242,0.570511805,375790;4897,AGRN;NRCAM
GO:0046717,acid secretion (GO:0046717),9,2,0.620626401,3.222550629,0.123859242,0.570511805,5244;65010,SLC26A6;ABCB4
GO:1904019,epithelial cell apoptotic process (GO:1904019),9,2,0.620626401,3.222550629,0.123859242,0.570511805,2934;6262,GSN;RYR2
GO:0045920,negative regulation of exocytosis (GO:0045920),9,2,0.620626401,3.222550629,0.123859242,0.570511805,6622;29091,STXBP6;SNCA
GO:0050910,detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),9,2,0.620626401,3.222550629,0.123859242,0.570511805,3815;1301,COL11A1;KIT
GO:0002448,mast cell mediated immunity (GO:0002448),9,2,0.620626401,3.222550629,0.123859242,0.570511805,3815;8013,NR4A3;KIT
GO:0045987,positive regulation of smooth muscle contraction (GO:0045987),9,2,0.620626401,3.222550629,0.123859242,0.570511805,6722;93649,MYOCD;SRF
GO:0035767,endothelial cell chemotaxis (GO:0035767),9,2,0.620626401,3.222550629,0.123859242,0.570511805,1960;3164,NR4A1;EGR3
GO:1904667,negative regulation of ubiquitin protein ligase activity (GO:1904667),9,2,0.620626401,3.222550629,0.123859242,0.570511805,4085;9532,BAG2;MAD2L1
GO:0048741,skeletal muscle fiber development (GO:0048741),9,2,0.620626401,3.222550629,0.123859242,0.570511805,58;6495,ACTA1;SIX1
GO:0048548,regulation of pinocytosis (GO:0048548),9,2,0.620626401,3.222550629,0.123859242,0.570511805,857;558,CAV1;AXL
GO:0003094,glomerular filtration (GO:0003094),9,2,0.620626401,3.222550629,0.123859242,0.570511805,4162;947,CD34;MCAM
GO:0007512,adult heart development (GO:0007512),9,2,0.620626401,3.222550629,0.123859242,0.570511805,80274;9464,HAND2;SCUBE1
GO:0060732,positive regulation of inositol phosphate biosynthetic process (GO:0060732),9,2,0.620626401,3.222550629,0.123859242,0.570511805,6622;5745,PTH1R;SNCA
GO:1904322,cellular response to forskolin (GO:1904322),9,2,0.620626401,3.222550629,0.123859242,0.570511805,111;108,ADCY5;ADCY2
GO:1904321,response to forskolin (GO:1904321),9,2,0.620626401,3.222550629,0.123859242,0.570511805,111;108,ADCY5;ADCY2
GO:1905953,negative regulation of lipid localization (GO:1905953),9,2,0.620626401,3.222550629,0.123859242,0.570511805,3690;3569,IL6;ITGB3
GO:2001171,positive regulation of ATP biosynthetic process (GO:2001171),9,2,0.620626401,3.222550629,0.123859242,0.570511805,10891;55022,PID1;PPARGC1A
GO:0050865,regulation of cell activation (GO:0050865),9,2,0.620626401,3.222550629,0.123859242,0.570511805,3569;11117,IL6;EMILIN1
GO:0044320,cellular response to leptin stimulus (GO:0044320),9,2,0.620626401,3.222550629,0.123859242,0.570511805,3953;8013,NR4A3;LEPR
GO:0044321,response to leptin (GO:0044321),9,2,0.620626401,3.222550629,0.123859242,0.570511805,3953;8013,NR4A3;LEPR
GO:2000269,regulation of fibroblast apoptotic process (GO:2000269),9,2,0.620626401,3.222550629,0.123859242,0.570511805,2621;6422,SFRP1;GAS6
GO:0048333,mesodermal cell differentiation (GO:0048333),9,2,0.620626401,3.222550629,0.123859242,0.570511805,3690;8516,ITGA8;ITGB3
GO:0003183,mitral valve morphogenesis (GO:0003183),9,2,0.620626401,3.222550629,0.123859242,0.570511805,8642;6659,SOX4;DCHS1
GO:1902959,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),9,2,0.620626401,3.222550629,0.123859242,0.570511805,1944;274,BIN1;EFNA3
GO:2001014,regulation of skeletal muscle cell differentiation (GO:2001014),9,2,0.620626401,3.222550629,0.123859242,0.570511805,4208;93649,MYOCD;MEF2C
GO:0060100,"positive regulation of phagocytosis, engulfment (GO:0060100)",9,2,0.620626401,3.222550629,0.123859242,0.570511805,3071;718,C3;NCKAP1L
GO:0006958,"complement activation, classical pathway (GO:0006958)",9,2,0.620626401,3.222550629,0.123859242,0.570511805,715;716,C1R;C1S
GO:0060192,negative regulation of lipase activity (GO:0060192),9,2,0.620626401,3.222550629,0.123859242,0.570511805,341;5997,RGS2;APOC1
GO:0010873,positive regulation of cholesterol esterification (GO:0010873),9,2,0.620626401,3.222550629,0.123859242,0.570511805,341;185,AGTR1;APOC1
GO:0060353,regulation of cell adhesion molecule production (GO:0060353),9,2,0.620626401,3.222550629,0.123859242,0.570511805,857;81035,CAV1;COLEC12
GO:1903596,regulation of gap junction assembly (GO:1903596),9,2,0.620626401,3.222550629,0.123859242,0.570511805,857;6910,CAV1;TBX5
GO:0060394,negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),9,2,0.620626401,3.222550629,0.123859242,0.570511805,11117;22943,EMILIN1;DKK1
GO:0085020,protein K6-linked ubiquitination (GO:0085020),9,2,0.620626401,3.222550629,0.123859242,0.570511805,672;29089,BRCA1;UBE2T
GO:0097104,postsynaptic membrane assembly (GO:0097104),9,2,0.620626401,3.222550629,0.123859242,0.570511805,9379;9378,NRXN1;NRXN2
GO:0035999,tetrahydrofolate interconversion (GO:0035999),9,2,0.620626401,3.222550629,0.123859242,0.570511805,25902;7298,MTHFD1L;TYMS
GO:0033280,response to vitamin D (GO:0033280),9,2,0.620626401,3.222550629,0.123859242,0.570511805,6696;6422,SFRP1;SPP1
GO:0019852,L-ascorbic acid metabolic process (GO:0019852),9,2,0.620626401,3.222550629,0.123859242,0.570511805,9104;6515,RGN;SLC2A3
GO:0035115,embryonic forelimb morphogenesis (GO:0035115),9,2,0.620626401,3.222550629,0.123859242,0.570511805,775;6910,CACNA1C;TBX5
GO:0060039,pericardium development (GO:0060039),9,2,0.620626401,3.222550629,0.123859242,0.570511805,653;6910,BMP5;TBX5
GO:0051838,cytolysis by host of symbiont cells (GO:0051838),9,2,0.620626401,3.222550629,0.123859242,0.570511805,3853;3078,CFHR1;KRT6A
GO:0051801,cytolysis in other organism involved in symbiotic interaction (GO:0051801),9,2,0.620626401,3.222550629,0.123859242,0.570511805,3853;3078,CFHR1;KRT6A
GO:0035358,regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),9,2,0.620626401,3.222550629,0.123859242,0.570511805,5740;55885,LMO3;PTGIS
GO:2000095,"regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",9,2,0.620626401,3.222550629,0.123859242,0.570511805,22943;84870,RSPO3;DKK1
GO:0090101,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),108,11,7.447516815,1.477002372,0.12472368,0.573614413,7048;857;11117;4093;63976;10252;22943;8483;9863;348093;7041,SPRY1;TGFBR2;CAV1;RBPMS2;MAGI2;EMILIN1;CILP;TGFB1I1;SMAD9;PRDM16;DKK1
GO:0031396,regulation of protein ubiquitination (GO:0031396),108,11,7.447516815,1.477002372,0.12472368,0.573614413,11170;284;857;6659;8864;120892;672;9636;330;55215;9532,FAM107A;FANCI;LRRK2;SOX4;PER2;CAV1;BRCA1;BAG2;BIRC3;ISG15;ANGPT1
GO:0032526,response to retinoic acid (GO:0032526),61,7,4.206467831,1.664104014,0.125374929,0.57616873,358;2042;7483;7472;8324;2627;4277,AQP1;EPHA3;GATA6;FZD7;WNT2;WNT9A;MICB
GO:0010243,response to organonitrogen compound (GO:0010243),39,5,2.689381072,1.859163825,0.128157286,0.586712448,3569;338328;7226;11213;3663,GPIHBP1;IL6;TRPM2;IRAK3;IRF5
GO:0050773,regulation of dendrite development (GO:0050773),39,5,2.689381072,1.859163825,0.128157286,0.586712448,23043;23242;6383;653;7804,BMP5;SDC2;LRP8;TNIK;COBL
GO:2001244,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),39,5,2.689381072,1.859163825,0.128157286,0.586712448,857;596;4487;26471;138151,NACC2;CAV1;BCL2;MSX1;NUPR1
GO:0061097,regulation of protein tyrosine kinase activity (GO:0061097),39,5,2.689381072,1.859163825,0.128157286,0.586712448,2621;857;5649;7804;146433,RELN;IL34;GAS6;CAV1;LRP8
GO:0048259,regulation of receptor-mediated endocytosis (GO:0048259),39,5,2.689381072,1.859163825,0.128157286,0.586712448,6366;341;1191;22943;718,CLU;C3;CCL21;APOC1;DKK1
GO:0006836,neurotransmitter transport (GO:0006836),73,8,5.033969699,1.58920305,0.128868754,0.587731471,6581;2571;9379;9378;3177;477;6812;5799,ATP1A2;NRXN1;PTPRN2;SLC22A3;NRXN2;GAD1;STXBP1;SLC29A2
GO:0050806,positive regulation of synaptic transmission (GO:0050806),73,8,5.033969699,1.58920305,0.128868754,0.587731471,9378;2048;5649;2906;4776;6347;5590;57616,RELN;NRXN1;GRIN2D;CCL2;NFATC4;TSHZ3;EPHB2;PRKCZ
GO:0035023,regulation of Rho protein signal transduction (GO:0035023),73,8,5.033969699,1.58920305,0.128868754,0.587731471,10395;1902;54922;3925;90627;25959;65078;9754,STARD13;STARD8;RTN4R;KANK2;LPAR1;STMN1;DLC1;RASIP1
GO:0007162,negative regulation of cell adhesion (GO:0007162),73,8,5.033969699,1.58920305,0.128868754,0.587731471,284;83700;2048;8324;6376;1843;2192;10391,DUSP1;JAM3;CX3CL1;FZD7;CORO2B;FBLN1;EPHB2;ANGPT1
GO:0051336,regulation of hydrolase activity (GO:0051336),73,8,5.033969699,1.58920305,0.128868754,0.587731471,5909;4915;857;2042;54922;11149;5592;55843,EPHA3;CAV1;BVES;ARHGAP15;RAP1GAP;PRKG1;NTRK2;RASIP1
GO:0051260,protein homooligomerization (GO:0051260),121,12,8.343977172,1.438163091,0.129635094,0.590778281,32;1894;84976;10721;7226;6263;286133;641;7732;79689;138151;7083,SCARA5;POLQ;NACC2;BLM;ACACB;RNF112;RYR3;ECT2;TK1;STEAP4;TRPM2;DISP1
GO:0010595,positive regulation of endothelial cell migration (GO:0010595),85,9,5.861471567,1.535450594,0.130551932,0.593935373,388;284;3690;2247;10000;2260;64094;84913;6237,FGF2;RHOB;SMOC2;ATOH8;FGFR1;RRAS;ITGB3;AKT3;ANGPT1
GO:0046578,regulation of Ras protein signal transduction (GO:0046578),85,9,5.861471567,1.535450594,0.130551932,0.593935373,10395;3479;9928;2048;10252;2305;90627;25959;9754,SPRY1;FOXM1;KIF14;STARD13;STARD8;KANK2;IGF1;DLC1;EPHB2
GO:0050804,modulation of chemical synaptic transmission (GO:0050804),109,11,7.516475304,1.463451891,0.130624283,0.593935373,627;4884;4208;5649;66000;120892;477;23542;7804;2901;2899,ATP1A2;RELN;LRRK2;MEF2C;GRIK3;BDNF;LRP8;MAPK8IP2;NPTX1;TMEM108;GRIK5
GO:0070059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),29,4,1.999796182,2.000203839,0.1360107,0.614707004,489;596;3708;79094,ITPR1;BCL2;ATP2A3;CHAC1
GO:0043030,regulation of macrophage activation (GO:0043030),29,4,1.999796182,2.000203839,0.1360107,0.614707004,3569;145581;90865;4345,IL6;IL33;LRFN5;CD200
GO:0002831,regulation of response to biotic stimulus (GO:0002831),29,4,1.999796182,2.000203839,0.1360107,0.614707004,2627;6376;7804;330,GATA6;CX3CL1;LRP8;BIRC3
GO:0006942,regulation of striated muscle contraction (GO:0006942),29,4,1.999796182,2.000203839,0.1360107,0.614707004,1756;287;6262;477,ATP1A2;ANK2;DMD;RYR2
GO:0002687,positive regulation of leukocyte migration (GO:0002687),29,4,1.999796182,2.000203839,0.1360107,0.614707004,3569;3570;83700;3071,IL6;JAM3;NCKAP1L;IL6R
GO:0061028,establishment of endothelial barrier (GO:0061028),29,4,1.999796182,2.000203839,0.1360107,0.614707004,5138;5144;10411;91663,PDE2A;MYADM;PDE4D;RAPGEF3
GO:0010719,negative regulation of epithelial to mesenchymal transition (GO:0010719),29,4,1.999796182,2.000203839,0.1360107,0.614707004,653;6910;6422;10252,SPRY1;SFRP1;BMP5;TBX5
GO:2001238,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),29,4,1.999796182,2.000203839,0.1360107,0.614707004,3624;857;8742;6422,SFRP1;INHBA;CAV1;TNFSF12
GO:0045600,positive regulation of fat cell differentiation (GO:0045600),51,6,3.51688294,1.706056216,0.137071085,0.618105246,7538;7704;6495;6422;3398;55885,ZBTB16;ZFP36;SFRP1;LMO3;ID2;SIX1
GO:0042770,signal transduction in response to DNA damage (GO:0042770),51,6,3.51688294,1.706056216,0.137071085,0.618105246,63967;1111;1869;83990;29980;144455,CLSPN;BRIP1;E2F7;CHEK1;DONSON;E2F1
GO:0032508,DNA duplex unwinding (GO:0032508),51,6,3.51688294,1.706056216,0.137071085,0.618105246,4171;80119;9401;641;4173;5888,RECQL4;MCM2;BLM;RAD51;MCM4;PIF1
GO:0031113,regulation of microtubule polymerization (GO:0031113),40,5,2.758339561,1.812684729,0.138673862,0.619301725,6622;25999;3925;84722;89795,NAV3;STMN1;CLIP3;PSRC1;SNCA
GO:0010812,negative regulation of cell-substrate adhesion (GO:0010812),40,5,2.758339561,1.812684729,0.138673862,0.619301725,9723;8324;6376;2192;10391,SEMA3E;CX3CL1;FZD7;CORO2B;FBLN1
GO:0048863,stem cell differentiation (GO:0048863),40,5,2.758339561,1.812684729,0.138673862,0.619301725,3815;4208;6422;4222;4072,MEOX1;SFRP1;MEF2C;KIT;EPCAM
GO:0001516,prostaglandin biosynthetic process (GO:0001516),19,3,1.310211292,2.289707026,0.139190922,0.619301725,5730;5740;5742,PTGS1;PTGDS;PTGIS
GO:0006067,ethanol metabolic process (GO:0006067),19,3,1.310211292,2.289707026,0.139190922,0.619301725,125;126;217,ADH1B;ALDH2;ADH1C
GO:1902001,fatty acid transmembrane transport (GO:1902001),19,3,1.310211292,2.289707026,0.139190922,0.619301725,32;5563;51422,ACACB;PRKAG2;PRKAA2
GO:0061384,heart trabecula morphogenesis (GO:0061384),19,3,1.310211292,2.289707026,0.139190922,0.619301725,1901;7049;653,BMP5;TGFBR3;S1PR1
GO:0035088,establishment or maintenance of apical/basal cell polarity (GO:0035088),19,3,1.310211292,2.289707026,0.139190922,0.619301725,1740;25932;117583,DLG2;PARD3B;CLIC4
GO:0032965,regulation of collagen biosynthetic process (GO:0032965),19,3,1.310211292,2.289707026,0.139190922,0.619301725,3569;11117;90993,IL6;EMILIN1;CREB3L1
GO:0071280,cellular response to copper ion (GO:0071280),19,3,1.310211292,2.289707026,0.139190922,0.619301725,6622;358;4499,AQP1;MT1M;SNCA
GO:0001657,ureteric bud development (GO:0001657),19,3,1.310211292,2.289707026,0.139190922,0.619301725,9353;6495;6943,TCF21;SLIT2;SIX1
GO:0002688,regulation of leukocyte chemotaxis (GO:0002688),19,3,1.310211292,2.289707026,0.139190922,0.619301725,3569;3570;9353,IL6;SLIT2;IL6R
GO:0030856,regulation of epithelial cell differentiation (GO:0030856),19,3,1.310211292,2.289707026,0.139190922,0.619301725,857;23764;81575,APOLD1;CAV1;MAFF
GO:0070542,response to fatty acid (GO:0070542),19,3,1.310211292,2.289707026,0.139190922,0.619301725,6319;5166;55022,PDK4;PID1;SCD
GO:0046655,folic acid metabolic process (GO:0046655),19,3,1.310211292,2.289707026,0.139190922,0.619301725,6573;2350;25902,SLC19A1;MTHFD1L;FOLR2
GO:0000729,DNA double-strand break processing (GO:0000729),19,3,1.310211292,2.289707026,0.139190922,0.619301725,1763;672;641,DNA2;BLM;BRCA1
GO:0006305,DNA alkylation (GO:0006305),19,3,1.310211292,2.289707026,0.139190922,0.619301725,2353;3070;1789,FOS;DNMT3B;HELLS
GO:0044728,DNA methylation or demethylation (GO:0044728),19,3,1.310211292,2.289707026,0.139190922,0.619301725,2353;3070;1789,FOS;DNMT3B;HELLS
GO:0006812,cation transport (GO:0006812),173,16,11.9298186,1.341177141,0.141355547,0.628467598,6332;8884;358;6581;3779;3777;6330;8671;6546;7226;3752;477;10060;3755;3778;2258,ATP1A2;SCN7A;AQP1;KCNMB1;SLC5A6;FGF13;KCNK3;KCNMA1;SCN4B;SLC22A3;ABCC9;KCND3;TRPM2;SLC4A4;KCNG1;SLC8A1
GO:0051345,positive regulation of hydrolase activity (GO:0051345),148,14,10.20585638,1.371761417,0.142081739,0.630763172,375790;6366;5909;1894;10979;10411;6422;6376;6347;10235;2146;4345;65078;9824,SFRP1;RASGRP2;RTN4R;ARHGAP11A;CX3CL1;FERMT2;ECT2;CCL2;RAPGEF3;EZH2;RAP1GAP;AGRN;CD200;CCL21
GO:0007420,brain development (GO:0007420),148,14,10.20585638,1.371761417,0.142081739,0.630763172,7048;152330;2045;4781;5649;347;2906;4826;1959;54510;5463;1063;10763;5050,TGFBR2;RELN;CENPF;NNAT;EPHA7;NES;GRIN2D;CNTN4;PAFAH1B3;EGR2;NFIB;APOD;POU6F1;PCDH18
GO:0017015,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),99,10,6.826890414,1.464795741,0.144086629,0.637829662,7048;857;11117;7049;63976;10252;9839;8425;1028;7041,SPRY1;TGFBR2;TGFBR3;CAV1;ZEB2;LTBP4;EMILIN1;TGFB1I1;CDKN1C;PRDM16
GO:0048639,positive regulation of developmental growth (GO:0048639),52,6,3.585841429,1.673247442,0.146509531,0.637829662,375790;2690;627;3897;9423;8437,GHR;L1CAM;BDNF;AGRN;NTN1;RASAL1
GO:0120039,plasma membrane bounded cell projection morphogenesis (GO:0120039),52,6,3.585841429,1.673247442,0.146509531,0.637829662,23043;8522;627;3071;120892;9201,LRRK2;GAS7;BDNF;DCLK1;NCKAP1L;TNIK
GO:0043650,dicarboxylic acid biosynthetic process (GO:0043650),10,2,0.68958489,2.900295567,0.148024019,0.637829662,23498;25902,HAAO;MTHFD1L
GO:0031953,negative regulation of protein autophosphorylation (GO:0031953),10,2,0.68958489,2.900295567,0.148024019,0.637829662,5167;857,CAV1;ENPP1
GO:1904035,regulation of epithelial cell apoptotic process (GO:1904035),10,2,0.68958489,2.900295567,0.148024019,0.637829662,7538;26471,ZFP36;NUPR1
GO:0061003,positive regulation of dendritic spine morphogenesis (GO:0061003),10,2,0.68958489,2.900295567,0.148024019,0.637829662,5649;7804,RELN;LRP8
GO:0061154,endothelial tube morphogenesis (GO:0061154),10,2,0.68958489,2.900295567,0.148024019,0.637829662,388;90627,STARD13;RHOB
GO:1901998,toxin transport (GO:1901998),10,2,0.68958489,2.900295567,0.148024019,0.637829662,6581;118429,ANTXR2;SLC22A3
GO:0016322,neuron remodeling (GO:0016322),10,2,0.68958489,2.900295567,0.148024019,0.637829662,6376;718,CX3CL1;C3
GO:0097205,renal filtration (GO:0097205),10,2,0.68958489,2.900295567,0.148024019,0.637829662,4162;947,CD34;MCAM
GO:1903205,regulation of hydrogen peroxide-induced cell death (GO:1903205),10,2,0.68958489,2.900295567,0.148024019,0.637829662,5831;120892,LRRK2;PYCR1
GO:0001921,positive regulation of receptor recycling (GO:0001921),10,2,0.68958489,2.900295567,0.148024019,0.637829662,6622;11149,BVES;SNCA
GO:0002357,defense response to tumor cell (GO:0002357),10,2,0.68958489,2.900295567,0.148024019,0.637829662,9314;27303,KLF4;RBMS3
GO:0038180,nerve growth factor signaling pathway (GO:0038180),10,2,0.68958489,2.900295567,0.148024019,0.637829662,627;9863,BDNF;MAGI2
GO:1905521,regulation of macrophage migration (GO:1905521),10,2,0.68958489,2.900295567,0.148024019,0.637829662,11117;4345,EMILIN1;CD200
GO:0002053,positive regulation of mesenchymal cell proliferation (GO:0002053),10,2,0.68958489,2.900295567,0.148024019,0.637829662,7048;4609,TGFBR2;MYC
GO:0014812,muscle cell migration (GO:0014812),10,2,0.68958489,2.900295567,0.148024019,0.637829662,3690;6495,SIX1;ITGB3
GO:0032288,myelin assembly (GO:0032288),10,2,0.68958489,2.900295567,0.148024019,0.637829662,5376;11076,TPPP;PMP22
GO:0043217,myelin maintenance (GO:0043217),10,2,0.68958489,2.900295567,0.148024019,0.637829662,1191;57716,CLU;PRX
GO:0060099,"regulation of phagocytosis, engulfment (GO:0060099)",10,2,0.68958489,2.900295567,0.148024019,0.637829662,3071;718,C3;NCKAP1L
GO:0060761,negative regulation of response to cytokine stimulus (GO:0060761),10,2,0.68958489,2.900295567,0.148024019,0.637829662,11213;9314,KLF4;IRAK3
GO:0046466,membrane lipid catabolic process (GO:0046466),10,2,0.68958489,2.900295567,0.148024019,0.637829662,27293;5168,ENPP2;SMPDL3B
GO:0034115,negative regulation of heterotypic cell-cell adhesion (GO:0034115),10,2,0.68958489,2.900295567,0.148024019,0.637829662,91663;9314,KLF4;MYADM
GO:0070587,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),10,2,0.68958489,2.900295567,0.148024019,0.637829662,91663;9314,KLF4;MYADM
GO:0003158,endothelium development (GO:0003158),10,2,0.68958489,2.900295567,0.148024019,0.637829662,80274;947,CD34;SCUBE1
GO:0034616,response to laminar fluid shear stress (GO:0034616),10,2,0.68958489,2.900295567,0.148024019,0.637829662,10365;9314,KLF2;KLF4
GO:0043951,negative regulation of cAMP-mediated signaling (GO:0043951),10,2,0.68958489,2.900295567,0.148024019,0.637829662,5138;5144,PDE2A;PDE4D
GO:0048520,positive regulation of behavior (GO:0048520),10,2,0.68958489,2.900295567,0.148024019,0.637829662,4208;8013,NR4A3;MEF2C
GO:0042754,negative regulation of circadian rhythm (GO:0042754),10,2,0.68958489,2.900295567,0.148024019,0.637829662,8864;1408,CRY2;PER2
GO:0006182,cGMP biosynthetic process (GO:0006182),10,2,0.68958489,2.900295567,0.148024019,0.637829662,4881;4882,NPR1;NPR2
GO:0007168,receptor guanylyl cyclase signaling pathway (GO:0007168),10,2,0.68958489,2.900295567,0.148024019,0.637829662,4881;4882,NPR1;NPR2
GO:0060218,hematopoietic stem cell differentiation (GO:0060218),10,2,0.68958489,2.900295567,0.148024019,0.637829662,6422;4222,MEOX1;SFRP1
GO:0045898,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),10,2,0.68958489,2.900295567,0.148024019,0.637829662,2099;7067,THRA;ESR1
GO:0035136,forelimb morphogenesis (GO:0035136),10,2,0.68958489,2.900295567,0.148024019,0.637829662,775;6910,CACNA1C;TBX5
GO:0001782,B cell homeostasis (GO:0001782),10,2,0.68958489,2.900295567,0.148024019,0.637829662,3071;4208,MEF2C;NCKAP1L
GO:0070296,sarcoplasmic reticulum calcium ion transport (GO:0070296),10,2,0.68958489,2.900295567,0.148024019,0.637829662,287;6262,ANK2;RYR2
GO:0140042,lipid droplet formation (GO:0140042),10,2,0.68958489,2.900295567,0.148024019,0.637829662,8605;6713,PLA2G4C;SQLE
GO:0090657,telomeric loop disassembly (GO:0090657),10,2,0.68958489,2.900295567,0.148024019,0.637829662,9401;641,RECQL4;BLM
GO:0006073,cellular glucan metabolic process (GO:0006073),10,2,0.68958489,2.900295567,0.148024019,0.637829662,51422;5837,PYGM;PRKAG2
GO:0072711,cellular response to hydroxyurea (GO:0072711),10,2,0.68958489,2.900295567,0.148024019,0.637829662,8914;641,TIMELESS;BLM
GO:0045937,positive regulation of phosphate metabolic process (GO:0045937),30,4,2.068754671,1.933530378,0.148901563,0.638407486,6622;5745;3071;8324,PTH1R;FZD7;NCKAP1L;SNCA
GO:0032692,negative regulation of interleukin-1 production (GO:0032692),30,4,2.068754671,1.933530378,0.148901563,0.638407486,3479;2621;114548;6376,GAS6;CX3CL1;IGF1;NLRP3
GO:0019229,regulation of vasoconstriction (GO:0019229),30,4,2.068754671,1.933530378,0.148901563,0.638407486,857;185;624;8864,AGTR1;PER2;BDKRB2;CAV1
GO:0046785,microtubule polymerization (GO:0046785),30,4,2.068754671,1.933530378,0.148901563,0.638407486,22974;11076;2258;51673,TPPP;TPPP3;TPX2;FGF13
GO:0014020,primary neural tube formation (GO:0014020),30,4,2.068754671,1.933530378,0.148901563,0.638407486,23242;10395;25902;6491,STIL;MTHFD1L;DLC1;COBL
GO:1904062,regulation of cation transmembrane transport (GO:1904062),30,4,2.068754671,1.933530378,0.148901563,0.638407486,3757;493;6640;7871,KCNH2;SLMAP;ATP2B4;SNTA1
GO:0006334,nucleosome assembly (GO:0006334),30,4,2.068754671,1.933530378,0.148901563,0.638407486,8208;4675;4674;55723,CHAF1B;ASF1B;NAP1L2;NAP1L3
GO:0030865,cortical cytoskeleton organization (GO:0030865),41,5,2.82729805,1.768472906,0.149554945,0.639839697,399;388;390;5881;3071,RHOB;RAC3;NCKAP1L;RND3;RHOH
GO:0048705,skeletal system morphogenesis (GO:0048705),41,5,2.82729805,1.768472906,0.149554945,0.639839697,4322;6495;2201;5156;2260,MMP13;FGFR1;SIX1;FBN2;PDGFRA
GO:0070848,response to growth factor (GO:0070848),41,5,2.82729805,1.768472906,0.149554945,0.639839697,7048;4609;6422;2627;9314,SFRP1;TGFBR2;KLF4;GATA6;MYC
GO:0031669,cellular response to nutrient levels (GO:0031669),64,7,4.413343298,1.586099138,0.150373161,0.642882697,11170;3625;120892;6422;5563;5166;7942,PDK4;FAM107A;SFRP1;LRRK2;TFEB;INHBB;PRKAA2
GO:1903322,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),76,8,5.240845166,1.526471351,0.151864678,0.648337058,11170;284;857;9759;120892;672;330;55215,FAM107A;FANCI;LRRK2;CAV1;BRCA1;BIRC3;HDAC4;ANGPT1
GO:0034644,cellular response to UV (GO:0034644),76,8,5.240845166,1.526471351,0.151864678,0.648337058,358;9212;1111;4609;3373;993;4312;4239,MFAP4;AQP1;HYAL1;AURKB;CDC25A;CHEK1;MMP1;MYC
GO:0016310,phosphorylation (GO:0016310),398,33,27.44547863,1.20238384,0.155263947,0.659198341,23043;7048;2621;1608;2869;983;6790;9212;5347;1511;5579;660;1111;9833;2048;2045;120892;5563;5166;51422;898;10733;4751;10000;9535;332;6347;9201;30811;11213;5590;5592;2260,PDK4;CTSG;BMX;PRKCB;AURKA;TGFBR2;LRRK2;CCNE1;GAS6;NEK2;BIRC5;MELK;EPHA7;PLK1;CDK1;AURKB;PLK4;CCL2;CHEK1;DCLK1;FGFR1;GRK5;PRKG1;PRKAG2;IRAK3;TNIK;AKT3;DGKG;EPHB2;GMFG;PRKCZ;PRKAA2;HUNK
GO:0030858,positive regulation of epithelial cell differentiation (GO:0030858),20,3,1.379169781,2.175221675,0.155834444,0.659198341,2247;55273;84913,FGF2;TMEM100;ATOH8
GO:0050775,positive regulation of dendrite morphogenesis (GO:0050775),20,3,1.379169781,2.175221675,0.155834444,0.659198341,5649;5789;7804,RELN;LRP8;PTPRD
GO:0032365,intracellular lipid transport (GO:0032365),20,3,1.379169781,2.175221675,0.155834444,0.659198341,32;5563;51422,ACACB;PRKAG2;PRKAA2
GO:0071875,adrenergic receptor signaling pathway (GO:0071875),20,3,1.379169781,2.175221675,0.155834444,0.659198341,154;150;5144,PDE4D;ADRA2A;ADRB2
GO:0042908,xenobiotic transport (GO:0042908),20,3,1.379169781,2.175221675,0.155834444,0.659198341,10351;6581;5243,ABCA8;SLC22A3;ABCB1
GO:0014910,regulation of smooth muscle cell migration (GO:0014910),20,3,1.379169781,2.175221675,0.155834444,0.659198341,3479;9353;3488,SLIT2;IGF1;IGFBP5
GO:0045823,positive regulation of heart contraction (GO:0045823),20,3,1.379169781,2.175221675,0.155834444,0.659198341,6262;477;5997,ATP1A2;RGS2;RYR2
GO:0010888,negative regulation of lipid storage (GO:0010888),20,3,1.379169781,2.175221675,0.155834444,0.659198341,3690;3569;1066,IL6;CES1;ITGB3
GO:0060317,cardiac epithelial to mesenchymal transition (GO:0060317),20,3,1.379169781,2.175221675,0.155834444,0.659198341,10439;7049;10252,SPRY1;TGFBR3;OLFM1
GO:1901699,cellular response to nitrogen compound (GO:1901699),20,3,1.379169781,2.175221675,0.155834444,0.659198341,493;8914;641,TIMELESS;BLM;ATP2B4
GO:0071622,regulation of granulocyte chemotaxis (GO:0071622),20,3,1.379169781,2.175221675,0.155834444,0.659198341,83700;146433;683,IL34;JAM3;BST1
GO:0045736,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),20,3,1.379169781,2.175221675,0.155834444,0.659198341,5347;93649;1028,MYOCD;PLK1;CDKN1C
GO:0030855,epithelial cell differentiation (GO:0030855),101,10,6.964807392,1.435789884,0.157806095,0.667069223,80274;983;1066;6495;6943;8324;2627;144455;79733;6876,TCF21;GATA6;TAGLN;E2F7;CDK1;FZD7;SCUBE1;CES1;SIX1;E2F8
GO:0006694,steroid biosynthetic process (GO:0006694),65,7,4.482301787,1.561697613,0.159188314,0.671966965,1593;9023;51302;8309;51422;6713;1717,ACOX2;CH25H;CYP39A1;PRKAG2;DHCR7;CYP27A1;SQLE
GO:0001952,regulation of cell-matrix adhesion (GO:0001952),65,7,4.482301787,1.561697613,0.159188314,0.671966965,6366;9723;2042;6422;6376;2824;683,SFRP1;EPHA3;SEMA3E;CX3CL1;CCL21;GPM6B;BST1
GO:0030199,collagen fibril organization (GO:0030199),89,9,6.137305523,1.466441579,0.159319654,0.67204943,7092;1294;7373;1286;1292;81578;1288;1805;1301,COL14A1;COL11A1;DPT;COL21A1;COL4A4;TLL1;COL6A2;COL7A1;COL4A6
GO:0001938,positive regulation of endothelial cell proliferation (GO:0001938),77,8,5.309803655,1.506647048,0.159941784,0.674200607,3690;185;8742;1960;2247;3164;10000;2260,NR4A1;AGTR1;EGR3;FGF2;FGFR1;TNFSF12;ITGB3;AKT3
GO:0042177,negative regulation of protein catabolic process (GO:0042177),42,5,2.896256539,1.726366409,0.160782685,0.675377162,2316;6622;4085;11213;7079,FLNA;MAD2L1;TIMP4;IRAK3;SNCA
GO:0032642,regulation of chemokine production (GO:0032642),42,5,2.896256539,1.726366409,0.160782685,0.675377162,3569;3570;1958;85480;90865,IL6;IL33;EGR1;TSLP;IL6R
GO:0071300,cellular response to retinoic acid (GO:0071300),42,5,2.896256539,1.726366409,0.160782685,0.675377162,358;2042;7483;7472;8324,AQP1;EPHA3;FZD7;WNT2;WNT9A
GO:2000779,regulation of double-strand break repair (GO:2000779),42,5,2.896256539,1.726366409,0.160782685,0.675377162,1111;2305;8914;5888;10635,FOXM1;TIMELESS;RAD51AP1;RAD51;CHEK1
GO:1990573,potassium ion import across plasma membrane (GO:1990573),42,5,2.896256539,1.726366409,0.160782685,0.675377162,3757;477;10060;482;84561,ATP1A2;ATP1B2;SLC12A8;KCNH2;ABCC9
GO:0030641,regulation of cellular pH (GO:0030641),31,4,2.13771316,1.87115843,0.162238923,0.679025896,65010;8671;84679;285195,SLC9A9;SLC26A6;SLC4A4;SLC9A7
GO:0050732,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),31,4,2.13771316,1.87115843,0.162238923,0.679025896,857;6422;9021;5590,SFRP1;CAV1;SOCS3;PRKCZ
GO:0060606,tube closure (GO:0060606),31,4,2.13771316,1.87115843,0.162238923,0.679025896,23242;10395;25902;6491,STIL;MTHFD1L;DLC1;COBL
GO:1903052,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),31,4,2.13771316,1.87115843,0.162238923,0.679025896,1191;641700;26471;9532,ECSCR;CLU;BAG2;NUPR1
GO:0071805,potassium ion transmembrane transport (GO:0071805),139,13,9.585229975,1.356253322,0.162271381,0.679025896,23704;3757;3777;57419;3752;477;10060;3755;482;84561;84679;285195;3782,ATP1A2;SLC9A9;SLC24A3;ATP1B2;KCNN3;SLC12A8;KCNK3;KCNH2;ABCC9;KCND3;KCNG1;KCNE4;SLC9A7
GO:0033993,response to lipid (GO:0033993),114,11,7.861267749,1.399265405,0.162329099,0.679025896,6622;6401;6319;6696;6403;2627;11213;2878;2099;4277;85315,GPX3;GATA6;SPP1;SELP;SCD;PAQR8;SELE;IRAK3;ESR1;MICB;SNCA
GO:0010941,regulation of cell death (GO:0010941),102,10,7.033765881,1.421713513,0.164900093,0.688821721,6622;10979;1191;6659;8309;2247;120892;22943;1410;10562,CRYAB;ACOX2;FGF2;LRRK2;SOX4;CLU;FERMT2;OLFM4;DKK1;SNCA
GO:0034329,cell junction assembly (GO:0034329),102,10,7.033765881,1.421713513,0.164900093,0.688821721,2316;627;10979;8642;9379;9378;7122;4897;2318;55679,CLDN5;FLNC;NRXN1;LIMS2;FLNA;FERMT2;BDNF;NRXN2;NRCAM;DCHS1
GO:2001022,positive regulation of response to DNA damage stimulus (GO:2001022),54,6,3.723758408,1.611275315,0.166232072,0.692561847,4609;4487;672;3090;2070;138151,HIC1;NACC2;BRCA1;MSX1;EYA4;MYC
GO:0006814,sodium ion transport (GO:0006814),90,9,6.206264013,1.450147783,0.166954941,0.692561847,6332;8884;6330;6324;8671;57419;6546;477;2258,ATP1A2;SCN7A;SLC24A3;SLC5A6;FGF13;SCN4B;SLC4A4;SCN1B;SLC8A1
GO:0032436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),78,8,5.378762144,1.48733106,0.16821555,0.692561847,857;991;5347;1191;120892;285671;863;9532,LRRK2;RNF180;CLU;CDC20;CAV1;PLK1;BAG2;CBFA2T3
GO:0010942,positive regulation of cell death (GO:0010942),66,7,4.551260276,1.538035528,0.168231894,0.692561847,6622;1191;8309;120892;22943;2353;1958,ACOX2;FOS;EGR1;LRRK2;CLU;DKK1;SNCA
GO:0001678,cellular glucose homeostasis (GO:0001678),43,5,2.965215028,1.686218353,0.172338323,0.692561847,4804;2621;6659;10891;5563,SOX4;NGFR;GAS6;PPARGC1A;PRKAA2
GO:0046546,development of primary male sexual characteristics (GO:0046546),43,5,2.965215028,1.686218353,0.172338323,0.692561847,3815;3624;51804;7482;2627,GATA6;INHBA;WNT2B;SIX4;KIT
GO:0008584,male gonad development (GO:0008584),43,5,2.965215028,1.686218353,0.172338323,0.692561847,3815;3624;51804;7482;2627,GATA6;INHBA;WNT2B;SIX4;KIT
GO:0001947,heart looping (GO:0001947),43,5,2.965215028,1.686218353,0.172338323,0.692561847,7048;6722;4208;64321;6491,SOX17;TGFBR2;MEF2C;SRF;STIL
GO:1990440,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),11,2,0.758543379,2.636632333,0.173024644,0.692561847,467;90993,ATF3;CREB3L1
GO:1905954,positive regulation of lipid localization (GO:1905954),11,2,0.758543379,2.636632333,0.173024644,0.692561847,718;29923,C3;HILPDA
GO:0048009,insulin-like growth factor receptor signaling pathway (GO:0048009),11,2,0.758543379,2.636632333,0.173024644,0.692561847,2690;3479,GHR;IGF1
GO:0010642,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),11,2,0.758543379,2.636632333,0.173024644,0.692561847,6622;347,APOD;SNCA
GO:0048012,hepatocyte growth factor receptor signaling pathway (GO:0048012),11,2,0.758543379,2.636632333,0.173024644,0.692561847,3082;3925,HGF;STMN1
GO:0010838,positive regulation of keratinocyte proliferation (GO:0010838),11,2,0.758543379,2.636632333,0.173024644,0.692561847,2252;374,FGF7;AREG
GO:0033625,positive regulation of integrin activation (GO:0033625),11,2,0.758543379,2.636632333,0.173024644,0.692561847,10979;54922,FERMT2;RASIP1
GO:0031274,positive regulation of pseudopodium assembly (GO:0031274),11,2,0.758543379,2.636632333,0.173024644,0.692561847,10435;6366,CDC42EP2;CCL21
GO:0031272,regulation of pseudopodium assembly (GO:0031272),11,2,0.758543379,2.636632333,0.173024644,0.692561847,10435;6366,CDC42EP2;CCL21
GO:2000402,negative regulation of lymphocyte migration (GO:2000402),11,2,0.758543379,2.636632333,0.173024644,0.692561847,347;4345,CD200;APOD
GO:0051770,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),11,2,0.758543379,2.636632333,0.173024644,0.692561847,6347;90865,IL33;CCL2
GO:0010665,regulation of cardiac muscle cell apoptotic process (GO:0010665),11,2,0.758543379,2.636632333,0.173024644,0.692561847,9464;26471,HAND2;NUPR1
GO:1903817,negative regulation of voltage-gated potassium channel activity (GO:1903817),11,2,0.758543379,2.636632333,0.173024644,0.692561847,23704;857,CAV1;KCNE4
GO:0099622,cardiac muscle cell membrane repolarization (GO:0099622),11,2,0.758543379,2.636632333,0.173024644,0.692561847,3757;3752,KCNH2;KCND3
GO:0051931,regulation of sensory perception (GO:0051931),11,2,0.758543379,2.636632333,0.173024644,0.692561847,11343;55273,MGLL;TMEM100
GO:0045651,positive regulation of macrophage differentiation (GO:0045651),11,2,0.758543379,2.636632333,0.173024644,0.692561847,146433;3398,IL34;ID2
GO:0010635,regulation of mitochondrial fusion (GO:0010635),11,2,0.758543379,2.636632333,0.173024644,0.692561847,55022;7037,PID1;TFRC
GO:1902932,positive regulation of alcohol biosynthetic process (GO:1902932),11,2,0.758543379,2.636632333,0.173024644,0.692561847,6622;5745,PTH1R;SNCA
GO:0045217,cell-cell junction maintenance (GO:0045217),11,2,0.758543379,2.636632333,0.173024644,0.692561847,10979;91663,MYADM;FERMT2
GO:0050818,regulation of coagulation (GO:0050818),11,2,0.758543379,2.636632333,0.173024644,0.692561847,857;2048,CAV1;EPHB2
GO:0046033,AMP metabolic process (GO:0046033),11,2,0.758543379,2.636632333,0.173024644,0.692561847,205;4907,NT5E;AK4
GO:0032736,positive regulation of interleukin-13 production (GO:0032736),11,2,0.758543379,2.636632333,0.173024644,0.692561847,5590;85480,TSLP;PRKCZ
GO:0071425,hematopoietic stem cell proliferation (GO:0071425),11,2,0.758543379,2.636632333,0.173024644,0.692561847,947;7482,CD34;WNT2B
GO:1904948,midbrain dopaminergic neuron differentiation (GO:1904948),11,2,0.758543379,2.636632333,0.173024644,0.692561847,7472;4929,NR4A2;WNT2
GO:0099068,postsynapse assembly (GO:0099068),11,2,0.758543379,2.636632333,0.173024644,0.692561847,9379;9378,NRXN1;NRXN2
GO:0010464,regulation of mesenchymal cell proliferation (GO:0010464),11,2,0.758543379,2.636632333,0.173024644,0.692561847,7048;4609,TGFBR2;MYC
GO:0046851,negative regulation of bone remodeling (GO:0046851),11,2,0.758543379,2.636632333,0.173024644,0.692561847,3569;6422,IL6;SFRP1
GO:0032332,positive regulation of chondrocyte differentiation (GO:0032332),11,2,0.758543379,2.636632333,0.173024644,0.692561847,7704;91461,ZBTB16;PKDCC
GO:0035914,skeletal muscle cell differentiation (GO:0035914),11,2,0.758543379,2.636632333,0.173024644,0.692561847,51804;1959,SIX4;EGR2
GO:0048246,macrophage chemotaxis (GO:0048246),11,2,0.758543379,2.636632333,0.173024644,0.692561847,1910;6347,EDNRB;CCL2
GO:0002455,humoral immune response mediated by circulating immunoglobulin (GO:0002455),11,2,0.758543379,2.636632333,0.173024644,0.692561847,715;716,C1R;C1S
GO:1904893,negative regulation of receptor signaling pathway via STAT (GO:1904893),11,2,0.758543379,2.636632333,0.173024644,0.692561847,857;9021,CAV1;SOCS3
GO:0061053,somite development (GO:0061053),11,2,0.758543379,2.636632333,0.173024644,0.692561847,4223;4222,MEOX1;MEOX2
GO:0046653,tetrahydrofolate metabolic process (GO:0046653),11,2,0.758543379,2.636632333,0.173024644,0.692561847,25902;7298,MTHFD1L;TYMS
GO:0009084,glutamine family amino acid biosynthetic process (GO:0009084),11,2,0.758543379,2.636632333,0.173024644,0.692561847,5831;162417,PYCR1;NAGS
GO:0006684,sphingomyelin metabolic process (GO:0006684),11,2,0.758543379,2.636632333,0.173024644,0.692561847,166929;10351,ABCA8;SGMS2
GO:0042984,regulation of amyloid precursor protein biosynthetic process (GO:0042984),11,2,0.758543379,2.636632333,0.173024644,0.692561847,9452;64168,ITM2A;NECAB1
GO:0048096,chromatin-mediated maintenance of transcription (GO:0048096),11,2,0.758543379,2.636632333,0.173024644,0.692561847,1111;55038,CDCA4;CHEK1
GO:0006885,regulation of pH (GO:0006885),11,2,0.758543379,2.636632333,0.173024644,0.692561847,5166;84679,PDK4;SLC9A7
GO:0031643,positive regulation of myelination (GO:0031643),11,2,0.758543379,2.636632333,0.173024644,0.692561847,11076;1959,TPPP;EGR2
GO:0031061,negative regulation of histone methylation (GO:0031061),11,2,0.758543379,2.636632333,0.173024644,0.692561847,672;1789,BRCA1;DNMT3B
GO:0033147,negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),11,2,0.758543379,2.636632333,0.173024644,0.692561847,672;25959,BRCA1;KANK2
GO:0032958,inositol phosphate biosynthetic process (GO:0032958),11,2,0.758543379,2.636632333,0.173024644,0.692561847,2247;3707,FGF2;ITPKB
GO:1903318,negative regulation of protein maturation (GO:1903318),11,2,0.758543379,2.636632333,0.173024644,0.692561847,120892;79094,LRRK2;CHAC1
GO:0072710,response to hydroxyurea (GO:0072710),11,2,0.758543379,2.636632333,0.173024644,0.692561847,8914;641,TIMELESS;BLM
GO:0048041,focal adhesion assembly (GO:0048041),21,3,1.44812827,2.07163969,0.17305405,0.692561847,10395;10580;10979,SORBS1;FERMT2;DLC1
GO:0007026,negative regulation of microtubule depolymerization (GO:0007026),21,3,1.44812827,2.07163969,0.17305405,0.692561847,22974;2258;89795,TPX2;FGF13;NAV3
GO:0032413,negative regulation of ion transmembrane transporter activity (GO:0032413),21,3,1.44812827,2.07163969,0.17305405,0.692561847,150;5350;845,CASQ2;PLN;ADRA2A
GO:0051402,neuron apoptotic process (GO:0051402),21,3,1.44812827,2.07163969,0.17305405,0.692561847,4804;11113;596,NGFR;CIT;BCL2
GO:0002726,positive regulation of T cell cytokine production (GO:0002726),21,3,1.44812827,2.07163969,0.17305405,0.692561847,3569;114548;5590,IL6;NLRP3;PRKCZ
GO:0060759,regulation of response to cytokine stimulus (GO:0060759),21,3,1.44812827,2.07163969,0.17305405,0.692561847,3977;9314;100130733,LRRC70;KLF4;LIFR
GO:0071241,cellular response to inorganic substance (GO:0071241),21,3,1.44812827,2.07163969,0.17305405,0.692561847,358;8914;641,AQP1;TIMELESS;BLM
GO:1903077,negative regulation of protein localization to plasma membrane (GO:1903077),21,3,1.44812827,2.07163969,0.17305405,0.692561847,55022;91461;131578,PID1;PKDCC;LRRC15
GO:0030206,chondroitin sulfate biosynthetic process (GO:0030206),21,3,1.44812827,2.07163969,0.17305405,0.692561847,55790;1634;1464,CSGALNACT1;DCN;CSPG4
GO:1904376,negative regulation of protein localization to cell periphery (GO:1904376),21,3,1.44812827,2.07163969,0.17305405,0.692561847,55022;89958;131578,SAPCD2;PID1;LRRC15
GO:0043068,positive regulation of programmed cell death (GO:0043068),284,24,19.58421088,1.225477,0.175727064,0.701970291,388;6622;4804;1894;3569;6196;9353;7153;1191;9833;6659;10439;322;120892;6422;3778;1869;274;3663;25999;54507;79845;4616;10687,IL6;SFRP1;LRRK2;SOX4;CLU;NGFR;BIN1;ADAMTSL4;TOP2A;MELK;OLFM1;KCNMA1;RHOB;SLIT2;RPS6KA2;APBB1;RNF122;ECT2;E2F1;GADD45B;CLIP3;IRF5;SNCA;PNMA2
GO:0015909,long-chain fatty acid transport (GO:0015909),32,4,2.206671649,1.812684729,0.175988892,0.701970291,32;2167;5563;51422,ACACB;PRKAG2;FABP4;PRKAA2
GO:0002244,hematopoietic progenitor cell differentiation (GO:0002244),32,4,2.206671649,1.812684729,0.175988892,0.701970291,3815;3624;6422;4222,MEOX1;SFRP1;INHBA;KIT
GO:1904894,positive regulation of receptor signaling pathway via STAT (GO:1904894),32,4,2.206671649,1.812684729,0.175988892,0.701970291,3815;2690;3569;85480,IL6;TSLP;GHR;KIT
GO:0071333,cellular response to glucose stimulus (GO:0071333),32,4,2.206671649,1.812684729,0.175988892,0.701970291,2621;6659;5563;5799,SOX4;GAS6;PTPRN2;PRKAA2
GO:0043535,regulation of blood vessel endothelial cell migration (GO:0043535),55,6,3.792716897,1.5819794,0.176492587,0.703512561,284;4208;2247;493;10000;2260,FGF2;MEF2C;FGFR1;ATP2B4;AKT3;ANGPT1
GO:0051129,negative regulation of cellular component organization (GO:0051129),79,8,5.447720633,1.468504084,0.17667987,0.703792377,3306;1191;2042;23208;10411;11213;5590;1410,CRYAB;EPHA3;CLU;HSPA2;RAPGEF3;IRAK3;PRKCZ;SYT11
GO:0001523,retinoid metabolic process (GO:0001523),92,9,6.344180991,1.418622831,0.182726521,0.726915367,375790;338328;10082;6383;7804;5947;125;83875;126,ADH1B;GPIHBP1;BCO2;SDC2;LRP8;AGRN;ADH1C;RBP1;GPC6
GO:0001936,regulation of endothelial cell proliferation (GO:0001936),92,9,6.344180991,1.418622831,0.182726521,0.726915367,284;3690;857;8742;1960;2247;3164;10000;84913,NR4A1;EGR3;FGF2;CAV1;ATOH8;TNFSF12;ITGB3;AKT3;ANGPT1
GO:0001578,microtubule bundle formation (GO:0001578),44,5,3.034173517,1.647895208,0.184202333,0.73181773,5347;11076;10112;84722;51673,TPPP;TPPP3;KIF20A;PLK1;PSRC1
GO:2000351,regulation of endothelial cell apoptotic process (GO:2000351),44,5,3.034173517,1.647895208,0.184202333,0.73181773,284;2621;79625;6347;641700,ECSCR;GAS6;CCL2;NDNF;ANGPT1
GO:0031398,positive regulation of protein ubiquitination (GO:0031398),80,8,5.516679122,1.450147783,0.185328294,0.73580474,11170;284;857;5347;120892;672;330;55215,FAM107A;FANCI;LRRK2;CAV1;BRCA1;PLK1;BIRC3;ANGPT1
GO:0030512,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),68,7,4.689177254,1.492799189,0.186970295,0.741472503,7048;857;11117;63976;2201;10252;7041,SPRY1;TGFBR2;CAV1;EMILIN1;TGFB1I1;FBN2;PRDM16
GO:0009892,negative regulation of metabolic process (GO:0009892),56,6,3.861675386,1.553729768,0.187002548,0.741472503,341;4857;11096;5334;23090;83643,NOVA1;CCDC3;ADAMTS5;PLCL1;APOC1;ZNF423
GO:1901796,regulation of signal transduction by p53 class mediator (GO:1901796),156,14,10.75752429,1.301414677,0.188470369,0.74679986,22974;983;6790;9212;1111;1763;5563;51422;83990;116028;672;641;9156;9099,AURKA;DNA2;EXO1;BLM;BRCA1;TPX2;USP2;BRIP1;CDK1;AURKB;CHEK1;PRKAG2;RMI2;PRKAA2
GO:2000008,regulation of protein localization to cell surface (GO:2000008),33,4,2.275630138,1.757754889,0.190116859,0.748347294,627;4130;2824;79608,RIC3;BDNF;MAP1A;GPM6B
GO:0010874,regulation of cholesterol efflux (GO:0010874),33,4,2.275630138,1.757754889,0.190116859,0.748347294,857;10351;26154;1066,ABCA8;CAV1;CES1;ABCA12
GO:0008206,bile acid metabolic process (GO:0008206),33,4,2.275630138,1.757754889,0.190116859,0.748347294,1593;9023;51302;8309,ACOX2;CH25H;CYP39A1;CYP27A1
GO:0050869,negative regulation of B cell activation (GO:0050869),22,3,1.517086759,1.97747425,0.190775824,0.748347294,3624;6422;3398,SFRP1;INHBA;ID2
GO:0071470,cellular response to osmotic stress (GO:0071470),22,3,1.517086759,1.97747425,0.190775824,0.748347294,358;4638;92241,AQP1;MYLK;RCSD1
GO:0032703,negative regulation of interleukin-2 production (GO:0032703),22,3,1.517086759,1.97747425,0.190775824,0.748347294,7538;947;89795,ZFP36;CD34;NAV3
GO:2000144,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",22,3,1.517086759,1.97747425,0.190775824,0.748347294,6722;4286;8061,SRF;MITF;FOSL1
GO:0001774,microglial cell activation (GO:0001774),22,3,1.517086759,1.97747425,0.190775824,0.748347294,6622;1191;6376,CLU;CX3CL1;SNCA
GO:0008585,female gonad development (GO:0008585),22,3,1.517086759,1.97747425,0.190775824,0.748347294,3815;3624;3625,INHBA;KIT;INHBB
GO:1902414,protein localization to cell junction (GO:1902414),22,3,1.517086759,1.97747425,0.190775824,0.748347294,84952;83700;10979,CGNL1;JAM3;FERMT2
GO:2000179,positive regulation of neural precursor cell proliferation (GO:2000179),22,3,1.517086759,1.97747425,0.190775824,0.748347294,10763;6376;9760,NES;CX3CL1;TOX
GO:0051055,negative regulation of lipid biosynthetic process (GO:0051055),22,3,1.517086759,1.97747425,0.190775824,0.748347294,341;653;672,BMP5;BRCA1;APOC1
GO:0034389,lipid droplet organization (GO:0034389),22,3,1.517086759,1.97747425,0.190775824,0.748347294,8605;29923;6713,PLA2G4C;HILPDA;SQLE
GO:1904030,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),22,3,1.517086759,1.97747425,0.190775824,0.748347294,5347;93649;1028,MYOCD;PLK1;CDKN1C
GO:0035970,peptidyl-threonine dephosphorylation (GO:0035970),22,3,1.517086759,1.97747425,0.190775824,0.748347294,1847;1843;1850,DUSP1;DUSP8;DUSP5
GO:0033138,positive regulation of peptidyl-serine phosphorylation (GO:0033138),93,9,6.41313948,1.403368823,0.190852837,0.748347294,6622;627;2621;3569;857;493;10411;7037;1440,IL6;GAS6;CSF3;CAV1;BDNF;RAPGEF3;ATP2B4;TFRC;SNCA
GO:0007200,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),81,8,5.585637611,1.432244724,0.194154058,0.753770474,9630;1902;150;5745;5733;185;2099;6869,AGTR1;PTH1R;TACR1;LPAR1;ADRA2A;GNA14;PTGER3;ESR1
GO:0007264,small GTPase mediated signal transduction (GO:0007264),106,10,7.309599837,1.368063946,0.194753182,0.753770474,3479;150;9423;2247;890;10235;9077;6237;85004;6236,RASGRP2;FGF2;RERG;RRAD;CCNA2;ADRA2A;IGF1;NTN1;DIRAS3;RRAS
GO:0046626,regulation of insulin receptor signaling pathway (GO:0046626),45,5,3.103132006,1.611275315,0.196354556,0.753770474,5167;10580;5579;55022;5590,PRKCB;SORBS1;PID1;PRKCZ;ENPP1
GO:0071478,cellular response to radiation (GO:0071478),45,5,3.103132006,1.611275315,0.196354556,0.753770474,388;1894;641;5888;10635,BLM;RHOB;RAD51AP1;RAD51;ECT2
GO:0050921,positive regulation of chemotaxis (GO:0050921),45,5,3.103132006,1.611275315,0.196354556,0.753770474,6366;3569;3570;2247;64094,IL6;FGF2;SMOC2;CCL21;IL6R
GO:0046425,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),45,5,3.103132006,1.611275315,0.196354556,0.753770474,3815;2690;3569;857;9021,IL6;CAV1;GHR;SOCS3;KIT
GO:0031330,negative regulation of cellular catabolic process (GO:0031330),69,7,4.758135743,1.471164418,0.196647048,0.753770474,341;596;54922;3953;3082;26471;7079,BCL2;TIMP4;LEPR;HGF;APOC1;RASIP1;NUPR1
GO:0019369,arachidonic acid metabolic process (GO:0019369),57,6,3.930633875,1.526471351,0.197748775,0.753770474,11343;5730;5740;8605;2053;5742,MGLL;PTGS1;PLA2G4C;PTGDS;EPHX2;PTGIS
GO:0043648,dicarboxylic acid metabolic process (GO:0043648),57,6,3.930633875,1.526471351,0.197748775,0.753770474,137872;6573;23498;162417;2350;25902,HAAO;SLC19A1;MTHFD1L;FOLR2;ADHFE1;NAGS
GO:1901653,cellular response to peptide (GO:1901653),57,6,3.930633875,1.526471351,0.197748775,0.753770474,154;4804;3479;857;781;8914,TIMELESS;NGFR;CAV1;IGF1;ADRB2;CACNA2D1
GO:0006554,lysine catabolic process (GO:0006554),12,2,0.827501868,2.416912972,0.198631248,0.753770474,501;1428,CRYM;ALDH7A1
GO:0006553,lysine metabolic process (GO:0006553),12,2,0.827501868,2.416912972,0.198631248,0.753770474,501;1428,CRYM;ALDH7A1
GO:1903799,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),12,2,0.827501868,2.416912972,0.198631248,0.753770474,3569;2099,IL6;ESR1
GO:0046321,positive regulation of fatty acid oxidation (GO:0046321),12,2,0.827501868,2.416912972,0.198631248,0.753770474,10891;8013,NR4A3;PPARGC1A
GO:0021952,central nervous system projection neuron axonogenesis (GO:0021952),12,2,0.827501868,2.416912972,0.198631248,0.753770474,2048;4781,NFIB;EPHB2
GO:0015791,polyol transport (GO:0015791),12,2,0.827501868,2.416912972,0.198631248,0.753770474,65010;358,AQP1;SLC26A6
GO:1901881,positive regulation of protein depolymerization (GO:1901881),12,2,0.827501868,2.416912972,0.198631248,0.753770474,1073;10763,CFL2;NES
GO:0043117,positive regulation of vascular permeability (GO:0043117),12,2,0.827501868,2.416912972,0.198631248,0.753770474,284;5138,PDE2A;ANGPT1
GO:0070585,protein localization to mitochondrion (GO:0070585),12,2,0.827501868,2.416912972,0.198631248,0.753770474,120892;9636,LRRK2;ISG15
GO:0090136,epithelial cell-cell adhesion (GO:0090136),12,2,0.827501868,2.416912972,0.198631248,0.753770474,3815;11149,BVES;KIT
GO:0030219,megakaryocyte differentiation (GO:0030219),12,2,0.827501868,2.416912972,0.198631248,0.753770474,3815;6886,KIT;TAL1
GO:0061548,ganglion development (GO:0061548),12,2,0.827501868,2.416912972,0.198631248,0.753770474,10381;8633,UNC5C;TUBB3
GO:0072112,glomerular visceral epithelial cell differentiation (GO:0072112),12,2,0.827501868,2.416912972,0.198631248,0.753770474,9863;28999,MAGI2;KLF15
GO:0106057,negative regulation of calcineurin-mediated signaling (GO:0106057),12,2,0.827501868,2.416912972,0.198631248,0.753770474,493;1827,RCAN1;ATP2B4
GO:0070885,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),12,2,0.827501868,2.416912972,0.198631248,0.753770474,493;1827,RCAN1;ATP2B4
GO:0098660,inorganic ion transmembrane transport (GO:0098660),12,2,0.827501868,2.416912972,0.198631248,0.753770474,8912;10060,CACNA1H;ABCC9
GO:0080134,regulation of response to stress (GO:0080134),12,2,0.827501868,2.416912972,0.198631248,0.753770474,5243;10391,ABCB1;CORO2B
GO:0051354,negative regulation of oxidoreductase activity (GO:0051354),12,2,0.827501868,2.416912972,0.198631248,0.753770474,6622;8639,AOC3;SNCA
GO:1903319,positive regulation of protein maturation (GO:1903319),12,2,0.827501868,2.416912972,0.198631248,0.753770474,6659;9532,SOX4;BAG2
GO:0034138,toll-like receptor 3 signaling pathway (GO:0034138),12,2,0.827501868,2.416912972,0.198631248,0.753770474,81035;51435,COLEC12;SCARA3
GO:0035067,negative regulation of histone acetylation (GO:0035067),12,2,0.827501868,2.416912972,0.198631248,0.753770474,6622;672,BRCA1;SNCA
GO:0002313,mature B cell differentiation involved in immune response (GO:0002313),12,2,0.827501868,2.416912972,0.198631248,0.753770474,3569;1880,IL6;GPR183
GO:0045717,negative regulation of fatty acid biosynthetic process (GO:0045717),12,2,0.827501868,2.416912972,0.198631248,0.753770474,341;672,BRCA1;APOC1
GO:0014821,phasic smooth muscle contraction (GO:0014821),12,2,0.827501868,2.416912972,0.198631248,0.753770474,5733;1910,EDNRB;PTGER3
GO:0035051,cardiocyte differentiation (GO:0035051),12,2,0.827501868,2.416912972,0.198631248,0.753770474,2627;93649,MYOCD;GATA6
GO:0090190,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),12,2,0.827501868,2.416912972,0.198631248,0.753770474,51804;6495,SIX4;SIX1
GO:0060259,regulation of feeding behavior (GO:0060259),12,2,0.827501868,2.416912972,0.198631248,0.753770474,3953;8013,NR4A3;LEPR
GO:0010614,negative regulation of cardiac muscle hypertrophy (GO:0010614),12,2,0.827501868,2.416912972,0.198631248,0.753770474,493;5997,RGS2;ATP2B4
GO:1902101,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),12,2,0.827501868,2.416912972,0.198631248,0.753770474,9700;9787,DLGAP5;ESPL1
GO:0045842,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),12,2,0.827501868,2.416912972,0.198631248,0.753770474,9700;9787,DLGAP5;ESPL1
GO:1901970,positive regulation of mitotic sister chromatid separation (GO:1901970),12,2,0.827501868,2.416912972,0.198631248,0.753770474,9700;9787,DLGAP5;ESPL1
GO:0033700,phospholipid efflux (GO:0033700),12,2,0.827501868,2.416912972,0.198631248,0.753770474,341;26154,ABCA12;APOC1
GO:0010872,regulation of cholesterol esterification (GO:0010872),12,2,0.827501868,2.416912972,0.198631248,0.753770474,341;185,AGTR1;APOC1
GO:1905907,negative regulation of amyloid fibril formation (GO:1905907),12,2,0.827501868,2.416912972,0.198631248,0.753770474,1191;1410,CRYAB;CLU
GO:1900047,negative regulation of hemostasis (GO:1900047),12,2,0.827501868,2.416912972,0.198631248,0.753770474,947;7035,CD34;TFPI
GO:0000002,mitochondrial genome maintenance (GO:0000002),12,2,0.827501868,2.416912972,0.198631248,0.753770474,291;10000,AKT3;SLC25A4
GO:0002689,negative regulation of leukocyte chemotaxis (GO:0002689),12,2,0.827501868,2.416912972,0.198631248,0.753770474,9353;1843,DUSP1;SLIT2
GO:0010755,regulation of plasminogen activation (GO:0010755),12,2,0.827501868,2.416912972,0.198631248,0.753770474,7123;2161,CLEC3B;F12
GO:0035418,protein localization to synapse (GO:0035418),12,2,0.827501868,2.416912972,0.198631248,0.753770474,9379;9378,NRXN1;NRXN2
GO:0090329,regulation of DNA-dependent DNA replication (GO:0090329),12,2,0.827501868,2.416912972,0.198631248,0.753770474,81620;641,BLM;CDT1
GO:0030208,dermatan sulfate biosynthetic process (GO:0030208),12,2,0.827501868,2.416912972,0.198631248,0.753770474,1634;1464,DCN;CSPG4
GO:0060078,regulation of postsynaptic membrane potential (GO:0060078),34,4,2.344588627,1.706056216,0.204587781,0.772473085,4208;2906;120892;23542,LRRK2;MEF2C;GRIN2D;MAPK8IP2
GO:1902003,regulation of amyloid-beta formation (GO:1902003),34,4,2.344588627,1.706056216,0.204587781,0.772473085,4915;3479;1191;274,CLU;BIN1;IGF1;NTRK2
GO:0031648,protein destabilization (GO:0031648),34,4,2.344588627,1.706056216,0.204587781,0.772473085,2934;6622;5347;64321,SOX17;GSN;PLK1;SNCA
GO:0001843,neural tube closure (GO:0001843),34,4,2.344588627,1.706056216,0.204587781,0.772473085,23242;10395;25902;6491,STIL;MTHFD1L;DLC1;COBL
GO:0033628,regulation of cell adhesion mediated by integrin (GO:0033628),34,4,2.344588627,1.706056216,0.204587781,0.772473085,5881;6366;83700;3071,JAM3;RAC3;NCKAP1L;CCL21
GO:0048545,response to steroid hormone (GO:0048545),34,4,2.344588627,1.706056216,0.204587781,0.772473085,857;477;7035;85315,ATP1A2;CAV1;PAQR8;TFPI
GO:0034502,protein localization to chromosome (GO:0034502),34,4,2.344588627,1.706056216,0.204587781,0.772473085,5347;1058;2099;25900,CENPA;PLK1;IFFO1;ESR1
GO:0061512,protein localization to cilium (GO:0061512),34,4,2.344588627,1.706056216,0.204587781,0.772473085,225689;29887;23090;7275,SNX10;MAPK15;TUB;ZNF423
GO:0016125,sterol metabolic process (GO:0016125),70,7,4.827094232,1.450147783,0.206516173,0.778105958,1593;1066;9023;51302;51422;6713;1717,CH25H;CYP39A1;PRKAG2;CES1;DHCR7;CYP27A1;SQLE
GO:0043009,chordate embryonic development (GO:0043009),58,6,3.999592364,1.500152879,0.208717657,0.778105958,51804;2294;653;672;2260;6491,FOXF1;BMP5;STIL;BRCA1;SIX4;FGFR1
GO:0099601,regulation of neurotransmitter receptor activity (GO:0099601),58,6,3.999592364,1.500152879,0.208717657,0.778105958,1740;4884;4208;5649;23542;66004,RELN;MEF2C;DLG2;LYNX1;MAPK8IP2;NPTX1
GO:0009152,purine ribonucleotide biosynthetic process (GO:0009152),46,5,3.172090495,1.57624759,0.208774331,0.778105958,111;196883;108;4881;4882,ADCY5;NPR1;ADCY4;NPR2;ADCY2
GO:0046824,positive regulation of nucleocytoplasmic transport (GO:0046824),46,5,3.172090495,1.57624759,0.208774331,0.778105958,2316;1894;2621;10411;51512,GAS6;GTSE1;FLNA;ECT2;RAPGEF3
GO:0051101,regulation of DNA binding (GO:0051101),46,5,3.172090495,1.57624759,0.208774331,0.778105958,3479;81620;1869;22927;55355,HJURP;CDT1;E2F1;IGF1;HABP4
GO:2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),23,3,1.586045248,1.891497109,0.208927469,0.778105958,596;2537;2070,BCL2;IFI6;EYA4
GO:1901099,negative regulation of signal transduction in absence of ligand (GO:1901099),23,3,1.586045248,1.891497109,0.208927469,0.778105958,596;2537;2070,BCL2;IFI6;EYA4
GO:1903846,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),23,3,1.586045248,1.891497109,0.208927469,0.778105958,9839;1028;7041,ZEB2;TGFB1I1;CDKN1C
GO:0030511,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),23,3,1.586045248,1.891497109,0.208927469,0.778105958,9839;1028;7041,ZEB2;TGFB1I1;CDKN1C
GO:1905332,positive regulation of morphogenesis of an epithelium (GO:1905332),23,3,1.586045248,1.891497109,0.208927469,0.778105958,51804;2247;6495,FGF2;SIX4;SIX1
GO:0071675,regulation of mononuclear cell migration (GO:0071675),23,3,1.586045248,1.891497109,0.208927469,0.778105958,9353;653;146433,BMP5;IL34;SLIT2
GO:0090140,regulation of mitochondrial fission (GO:0090140),23,3,1.586045248,1.891497109,0.208927469,0.778105958,6790;120892;1634,AURKA;LRRK2;DCN
GO:0090317,negative regulation of intracellular protein transport (GO:0090317),23,3,1.586045248,1.891497109,0.208927469,0.778105958,51715;347;120892,LRRK2;RAB23;APOD
GO:0060390,regulation of SMAD protein signal transduction (GO:0060390),23,3,1.586045248,1.891497109,0.208927469,0.778105958,8483;25937;11030,RBPMS;CILP;WWTR1
GO:2000116,regulation of cysteine-type endopeptidase activity (GO:2000116),23,3,1.586045248,1.891497109,0.208927469,0.778105958,4804;2045;330,NGFR;EPHA7;BIRC3
GO:0032515,negative regulation of phosphoprotein phosphatase activity (GO:0032515),23,3,1.586045248,1.891497109,0.208927469,0.778105958,3071;1408;84152,CRY2;PPP1R1B;NCKAP1L
GO:0046688,response to copper ion (GO:0046688),23,3,1.586045248,1.891497109,0.208927469,0.778105958,6622;358;4499,AQP1;MT1M;SNCA
GO:0046825,regulation of protein export from nucleus (GO:0046825),23,3,1.586045248,1.891497109,0.208927469,0.778105958,2621;10411;51512,GAS6;GTSE1;RAPGEF3
GO:0002092,positive regulation of receptor internalization (GO:0002092),23,3,1.586045248,1.891497109,0.208927469,0.778105958,6401;284;9863,MAGI2;SELE;ANGPT1
GO:0006306,DNA methylation (GO:0006306),23,3,1.586045248,1.891497109,0.208927469,0.778105958,2353;3070;1789,FOS;DNMT3B;HELLS
GO:1904353,regulation of telomere capping (GO:1904353),23,3,1.586045248,1.891497109,0.208927469,0.778105958,9212;225689;4751,NEK2;AURKB;MAPK15
GO:0031347,regulation of defense response (GO:0031347),83,8,5.723554589,1.397732803,0.212309099,0.790210522,6401;11343;185;81792;7804;330;11274;683,MGLL;AGTR1;USP18;LRP8;BIRC3;SELE;BST1;ADAMTS12
GO:0007268,chemical synaptic transmission (GO:0007268),306,25,21.10129764,1.184761261,0.215400477,0.801220462,8572;6622;5577;1740;1837;3779;2571;5354;5376;27115;4359;4884;783;785;3777;9379;9378;4857;6196;2906;6812;79608;5799;2901;2899,PLP1;KCNMB1;NOVA1;GRIK3;NRXN1;DLG2;PDLIM4;PMP22;KCNK3;PTPRN2;RIC3;RPS6KA2;MPZ;GRIN2D;PDE7B;PRKAR2B;DTNA;CACNB2;NRXN2;CACNB4;NPTX1;GAD1;GRIK5;STXBP1;SNCA
GO:0010038,response to metal ion (GO:0010038),71,7,4.896052721,1.429723167,0.216567767,0.804566653,7139;6622;857;23498;596;7220;3778,HAAO;CAV1;KCNMA1;BCL2;TNNT2;TRPC1;SNCA
GO:0002573,myeloid leukocyte differentiation (GO:0002573),71,7,4.896052721,1.429723167,0.216567767,0.804566653,3815;7048;1880;1869;1440;29887;863,TGFBR2;CSF3;GPR183;SNX10;E2F1;CBFA2T3;KIT
GO:0032675,regulation of interleukin-6 production (GO:0032675),109,10,7.516475304,1.33041081,0.218577577,0.811453337,2621;3569;3570;3071;23208;6376;11213;85480;90865;4345,IL6;IL33;GAS6;TSLP;CX3CL1;NCKAP1L;CD200;IRAK3;IL6R;SYT11
GO:1902808,positive regulation of cell cycle G1/S phase transition (GO:1902808),35,4,2.413547116,1.657311752,0.21936644,0.811453337,3373;2146;9510;894,ADAMTS1;HYAL1;CCND2;EZH2
GO:2000243,positive regulation of reproductive process (GO:2000243),35,4,2.413547116,1.657311752,0.21936644,0.811453337,8912;3624;3625;6869,INHBA;TACR1;CACNA1H;INHBB
GO:0015701,bicarbonate transport (GO:0015701),35,4,2.413547116,1.657311752,0.21936644,0.811453337,65010;358;8671;768,AQP1;SLC26A6;CA9;SLC4A4
GO:1904646,cellular response to amyloid-beta (GO:1904646),35,4,2.413547116,1.657311752,0.21936644,0.811453337,154;4804;3479;781,NGFR;IGF1;ADRB2;CACNA2D1
GO:0010633,negative regulation of epithelial cell migration (GO:0010633),35,4,2.413547116,1.657311752,0.21936644,0.811453337,56999;9353;6781;1634,DCN;SLIT2;ADAMTS9;STC1
GO:1902116,negative regulation of organelle assembly (GO:1902116),35,4,2.413547116,1.657311752,0.21936644,0.811453337,9638;120892;672;26471,LRRK2;BRCA1;FEZ1;NUPR1
GO:0061371,determination of heart left/right asymmetry (GO:0061371),47,5,3.241048984,1.542710408,0.22144062,0.815124936,7048;6722;4208;64321;6491,SOX17;TGFBR2;MEF2C;SRF;STIL
GO:0006576,cellular biogenic amine metabolic process (GO:0006576),13,2,0.896460357,2.23099659,0.224641632,0.815124936,6581;4953,SLC22A3;ODC1
GO:0060213,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),13,2,0.896460357,2.23099659,0.224641632,0.815124936,7538;7832,ZFP36;BTG2
GO:1901985,positive regulation of protein acetylation (GO:1901985),13,2,0.896460357,2.23099659,0.224641632,0.815124936,10411;5563,RAPGEF3;PRKAA2
GO:0007194,negative regulation of adenylate cyclase activity (GO:0007194),13,2,0.896460357,2.23099659,0.224641632,0.815124936,1910;5064,EDNRB;PALM
GO:0010640,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),13,2,0.896460357,2.23099659,0.224641632,0.815124936,6622;347,APOD;SNCA
GO:0001778,plasma membrane repair (GO:0001778),13,2,0.896460357,2.23099659,0.224641632,0.815124936,309;23208,ANXA6;SYT11
GO:0055006,cardiac cell development (GO:0055006),13,2,0.896460357,2.23099659,0.224641632,0.815124936,6546;4629,MYH11;SLC8A1
GO:1904892,regulation of receptor signaling pathway via STAT (GO:1904892),13,2,0.896460357,2.23099659,0.224641632,0.815124936,3569;85480,IL6;TSLP
GO:0010765,positive regulation of sodium ion transport (GO:0010765),13,2,0.896460357,2.23099659,0.224641632,0.815124936,6330;6324,SCN4B;SCN1B
GO:1901096,regulation of autophagosome maturation (GO:1901096),13,2,0.896460357,2.23099659,0.224641632,0.815124936,154;79443,FYCO1;ADRB2
GO:0051930,regulation of sensory perception of pain (GO:0051930),13,2,0.896460357,2.23099659,0.224641632,0.815124936,11343;55273,MGLL;TMEM100
GO:0035296,regulation of tube diameter (GO:0035296),13,2,0.896460357,2.23099659,0.224641632,0.815124936,185;4881,AGTR1;NPR1
GO:0003018,vascular process in circulatory system (GO:0003018),13,2,0.896460357,2.23099659,0.224641632,0.815124936,185;4881,AGTR1;NPR1
GO:2000010,positive regulation of protein localization to cell surface (GO:2000010),13,2,0.896460357,2.23099659,0.224641632,0.815124936,4130;79608,RIC3;MAP1A
GO:0010676,positive regulation of cellular carbohydrate metabolic process (GO:0010676),13,2,0.896460357,2.23099659,0.224641632,0.815124936,6622;5745,PTH1R;SNCA
GO:0010039,response to iron ion (GO:0010039),13,2,0.896460357,2.23099659,0.224641632,0.815124936,6622;596,BCL2;SNCA
GO:1900373,positive regulation of purine nucleotide biosynthetic process (GO:1900373),13,2,0.896460357,2.23099659,0.224641632,0.815124936,10891;55022,PID1;PPARGC1A
GO:0046323,glucose import (GO:0046323),13,2,0.896460357,2.23099659,0.224641632,0.815124936,6517;6515,SLC2A4;SLC2A3
GO:0022011,myelination in peripheral nervous system (GO:0022011),13,2,0.896460357,2.23099659,0.224641632,0.815124936,57716;163175,LGI4;PRX
GO:0046823,negative regulation of nucleocytoplasmic transport (GO:0046823),13,2,0.896460357,2.23099659,0.224641632,0.815124936,51715;347,RAB23;APOD
GO:0019934,cGMP-mediated signaling (GO:0019934),13,2,0.896460357,2.23099659,0.224641632,0.815124936,5138;358,AQP1;PDE2A
GO:0003215,cardiac right ventricle morphogenesis (GO:0003215),13,2,0.896460357,2.23099659,0.224641632,0.815124936,6659;23414,SOX4;ZFPM2
GO:0060389,pathway-restricted SMAD protein phosphorylation (GO:0060389),13,2,0.896460357,2.23099659,0.224641632,0.815124936,7048;7049,TGFBR2;TGFBR3
GO:0010224,response to UV-B (GO:0010224),13,2,0.896460357,2.23099659,0.224641632,0.815124936,3373;4239,MFAP4;HYAL1
GO:2000516,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",13,2,0.896460357,2.23099659,0.224641632,0.815124936,7048;3071,TGFBR2;NCKAP1L
GO:0046628,positive regulation of insulin receptor signaling pathway (GO:0046628),13,2,0.896460357,2.23099659,0.224641632,0.815124936,10580;5590,SORBS1;PRKCZ
GO:0060537,muscle tissue development (GO:0060537),13,2,0.896460357,2.23099659,0.224641632,0.815124936,1465;5239,PGM5;CSRP1
GO:0021510,spinal cord development (GO:0021510),13,2,0.896460357,2.23099659,0.224641632,0.815124936,6659;5649,RELN;SOX4
GO:0030205,dermatan sulfate metabolic process (GO:0030205),13,2,0.896460357,2.23099659,0.224641632,0.815124936,1634;1464,DCN;CSPG4
GO:0034401,chromatin organization involved in regulation of transcription (GO:0034401),13,2,0.896460357,2.23099659,0.224641632,0.815124936,1111;55038,CDCA4;CHEK1
GO:0030307,positive regulation of cell growth (GO:0030307),97,9,6.688973436,1.345497943,0.224833995,0.815124936,9472;627;3479;596;3897;9423;6422;3373;8437,SFRP1;HYAL1;BCL2;L1CAM;BDNF;AKAP6;IGF1;NTN1;RASAL1
GO:0031349,positive regulation of defense response (GO:0031349),97,9,6.688973436,1.345497943,0.224833995,0.815124936,6622;5734;5138;185;4208;6376;85480;90865;5320,AGTR1;PDE2A;IL33;MEF2C;TSLP;PLA2G2A;CX3CL1;PTGER4;SNCA
GO:0002237,response to molecule of bacterial origin (GO:0002237),72,7,4.96501121,1.4098659,0.226791651,0.820609143,6622;6401;3569;2920;6403;11213;3663,IL6;SELP;CXCL2;SELE;IRAK3;IRF5;SNCA
GO:0036003,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),24,3,1.655003737,1.812684729,0.227438834,0.820609143,10365;467;90993,KLF2;ATF3;CREB3L1
GO:0043491,protein kinase B signaling (GO:0043491),24,3,1.655003737,1.812684729,0.227438834,0.820609143,3479;2621;6347,GAS6;CCL2;IGF1
GO:1900745,positive regulation of p38MAPK cascade (GO:1900745),24,3,1.655003737,1.812684729,0.227438834,0.820609143,9464;4616;285613,HAND2;RELL2;GADD45B
GO:0009154,purine ribonucleotide catabolic process (GO:0009154),24,3,1.655003737,1.812684729,0.227438834,0.820609143,5138;5144;4907,PDE2A;PDE4D;NT5E
GO:0030837,negative regulation of actin filament polymerization (GO:0030837),24,3,1.655003737,1.812684729,0.227438834,0.820609143,2934;9353;91663,GSN;MYADM;SLIT2
GO:1901880,negative regulation of protein depolymerization (GO:1901880),24,3,1.655003737,1.812684729,0.227438834,0.820609143,22974;2258;89795,TPX2;FGF13;NAV3
GO:0010332,response to gamma radiation (GO:0010332),24,3,1.655003737,1.812684729,0.227438834,0.820609143,4609;1410;2177,CRYAB;FANCD2;MYC
GO:0032680,regulation of tumor necrosis factor production (GO:0032680),123,11,8.48189415,1.296880131,0.227786991,0.821372289,7538;3479;2621;3569;947;1191;2048;23208;6376;11213;90865,IL6;ZFP36;IL33;CD34;CLU;GAS6;CX3CL1;IGF1;IRAK3;EPHB2;SYT11
GO:1901800,positive regulation of proteasomal protein catabolic process (GO:1901800),85,8,5.861471567,1.364844972,0.23108546,0.831925274,5347;1191;120892;285671;863;641700;26471;9532,LRRK2;RNF180;ECSCR;CLU;PLK1;BAG2;CBFA2T3;NUPR1
GO:0034249,negative regulation of cellular amide metabolic process (GO:0034249),85,8,5.861471567,1.364844972,0.23108546,0.831925274,4915;3479;1191;7298;3488;274;7832;23034,CLU;BIN1;SAMD4A;IGF1;TYMS;BTG2;NTRK2;IGFBP5
GO:1990869,cellular response to chemokine (GO:1990869),60,6,4.137509342,1.450147783,0.231267199,0.831925274,6366;2920;6387;6376;1843;6347,DUSP1;CXCL12;CX3CL1;CCL2;CXCL2;CCL21
GO:0018107,peptidyl-threonine phosphorylation (GO:0018107),60,6,4.137509342,1.450147783,0.231267199,0.831925274,7048;11113;983;1111;120892;388228,TGFBR2;LRRK2;CDK1;CIT;CHEK1;SBK1
GO:0032663,regulation of interleukin-2 production (GO:0032663),48,5,3.310007473,1.510570608,0.234332129,0.838740911,7538;5144;947;5142;89795,ZFP36;CD34;PDE4B;PDE4D;NAV3
GO:0043536,positive regulation of blood vessel endothelial cell migration (GO:0043536),48,5,3.310007473,1.510570608,0.234332129,0.838740911,284;2247;57381;10000;2260,RHOJ;FGF2;FGFR1;AKT3;ANGPT1
GO:0070373,negative regulation of ERK1 and ERK2 cascade (GO:0070373),48,5,3.310007473,1.510570608,0.234332129,0.838740911,11117;2048;10252;2192;55885,SPRY1;LMO3;EMILIN1;FBLN1;EPHB2
GO:0032872,regulation of stress-activated MAPK cascade (GO:0032872),48,5,3.310007473,1.510570608,0.234332129,0.838740911,4609;7049;2305;23542;5187,PER1;FOXM1;TGFBR3;MAPK8IP2;MYC
GO:0060341,regulation of cellular localization (GO:0060341),48,5,3.310007473,1.510570608,0.234332129,0.838740911,2934;111;26154;120892;10615,ADCY5;SPAG5;LRRK2;GSN;ABCA12
GO:0032653,regulation of interleukin-10 production (GO:0032653),48,5,3.310007473,1.510570608,0.234332129,0.838740911,3569;947;9636;5590;85480,IL6;CD34;TSLP;ISG15;PRKCZ
GO:0042306,regulation of protein import into nucleus (GO:0042306),36,4,2.482505605,1.611275315,0.234417689,0.838740911,2316;1894;51715;347,FLNA;ECT2;RAB23;APOD
GO:0002090,regulation of receptor internalization (GO:0002090),36,4,2.482505605,1.611275315,0.234417689,0.838740911,6401;284;22943;9863,MAGI2;SELE;ANGPT1;DKK1
GO:0032873,negative regulation of stress-activated MAPK cascade (GO:0032873),36,4,2.482505605,1.611275315,0.234417689,0.838740911,4609;2305;1843;5187,PER1;DUSP1;FOXM1;MYC
GO:2000142,"regulation of DNA-templated transcription, initiation (GO:2000142)",61,6,4.206467831,1.426374869,0.242819083,0.86776784,3569;983;891;4286;8061;7067,IL6;CCNB1;CDK1;THRA;MITF;FOSL1
GO:0030100,regulation of endocytosis (GO:0030100),61,6,4.206467831,1.426374869,0.242819083,0.86776784,6622;2042;933;23208;25999;11037,EPHA3;CD22;STON1;CLIP3;SYT11;SNCA
GO:0044272,sulfur compound biosynthetic process (GO:0044272),112,10,7.723350771,1.294774806,0.243491915,0.868181347,284;55790;79094;1634;1464;1036;2949;4958;4969;5549,CSGALNACT1;OGN;PRELP;GSTM5;CDO1;DCN;OMD;CSPG4;CHAC1;ANGPT1
GO:0034599,cellular response to oxidative stress (GO:0034599),125,11,8.619811128,1.276130049,0.243594657,0.868181347,7168;6622;5831;10891;120892;5563;5156;132864;2353;2878;6649,GPX3;SOD3;FOS;LRRK2;PYCR1;PPARGC1A;CPEB2;TPM1;PDGFRA;PRKAA2;SNCA
GO:0022607,cellular component assembly (GO:0022607),258,21,17.79129017,1.180352847,0.244948638,0.868181347,2316;2934;55742;11170;800;399;5881;2621;10979;3071;10891;57381;2318;55679;6450;2824;9319;4286;9735;2175;8208,FAM107A;RHOJ;KNTC1;FLNC;GSN;LIMS2;GAS6;TRIP13;CHAF1B;FANCA;PPARGC1A;FLNA;RAC3;FERMT2;NCKAP1L;CALD1;MITF;GPM6B;PARVA;SH3BGR;RHOH
GO:1903573,negative regulation of response to endoplasmic reticulum stress (GO:1903573),25,3,1.723962226,1.74017734,0.246242337,0.868181347,1191;120892;90993,LRRK2;CLU;CREB3L1
GO:0045604,regulation of epidermal cell differentiation (GO:0045604),25,3,1.723962226,1.74017734,0.246242337,0.868181347,7538;26154;23764,ZFP36;MAFF;ABCA12
GO:0014059,regulation of dopamine secretion (GO:0014059),25,3,1.723962226,1.74017734,0.246242337,0.868181347,6622;83849;23208,SYT15;SYT11;SNCA
GO:0032374,regulation of cholesterol transport (GO:0032374),25,3,1.723962226,1.74017734,0.246242337,0.868181347,5244;341;10351,ABCA8;ABCB4;APOC1
GO:0010800,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),25,3,1.723962226,1.74017734,0.246242337,0.868181347,1116;5347;51422,PLK1;PRKAG2;CHI3L1
GO:0031062,positive regulation of histone methylation (GO:0031062),25,3,1.723962226,1.74017734,0.246242337,0.868181347,672;4602;1789,BRCA1;DNMT3B;MYB
GO:0010677,negative regulation of cellular carbohydrate metabolic process (GO:0010677),25,3,1.723962226,1.74017734,0.246242337,0.868181347,9759;863;26471,CBFA2T3;HDAC4;NUPR1
GO:2000677,regulation of transcription regulatory region DNA binding (GO:2000677),25,3,1.723962226,1.74017734,0.246242337,0.868181347,3479;9464;8864,PER2;HAND2;IGF1
GO:0070613,regulation of protein processing (GO:0070613),25,3,1.723962226,1.74017734,0.246242337,0.868181347,120892;79094;9532,LRRK2;BAG2;CHAC1
GO:0034114,regulation of heterotypic cell-cell adhesion (GO:0034114),25,3,1.723962226,1.74017734,0.246242337,0.868181347,91663;4680;9314,KLF4;MYADM;CEACAM6
GO:0043949,regulation of cAMP-mediated signaling (GO:0043949),25,3,1.723962226,1.74017734,0.246242337,0.868181347,5577;5138;5144,PDE2A;PDE4D;PRKAR2B
GO:0043171,peptide catabolic process (GO:0043171),25,3,1.723962226,1.74017734,0.246242337,0.868181347,79094;10404;10004,NAALADL1;CPQ;CHAC1
GO:0055078,sodium ion homeostasis (GO:0055078),25,3,1.723962226,1.74017734,0.246242337,0.868181347,6546;477;482,ATP1A2;ATP1B2;SLC8A1
GO:1902230,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),25,3,1.723962226,1.74017734,0.246242337,0.868181347,596;1191;6387,CLU;CXCL12;BCL2
GO:0006986,response to unfolded protein (GO:0006986),49,5,3.378965962,1.479742636,0.247427419,0.868181347,3306;25822;26353;27129;3316,HSPB2;HSPB7;HSPA2;HSPB8;DNAJB5
GO:0071260,cellular response to mechanical stimulus (GO:0071260),49,5,3.378965962,1.479742636,0.247427419,0.868181347,5734;5138;358;1111;22927,AQP1;PDE2A;CHEK1;HABP4;PTGER4
GO:0042542,response to hydrogen peroxide (GO:0042542),49,5,3.378965962,1.479742636,0.247427419,0.868181347,388;1894;3569;358;7226,IL6;AQP1;RHOB;ECT2;TRPM2
GO:0032268,regulation of cellular protein metabolic process (GO:0032268),49,5,3.378965962,1.479742636,0.247427419,0.868181347,3624;185;1910;9314;29128,AGTR1;EDNRB;KLF4;INHBA;UHRF1
GO:0045646,regulation of erythrocyte differentiation (GO:0045646),37,4,2.551464094,1.567727333,0.249706664,0.868181347,7538;3624;3071;6886,ZFP36;INHBA;NCKAP1L;TAL1
GO:0045639,positive regulation of myeloid cell differentiation (GO:0045639),37,4,2.551464094,1.567727333,0.249706664,0.868181347,3624;3071;1440;6886,INHBA;CSF3;NCKAP1L;TAL1
GO:1904036,negative regulation of epithelial cell apoptotic process (GO:1904036),37,4,2.551464094,1.567727333,0.249706664,0.868181347,284;2621;79625;26471,GAS6;NDNF;ANGPT1;NUPR1
GO:0008272,sulfate transport (GO:0008272),14,2,0.965418846,2.07163969,0.250878556,0.868181347,65010;29127,SLC26A6;RACGAP1
GO:0006706,steroid catabolic process (GO:0006706),14,2,0.965418846,2.07163969,0.250878556,0.868181347,8630;6696,SPP1;HSD17B6
GO:0009141,nucleoside triphosphate metabolic process (GO:0009141),14,2,0.965418846,2.07163969,0.250878556,0.868181347,5167;205,AK4;ENPP1
GO:0003015,heart process (GO:0003015),14,2,0.965418846,2.07163969,0.250878556,0.868181347,70;6444,ACTC1;SGCD
GO:1900273,positive regulation of long-term synaptic potentiation (GO:1900273),14,2,0.965418846,2.07163969,0.250878556,0.868181347,2048;5649,RELN;EPHB2
GO:0046903,secretion (GO:0046903),14,2,0.965418846,2.07163969,0.250878556,0.868181347,4881;10516,NPR1;FBLN5
GO:0031280,negative regulation of cyclase activity (GO:0031280),14,2,0.965418846,2.07163969,0.250878556,0.868181347,1910;5064,EDNRB;PALM
GO:0008643,carbohydrate transport (GO:0008643),14,2,0.965418846,2.07163969,0.250878556,0.868181347,65010;358,AQP1;SLC26A6
GO:0050892,intestinal absorption (GO:0050892),14,2,0.965418846,2.07163969,0.250878556,0.868181347,65010;150,SLC26A6;ADRA2A
GO:0060191,regulation of lipase activity (GO:0060191),14,2,0.965418846,2.07163969,0.250878556,0.868181347,6622;338328,GPIHBP1;SNCA
GO:0002768,immune response-regulating cell surface receptor signaling pathway (GO:0002768),14,2,0.965418846,2.07163969,0.250878556,0.868181347,3815;4277,KIT;MICB
GO:0048538,thymus development (GO:0048538),14,2,0.965418846,2.07163969,0.250878556,0.868181347,9464;6495,HAND2;SIX1
GO:0001569,branching involved in blood vessel morphogenesis (GO:0001569),14,2,0.965418846,2.07163969,0.250878556,0.868181347,7048;9723,TGFBR2;SEMA3E
GO:0051769,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),14,2,0.965418846,2.07163969,0.250878556,0.868181347,6347;90865,IL33;CCL2
GO:1901018,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),14,2,0.965418846,2.07163969,0.250878556,0.868181347,287;482,ANK2;ATP1B2
GO:0043243,positive regulation of protein-containing complex disassembly (GO:0043243),14,2,0.965418846,2.07163969,0.250878556,0.868181347,154;79443,FYCO1;ADRB2
GO:0071360,cellular response to exogenous dsRNA (GO:0071360),14,2,0.965418846,2.07163969,0.250878556,0.868181347,857;81035,CAV1;COLEC12
GO:1905897,regulation of response to endoplasmic reticulum stress (GO:1905897),14,2,0.965418846,2.07163969,0.250878556,0.868181347,1191;26471,CLU;NUPR1
GO:0035904,aorta development (GO:0035904),14,2,0.965418846,2.07163969,0.250878556,0.868181347,5138;56999,PDE2A;ADAMTS9
GO:1905517,macrophage migration (GO:1905517),14,2,0.965418846,2.07163969,0.250878556,0.868181347,1910;6347,EDNRB;CCL2
GO:0045725,positive regulation of glycogen biosynthetic process (GO:0045725),14,2,0.965418846,2.07163969,0.250878556,0.868181347,3479;10580,SORBS1;IGF1
GO:0090036,regulation of protein kinase C signaling (GO:0090036),14,2,0.965418846,2.07163969,0.250878556,0.868181347,1608;91663,MYADM;DGKG
GO:0003171,atrioventricular valve development (GO:0003171),14,2,0.965418846,2.07163969,0.250878556,0.868181347,7048;6586,SLIT3;TGFBR2
GO:0062009,secondary palate development (GO:0062009),14,2,0.965418846,2.07163969,0.250878556,0.868181347,7048;7049,TGFBR2;TGFBR3
GO:0016569,covalent chromatin modification (GO:0016569),14,2,0.965418846,2.07163969,0.250878556,0.868181347,9212;3070,AURKB;HELLS
GO:0046638,positive regulation of alpha-beta T cell differentiation (GO:0046638),14,2,0.965418846,2.07163969,0.250878556,0.868181347,7048;3071,TGFBR2;NCKAP1L
GO:1900078,positive regulation of cellular response to insulin stimulus (GO:1900078),14,2,0.965418846,2.07163969,0.250878556,0.868181347,10580;5590,SORBS1;PRKCZ
GO:0034374,low-density lipoprotein particle remodeling (GO:0034374),14,2,0.965418846,2.07163969,0.250878556,0.868181347,185;5320,AGTR1;PLA2G2A
GO:0050819,negative regulation of coagulation (GO:0050819),14,2,0.965418846,2.07163969,0.250878556,0.868181347,947;7035,CD34;TFPI
GO:0048385,regulation of retinoic acid receptor signaling pathway (GO:0048385),14,2,0.965418846,2.07163969,0.250878556,0.868181347,10365;2146,KLF2;EZH2
GO:0070262,peptidyl-serine dephosphorylation (GO:0070262),14,2,0.965418846,2.07163969,0.250878556,0.868181347,1843;5521,DUSP1;PPP2R2B
GO:0051093,negative regulation of developmental process (GO:0051093),75,7,5.171886677,1.353471264,0.258391959,0.892467947,22899;2621;4781;10411;6422;2305;7037,SFRP1;FOXM1;GAS6;ARHGEF15;RAPGEF3;NFIB;TFRC
GO:0006367,transcription initiation from RNA polymerase II promoter (GO:0006367),140,12,9.654188464,1.242983814,0.258511436,0.892467947,3164;10891;6910;4929;8013;2099;1870;25937;7025;5241;7067;4306,NR4A1;NR4A3;NR4A2;PGR;NR3C2;PPARGC1A;NR2F1;WWTR1;THRA;E2F2;ESR1;TBX5
GO:0031397,negative regulation of protein ubiquitination (GO:0031397),50,5,3.447924451,1.450147783,0.260705009,0.892467947,857;6659;8864;9636;9532,SOX4;PER2;CAV1;BAG2;ISG15
GO:0062197,cellular response to chemical stress (GO:0062197),101,9,6.964807392,1.292210896,0.260887666,0.892467947,6622;857;5831;10891;120892;5563;132864;2878;6649,GPX3;SOD3;LRRK2;PYCR1;CAV1;PPARGC1A;CPEB2;PRKAA2;SNCA
GO:0045824,negative regulation of innate immune response (GO:0045824),38,4,2.620422583,1.526471351,0.265198975,0.892467947,2;9636;11213;11274,A2M;USP18;IRAK3;ISG15
GO:0032691,negative regulation of interleukin-1 beta production (GO:0032691),26,3,1.792920715,1.673247442,0.265273287,0.892467947,3479;114548;6376,CX3CL1;IGF1;NLRP3
GO:0051491,positive regulation of filopodium assembly (GO:0051491),26,3,1.792920715,1.673247442,0.265273287,0.892467947,375790;6366;5064,AGRN;CCL21;PALM
GO:0042573,retinoic acid metabolic process (GO:0042573),26,3,1.792920715,1.673247442,0.265273287,0.892467947,125;83875;126,ADH1B;BCO2;ADH1C
GO:0090025,regulation of monocyte chemotaxis (GO:0090025),26,3,1.792920715,1.673247442,0.265273287,0.892467947,9353;6387;1843,DUSP1;CXCL12;SLIT2
GO:1903131,mononuclear cell differentiation (GO:1903131),26,3,1.792920715,1.673247442,0.265273287,0.892467947,2621;7226;558,GAS6;AXL;TRPM2
GO:0001656,metanephros development (GO:0001656),26,3,1.792920715,1.673247442,0.265273287,0.892467947,51804;64321;6495,SOX17;SIX4;SIX1
GO:1901342,regulation of vasculature development (GO:1901342),26,3,1.792920715,1.673247442,0.265273287,0.892467947,3569;2247;6422,IL6;SFRP1;FGF2
GO:0016242,negative regulation of macroautophagy (GO:0016242),26,3,1.792920715,1.673247442,0.265273287,0.892467947,9638;120892;26471,LRRK2;FEZ1;NUPR1
GO:0006029,proteoglycan metabolic process (GO:0006029),26,3,1.792920715,1.673247442,0.265273287,0.892467947,3479;55790;81792,CSGALNACT1;IGF1;ADAMTS12
GO:0072330,monocarboxylic acid biosynthetic process (GO:0072330),63,6,4.344384809,1.381093127,0.266403761,0.892467947,1593;9023;51302;8309;8864;2593,ACOX2;PER2;CH25H;CYP39A1;CYP27A1;GAMT
GO:0006767,water-soluble vitamin metabolic process (GO:0006767),76,7,5.240845166,1.335662432,0.269199074,0.892467947,5167;6573;2350;8884;6515;25902;316,AOX1;SLC5A6;SLC19A1;MTHFD1L;FOLR2;SLC2A3;ENPP1
GO:0065004,protein-DNA complex assembly (GO:0065004),115,10,7.930226238,1.260998072,0.269357426,0.892467947,4171;81620;8208;990;4173;23594;4998;5888;4675;4674,ORC1;MCM2;CHAF1B;CDC6;RAD51;ORC6;CDT1;MCM4;NAP1L2;NAP1L3
GO:0019932,second-messenger-mediated signaling (GO:0019932),89,8,6.137305523,1.303503625,0.270247419,0.892467947,6401;79625;185;1910;6262;1827;10231;120892,RCAN2;AGTR1;EDNRB;LRRK2;RCAN1;NDNF;SELE;RYR2
GO:0051051,negative regulation of transport (GO:0051051),51,5,3.51688294,1.421713513,0.274143479,0.892467947,6622;3690;2042;23208;1410,CRYAB;EPHA3;ITGB3;SYT11;SNCA
GO:0008406,gonad development (GO:0008406),51,5,3.51688294,1.421713513,0.274143479,0.892467947,3815;3624;51804;7482;2627,GATA6;INHBA;WNT2B;SIX4;KIT
GO:0030301,cholesterol transport (GO:0030301),51,5,3.51688294,1.421713513,0.274143479,0.892467947,857;341;10351;1066;1191,ABCA8;CLU;CAV1;CES1;APOC1
GO:1902236,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),15,2,1.034377335,1.933530378,0.277187261,0.892467947,120892;90993,LRRK2;CREB3L1
GO:0060211,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),15,2,1.034377335,1.933530378,0.277187261,0.892467947,7538;7832,ZFP36;BTG2
GO:0071243,cellular response to arsenic-containing substance (GO:0071243),15,2,1.034377335,1.933530378,0.277187261,0.892467947,467;132864,CPEB2;ATF3
GO:0002695,negative regulation of leukocyte activation (GO:0002695),15,2,1.034377335,1.933530378,0.277187261,0.892467947,145581;4345,LRFN5;CD200
GO:2000765,regulation of cytoplasmic translation (GO:2000765),15,2,1.034377335,1.933530378,0.277187261,0.892467947,221662;132864,RBM24;CPEB2
GO:1905906,regulation of amyloid fibril formation (GO:1905906),15,2,1.034377335,1.933530378,0.277187261,0.892467947,1191;1410,CRYAB;CLU
GO:0050974,detection of mechanical stimulus involved in sensory perception (GO:0050974),15,2,1.034377335,1.933530378,0.277187261,0.892467947,3815;1301,COL11A1;KIT
GO:0051047,positive regulation of secretion (GO:0051047),15,2,1.034377335,1.933530378,0.277187261,0.892467947,358;4881,AQP1;NPR1
GO:0051293,establishment of spindle localization (GO:0051293),15,2,1.034377335,1.933530378,0.277187261,0.892467947,9700;51203,NUSAP1;ESPL1
GO:0051271,negative regulation of cellular component movement (GO:0051271),15,2,1.034377335,1.933530378,0.277187261,0.892467947,7049;2192,TGFBR3;FBLN1
GO:0055003,cardiac myofibril assembly (GO:0055003),15,2,1.034377335,1.933530378,0.277187261,0.892467947,70;5156,ACTC1;PDGFRA
GO:0051444,negative regulation of ubiquitin-protein transferase activity (GO:0051444),15,2,1.034377335,1.933530378,0.277187261,0.892467947,4085;9532,BAG2;MAD2L1
GO:1905168,positive regulation of double-strand break repair via homologous recombination (GO:1905168),15,2,1.034377335,1.933530378,0.277187261,0.892467947,8914;10635,TIMELESS;RAD51AP1
GO:0001890,placenta development (GO:0001890),15,2,1.034377335,1.933530378,0.277187261,0.892467947,144455;79733,E2F7;E2F8
GO:0061180,mammary gland epithelium development (GO:0061180),15,2,1.034377335,1.933530378,0.277187261,0.892467947,7472;3398,WNT2;ID2
GO:0086013,membrane repolarization during cardiac muscle cell action potential (GO:0086013),15,2,1.034377335,1.933530378,0.277187261,0.892467947,3757;3752,KCNH2;KCND3
GO:2001026,regulation of endothelial cell chemotaxis (GO:2001026),15,2,1.034377335,1.933530378,0.277187261,0.892467947,2247;64094,FGF2;SMOC2
GO:0031057,negative regulation of histone modification (GO:0031057),15,2,1.034377335,1.933530378,0.277187261,0.892467947,6622;672,BRCA1;SNCA
GO:0071391,cellular response to estrogen stimulus (GO:0071391),15,2,1.034377335,1.933530378,0.277187261,0.892467947,6422;10865,SFRP1;ARID5A
GO:0070875,positive regulation of glycogen metabolic process (GO:0070875),15,2,1.034377335,1.933530378,0.277187261,0.892467947,3479;10580,SORBS1;IGF1
GO:0060766,negative regulation of androgen receptor signaling pathway (GO:0060766),15,2,1.034377335,1.933530378,0.277187261,0.892467947,6943;6422,TCF21;SFRP1
GO:0032816,positive regulation of natural killer cell activation (GO:0032816),15,2,1.034377335,1.933530378,0.277187261,0.892467947,2621;558,GAS6;AXL
GO:0090189,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),15,2,1.034377335,1.933530378,0.277187261,0.892467947,51804;6495,SIX4;SIX1
GO:1902692,regulation of neuroblast proliferation (GO:1902692),15,2,1.034377335,1.933530378,0.277187261,0.892467947,120892;6376,LRRK2;CX3CL1
GO:0006953,acute-phase response (GO:0006953),15,2,1.034377335,1.933530378,0.277187261,0.892467947,3569;3570,IL6;IL6R
GO:0043517,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",15,2,1.034377335,1.933530378,0.277187261,0.892467947,4487;3090,HIC1;MSX1
GO:0001574,ganglioside biosynthetic process (GO:0001574),15,2,1.034377335,1.933530378,0.277187261,0.892467947,30815;256435,ST6GALNAC6;ST6GALNAC3
GO:0010955,negative regulation of protein processing (GO:0010955),15,2,1.034377335,1.933530378,0.277187261,0.892467947,120892;79094,LRRK2;CHAC1
GO:0071786,endoplasmic reticulum tubular network organization (GO:0071786),15,2,1.034377335,1.933530378,0.277187261,0.892467947,65055;51308,REEP1;REEP2
GO:0031573,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),15,2,1.034377335,1.933530378,0.277187261,0.892467947,2177;146956,EME1;FANCD2
GO:0045637,regulation of myeloid cell differentiation (GO:0045637),64,6,4.413343298,1.359513547,0.278406927,0.892467947,5579;4208;7704;8013;1440;10398,NR4A3;ZBTB16;PRKCB;MEF2C;MYL9;CSF3
GO:2001243,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),64,6,4.413343298,1.359513547,0.278406927,0.892467947,596;1191;6387;120892;90993;219790,LRRK2;CLU;CXCL12;BCL2;CREB3L1;RTKN2
GO:0007009,plasma membrane organization (GO:0007009),64,6,4.413343298,1.359513547,0.278406927,0.892467947,309;287;23208;274;30846;57088,ANK2;BIN1;ANXA6;EHD2;PLSCR4;SYT11
GO:0036388,pre-replicative complex assembly (GO:0036388),64,6,4.413343298,1.359513547,0.278406927,0.892467947,4171;81620;990;4173;23594;4998,ORC1;MCM2;CDC6;ORC6;CDT1;MCM4
GO:0050709,negative regulation of protein secretion (GO:0050709),39,4,2.689381072,1.48733106,0.280860882,0.892467947,150;3625;6422;4345,SFRP1;ADRA2A;CD200;INHBB
GO:0043542,endothelial cell migration (GO:0043542),39,4,2.689381072,1.48733106,0.280860882,0.892467947,8742;1960;3164;90627,NR4A1;EGR3;STARD13;TNFSF12
GO:0050999,regulation of nitric-oxide synthase activity (GO:0050999),39,4,2.689381072,1.48733106,0.280860882,0.892467947,857;493;114757;115677,NOSTRIN;CAV1;CYGB;ATP2B4
GO:0042476,odontogenesis (GO:0042476),39,4,2.689381072,1.48733106,0.280860882,0.892467947,3624;358;5308;4487,AQP1;INHBA;MSX1;PITX2
GO:0031324,negative regulation of cellular metabolic process (GO:0031324),39,4,2.689381072,1.48733106,0.280860882,0.892467947,3690;1910;672;5806,EDNRB;BRCA1;PTX3;ITGB3
GO:0043433,negative regulation of DNA-binding transcription factor activity (GO:0043433),143,12,9.861063931,1.216907231,0.282169086,0.892467947,2316;2621;114548;5740;9759;11213;2099;9314;3398;4345;26471;56849,KLF4;GAS6;TCEAL7;FLNA;PTGIS;ID2;HDAC4;CD200;IRAK3;NLRP3;ESR1;NUPR1
GO:0045648,positive regulation of erythrocyte differentiation (GO:0045648),27,3,1.861879204,1.611275315,0.284470135,0.892467947,3624;3071;6886,INHBA;NCKAP1L;TAL1
GO:0051149,positive regulation of muscle cell differentiation (GO:0051149),27,3,1.861879204,1.611275315,0.284470135,0.892467947,4208;93649;91653,MYOCD;MEF2C;BOC
GO:0051785,positive regulation of nuclear division (GO:0051785),27,3,1.861879204,1.611275315,0.284470135,0.892467947,3479;6790;51203,AURKA;NUSAP1;IGF1
GO:0007159,leukocyte cell-cell adhesion (GO:0007159),27,3,1.861879204,1.611275315,0.284470135,0.892467947,6401;4907;6403,SELP;SELE;NT5E
GO:0034121,regulation of toll-like receptor signaling pathway (GO:0034121),27,3,1.861879204,1.611275315,0.284470135,0.892467947,27293;11213;330,BIRC3;IRAK3;SMPDL3B
GO:0045429,positive regulation of nitric oxide biosynthetic process (GO:0045429),27,3,1.861879204,1.611275315,0.284470135,0.892467947,1191;10365;9314,KLF2;KLF4;CLU
GO:0002526,acute inflammatory response (GO:0002526),27,3,1.861879204,1.611275315,0.284470135,0.892467947,3569;388125;3570,IL6;C2CD4B;IL6R
GO:2000352,negative regulation of endothelial cell apoptotic process (GO:2000352),27,3,1.861879204,1.611275315,0.284470135,0.892467947,284;2621;79625,GAS6;NDNF;ANGPT1
GO:0007176,regulation of epidermal growth factor-activated receptor activity (GO:0007176),27,3,1.861879204,1.611275315,0.284470135,0.892467947,150;1839;374,ADRA2A;HBEGF;AREG
GO:0050650,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),27,3,1.861879204,1.611275315,0.284470135,0.892467947,55790;1634;1464,CSGALNACT1;DCN;CSPG4
GO:0015949,nucleobase-containing small molecule interconversion (GO:0015949),27,3,1.861879204,1.611275315,0.284470135,0.892467947,205;6241;7298,RRM2;TYMS;AK4
GO:0005977,glycogen metabolic process (GO:0005977),27,3,1.861879204,1.611275315,0.284470135,0.892467947,8864;51422;5837,PYGM;PER2;PRKAG2
GO:0050728,negative regulation of inflammatory response (GO:0050728),211,17,14.55024118,1.168365513,0.28747035,0.892467947,111;196883;154;108;5577;3479;3569;5745;10267;5734;7434;114548;5740;145581;27293;9314;4345,IL6;ADCY5;VIPR2;PTH1R;KLF4;LRFN5;RAMP1;ADCY4;PTGIS;PRKAR2B;IGF1;CD200;NLRP3;ADRB2;PTGER4;ADCY2;SMPDL3B
GO:1903078,positive regulation of protein localization to plasma membrane (GO:1903078),52,5,3.585841429,1.394372869,0.287721558,0.892467947,10580;2048;2042;493;25999,SORBS1;EPHA3;ATP2B4;CLIP3;EPHB2
GO:1904377,positive regulation of protein localization to cell periphery (GO:1904377),52,5,3.585841429,1.394372869,0.287721558,0.892467947,10580;2048;2042;493;25999,SORBS1;EPHA3;ATP2B4;CLIP3;EPHB2
GO:0030509,BMP signaling pathway (GO:0030509),65,6,4.482301787,1.338597954,0.290530853,0.892467947,7049;656;56963;653;4093;55273,BMP5;TGFBR3;TMEM100;BMP8B;SMAD9;RGMA
GO:0071456,cellular response to hypoxia (GO:0071456),131,11,9.033562063,1.217681345,0.293196132,0.892467947,358;205;79625;4609;5740;768;6422;2627;64344;132864;29923,AQP1;SFRP1;HIF3A;GATA6;CPEB2;PTGIS;NDNF;CA9;HILPDA;MYC;AK4
GO:0046777,protein autophosphorylation (GO:0046777),158,13,10.89544127,1.193159568,0.294812826,0.892467947,23043;3815;4915;2869;6790;9212;660;9833;120892;5156;225689;4751;2260,BMX;AURKA;LRRK2;NEK2;MELK;AURKB;FGFR1;GRK5;KIT;MAPK15;TNIK;NTRK2;PDGFRA
GO:0051489,regulation of filopodium assembly (GO:0051489),40,4,2.758339561,1.450147783,0.29665944,0.892467947,375790;6366;7226;5064,TRPM2;AGRN;CCL21;PALM
GO:0072676,lymphocyte migration (GO:0072676),40,4,2.758339561,1.450147783,0.29665944,0.892467947,1901;6366;6376;6347,S1PR1;CX3CL1;CCL2;CCL21
GO:0006639,acylglycerol metabolic process (GO:0006639),40,4,2.758339561,1.450147783,0.29665944,0.892467947,11343;857;341;1608,MGLL;CAV1;APOC1;DGKG
GO:0018958,phenol-containing compound metabolic process (GO:0018958),5,1,0.344792445,2.900295567,0.300442584,0.892467947,285671,RNF180
GO:0009143,nucleoside triphosphate catabolic process (GO:0009143),5,1,0.344792445,2.900295567,0.300442584,0.892467947,5167,ENPP1
GO:0042420,dopamine catabolic process (GO:0042420),5,1,0.344792445,2.900295567,0.300442584,0.892467947,4129,MAOB
GO:0002634,regulation of germinal center formation (GO:0002634),5,1,0.344792445,2.900295567,0.300442584,0.892467947,4208,MEF2C
GO:0071472,cellular response to salt stress (GO:0071472),5,1,0.344792445,2.900295567,0.300442584,0.892467947,358,AQP1
GO:0038066,p38MAPK cascade (GO:0038066),5,1,0.344792445,2.900295567,0.300442584,0.892467947,7538,ZFP36
GO:0009651,response to salt stress (GO:0009651),5,1,0.344792445,2.900295567,0.300442584,0.892467947,358,AQP1
GO:0051891,positive regulation of cardioblast differentiation (GO:0051891),5,1,0.344792445,2.900295567,0.300442584,0.892467947,6910,TBX5
GO:0051890,regulation of cardioblast differentiation (GO:0051890),5,1,0.344792445,2.900295567,0.300442584,0.892467947,6910,TBX5
GO:1905870,positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),5,1,0.344792445,2.900295567,0.300442584,0.892467947,221662,RBM24
GO:0031279,regulation of cyclase activity (GO:0031279),5,1,0.344792445,2.900295567,0.300442584,0.892467947,10486,CAP2
GO:0008063,Toll signaling pathway (GO:0008063),5,1,0.344792445,2.900295567,0.300442584,0.892467947,57161,PELI2
GO:1905144,response to acetylcholine (GO:1905144),5,1,0.344792445,2.900295567,0.300442584,0.892467947,493,ATP2B4
GO:0007614,short-term memory (GO:0007614),5,1,0.344792445,2.900295567,0.300442584,0.892467947,6517,SLC2A4
GO:0032782,bile acid secretion (GO:0032782),5,1,0.344792445,2.900295567,0.300442584,0.892467947,5244,ABCB4
GO:0070640,vitamin D3 metabolic process (GO:0070640),5,1,0.344792445,2.900295567,0.300442584,0.892467947,1593,CYP27A1
GO:0060161,positive regulation of dopamine receptor signaling pathway (GO:0060161),5,1,0.344792445,2.900295567,0.300442584,0.892467947,120892,LRRK2
GO:0009750,response to fructose (GO:0009750),5,1,0.344792445,2.900295567,0.300442584,0.892467947,65010,SLC26A6
GO:0140361,cyclic-GMP-AMP transmembrane import across plasma membrane (GO:0140361),5,1,0.344792445,2.900295567,0.300442584,0.892467947,6573,SLC19A1
GO:1903960,negative regulation of anion transmembrane transport (GO:1903960),5,1,0.344792445,2.900295567,0.300442584,0.892467947,8501,SLC43A1
GO:1903729,regulation of plasma membrane organization (GO:1903729),5,1,0.344792445,2.900295567,0.300442584,0.892467947,2934,GSN
GO:0036006,cellular response to macrophage colony-stimulating factor stimulus (GO:0036006),5,1,0.344792445,2.900295567,0.300442584,0.892467947,5138,PDE2A
GO:0036005,response to macrophage colony-stimulating factor (GO:0036005),5,1,0.344792445,2.900295567,0.300442584,0.892467947,5138,PDE2A
GO:0086100,endothelin receptor signaling pathway (GO:0086100),5,1,0.344792445,2.900295567,0.300442584,0.892467947,1910,EDNRB
GO:1903348,positive regulation of bicellular tight junction assembly (GO:1903348),5,1,0.344792445,2.900295567,0.300442584,0.892467947,7122,CLDN5
GO:2000618,regulation of histone H4-K16 acetylation (GO:2000618),5,1,0.344792445,2.900295567,0.300442584,0.892467947,672,BRCA1
GO:0036018,cellular response to erythropoietin (GO:0036018),5,1,0.344792445,2.900295567,0.300442584,0.892467947,3815,KIT
GO:0002327,immature B cell differentiation (GO:0002327),5,1,0.344792445,2.900295567,0.300442584,0.892467947,3815,KIT
GO:0002705,positive regulation of leukocyte mediated immunity (GO:0002705),5,1,0.344792445,2.900295567,0.300442584,0.892467947,3815,KIT
GO:0002730,regulation of dendritic cell cytokine production (GO:0002730),5,1,0.344792445,2.900295567,0.300442584,0.892467947,3815,KIT
GO:0090259,regulation of retinal ganglion cell axon guidance (GO:0090259),5,1,0.344792445,2.900295567,0.300442584,0.892467947,9353,SLIT2
GO:0032534,regulation of microvillus assembly (GO:0032534),5,1,0.344792445,2.900295567,0.300442584,0.892467947,5909,RAP1GAP
GO:0036120,cellular response to platelet-derived growth factor stimulus (GO:0036120),5,1,0.344792445,2.900295567,0.300442584,0.892467947,3373,HYAL1
GO:0034316,negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),5,1,0.344792445,2.900295567,0.300442584,0.892467947,9535,GMFG
GO:0070836,caveola assembly (GO:0070836),5,1,0.344792445,2.900295567,0.300442584,0.892467947,857,CAV1
GO:0032430,positive regulation of phospholipase A2 activity (GO:0032430),5,1,0.344792445,2.900295567,0.300442584,0.892467947,185,AGTR1
GO:0010764,negative regulation of fibroblast migration (GO:0010764),5,1,0.344792445,2.900295567,0.300442584,0.892467947,2247,FGF2
GO:0014894,response to denervation involved in regulation of muscle adaptation (GO:0014894),5,1,0.344792445,2.900295567,0.300442584,0.892467947,9759,HDAC4
GO:0098915,membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915),5,1,0.344792445,2.900295567,0.300442584,0.892467947,3757,KCNH2
GO:0060452,positive regulation of cardiac muscle contraction (GO:0060452),5,1,0.344792445,2.900295567,0.300442584,0.892467947,5997,RGS2
GO:0086043,bundle of His cell action potential (GO:0086043),5,1,0.344792445,2.900295567,0.300442584,0.892467947,781,CACNA2D1
GO:1901979,regulation of inward rectifier potassium channel activity (GO:1901979),5,1,0.344792445,2.900295567,0.300442584,0.892467947,857,CAV1
GO:0086046,membrane depolarization during SA node cell action potential (GO:0086046),5,1,0.344792445,2.900295567,0.300442584,0.892467947,287,ANK2
GO:0086018,SA node cell to atrial cardiac muscle cell signaling (GO:0086018),5,1,0.344792445,2.900295567,0.300442584,0.892467947,287,ANK2
GO:0106049,regulation of cellular response to osmotic stress (GO:0106049),5,1,0.344792445,2.900295567,0.300442584,0.892467947,79085,SLC25A23
GO:0030263,apoptotic chromosome condensation (GO:0030263),5,1,0.344792445,2.900295567,0.300442584,0.892467947,7153,TOP2A
GO:0051339,regulation of lyase activity (GO:0051339),5,1,0.344792445,2.900295567,0.300442584,0.892467947,10486,CAP2
GO:0031642,negative regulation of myelination (GO:0031642),5,1,0.344792445,2.900295567,0.300442584,0.892467947,58494,JAM2
GO:0048312,intracellular distribution of mitochondria (GO:0048312),5,1,0.344792445,2.900295567,0.300442584,0.892467947,120892,LRRK2
GO:0035509,negative regulation of myosin-light-chain-phosphatase activity (GO:0035509),5,1,0.344792445,2.900295567,0.300442584,0.892467947,3071,NCKAP1L
GO:0060252,positive regulation of glial cell proliferation (GO:0060252),5,1,0.344792445,2.900295567,0.300442584,0.892467947,3569,IL6
GO:0031652,positive regulation of heat generation (GO:0031652),5,1,0.344792445,2.900295567,0.300442584,0.892467947,5733,PTGER3
GO:0031620,regulation of fever generation (GO:0031620),5,1,0.344792445,2.900295567,0.300442584,0.892467947,5733,PTGER3
GO:0042416,dopamine biosynthetic process (GO:0042416),5,1,0.344792445,2.900295567,0.300442584,0.892467947,6622,SNCA
GO:1903421,regulation of synaptic vesicle recycling (GO:1903421),5,1,0.344792445,2.900295567,0.300442584,0.892467947,6622,SNCA
GO:1905710,positive regulation of membrane permeability (GO:1905710),5,1,0.344792445,2.900295567,0.300442584,0.892467947,83700,JAM3
GO:0006837,serotonin transport (GO:0006837),5,1,0.344792445,2.900295567,0.300442584,0.892467947,6581,SLC22A3
GO:0051610,serotonin uptake (GO:0051610),5,1,0.344792445,2.900295567,0.300442584,0.892467947,6581,SLC22A3
GO:1903208,negative regulation of hydrogen peroxide-induced neuron death (GO:1903208),5,1,0.344792445,2.900295567,0.300442584,0.892467947,8013,NR4A3
GO:0051901,positive regulation of mitochondrial depolarization (GO:0051901),5,1,0.344792445,2.900295567,0.300442584,0.892467947,1634,DCN
GO:0001768,establishment of T cell polarity (GO:0001768),5,1,0.344792445,2.900295567,0.300442584,0.892467947,6366,CCL21
GO:1905809,negative regulation of synapse organization (GO:1905809),5,1,0.344792445,2.900295567,0.300442584,0.892467947,22899,ARHGEF15
GO:0044381,glucose import in response to insulin stimulus (GO:0044381),5,1,0.344792445,2.900295567,0.300442584,0.892467947,6517,SLC2A4
GO:0014831,gastro-intestinal system smooth muscle contraction (GO:0014831),5,1,0.344792445,2.900295567,0.300442584,0.892467947,5733,PTGER3
GO:0060038,cardiac muscle cell proliferation (GO:0060038),5,1,0.344792445,2.900295567,0.300442584,0.892467947,7049,TGFBR3
GO:0010936,negative regulation of macrophage cytokine production (GO:0010936),5,1,0.344792445,2.900295567,0.300442584,0.892467947,11213,IRAK3
GO:1905007,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),5,1,0.344792445,2.900295567,0.300442584,0.892467947,7048,TGFBR2
GO:0014855,striated muscle cell proliferation (GO:0014855),5,1,0.344792445,2.900295567,0.300442584,0.892467947,7049,TGFBR3
GO:1901984,negative regulation of protein acetylation (GO:1901984),5,1,0.344792445,2.900295567,0.300442584,0.892467947,28999,KLF15
GO:0034392,negative regulation of smooth muscle cell apoptotic process (GO:0034392),5,1,0.344792445,2.900295567,0.300442584,0.892467947,3479,IGF1
GO:0035624,receptor transactivation (GO:0035624),5,1,0.344792445,2.900295567,0.300442584,0.892467947,150,ADRA2A
GO:0045955,negative regulation of calcium ion-dependent exocytosis (GO:0045955),5,1,0.344792445,2.900295567,0.300442584,0.892467947,150,ADRA2A
GO:0072124,regulation of glomerular mesangial cell proliferation (GO:0072124),5,1,0.344792445,2.900295567,0.300442584,0.892467947,3570,IL6R
GO:1901509,regulation of endothelial tube morphogenesis (GO:1901509),5,1,0.344792445,2.900295567,0.300442584,0.892467947,81792,ADAMTS12
GO:1905605,positive regulation of blood-brain barrier permeability (GO:1905605),5,1,0.344792445,2.900295567,0.300442584,0.892467947,284,ANGPT1
GO:0003348,cardiac endothelial cell differentiation (GO:0003348),5,1,0.344792445,2.900295567,0.300442584,0.892467947,64321,SOX17
GO:0060956,endocardial cell differentiation (GO:0060956),5,1,0.344792445,2.900295567,0.300442584,0.892467947,64321,SOX17
GO:2000563,"positive regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000563)",5,1,0.344792445,2.900295567,0.300442584,0.892467947,7048,TGFBR2
GO:0003175,tricuspid valve development (GO:0003175),5,1,0.344792445,2.900295567,0.300442584,0.892467947,7048,TGFBR2
GO:0003186,tricuspid valve morphogenesis (GO:0003186),5,1,0.344792445,2.900295567,0.300442584,0.892467947,7048,TGFBR2
GO:0032369,negative regulation of lipid transport (GO:0032369),5,1,0.344792445,2.900295567,0.300442584,0.892467947,3690,ITGB3
GO:0060911,cardiac cell fate commitment (GO:0060911),5,1,0.344792445,2.900295567,0.300442584,0.892467947,64321,SOX17
GO:0009950,dorsal/ventral axis specification (GO:0009950),5,1,0.344792445,2.900295567,0.300442584,0.892467947,6422,SFRP1
GO:0055012,ventricular cardiac muscle cell differentiation (GO:0055012),5,1,0.344792445,2.900295567,0.300442584,0.892467947,4208,MEF2C
GO:0020027,hemoglobin metabolic process (GO:0020027),5,1,0.344792445,2.900295567,0.300442584,0.892467947,3624,INHBA
GO:0045650,negative regulation of macrophage differentiation (GO:0045650),5,1,0.344792445,2.900295567,0.300442584,0.892467947,3624,INHBA
GO:0061298,retina vasculature development in camera-type eye (GO:0061298),5,1,0.344792445,2.900295567,0.300442584,0.892467947,5156,PDGFRA
GO:0071394,cellular response to testosterone stimulus (GO:0071394),5,1,0.344792445,2.900295567,0.300442584,0.892467947,6696,SPP1
GO:0072683,T cell extravasation (GO:0072683),5,1,0.344792445,2.900295567,0.300442584,0.892467947,6347,CCL2
GO:0045794,negative regulation of cell volume (GO:0045794),5,1,0.344792445,2.900295567,0.300442584,0.892467947,3778,KCNMA1
GO:0061888,regulation of astrocyte activation (GO:0061888),5,1,0.344792445,2.900295567,0.300442584,0.892467947,3569,IL6
GO:2000674,regulation of type B pancreatic cell apoptotic process (GO:2000674),5,1,0.344792445,2.900295567,0.300442584,0.892467947,3569,IL6
GO:2000373,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),5,1,0.344792445,2.900295567,0.300442584,0.892467947,29128,UHRF1
GO:2000371,regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),5,1,0.344792445,2.900295567,0.300442584,0.892467947,29128,UHRF1
GO:1903018,regulation of glycoprotein metabolic process (GO:1903018),5,1,0.344792445,2.900295567,0.300442584,0.892467947,5806,PTX3
GO:0010727,negative regulation of hydrogen peroxide metabolic process (GO:0010727),5,1,0.344792445,2.900295567,0.300442584,0.892467947,255027,MPV17L
GO:0046461,neutral lipid catabolic process (GO:0046461),5,1,0.344792445,2.900295567,0.300442584,0.892467947,11343,MGLL
GO:0048550,negative regulation of pinocytosis (GO:0048550),5,1,0.344792445,2.900295567,0.300442584,0.892467947,857,CAV1
GO:0032371,regulation of sterol transport (GO:0032371),5,1,0.344792445,2.900295567,0.300442584,0.892467947,341,APOC1
GO:0072584,caveolin-mediated endocytosis (GO:0072584),5,1,0.344792445,2.900295567,0.300442584,0.892467947,857,CAV1
GO:1903044,protein localization to membrane raft (GO:1903044),5,1,0.344792445,2.900295567,0.300442584,0.892467947,857,CAV1
GO:0010455,positive regulation of cell fate commitment (GO:0010455),5,1,0.344792445,2.900295567,0.300442584,0.892467947,2247,FGF2
GO:0098838,folate transmembrane transport (GO:0098838),5,1,0.344792445,2.900295567,0.300442584,0.892467947,6573,SLC19A1
GO:0015866,ADP transport (GO:0015866),5,1,0.344792445,2.900295567,0.300442584,0.892467947,291,SLC25A4
GO:1901524,regulation of mitophagy (GO:1901524),5,1,0.344792445,2.900295567,0.300442584,0.892467947,291,SLC25A4
GO:0015893,drug transport (GO:0015893),5,1,0.344792445,2.900295567,0.300442584,0.892467947,6573,SLC19A1
GO:0071321,cellular response to cGMP (GO:0071321),5,1,0.344792445,2.900295567,0.300442584,0.892467947,5138,PDE2A
GO:0070305,response to cGMP (GO:0070305),5,1,0.344792445,2.900295567,0.300442584,0.892467947,5138,PDE2A
GO:0014037,Schwann cell differentiation (GO:0014037),5,1,0.344792445,2.900295567,0.300442584,0.892467947,1959,EGR2
GO:0042428,serotonin metabolic process (GO:0042428),5,1,0.344792445,2.900295567,0.300442584,0.892467947,285671,RNF180
GO:0010754,negative regulation of cGMP-mediated signaling (GO:0010754),5,1,0.344792445,2.900295567,0.300442584,0.892467947,5138,PDE2A
GO:0071681,cellular response to indole-3-methanol (GO:0071681),5,1,0.344792445,2.900295567,0.300442584,0.892467947,672,BRCA1
GO:0071680,response to indole-3-methanol (GO:0071680),5,1,0.344792445,2.900295567,0.300442584,0.892467947,672,BRCA1
GO:0072079,nephron tubule formation (GO:0072079),5,1,0.344792445,2.900295567,0.300442584,0.892467947,6495,SIX1
GO:0072162,metanephric mesenchymal cell differentiation (GO:0072162),5,1,0.344792445,2.900295567,0.300442584,0.892467947,6943,TCF21
GO:0038030,non-canonical Wnt signaling pathway via MAPK cascade (GO:0038030),5,1,0.344792445,2.900295567,0.300442584,0.892467947,8324,FZD7
GO:0009249,protein lipoylation (GO:0009249),5,1,0.344792445,2.900295567,0.300442584,0.892467947,4826,NNAT
GO:0090235,regulation of metaphase plate congression (GO:0090235),5,1,0.344792445,2.900295567,0.300442584,0.892467947,10615,SPAG5
GO:1902255,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902255),5,1,0.344792445,2.900295567,0.300442584,0.892467947,4487,MSX1
GO:0048703,embryonic viscerocranium morphogenesis (GO:0048703),5,1,0.344792445,2.900295567,0.300442584,0.892467947,25902,MTHFD1L
GO:0006561,proline biosynthetic process (GO:0006561),5,1,0.344792445,2.900295567,0.300442584,0.892467947,5831,PYCR1
GO:0055081,anion homeostasis (GO:0055081),5,1,0.344792445,2.900295567,0.300442584,0.892467947,79901,CYBRD1
GO:0021702,cerebellar Purkinje cell differentiation (GO:0021702),5,1,0.344792445,2.900295567,0.300442584,0.892467947,23017,FAIM2
GO:0015677,copper ion import (GO:0015677),5,1,0.344792445,2.900295567,0.300442584,0.892467947,79689,STEAP4
GO:0060688,regulation of morphogenesis of a branching structure (GO:0060688),5,1,0.344792445,2.900295567,0.300442584,0.892467947,120892,LRRK2
GO:0035405,histone-threonine phosphorylation (GO:0035405),5,1,0.344792445,2.900295567,0.300442584,0.892467947,5579,PRKCB
GO:0032911,negative regulation of transforming growth factor beta1 production (GO:0032911),5,1,0.344792445,2.900295567,0.300442584,0.892467947,2627,GATA6
GO:0009448,gamma-aminobutyric acid metabolic process (GO:0009448),5,1,0.344792445,2.900295567,0.300442584,0.892467947,2571,GAD1
GO:0015670,carbon dioxide transport (GO:0015670),5,1,0.344792445,2.900295567,0.300442584,0.892467947,358,AQP1
GO:1901537,positive regulation of DNA demethylation (GO:1901537),5,1,0.344792445,2.900295567,0.300442584,0.892467947,9760,TOX
GO:0071236,cellular response to antibiotic (GO:0071236),5,1,0.344792445,2.900295567,0.300442584,0.892467947,4208,MEF2C
GO:1901142,insulin metabolic process (GO:1901142),5,1,0.344792445,2.900295567,0.300442584,0.892467947,5126,PCSK2
GO:0051987,positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),5,1,0.344792445,2.900295567,0.300442584,0.892467947,891,CCNB1
GO:0097734,extracellular exosome biogenesis (GO:0097734),5,1,0.344792445,2.900295567,0.300442584,0.892467947,947,CD34
GO:1903961,positive regulation of anion transmembrane transport (GO:1903961),5,1,0.344792445,2.900295567,0.300442584,0.892467947,5243,ABCB1
GO:0003128,heart field specification (GO:0003128),5,1,0.344792445,2.900295567,0.300442584,0.892467947,4208,MEF2C
GO:0003139,secondary heart field specification (GO:0003139),5,1,0.344792445,2.900295567,0.300442584,0.892467947,4208,MEF2C
GO:0021871,forebrain regionalization (GO:0021871),5,1,0.344792445,2.900295567,0.300442584,0.892467947,7482,WNT2B
GO:0072383,plus-end-directed vesicle transport along microtubule (GO:0072383),5,1,0.344792445,2.900295567,0.300442584,0.892467947,79443,FYCO1
GO:0010807,regulation of synaptic vesicle priming (GO:0010807),5,1,0.344792445,2.900295567,0.300442584,0.892467947,6812,STXBP1
GO:2001225,regulation of chloride transport (GO:2001225),5,1,0.344792445,2.900295567,0.300442584,0.892467947,5243,ABCB1
GO:0120041,positive regulation of macrophage proliferation (GO:0120041),5,1,0.344792445,2.900295567,0.300442584,0.892467947,146433,IL34
GO:0110089,regulation of hippocampal neuron apoptotic process (GO:0110089),5,1,0.344792445,2.900295567,0.300442584,0.892467947,6376,CX3CL1
GO:1903429,regulation of cell maturation (GO:1903429),5,1,0.344792445,2.900295567,0.300442584,0.892467947,120892,LRRK2
GO:0002638,negative regulation of immunoglobulin production (GO:0002638),5,1,0.344792445,2.900295567,0.300442584,0.892467947,933,CD22
GO:1902563,regulation of neutrophil activation (GO:1902563),5,1,0.344792445,2.900295567,0.300442584,0.892467947,5320,PLA2G2A
GO:0048003,antigen processing and presentation of lipid antigen via MHC class Ib (GO:0048003),5,1,0.344792445,2.900295567,0.300442584,0.892467947,911,CD1C
GO:0048006,"antigen processing and presentation, endogenous lipid antigen via MHC class Ib (GO:0048006)",5,1,0.344792445,2.900295567,0.300442584,0.892467947,911,CD1C
GO:0048007,"antigen processing and presentation, exogenous lipid antigen via MHC class Ib (GO:0048007)",5,1,0.344792445,2.900295567,0.300442584,0.892467947,911,CD1C
GO:0043378,"positive regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043378)",5,1,0.344792445,2.900295567,0.300442584,0.892467947,3071,NCKAP1L
GO:0045743,positive regulation of fibroblast growth factor receptor signaling pathway (GO:0045743),5,1,0.344792445,2.900295567,0.300442584,0.892467947,64094,SMOC2
GO:0048641,regulation of skeletal muscle tissue development (GO:0048641),5,1,0.344792445,2.900295567,0.300442584,0.892467947,4208,MEF2C
GO:0061326,renal tubule development (GO:0061326),5,1,0.344792445,2.900295567,0.300442584,0.892467947,4208,MEF2C
GO:0010728,regulation of hydrogen peroxide biosynthetic process (GO:0010728),5,1,0.344792445,2.900295567,0.300442584,0.892467947,255027,MPV17L
GO:1905049,negative regulation of metallopeptidase activity (GO:1905049),5,1,0.344792445,2.900295567,0.300442584,0.892467947,8434,RECK
GO:0060425,lung morphogenesis (GO:0060425),5,1,0.344792445,2.900295567,0.300442584,0.892467947,6943,TCF21
GO:2000288,positive regulation of myoblast proliferation (GO:2000288),5,1,0.344792445,2.900295567,0.300442584,0.892467947,2627,GATA6
GO:0051106,positive regulation of DNA ligation (GO:0051106),5,1,0.344792445,2.900295567,0.300442584,0.892467947,5888,RAD51
GO:0038146,chemokine (C-X-C motif) ligand 12 signaling pathway (GO:0038146),5,1,0.344792445,2.900295567,0.300442584,0.892467947,6387,CXCL12
GO:0043504,mitochondrial DNA repair (GO:0043504),5,1,0.344792445,2.900295567,0.300442584,0.892467947,1763,DNA2
GO:0006798,polyphosphate catabolic process (GO:0006798),5,1,0.344792445,2.900295567,0.300442584,0.892467947,158471,PRUNE2
GO:0048671,negative regulation of collateral sprouting (GO:0048671),5,1,0.344792445,2.900295567,0.300442584,0.892467947,2258,FGF13
GO:0098708,glucose import across plasma membrane (GO:0098708),5,1,0.344792445,2.900295567,0.300442584,0.892467947,6515,SLC2A3
GO:0060044,negative regulation of cardiac muscle cell proliferation (GO:0060044),5,1,0.344792445,2.900295567,0.300442584,0.892467947,6910,TBX5
GO:0051418,microtubule nucleation by microtubule organizing center (GO:0051418),5,1,0.344792445,2.900295567,0.300442584,0.892467947,11076,TPPP
GO:2000617,positive regulation of histone H3-K9 acetylation (GO:2000617),5,1,0.344792445,2.900295567,0.300442584,0.892467947,672,BRCA1
GO:0032650,regulation of interleukin-1 alpha production (GO:0032650),5,1,0.344792445,2.900295567,0.300442584,0.892467947,6376,CX3CL1
GO:0021895,cerebral cortex neuron differentiation (GO:0021895),5,1,0.344792445,2.900295567,0.300442584,0.892467947,9760,TOX
GO:0030579,ubiquitin-dependent SMAD protein catabolic process (GO:0030579),5,1,0.344792445,2.900295567,0.300442584,0.892467947,7041,TGFB1I1
GO:0070200,establishment of protein localization to telomere (GO:0070200),5,1,0.344792445,2.900295567,0.300442584,0.892467947,675,BRCA2
GO:0070424,regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),5,1,0.344792445,2.900295567,0.300442584,0.892467947,330,BIRC3
GO:0001714,endodermal cell fate specification (GO:0001714),5,1,0.344792445,2.900295567,0.300442584,0.892467947,64321,SOX17
GO:0042438,melanin biosynthetic process (GO:0042438),5,1,0.344792445,2.900295567,0.300442584,0.892467947,7220,TRPC1
GO:1905097,regulation of guanyl-nucleotide exchange factor activity (GO:1905097),5,1,0.344792445,2.900295567,0.300442584,0.892467947,3925,STMN1
GO:1902498,regulation of protein autoubiquitination (GO:1902498),5,1,0.344792445,2.900295567,0.300442584,0.892467947,120892,LRRK2
GO:0070986,left/right axis specification (GO:0070986),5,1,0.344792445,2.900295567,0.300442584,0.892467947,5308,PITX2
GO:0071305,cellular response to vitamin D (GO:0071305),5,1,0.344792445,2.900295567,0.300442584,0.892467947,6422,SFRP1
GO:0009262,deoxyribonucleotide metabolic process (GO:0009262),5,1,0.344792445,2.900295567,0.300442584,0.892467947,6241,RRM2
GO:0006003,"fructose 2,6-bisphosphate metabolic process (GO:0006003)",5,1,0.344792445,2.900295567,0.300442584,0.892467947,5210,PFKFB4
GO:0015858,nucleoside transport (GO:0015858),5,1,0.344792445,2.900295567,0.300442584,0.892467947,3177,SLC29A2
GO:0015864,pyrimidine nucleoside transport (GO:0015864),5,1,0.344792445,2.900295567,0.300442584,0.892467947,3177,SLC29A2
GO:0015862,uridine transport (GO:0015862),5,1,0.344792445,2.900295567,0.300442584,0.892467947,3177,SLC29A2
GO:0097742,de novo centriole assembly (GO:0097742),5,1,0.344792445,2.900295567,0.300442584,0.892467947,10733,PLK4
GO:0098535,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation (GO:0098535),5,1,0.344792445,2.900295567,0.300442584,0.892467947,10733,PLK4
GO:1905874,regulation of postsynaptic density organization (GO:1905874),5,1,0.344792445,2.900295567,0.300442584,0.892467947,94030,LRRC4B
GO:0090207,regulation of triglyceride metabolic process (GO:0090207),5,1,0.344792445,2.900295567,0.300442584,0.892467947,718,C3
GO:0030578,PML body organization (GO:0030578),5,1,0.344792445,2.900295567,0.300442584,0.892467947,22927,HABP4
GO:0006379,mRNA cleavage (GO:0006379),5,1,0.344792445,2.900295567,0.300442584,0.892467947,6038,RNASE4
GO:0009221,pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),5,1,0.344792445,2.900295567,0.300442584,0.892467947,7298,TYMS
GO:0036414,histone citrullination (GO:0036414),5,1,0.344792445,2.900295567,0.300442584,0.892467947,29943,PADI1
GO:0018101,protein citrullination (GO:0018101),5,1,0.344792445,2.900295567,0.300442584,0.892467947,29943,PADI1
GO:1990166,protein localization to site of double-strand break (GO:1990166),5,1,0.344792445,2.900295567,0.300442584,0.892467947,25900,IFFO1
GO:2000253,positive regulation of feeding behavior (GO:2000253),5,1,0.344792445,2.900295567,0.300442584,0.892467947,8013,NR4A3
GO:0018406,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),5,1,0.344792445,2.900295567,0.300442584,0.892467947,283417,DPY19L2
GO:0018317,protein C-linked glycosylation via tryptophan (GO:0018317),5,1,0.344792445,2.900295567,0.300442584,0.892467947,283417,DPY19L2
GO:1901991,negative regulation of mitotic cell cycle phase transition (GO:1901991),92,8,6.344180991,1.260998072,0.300763877,0.892467947,11170;6790;23194;6347;9314;144455;25959;2273,FAM107A;FHL1;AURKA;KLF4;E2F7;KANK2;CCL2;FBXL7
GO:0032722,positive regulation of chemokine production (GO:0032722),53,5,3.654799918,1.368063946,0.301418212,0.892467947,3569;3570;1958;85480;90865,IL6;IL33;EGR1;TSLP;IL6R
GO:0050766,positive regulation of phagocytosis (GO:0050766),53,5,3.654799918,1.368063946,0.301418212,0.892467947,2621;3071;718;6347;7275,GAS6;CCL2;C3;NCKAP1L;TUB
GO:0032496,response to lipopolysaccharide (GO:0032496),159,13,10.96439976,1.18565542,0.302584049,0.892467947,7538;6622;6401;3569;1511;5142;4208;2920;114548;6403;6347;11213;558,IL6;CTSG;ZFP36;PDE4B;MEF2C;SELP;CCL2;AXL;CXCL2;SELE;IRAK3;NLRP3;SNCA
GO:0061158,3'-UTR-mediated mRNA destabilization (GO:0061158),16,2,1.103335824,1.812684729,0.303433215,0.892467947,7538;221662,RBM24;ZFP36
GO:0021915,neural tube development (GO:0021915),16,2,1.103335824,1.812684729,0.303433215,0.892467947,6659;6491,SOX4;STIL
GO:0071384,cellular response to corticosteroid stimulus (GO:0071384),16,2,1.103335824,1.812684729,0.303433215,0.892467947,7538;11170,FAM107A;ZFP36
GO:0045655,regulation of monocyte differentiation (GO:0045655),16,2,1.103335824,1.812684729,0.303433215,0.892467947,4609;146433,IL34;MYC
GO:0060143,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),16,2,1.103335824,1.812684729,0.303433215,0.892467947,10411;30846,EHD2;RAPGEF3
GO:0051350,negative regulation of lyase activity (GO:0051350),16,2,1.103335824,1.812684729,0.303433215,0.892467947,1910;5064,EDNRB;PALM
GO:0070633,transepithelial transport (GO:0070633),16,2,1.103335824,1.812684729,0.303433215,0.892467947,65010;5243,SLC26A6;ABCB1
GO:0061081,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),16,2,1.103335824,1.812684729,0.303433215,0.892467947,3815;8013,NR4A3;KIT
GO:2000353,positive regulation of endothelial cell apoptotic process (GO:2000353),16,2,1.103335824,1.812684729,0.303433215,0.892467947,6347;641700,ECSCR;CCL2
GO:0002694,regulation of leukocyte activation (GO:0002694),16,2,1.103335824,1.812684729,0.303433215,0.892467947,5320;4345,PLA2G2A;CD200
GO:0060339,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),16,2,1.103335824,1.812684729,0.303433215,0.892467947,9636;11274,USP18;ISG15
GO:0032656,regulation of interleukin-13 production (GO:0032656),16,2,1.103335824,1.812684729,0.303433215,0.892467947,5590;85480,TSLP;PRKCZ
GO:0046426,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),16,2,1.103335824,1.812684729,0.303433215,0.892467947,857;9021,CAV1;SOCS3
GO:0010544,negative regulation of platelet activation (GO:0010544),16,2,1.103335824,1.812684729,0.303433215,0.892467947,5156;5592,PRKG1;PDGFRA
GO:0008156,negative regulation of DNA replication (GO:0008156),16,2,1.103335824,1.812684729,0.303433215,0.892467947,990;64061,CDC6;TSPYL2
GO:0060485,mesenchyme development (GO:0060485),16,2,1.103335824,1.812684729,0.303433215,0.892467947,2294;4222,FOXF1;MEOX1
GO:0046683,response to organophosphorus (GO:0046683),16,2,1.103335824,1.812684729,0.303433215,0.892467947,10060;7298,ABCC9;TYMS
GO:0051873,killing by host of symbiont cells (GO:0051873),16,2,1.103335824,1.812684729,0.303433215,0.892467947,3853;3078,CFHR1;KRT6A
GO:0000712,resolution of meiotic recombination intermediates (GO:0000712),16,2,1.103335824,1.812684729,0.303433215,0.892467947,7153;146956,EME1;TOP2A
GO:0007064,mitotic sister chromatid cohesion (GO:0007064),16,2,1.103335824,1.812684729,0.303433215,0.892467947,113130;79075,CDCA5;DSCC1
GO:0090344,negative regulation of cell aging (GO:0090344),16,2,1.103335824,1.812684729,0.303433215,0.892467947,2305;10000,FOXM1;AKT3
GO:0072348,sulfur compound transport (GO:0072348),28,3,1.930837693,1.553729768,0.30377465,0.892467947,65010;8884;29127,SLC26A6;SLC5A6;RACGAP1
GO:2000026,regulation of multicellular organismal development (GO:2000026),28,3,1.930837693,1.553729768,0.30377465,0.892467947,983;29127;64321,SOX17;CDK1;RACGAP1
GO:1903036,positive regulation of response to wounding (GO:1903036),28,3,1.930837693,1.553729768,0.30377465,0.892467947,150;4638;1839,MYLK;ADRA2A;HBEGF
GO:0061178,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),28,3,1.930837693,1.553729768,0.30377465,0.892467947,111;150;26154,ADCY5;ADRA2A;ABCA12
GO:1904407,positive regulation of nitric oxide metabolic process (GO:1904407),28,3,1.930837693,1.553729768,0.30377465,0.892467947,1191;10365;9314,KLF2;KLF4;CLU
GO:0002637,regulation of immunoglobulin production (GO:0002637),28,3,1.930837693,1.553729768,0.30377465,0.892467947,3569;2048;933,IL6;CD22;EPHB2
GO:0018146,keratan sulfate biosynthetic process (GO:0018146),28,3,1.930837693,1.553729768,0.30377465,0.892467947,4958;4969;5549,OGN;PRELP;OMD
GO:0045859,regulation of protein kinase activity (GO:0045859),106,9,7.309599837,1.231257552,0.308232707,0.905123009,6622;6366;1894;2621;1062;5649;51422;25937;64061,RELN;GAS6;CENPE;ECT2;TSPYL2;WWTR1;PRKAG2;CCL21;SNCA
GO:0006915,apoptotic process (GO:0006915),228,18,15.7225355,1.144853513,0.309706974,0.909008115,388;4804;10395;7048;11113;596;2537;1111;4609;8742;64651;10293;7704;9833;158471;114548;9700;4171,CSRNP1;ZBTB16;TGFBR2;NGFR;MCM2;PRUNE2;MELK;TRAIP;RHOB;CIT;BCL2;CHEK1;ESPL1;TNFSF12;DLC1;NLRP3;IFI6;MYC
GO:0030155,regulation of cell adhesion (GO:0030155),133,11,9.171479041,1.199370347,0.310331632,0.910396993,7168;284;9928;388125;2048;2045;6387;3373;91663;1843;2192,DUSP1;KIF14;CXCL12;MYADM;EPHA7;HYAL1;C2CD4B;TPM1;FBLN1;EPHB2;ANGPT1
GO:0030217,T cell differentiation (GO:0030217),41,4,2.82729805,1.414778325,0.312562629,0.915601347,3815;399;6659;3953,SOX4;LEPR;KIT;RHOH
GO:0098657,import into cell (GO:0098657),41,4,2.82729805,1.414778325,0.312562629,0.915601347,6573;8884;3177;477,ATP1A2;SLC5A6;SLC19A1;SLC29A2
GO:0051960,regulation of nervous system development (GO:0051960),41,4,2.82729805,1.414778325,0.312562629,0.915601347,9928;8864;6376;163175,LGI4;KIF14;PER2;CX3CL1
GO:2001237,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),80,7,5.516679122,1.26887931,0.313503247,0.917016067,3479;596;2537;653;23017;672;2070,FAIM2;BMP5;BRCA1;BCL2;IGF1;IFI6;EYA4
GO:0033043,regulation of organelle organization (GO:0033043),80,7,5.516679122,1.26887931,0.313503247,0.917016067,5138;81620;91624;23208;225689;25932;9839,PDE2A;NEXN;ZEB2;CDT1;MAPK15;CLIC4;SYT11
GO:1903076,regulation of protein localization to plasma membrane (GO:1903076),80,7,5.516679122,1.26887931,0.313503247,0.917016067,10580;2048;2042;493;55022;25999;131578,SORBS1;EPHA3;PID1;ATP2B4;CLIP3;LRRC15;EPHB2
GO:0051094,positive regulation of developmental process (GO:0051094),174,14,11.99877709,1.166785573,0.313751561,0.917296027,23242;991;6790;6722;9378;7704;5649;653;10411;7037;5168;2260;7804;1634,ZBTB16;AURKA;RELN;BMP5;NRXN1;SRF;CDC20;DCN;LRP8;RAPGEF3;FGFR1;ENPP2;TFRC;COBL
GO:0019221,cytokine-mediated signaling pathway (GO:0019221),618,46,42.61634622,1.079398026,0.314088898,0.917645969,1901;3815;6366;2690;3569;3570;1511;596;2920;2537;4609;8742;6387;4684;2247;3953;6376;3082;4312;2162;332;6347;9021;9636;11213;2353;58985;3726;6935;3590;3572;1440;4692;1052;7804;1958;146433;3977;3663;64388;1326;57161;4001;85480;330;90865,IL6;CTSG;GREM2;NCAM1;IL33;FOS;EGR1;FGF2;IL34;CXCL12;BIRC5;TSLP;CSF3;F13A1;IL6ST;S1PR1;CX3CL1;GHR;SOCS3;BCL2;CCL2;LMNB1;LRP8;ZEB1;CXCL2;LIFR;MAP3K8;LEPR;HGF;TNFSF12;BIRC3;IL11RA;KIT;IRAK3;NDN;IL22RA1;CEBPD;ISG15;CCL21;JUNB;MMP1;PELI2;IL6R;IRF5;IFI6;MYC
GO:0022603,regulation of anatomical structure morphogenesis (GO:0022603),120,10,8.275018683,1.208456486,0.314176577,0.917645969,23043;3569;10979;6383;4208;2247;120892;6422;55022;7694,IL6;SFRP1;FGF2;LRRK2;MEF2C;PID1;SDC2;FERMT2;ZNF135;TNIK
GO:0018210,peptidyl-threonine modification (GO:0018210),67,6,4.620218765,1.298639806,0.315081921,0.919778465,7048;11113;983;1111;120892;388228,TGFBR2;LRRK2;CDK1;CIT;CHEK1;SBK1
GO:0002690,positive regulation of leukocyte chemotaxis (GO:0002690),54,5,3.723758408,1.342729429,0.315212716,0.919778465,2621;3569;3570;6387;146433,IL6;IL34;CXCL12;GAS6;IL6R
GO:0006835,dicarboxylic acid transport (GO:0006835),29,3,1.999796182,1.500152879,0.323132028,0.936983499,65010;6573;2350,SLC26A6;SLC19A1;FOLR2
GO:0051348,negative regulation of transferase activity (GO:0051348),29,3,1.999796182,1.500152879,0.323132028,0.936983499,7538;80119;1028,ZFP36;PIF1;CDKN1C
GO:0032689,negative regulation of interferon-gamma production (GO:0032689),29,3,1.999796182,1.500152879,0.323132028,0.936983499,2621;3624;558,INHBA;GAS6;AXL
GO:0061045,negative regulation of wound healing (GO:0061045),29,3,1.999796182,1.500152879,0.323132028,0.936983499,947;2247;7035,CD34;FGF2;TFPI
GO:0046686,response to cadmium ion (GO:0046686),29,3,1.999796182,1.500152879,0.323132028,0.936983499,23498;4499;2353,HAAO;FOS;MT1M
GO:1902041,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),42,4,2.896256539,1.381093127,0.328539465,0.936983499,653;6422;23017;672,FAIM2;SFRP1;BMP5;BRCA1
GO:1903321,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),55,5,3.792716897,1.318316167,0.329084729,0.936983499,857;6659;8864;9636;9532,SOX4;PER2;CAV1;BAG2;ISG15
GO:0015868,purine ribonucleotide transport (GO:0015868),17,2,1.172294313,1.706056216,0.329500066,0.936983499,291;6573,SLC19A1;SLC25A4
GO:0072091,regulation of stem cell proliferation (GO:0072091),17,2,1.172294313,1.706056216,0.329500066,0.936983499,2192;4072,FBLN1;EPCAM
GO:0071398,cellular response to fatty acid (GO:0071398),17,2,1.172294313,1.706056216,0.329500066,0.936983499,5166;55022,PDK4;PID1
GO:2000738,positive regulation of stem cell differentiation (GO:2000738),17,2,1.172294313,1.706056216,0.329500066,0.936983499,221662;6910,RBM24;TBX5
GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),17,2,1.172294313,1.706056216,0.329500066,0.936983499,154;150,ADRA2A;ADRB2
GO:0072529,pyrimidine-containing compound catabolic process (GO:0072529),17,2,1.172294313,1.706056216,0.329500066,0.936983499,4907;1808,DPYSL2;NT5E
GO:0031529,ruffle organization (GO:0031529),17,2,1.172294313,1.706056216,0.329500066,0.936983499,7168;6366,TPM1;CCL21
GO:0046597,negative regulation of viral entry into host cell (GO:0046597),17,2,1.172294313,1.706056216,0.329500066,0.936983499,2934;5806,GSN;PTX3
GO:0033688,regulation of osteoblast proliferation (GO:0033688),17,2,1.172294313,1.706056216,0.329500066,0.936983499,6422;4330,SFRP1;MN1
GO:0042063,gliogenesis (GO:0042063),17,2,1.172294313,1.706056216,0.329500066,0.936983499,4781;5649,RELN;NFIB
GO:0010669,epithelial structure maintenance (GO:0010669),17,2,1.172294313,1.706056216,0.329500066,0.936983499,12;7033,SERPINA3;TFF3
GO:0035909,aorta morphogenesis (GO:0035909),17,2,1.172294313,1.706056216,0.329500066,0.936983499,56999;4638,MYLK;ADAMTS9
GO:0045737,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),17,2,1.172294313,1.706056216,0.329500066,0.936983499,84722;894,CCND2;PSRC1
GO:0036149,phosphatidylinositol acyl-chain remodeling (GO:0036149),17,2,1.172294313,1.706056216,0.329500066,0.936983499,8605;5320,PLA2G4C;PLA2G2A
GO:0031341,regulation of cell killing (GO:0031341),17,2,1.172294313,1.706056216,0.329500066,0.936983499,8324;3075,FZD7;CFH
GO:0043457,regulation of cellular respiration (GO:0043457),17,2,1.172294313,1.706056216,0.329500066,0.936983499,63976;863,CBFA2T3;PRDM16
GO:0032780,negative regulation of ATPase activity (GO:0032780),17,2,1.172294313,1.706056216,0.329500066,0.936983499,7139;5350,PLN;TNNT2
GO:0009890,negative regulation of biosynthetic process (GO:0009890),17,2,1.172294313,1.706056216,0.329500066,0.936983499,3569;11117,IL6;EMILIN1
GO:0071359,cellular response to dsRNA (GO:0071359),17,2,1.172294313,1.706056216,0.329500066,0.936983499,857;81035,CAV1;COLEC12
GO:0001919,regulation of receptor recycling (GO:0001919),17,2,1.172294313,1.706056216,0.329500066,0.936983499,6622;11149,BVES;SNCA
GO:0060037,pharyngeal system development (GO:0060037),17,2,1.172294313,1.706056216,0.329500066,0.936983499,51804;653,BMP5;SIX4
GO:0045922,negative regulation of fatty acid metabolic process (GO:0045922),17,2,1.172294313,1.706056216,0.329500066,0.936983499,341;672,BRCA1;APOC1
GO:0043691,reverse cholesterol transport (GO:0043691),17,2,1.172294313,1.706056216,0.329500066,0.936983499,1066;1191,CLU;CES1
GO:0030277,maintenance of gastrointestinal epithelium (GO:0030277),17,2,1.172294313,1.706056216,0.329500066,0.936983499,12;7033,SERPINA3;TFF3
GO:0061952,midbody abscission (GO:0061952),17,2,1.172294313,1.706056216,0.329500066,0.936983499,10112;55165,KIF20A;CEP55
GO:0008277,regulation of G protein-coupled receptor signaling pathway (GO:0008277),82,7,5.6545961,1.237931034,0.336146376,0.936983499,11343;2869;718;5997;2788;8786;8490,RGS2;MGLL;GNG7;RGS5;C3;GRK5;RGS11
GO:0045911,positive regulation of DNA recombination (GO:0045911),30,3,2.068754671,1.450147783,0.342490969,0.936983499,7037;8914;10635,TIMELESS;RAD51AP1;TFRC
GO:0050433,regulation of catecholamine secretion (GO:0050433),30,3,2.068754671,1.450147783,0.342490969,0.936983499,6622;83849;23208,SYT15;SYT11;SNCA
GO:1900271,regulation of long-term synaptic potentiation (GO:1900271),30,3,2.068754671,1.450147783,0.342490969,0.936983499,11170;2048;5649,FAM107A;RELN;EPHB2
GO:0002009,morphogenesis of an epithelium (GO:0002009),30,3,2.068754671,1.450147783,0.342490969,0.936983499,6663;3853;8914,SOX10;TIMELESS;KRT6A
GO:0099024,plasma membrane invagination (GO:0099024),30,3,2.068754671,1.450147783,0.342490969,0.936983499,2934;9212;51454,GSN;AURKB;GULP1
GO:1903039,positive regulation of leukocyte cell-cell adhesion (GO:1903039),30,3,2.068754671,1.450147783,0.342490969,0.936983499,3569;6347;8013,NR4A3;IL6;CCL2
GO:0043392,negative regulation of DNA binding (GO:0043392),30,3,2.068754671,1.450147783,0.342490969,0.936983499,8864;1869;22927,PER2;E2F1;HABP4
GO:0048704,embryonic skeletal system morphogenesis (GO:0048704),30,3,2.068754671,1.450147783,0.342490969,0.936983499,7048;6495;5156,TGFBR2;SIX1;PDGFRA
GO:0048514,blood vessel morphogenesis (GO:0048514),56,5,3.861675386,1.294774806,0.343014355,0.936983499,7048;857;7049;54922;64321,SOX17;TGFBR2;TGFBR3;CAV1;RASIP1
GO:0070098,chemokine-mediated signaling pathway (GO:0070098),56,5,3.861675386,1.294774806,0.343014355,0.936983499,6366;2920;6387;6376;6347,CXCL12;CX3CL1;CCL2;CXCL2;CCL21
GO:0031348,negative regulation of defense response (GO:0031348),83,7,5.723554589,1.223016203,0.347552441,0.936983499,5734;114548;5740;145581;27293;11213;9314,KLF4;LRFN5;PTGIS;IRAK3;NLRP3;PTGER4;SMPDL3B
GO:0051225,spindle assembly (GO:0051225),83,7,5.723554589,1.223016203,0.347552441,0.936983499,2316;22974;3832;1104;4751;3833;57519,NEK2;TPX2;KIF11;KIFC1;FLNA;STARD9;RCC1
GO:0045647,negative regulation of erythrocyte differentiation (GO:0045647),6,1,0.413750934,2.416912972,0.348699399,0.936983499,7538,ZFP36
GO:0010042,response to manganese ion (GO:0010042),6,1,0.413750934,2.416912972,0.348699399,0.936983499,120892,LRRK2
GO:0030643,cellular phosphate ion homeostasis (GO:0030643),6,1,0.413750934,2.416912972,0.348699399,0.936983499,5167,ENPP1
GO:0072502,cellular trivalent inorganic anion homeostasis (GO:0072502),6,1,0.413750934,2.416912972,0.348699399,0.936983499,5167,ENPP1
GO:0045719,negative regulation of glycogen biosynthetic process (GO:0045719),6,1,0.413750934,2.416912972,0.348699399,0.936983499,5167,ENPP1
GO:0045622,regulation of T-helper cell differentiation (GO:0045622),6,1,0.413750934,2.416912972,0.348699399,0.936983499,4602,MYB
GO:0010985,negative regulation of lipoprotein particle clearance (GO:0010985),6,1,0.413750934,2.416912972,0.348699399,0.936983499,341,APOC1
GO:1905868,regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),6,1,0.413750934,2.416912972,0.348699399,0.936983499,221662,RBM24
GO:0034141,positive regulation of toll-like receptor 3 signaling pathway (GO:0034141),6,1,0.413750934,2.416912972,0.348699399,0.936983499,857,CAV1
GO:0071869,response to catecholamine (GO:0071869),6,1,0.413750934,2.416912972,0.348699399,0.936983499,8013,NR4A3
GO:0032373,positive regulation of sterol transport (GO:0032373),6,1,0.413750934,2.416912972,0.348699399,0.936983499,5244,ABCB4
GO:0030252,growth hormone secretion (GO:0030252),6,1,0.413750934,2.416912972,0.348699399,0.936983499,8425,LTBP4
GO:0060050,positive regulation of protein glycosylation (GO:0060050),6,1,0.413750934,2.416912972,0.348699399,0.936983499,10267,RAMP1
GO:1903790,guanine nucleotide transmembrane transport (GO:1903790),6,1,0.413750934,2.416912972,0.348699399,0.936983499,6573,SLC19A1
GO:0051956,negative regulation of amino acid transport (GO:0051956),6,1,0.413750934,2.416912972,0.348699399,0.936983499,8501,SLC43A1
GO:0030835,negative regulation of actin filament depolymerization (GO:0030835),6,1,0.413750934,2.416912972,0.348699399,0.936983499,2934,GSN
GO:1901552,positive regulation of endothelial cell development (GO:1901552),6,1,0.413750934,2.416912972,0.348699399,0.936983499,7122,CLDN5
GO:1903142,positive regulation of establishment of endothelial barrier (GO:1903142),6,1,0.413750934,2.416912972,0.348699399,0.936983499,7122,CLDN5
GO:0097484,dendrite extension (GO:0097484),6,1,0.413750934,2.416912972,0.348699399,0.936983499,66000,TMEM108
GO:0035855,megakaryocyte development (GO:0035855),6,1,0.413750934,2.416912972,0.348699399,0.936983499,3815,KIT
GO:0046877,regulation of saliva secretion (GO:0046877),6,1,0.413750934,2.416912972,0.348699399,0.936983499,358,AQP1
GO:1900122,positive regulation of receptor binding (GO:1900122),6,1,0.413750934,2.416912972,0.348699399,0.936983499,627,BDNF
GO:0031290,retinal ganglion cell axon guidance (GO:0031290),6,1,0.413750934,2.416912972,0.348699399,0.936983499,9353,SLIT2
GO:0044854,plasma membrane raft assembly (GO:0044854),6,1,0.413750934,2.416912972,0.348699399,0.936983499,857,CAV1
GO:0003093,regulation of glomerular filtration (GO:0003093),6,1,0.413750934,2.416912972,0.348699399,0.936983499,2621,GAS6
GO:0003159,morphogenesis of an endothelium (GO:0003159),6,1,0.413750934,2.416912972,0.348699399,0.936983499,388,RHOB
GO:1900748,positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),6,1,0.413750934,2.416912972,0.348699399,0.936983499,64094,SMOC2
GO:0051648,vesicle localization (GO:0051648),6,1,0.413750934,2.416912972,0.348699399,0.936983499,23208,SYT11
GO:0014897,striated muscle hypertrophy (GO:0014897),6,1,0.413750934,2.416912972,0.348699399,0.936983499,6262,RYR2
GO:0030091,protein repair (GO:0030091),6,1,0.413750934,2.416912972,0.348699399,0.936983499,253827,MSRB3
GO:0042976,activation of Janus kinase activity (GO:0042976),6,1,0.413750934,2.416912972,0.348699399,0.936983499,2690,GHR
GO:0014819,regulation of skeletal muscle contraction (GO:0014819),6,1,0.413750934,2.416912972,0.348699399,0.936983499,1756,DMD
GO:0071286,cellular response to magnesium ion (GO:0071286),6,1,0.413750934,2.416912972,0.348699399,0.936983499,6263,RYR3
GO:0006705,mineralocorticoid biosynthetic process (GO:0006705),6,1,0.413750934,2.416912972,0.348699399,0.936983499,8912,CACNA1H
GO:0009992,cellular water homeostasis (GO:0009992),6,1,0.413750934,2.416912972,0.348699399,0.936983499,358,AQP1
GO:0034698,response to gonadotropin (GO:0034698),6,1,0.413750934,2.416912972,0.348699399,0.936983499,7049,TGFBR3
GO:0097647,amylin receptor signaling pathway (GO:0097647),6,1,0.413750934,2.416912972,0.348699399,0.936983499,10267,RAMP1
GO:0072423,response to DNA damage checkpoint signaling (GO:0072423),6,1,0.413750934,2.416912972,0.348699399,0.936983499,146956,EME1
GO:1903748,negative regulation of establishment of protein localization to mitochondrion (GO:1903748),6,1,0.413750934,2.416912972,0.348699399,0.936983499,120892,LRRK2
GO:0072386,plus-end-directed organelle transport along microtubule (GO:0072386),6,1,0.413750934,2.416912972,0.348699399,0.936983499,79443,FYCO1
GO:0010556,regulation of macromolecule biosynthetic process (GO:0010556),6,1,0.413750934,2.416912972,0.348699399,0.936983499,4286,MITF
GO:0002579,positive regulation of antigen processing and presentation (GO:0002579),6,1,0.413750934,2.416912972,0.348699399,0.936983499,6366,CCL21
GO:0002606,positive regulation of dendritic cell antigen processing and presentation (GO:0002606),6,1,0.413750934,2.416912972,0.348699399,0.936983499,6366,CCL21
GO:0031622,positive regulation of fever generation (GO:0031622),6,1,0.413750934,2.416912972,0.348699399,0.936983499,5733,PTGER3
GO:1903721,positive regulation of I-kappaB phosphorylation (GO:1903721),6,1,0.413750934,2.416912972,0.348699399,0.936983499,6376,CX3CL1
GO:0032410,negative regulation of transporter activity (GO:0032410),6,1,0.413750934,2.416912972,0.348699399,0.936983499,6622,SNCA
GO:1903588,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903588),6,1,0.413750934,2.416912972,0.348699399,0.936983499,4804,NGFR
GO:0106300,protein-DNA covalent cross-linking repair (GO:0106300),6,1,0.413750934,2.416912972,0.348699399,0.936983499,10293,TRAIP
GO:0015874,norepinephrine transport (GO:0015874),6,1,0.413750934,2.416912972,0.348699399,0.936983499,6581,SLC22A3
GO:1990962,xenobiotic transport across blood-brain barrier (GO:1990962),6,1,0.413750934,2.416912972,0.348699399,0.936983499,5243,ABCB1
GO:0033574,response to testosterone (GO:0033574),6,1,0.413750934,2.416912972,0.348699399,0.936983499,6696,SPP1
GO:0001767,establishment of lymphocyte polarity (GO:0001767),6,1,0.413750934,2.416912972,0.348699399,0.936983499,6366,CCL21
GO:0006032,chitin catabolic process (GO:0006032),6,1,0.413750934,2.416912972,0.348699399,0.936983499,1116,CHI3L1
GO:0006030,chitin metabolic process (GO:0006030),6,1,0.413750934,2.416912972,0.348699399,0.936983499,1116,CHI3L1
GO:1904141,positive regulation of microglial cell migration (GO:1904141),6,1,0.413750934,2.416912972,0.348699399,0.936983499,6376,CX3CL1
GO:0010749,regulation of nitric oxide mediated signal transduction (GO:0010749),6,1,0.413750934,2.416912972,0.348699399,0.936983499,493,ATP2B4
GO:0014060,regulation of epinephrine secretion (GO:0014060),6,1,0.413750934,2.416912972,0.348699399,0.936983499,150,ADRA2A
GO:0090205,positive regulation of cholesterol metabolic process (GO:0090205),6,1,0.413750934,2.416912972,0.348699399,0.936983499,1066,CES1
GO:1903242,regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),6,1,0.413750934,2.416912972,0.348699399,0.936983499,493,ATP2B4
GO:0003223,ventricular compact myocardium morphogenesis (GO:0003223),6,1,0.413750934,2.416912972,0.348699399,0.936983499,7049,TGFBR3
GO:1900037,regulation of cellular response to hypoxia (GO:1900037),6,1,0.413750934,2.416912972,0.348699399,0.936983499,947,CD34
GO:0034334,adherens junction maintenance (GO:0034334),6,1,0.413750934,2.416912972,0.348699399,0.936983499,10979,FERMT2
GO:0007172,signal complex assembly (GO:0007172),6,1,0.413750934,2.416912972,0.348699399,0.936983499,23542,MAPK8IP2
GO:0043586,tongue development (GO:0043586),6,1,0.413750934,2.416912972,0.348699399,0.936983499,51804,SIX4
GO:0070092,regulation of glucagon secretion (GO:0070092),6,1,0.413750934,2.416912972,0.348699399,0.936983499,3569,IL6
GO:2000659,regulation of interleukin-1-mediated signaling pathway (GO:2000659),6,1,0.413750934,2.416912972,0.348699399,0.936983499,3569,IL6
GO:0072540,T-helper 17 cell lineage commitment (GO:0072540),6,1,0.413750934,2.416912972,0.348699399,0.936983499,3569,IL6
GO:0002828,regulation of type 2 immune response (GO:0002828),6,1,0.413750934,2.416912972,0.348699399,0.936983499,114548,NLRP3
GO:0051005,negative regulation of lipoprotein lipase activity (GO:0051005),6,1,0.413750934,2.416912972,0.348699399,0.936983499,341,APOC1
GO:0010986,positive regulation of lipoprotein particle clearance (GO:0010986),6,1,0.413750934,2.416912972,0.348699399,0.936983499,338328,GPIHBP1
GO:0046885,regulation of hormone biosynthetic process (GO:0046885),6,1,0.413750934,2.416912972,0.348699399,0.936983499,1958,EGR1
GO:0043570,maintenance of DNA repeat elements (GO:0043570),6,1,0.413750934,2.416912972,0.348699399,0.936983499,116028,RMI2
GO:2001223,negative regulation of neuron migration (GO:2001223),6,1,0.413750934,2.416912972,0.348699399,0.936983499,6376,CX3CL1
GO:0090184,positive regulation of kidney development (GO:0090184),6,1,0.413750934,2.416912972,0.348699399,0.936983499,4609,MYC
GO:0072311,glomerular epithelial cell differentiation (GO:0072311),6,1,0.413750934,2.416912972,0.348699399,0.936983499,28999,KLF15
GO:0061318,renal filtration cell differentiation (GO:0061318),6,1,0.413750934,2.416912972,0.348699399,0.936983499,28999,KLF15
GO:2000389,regulation of neutrophil extravasation (GO:2000389),6,1,0.413750934,2.416912972,0.348699399,0.936983499,10562,OLFM4
GO:0060563,neuroepithelial cell differentiation (GO:0060563),6,1,0.413750934,2.416912972,0.348699399,0.936983499,6659,SOX4
GO:0042421,norepinephrine biosynthetic process (GO:0042421),6,1,0.413750934,2.416912972,0.348699399,0.936983499,9464,HAND2
GO:0072161,mesenchymal cell differentiation involved in kidney development (GO:0072161),6,1,0.413750934,2.416912972,0.348699399,0.936983499,6943,TCF21
GO:0010994,free ubiquitin chain polymerization (GO:0010994),6,1,0.413750934,2.416912972,0.348699399,0.936983499,11065,UBE2C
GO:0044314,protein K27-linked ubiquitination (GO:0044314),6,1,0.413750934,2.416912972,0.348699399,0.936983499,29089,UBE2T
GO:0035519,protein K29-linked ubiquitination (GO:0035519),6,1,0.413750934,2.416912972,0.348699399,0.936983499,29089,UBE2T
GO:1905279,"regulation of retrograde transport, endosome to Golgi (GO:1905279)",6,1,0.413750934,2.416912972,0.348699399,0.936983499,120892,LRRK2
GO:0045722,positive regulation of gluconeogenesis (GO:0045722),6,1,0.413750934,2.416912972,0.348699399,0.936983499,10891,PPARGC1A
GO:0042426,choline catabolic process (GO:0042426),6,1,0.413750934,2.416912972,0.348699399,0.936983499,501,ALDH7A1
GO:1900038,negative regulation of cellular response to hypoxia (GO:1900038),6,1,0.413750934,2.416912972,0.348699399,0.936983499,947,CD34
GO:0050665,hydrogen peroxide biosynthetic process (GO:0050665),6,1,0.413750934,2.416912972,0.348699399,0.936983499,4129,MAOB
GO:1904889,regulation of excitatory synapse assembly (GO:1904889),6,1,0.413750934,2.416912972,0.348699399,0.936983499,94030,LRRC4B
GO:0007405,neuroblast proliferation (GO:0007405),6,1,0.413750934,2.416912972,0.348699399,0.936983499,29127,RACGAP1
GO:0060392,negative regulation of SMAD protein signal transduction (GO:0060392),6,1,0.413750934,2.416912972,0.348699399,0.936983499,8483,CILP
GO:0072080,nephron tubule development (GO:0072080),6,1,0.413750934,2.416912972,0.348699399,0.936983499,4208,MEF2C
GO:0006863,purine nucleobase transport (GO:0006863),6,1,0.413750934,2.416912972,0.348699399,0.936983499,3177,SLC29A2
GO:0046985,positive regulation of hemoglobin biosynthetic process (GO:0046985),6,1,0.413750934,2.416912972,0.348699399,0.936983499,9314,KLF4
GO:0050655,dermatan sulfate proteoglycan metabolic process (GO:0050655),6,1,0.413750934,2.416912972,0.348699399,0.936983499,55790,CSGALNACT1
GO:1901535,regulation of DNA demethylation (GO:1901535),6,1,0.413750934,2.416912972,0.348699399,0.936983499,9760,TOX
GO:0032020,ISG15-protein conjugation (GO:0032020),6,1,0.413750934,2.416912972,0.348699399,0.936983499,9636,ISG15
GO:0042985,negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),6,1,0.413750934,2.416912972,0.348699399,0.936983499,9452,ITM2A
GO:0044784,metaphase/anaphase transition of cell cycle (GO:0044784),6,1,0.413750934,2.416912972,0.348699399,0.936983499,10460,TACC3
GO:0007091,metaphase/anaphase transition of mitotic cell cycle (GO:0007091),6,1,0.413750934,2.416912972,0.348699399,0.936983499,10460,TACC3
GO:1904026,regulation of collagen fibril organization (GO:1904026),6,1,0.413750934,2.416912972,0.348699399,0.936983499,11117,EMILIN1
GO:0035404,histone-serine phosphorylation (GO:0035404),6,1,0.413750934,2.416912972,0.348699399,0.936983499,9212,AURKB
GO:0090435,protein localization to nuclear envelope (GO:0090435),6,1,0.413750934,2.416912972,0.348699399,0.936983499,5347,PLK1
GO:0051447,negative regulation of meiotic cell cycle (GO:0051447),6,1,0.413750934,2.416912972,0.348699399,0.936983499,1843,DUSP1
GO:0001692,histamine metabolic process (GO:0001692),6,1,0.413750934,2.416912972,0.348699399,0.936983499,6581,SLC22A3
GO:0001710,mesodermal cell fate commitment (GO:0001710),6,1,0.413750934,2.416912972,0.348699399,0.936983499,9314,KLF4
GO:0031076,embryonic camera-type eye development (GO:0031076),6,1,0.413750934,2.416912972,0.348699399,0.936983499,10763,NES
GO:0090394,negative regulation of excitatory postsynaptic potential (GO:0090394),6,1,0.413750934,2.416912972,0.348699399,0.936983499,120892,LRRK2
GO:0010359,regulation of anion channel activity (GO:0010359),6,1,0.413750934,2.416912972,0.348699399,0.936983499,5243,ABCB1
GO:0050859,negative regulation of B cell receptor signaling pathway (GO:0050859),6,1,0.413750934,2.416912972,0.348699399,0.936983499,933,CD22
GO:0010265,SCF complex assembly (GO:0010265),6,1,0.413750934,2.416912972,0.348699399,0.936983499,23194,FBXL7
GO:2000109,regulation of macrophage apoptotic process (GO:2000109),6,1,0.413750934,2.416912972,0.348699399,0.936983499,4208,MEF2C
GO:1900449,regulation of glutamate receptor signaling pathway (GO:1900449),6,1,0.413750934,2.416912972,0.348699399,0.936983499,6376,CX3CL1
GO:1902744,negative regulation of lamellipodium organization (GO:1902744),6,1,0.413750934,2.416912972,0.348699399,0.936983499,9353,SLIT2
GO:0021522,spinal cord motor neuron differentiation (GO:0021522),6,1,0.413750934,2.416912972,0.348699399,0.936983499,6659,SOX4
GO:0071824,protein-DNA complex subunit organization (GO:0071824),6,1,0.413750934,2.416912972,0.348699399,0.936983499,4609,MYC
GO:1901533,negative regulation of hematopoietic progenitor cell differentiation (GO:1901533),6,1,0.413750934,2.416912972,0.348699399,0.936983499,4602,MYB
GO:0006797,polyphosphate metabolic process (GO:0006797),6,1,0.413750934,2.416912972,0.348699399,0.936983499,158471,PRUNE2
GO:2001300,lipoxin metabolic process (GO:2001300),6,1,0.413750934,2.416912972,0.348699399,0.936983499,4056,LTC4S
GO:1901031,regulation of response to reactive oxygen species (GO:1901031),6,1,0.413750934,2.416912972,0.348699399,0.936983499,10516,FBLN5
GO:0072498,embryonic skeletal joint development (GO:0072498),6,1,0.413750934,2.416912972,0.348699399,0.936983499,7483,WNT9A
GO:0140271,hexose import across plasma membrane (GO:0140271),6,1,0.413750934,2.416912972,0.348699399,0.936983499,6515,SLC2A3
GO:0055022,negative regulation of cardiac muscle tissue growth (GO:0055022),6,1,0.413750934,2.416912972,0.348699399,0.936983499,6910,TBX5
GO:0046601,positive regulation of centriole replication (GO:0046601),6,1,0.413750934,2.416912972,0.348699399,0.936983499,10733,PLK4
GO:0010571,positive regulation of nuclear cell cycle DNA replication (GO:0010571),6,1,0.413750934,2.416912972,0.348699399,0.936983499,8317,CDC7
GO:0030174,regulation of DNA-dependent DNA replication initiation (GO:0030174),6,1,0.413750934,2.416912972,0.348699399,0.936983499,81620,CDT1
GO:0035116,embryonic hindlimb morphogenesis (GO:0035116),6,1,0.413750934,2.416912972,0.348699399,0.936983499,3899,AFF3
GO:0007185,transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),6,1,0.413750934,2.416912972,0.348699399,0.936983499,5789,PTPRD
GO:0014808,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0014808),6,1,0.413750934,2.416912972,0.348699399,0.936983499,6262,RYR2
GO:1902747,negative regulation of lens fiber cell differentiation (GO:1902747),6,1,0.413750934,2.416912972,0.348699399,0.936983499,10252,SPRY1
GO:1904491,protein localization to ciliary transition zone (GO:1904491),6,1,0.413750934,2.416912972,0.348699399,0.936983499,225689,MAPK15
GO:0051574,positive regulation of histone H3-K9 methylation (GO:0051574),6,1,0.413750934,2.416912972,0.348699399,0.936983499,4602,MYB
GO:0030593,neutrophil chemotaxis (GO:0030593),70,6,4.827094232,1.242983814,0.352448576,0.942885138,6366;3071;5142;2920;6376;6347,PDE4B;CX3CL1;CCL2;CXCL2;NCKAP1L;CCL21
GO:0051503,adenine nucleotide transport (GO:0051503),18,2,1.241252803,1.611275315,0.355287779,0.942885138,291;6573,SLC19A1;SLC25A4
GO:1903798,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),18,2,1.241252803,1.611275315,0.355287779,0.942885138,3569;2099,IL6;ESR1
GO:0071103,DNA conformation change (GO:0071103),18,2,1.241252803,1.611275315,0.355287779,0.942885138,7153;3149,HMGB3;TOP2A
GO:0006356,regulation of transcription by RNA polymerase I (GO:0006356),18,2,1.241252803,1.611275315,0.355287779,0.942885138,2316;387496,RASL11A;FLNA
GO:0045923,positive regulation of fatty acid metabolic process (GO:0045923),18,2,1.241252803,1.611275315,0.355287779,0.942885138,10891;8013,NR4A3;PPARGC1A
GO:0040014,regulation of multicellular organism growth (GO:0040014),18,2,1.241252803,1.611275315,0.355287779,0.942885138,2690;3479,GHR;IGF1
GO:0042044,fluid transport (GO:0042044),18,2,1.241252803,1.611275315,0.355287779,0.942885138,65010;358,AQP1;SLC26A6
GO:0032717,negative regulation of interleukin-8 production (GO:0032717),18,2,1.241252803,1.611275315,0.355287779,0.942885138,9314;284297,KLF4;SSC5D
GO:0090141,positive regulation of mitochondrial fission (GO:0090141),18,2,1.241252803,1.611275315,0.355287779,0.942885138,6790;1634,AURKA;DCN
GO:0072678,T cell migration (GO:0072678),18,2,1.241252803,1.611275315,0.355287779,0.942885138,1901;1880,S1PR1;GPR183
GO:1903055,positive regulation of extracellular matrix organization (GO:1903055),18,2,1.241252803,1.611275315,0.355287779,0.942885138,3569;11117,IL6;EMILIN1
GO:0000578,embryonic axis specification (GO:0000578),18,2,1.241252803,1.611275315,0.355287779,0.942885138,23242;6491,STIL;COBL
GO:0033233,regulation of protein sumoylation (GO:0033233),18,2,1.241252803,1.611275315,0.355287779,0.942885138,9759;1958,EGR1;HDAC4
GO:0050995,negative regulation of lipid catabolic process (GO:0050995),18,2,1.241252803,1.611275315,0.355287779,0.942885138,150;341,ADRA2A;APOC1
GO:0071634,regulation of transforming growth factor beta production (GO:0071634),18,2,1.241252803,1.611275315,0.355287779,0.942885138,947;4345,CD34;CD200
GO:0002696,positive regulation of leukocyte activation (GO:0002696),18,2,1.241252803,1.611275315,0.355287779,0.942885138,85480;90865,IL33;TSLP
GO:0032753,positive regulation of interleukin-4 production (GO:0032753),18,2,1.241252803,1.611275315,0.355287779,0.942885138,114548;5590,NLRP3;PRKCZ
GO:1901989,positive regulation of cell cycle phase transition (GO:1901989),18,2,1.241252803,1.611275315,0.355287779,0.942885138,2146;79915,ATAD5;EZH2
GO:0010744,positive regulation of macrophage derived foam cell differentiation (GO:0010744),18,2,1.241252803,1.611275315,0.355287779,0.942885138,185;5320,AGTR1;PLA2G2A
GO:0035455,response to interferon-alpha (GO:0035455),18,2,1.241252803,1.611275315,0.355287779,0.942885138,2621;558,GAS6;AXL
GO:0061036,positive regulation of cartilage development (GO:0061036),18,2,1.241252803,1.611275315,0.355287779,0.942885138,7704;91461,ZBTB16;PKDCC
GO:0071168,protein localization to chromatin (GO:0071168),18,2,1.241252803,1.611275315,0.355287779,0.942885138,5347;2099,PLK1;ESR1
GO:0035249,"synaptic transmission, glutamatergic (GO:0035249)",18,2,1.241252803,1.611275315,0.355287779,0.942885138,2901;2899,GRIK3;GRIK5
GO:1900181,negative regulation of protein localization to nucleus (GO:1900181),18,2,1.241252803,1.611275315,0.355287779,0.942885138,51715;347,RAB23;APOD
GO:0048147,negative regulation of fibroblast proliferation (GO:0048147),18,2,1.241252803,1.611275315,0.355287779,0.942885138,4609;6422,SFRP1;MYC
GO:0030520,intracellular estrogen receptor signaling pathway (GO:0030520),18,2,1.241252803,1.611275315,0.355287779,0.942885138,2099;133522,ESR1;PPARGC1B
GO:0031646,positive regulation of nervous system process (GO:0031646),18,2,1.241252803,1.611275315,0.355287779,0.942885138,11076;1959,TPPP;EGR2
GO:0010803,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),57,5,3.930633875,1.272059459,0.356982199,0.945711766,2621;10293;330;25999;83643,GAS6;TRAIP;CCDC3;BIRC3;CLIP3
GO:0006690,icosanoid metabolic process (GO:0006690),57,5,3.930633875,1.272059459,0.356982199,0.945711766,11343;5740;8605;5742;4056,MGLL;PTGS1;PLA2G4C;LTC4S;PTGIS
GO:0015718,monocarboxylic acid transport (GO:0015718),57,5,3.930633875,1.272059459,0.356982199,0.945711766,5244;65010;8884;9122;201232,SLC26A6;SLC5A6;SLC16A4;ABCB4;SLC16A13
GO:0032092,positive regulation of protein binding (GO:0032092),57,5,3.930633875,1.272059459,0.356982199,0.945711766,627;857;7122;120892;1440,CLDN5;LRRK2;CSF3;CAV1;BDNF
GO:0050708,regulation of protein secretion (GO:0050708),125,10,8.619811128,1.160118227,0.360511336,0.952541245,3479;150;3569;84976;775;322;8864;3708;10411;8736,IL6;ITPR1;MYOM1;PER2;APBB1;RAPGEF3;ADRA2A;IGF1;CACNA1C;DISP1
GO:0098655,cation transmembrane transport (GO:0098655),44,4,3.034173517,1.318316167,0.360595871,0.952541245,8912;7226;477;10060,ATP1A2;CACNA1H;ABCC9;TRPM2
GO:0030518,intracellular steroid hormone receptor signaling pathway (GO:0030518),44,4,3.034173517,1.318316167,0.360595871,0.952541245,2099;5241;4306;133522,PGR;NR3C2;ESR1;PPARGC1B
GO:0006693,prostaglandin metabolic process (GO:0006693),31,3,2.13771316,1.403368823,0.361803688,0.952541245,5730;5740;5742,PTGS1;PTGDS;PTGIS
GO:0045616,regulation of keratinocyte differentiation (GO:0045616),31,3,2.13771316,1.403368823,0.361803688,0.952541245,7538;26154;2118,ZFP36;ABCA12;ETV4
GO:0040017,positive regulation of locomotion (GO:0040017),31,3,2.13771316,1.403368823,0.361803688,0.952541245,6366;9423;11149,BVES;CCL21;NTN1
GO:0071677,positive regulation of mononuclear cell migration (GO:0071677),31,3,2.13771316,1.403368823,0.361803688,0.952541245,2621;6387;58494,JAM2;CXCL12;GAS6
GO:0050920,regulation of chemotaxis (GO:0050920),31,3,2.13771316,1.403368823,0.361803688,0.952541245,6366;1880;5156,GPR183;CCL21;PDGFRA
GO:0032148,activation of protein kinase B activity (GO:0032148),31,3,2.13771316,1.403368823,0.361803688,0.952541245,3479;150;2621,GAS6;ADRA2A;IGF1
GO:0051180,vitamin transport (GO:0051180),31,3,2.13771316,1.403368823,0.361803688,0.952541245,6573;2350;8884,SLC5A6;SLC19A1;FOLR2
GO:0010743,regulation of macrophage derived foam cell differentiation (GO:0010743),31,3,2.13771316,1.403368823,0.361803688,0.952541245,3690;185;5320,AGTR1;PLA2G2A;ITGB3
GO:0051443,positive regulation of ubiquitin-protein transferase activity (GO:0051443),31,3,2.13771316,1.403368823,0.361803688,0.952541245,11065;991;5347,UBE2C;CDC20;PLK1
GO:0048015,phosphatidylinositol-mediated signaling (GO:0048015),71,6,4.896052721,1.225477,0.36499142,0.952541245,3479;5156;2260;5334;84812;5332,PLCD4;PLCB4;FGFR1;PLCL1;IGF1;PDGFRA
GO:0048732,gland development (GO:0048732),71,6,4.896052721,1.225477,0.36499142,0.952541245,23242;857;9464;7049;6495;6943,TCF21;TGFBR3;CAV1;HAND2;SIX1;COBL
GO:0000302,response to reactive oxygen species (GO:0000302),58,5,3.999592364,1.250127399,0.37096942,0.952541245,7168;347;5156;3373;2353,FOS;HYAL1;TPM1;APOD;PDGFRA
GO:0001654,eye development (GO:0001654),58,5,3.999592364,1.250127399,0.37096942,0.952541245,775;2201;2202;5308;91851,CHRDL1;EFEMP1;FBN2;CACNA1C;PITX2
GO:0006879,cellular iron ion homeostasis (GO:0006879),58,5,3.999592364,1.250127399,0.37096942,0.952541245,79901;4609;286133;7037;9843,SCARA5;CYBRD1;TFRC;MYC;HEPH
GO:0009411,response to UV (GO:0009411),99,8,6.826890414,1.171836593,0.374383428,0.952541245,358;9212;4609;2237;993;51514;4239;51435,MFAP4;AQP1;DTL;AURKB;CDC25A;FEN1;SCARA3;MYC
GO:0051052,regulation of DNA metabolic process (GO:0051052),45,4,3.103132006,1.289020252,0.376619414,0.952541245,4609;81620;80119;3838,KPNA2;CDT1;PIF1;MYC
GO:0050714,positive regulation of protein secretion (GO:0050714),72,6,4.96501121,1.208456486,0.377555035,0.952541245,3479;6659;322;4826;8736;25924,MYOM1;MYRIP;SOX4;NNAT;APBB1;IGF1
GO:0050769,positive regulation of neurogenesis (GO:0050769),72,6,4.96501121,1.208456486,0.377555035,0.952541245,4804;4915;9353;6376;5789;5176,NGFR;SLIT2;CX3CL1;NTRK2;PTPRD;SERPINF1
GO:0009068,aspartate family amino acid catabolic process (GO:0009068),19,2,1.310211292,1.526471351,0.380710938,0.952541245,501;1428,CRYM;ALDH7A1
GO:0042417,dopamine metabolic process (GO:0042417),19,2,1.310211292,1.526471351,0.380710938,0.952541245,6622;4129,MAOB;SNCA
GO:0007616,long-term memory (GO:0007616),19,2,1.310211292,1.526471351,0.380710938,0.952541245,4776;6517,SLC2A4;NFATC4
GO:0090023,positive regulation of neutrophil chemotaxis (GO:0090023),19,2,1.310211292,1.526471351,0.380710938,0.952541245,6366;3071,NCKAP1L;CCL21
GO:0070723,response to cholesterol (GO:0070723),19,2,1.310211292,1.526471351,0.380710938,0.952541245,7048;1066,TGFBR2;CES1
GO:0031644,regulation of nervous system process (GO:0031644),19,2,1.310211292,1.526471351,0.380710938,0.952541245,4884;66000,NPTX1;TMEM108
GO:0048713,regulation of oligodendrocyte differentiation (GO:0048713),19,2,1.310211292,1.526471351,0.380710938,0.952541245,146433;23500,IL34;DAAM2
GO:0051693,actin filament capping (GO:0051693),19,2,1.310211292,1.526471351,0.380710938,0.952541245,2934;6840,GSN;SVIL
GO:0051016,barbed-end actin filament capping (GO:0051016),19,2,1.310211292,1.526471351,0.380710938,0.952541245,2934;6840,GSN;SVIL
GO:0051894,positive regulation of focal adhesion assembly (GO:0051894),19,2,1.310211292,1.526471351,0.380710938,0.952541245,10979;6422,SFRP1;FERMT2
GO:0033198,response to ATP (GO:0033198),19,2,1.310211292,1.526471351,0.380710938,0.952541245,6263;10060,RYR3;ABCC9
GO:1900746,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),19,2,1.310211292,1.526471351,0.380710938,0.952541245,1634;64094,DCN;SMOC2
GO:0002683,negative regulation of immune system process (GO:0002683),19,2,1.310211292,1.526471351,0.380710938,0.952541245,4345;127943,CD200;FCRLB
GO:0046902,regulation of mitochondrial membrane permeability (GO:0046902),19,2,1.310211292,1.526471351,0.380710938,0.952541245,291;596,BCL2;SLC25A4
GO:0032924,activin receptor signaling pathway (GO:0032924),19,2,1.310211292,1.526471351,0.380710938,0.952541245,3624;3625,INHBA;INHBB
GO:2000679,positive regulation of transcription regulatory region DNA binding (GO:2000679),19,2,1.310211292,1.526471351,0.380710938,0.952541245,3479;9464,HAND2;IGF1
GO:1905523,positive regulation of macrophage migration (GO:1905523),19,2,1.310211292,1.526471351,0.380710938,0.952541245,6376;146433,IL34;CX3CL1
GO:0003203,endocardial cushion morphogenesis (GO:0003203),19,2,1.310211292,1.526471351,0.380710938,0.952541245,7048;140628,GATA5;TGFBR2
GO:0046503,glycerolipid catabolic process (GO:0046503),19,2,1.310211292,1.526471351,0.380710938,0.952541245,11343;8605,MGLL;PLA2G4C
GO:0001941,postsynaptic membrane organization (GO:0001941),19,2,1.310211292,1.526471351,0.380710938,0.952541245,9379;9378,NRXN1;NRXN2
GO:0061436,establishment of skin barrier (GO:0061436),19,2,1.310211292,1.526471351,0.380710938,0.952541245,26154;3925,STMN1;ABCA12
GO:0033561,regulation of water loss via skin (GO:0033561),19,2,1.310211292,1.526471351,0.380710938,0.952541245,26154;3925,STMN1;ABCA12
GO:0032206,positive regulation of telomere maintenance (GO:0032206),32,3,2.206671649,1.359513547,0.381025909,0.952541245,9212;225689;4751,NEK2;AURKB;MAPK15
GO:0061001,regulation of dendritic spine morphogenesis (GO:0061001),32,3,2.206671649,1.359513547,0.381025909,0.952541245,5649;120892;7804,RELN;LRRK2;LRP8
GO:0048814,regulation of dendrite morphogenesis (GO:0048814),32,3,2.206671649,1.359513547,0.381025909,0.952541245,23043;6383;5789,SDC2;TNIK;PTPRD
GO:0046928,regulation of neurotransmitter secretion (GO:0046928),32,3,2.206671649,1.359513547,0.381025909,0.952541245,4208;23208;120892,LRRK2;MEF2C;SYT11
GO:0010638,positive regulation of organelle organization (GO:0010638),32,3,2.206671649,1.359513547,0.381025909,0.952541245,154;10891;79443,PPARGC1A;FYCO1;ADRB2
GO:0033146,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),32,3,2.206671649,1.359513547,0.381025909,0.952541245,672;2099;25959,BRCA1;KANK2;ESR1
GO:1990138,neuron projection extension (GO:1990138),32,3,2.206671649,1.359513547,0.381025909,0.952541245,54437;4131;66000,SEMA5B;MAP1B;TMEM108
GO:2000780,negative regulation of double-strand break repair (GO:2000780),32,3,2.206671649,1.359513547,0.381025909,0.952541245,10721;116028;55010,POLQ;PARPBP;RMI2
GO:0002062,chondrocyte differentiation (GO:0002062),32,3,2.206671649,1.359513547,0.381025909,0.952541245,4208;4781;7482,MEF2C;WNT2B;NFIB
GO:0048640,negative regulation of developmental growth (GO:0048640),32,3,2.206671649,1.359513547,0.381025909,0.952541245,56920;2258;65078,SEMA3G;FGF13;RTN4R
GO:0006469,negative regulation of protein kinase activity (GO:0006469),86,7,5.930430056,1.180352847,0.381980733,0.952541245,6622;857;104;6546;51422;25937;1028,CAV1;WWTR1;PRKAG2;CDKN1C;SLC8A1;ADARB1;SNCA
GO:0071219,cellular response to molecule of bacterial origin (GO:0071219),114,9,7.861267749,1.144853513,0.387213973,0.952541245,7538;3569;1511;5142;4208;2920;114548;6347;558,IL6;CTSG;ZFP36;PDE4B;MEF2C;CCL2;AXL;CXCL2;NLRP3
GO:0071621,granulocyte chemotaxis (GO:0071621),73,6,5.033969699,1.191902288,0.390126166,0.952541245,6366;3071;5142;2920;6376;6347,PDE4B;CX3CL1;CCL2;CXCL2;NCKAP1L;CCL21
GO:0043547,positive regulation of GTPase activity (GO:0043547),212,16,14.61919967,1.094451157,0.391163012,0.952541245,375790;83478;22899;84253;6366;5909;1894;10979;10411;6422;6376;6347;10235;2146;65078;9824,SFRP1;RASGRP2;RTN4R;ARHGEF15;ARHGAP11A;CX3CL1;FERMT2;ECT2;CCL2;RAPGEF3;EZH2;RAP1GAP;AGRN;GARNL3;ARHGAP24;CCL21
GO:0045910,negative regulation of DNA recombination (GO:0045910),46,4,3.172090495,1.260998072,0.39260466,0.952541245,10721;116028;641;55010,POLQ;BLM;PARPBP;RMI2
GO:1903827,regulation of cellular protein localization (GO:1903827),46,4,3.172090495,1.260998072,0.39260466,0.952541245,627;10082;4130;5563,BDNF;MAP1A;PRKAA2;GPC6
GO:0010821,regulation of mitochondrion organization (GO:0010821),46,4,3.172090495,1.260998072,0.39260466,0.952541245,5138;10891;120892;55022,PDE2A;LRRK2;PID1;PPARGC1A
GO:1901029,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),7,1,0.482709423,2.07163969,0.39363042,0.952541245,255027,MPV17L
GO:0042726,flavin-containing compound metabolic process (GO:0042726),7,1,0.482709423,2.07163969,0.39363042,0.952541245,5167,ENPP1
GO:0070874,negative regulation of glycogen metabolic process (GO:0070874),7,1,0.482709423,2.07163969,0.39363042,0.952541245,5167,ENPP1
GO:0006771,riboflavin metabolic process (GO:0006771),7,1,0.482709423,2.07163969,0.39363042,0.952541245,5167,ENPP1
GO:0042424,catecholamine catabolic process (GO:0042424),7,1,0.482709423,2.07163969,0.39363042,0.952541245,4129,MAOB
GO:0031086,"nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",7,1,0.482709423,2.07163969,0.39363042,0.952541245,7538,ZFP36
GO:0051153,regulation of striated muscle cell differentiation (GO:0051153),7,1,0.482709423,2.07163969,0.39363042,0.952541245,221662,RBM24
GO:0043279,response to alkaloid (GO:0043279),7,1,0.482709423,2.07163969,0.39363042,0.952541245,6262,RYR2
GO:0007191,adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),7,1,0.482709423,2.07163969,0.39363042,0.952541245,2774,GNAL
GO:0071868,cellular response to monoamine stimulus (GO:0071868),7,1,0.482709423,2.07163969,0.39363042,0.952541245,8013,NR4A3
GO:0060158,phospholipase C-activating dopamine receptor signaling pathway (GO:0060158),7,1,0.482709423,2.07163969,0.39363042,0.952541245,9630,GNA14
GO:2001138,regulation of phospholipid transport (GO:2001138),7,1,0.482709423,2.07163969,0.39363042,0.952541245,5244,ABCB4
GO:0040018,positive regulation of multicellular organism growth (GO:0040018),7,1,0.482709423,2.07163969,0.39363042,0.952541245,2690,GHR
GO:0048715,negative regulation of oligodendrocyte differentiation (GO:0048715),7,1,0.482709423,2.07163969,0.39363042,0.952541245,23500,DAAM2
GO:0010939,regulation of necrotic cell death (GO:0010939),7,1,0.482709423,2.07163969,0.39363042,0.952541245,10562,OLFM4
GO:1905330,regulation of morphogenesis of an epithelium (GO:1905330),7,1,0.482709423,2.07163969,0.39363042,0.952541245,81792,ADAMTS12
GO:0070729,cyclic nucleotide transport (GO:0070729),7,1,0.482709423,2.07163969,0.39363042,0.952541245,6573,SLC19A1
GO:0046113,nucleobase catabolic process (GO:0046113),7,1,0.482709423,2.07163969,0.39363042,0.952541245,1808,DPYSL2
GO:0060372,regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372),7,1,0.482709423,2.07163969,0.39363042,0.952541245,2316,FLNA
GO:0036089,cleavage furrow formation (GO:0036089),7,1,0.482709423,2.07163969,0.39363042,0.952541245,9212,AURKB
GO:0031340,positive regulation of vesicle fusion (GO:0031340),7,1,0.482709423,2.07163969,0.39363042,0.952541245,6622,SNCA
GO:0071476,cellular hypotonic response (GO:0071476),7,1,0.482709423,2.07163969,0.39363042,0.952541245,4638,MYLK
GO:0060232,delamination (GO:0060232),7,1,0.482709423,2.07163969,0.39363042,0.952541245,26154,ABCA12
GO:0006971,hypotonic response (GO:0006971),7,1,0.482709423,2.07163969,0.39363042,0.952541245,4638,MYLK
GO:0003376,sphingosine-1-phosphate receptor signaling pathway (GO:0003376),7,1,0.482709423,2.07163969,0.39363042,0.952541245,1901,S1PR1
GO:0046629,gamma-delta T cell activation (GO:0046629),7,1,0.482709423,2.07163969,0.39363042,0.952541245,4277,MICB
GO:0090240,positive regulation of histone H4 acetylation (GO:0090240),7,1,0.482709423,2.07163969,0.39363042,0.952541245,672,BRCA1
GO:0072015,glomerular visceral epithelial cell development (GO:0072015),7,1,0.482709423,2.07163969,0.39363042,0.952541245,9863,MAGI2
GO:1905063,regulation of vascular associated smooth muscle cell differentiation (GO:1905063),7,1,0.482709423,2.07163969,0.39363042,0.952541245,3815,KIT
GO:1903753,negative regulation of p38MAPK cascade (GO:1903753),7,1,0.482709423,2.07163969,0.39363042,0.952541245,1843,DUSP1
GO:0006930,"substrate-dependent cell migration, cell extension (GO:0006930)",7,1,0.482709423,2.07163969,0.39363042,0.952541245,9423,NTN1
GO:0051126,negative regulation of actin nucleation (GO:0051126),7,1,0.482709423,2.07163969,0.39363042,0.952541245,9535,GMFG
GO:2000394,positive regulation of lamellipodium morphogenesis (GO:2000394),7,1,0.482709423,2.07163969,0.39363042,0.952541245,5168,ENPP2
GO:1903764,regulation of potassium ion export across plasma membrane (GO:1903764),7,1,0.482709423,2.07163969,0.39363042,0.952541245,3757,KCNH2
GO:0044387,negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),7,1,0.482709423,2.07163969,0.39363042,0.952541245,104,ADARB1
GO:0045836,positive regulation of meiotic nuclear division (GO:0045836),7,1,0.482709423,2.07163969,0.39363042,0.952541245,10635,RAD51AP1
GO:0043584,nose development (GO:0043584),7,1,0.482709423,2.07163969,0.39363042,0.952541245,51804,SIX4
GO:0048549,positive regulation of pinocytosis (GO:0048549),7,1,0.482709423,2.07163969,0.39363042,0.952541245,558,AXL
GO:0072310,glomerular epithelial cell development (GO:0072310),7,1,0.482709423,2.07163969,0.39363042,0.952541245,9863,MAGI2
GO:1900028,negative regulation of ruffle assembly (GO:1900028),7,1,0.482709423,2.07163969,0.39363042,0.952541245,83478,ARHGAP24
GO:0052150,modulation by symbiont of host apoptotic process (GO:0052150),7,1,0.482709423,2.07163969,0.39363042,0.952541245,1511,CTSG
GO:1901077,regulation of relaxation of muscle (GO:1901077),7,1,0.482709423,2.07163969,0.39363042,0.952541245,5350,PLN
GO:0014061,regulation of norepinephrine secretion (GO:0014061),7,1,0.482709423,2.07163969,0.39363042,0.952541245,150,ADRA2A
GO:0044091,membrane biogenesis (GO:0044091),7,1,0.482709423,2.07163969,0.39363042,0.952541245,25999,CLIP3
GO:1904181,positive regulation of membrane depolarization (GO:1904181),7,1,0.482709423,2.07163969,0.39363042,0.952541245,1634,DCN
GO:0045989,positive regulation of striated muscle contraction (GO:0045989),7,1,0.482709423,2.07163969,0.39363042,0.952541245,5997,RGS2
GO:0010459,negative regulation of heart rate (GO:0010459),7,1,0.482709423,2.07163969,0.39363042,0.952541245,5350,PLN
GO:0086015,SA node cell action potential (GO:0086015),7,1,0.482709423,2.07163969,0.39363042,0.952541245,287,ANK2
GO:0046184,aldehyde biosynthetic process (GO:0046184),7,1,0.482709423,2.07163969,0.39363042,0.952541245,8912,CACNA1H
GO:0097646,calcitonin family receptor signaling pathway (GO:0097646),7,1,0.482709423,2.07163969,0.39363042,0.952541245,10267,RAMP1
GO:0045762,positive regulation of adenylate cyclase activity (GO:0045762),7,1,0.482709423,2.07163969,0.39363042,0.952541245,775,CACNA1C
GO:0033860,regulation of NAD(P)H oxidase activity (GO:0033860),7,1,0.482709423,2.07163969,0.39363042,0.952541245,185,AGTR1
GO:0001963,"synaptic transmission, dopaminergic (GO:0001963)",7,1,0.482709423,2.07163969,0.39363042,0.952541245,6622,SNCA
GO:0031645,negative regulation of nervous system process (GO:0031645),7,1,0.482709423,2.07163969,0.39363042,0.952541245,58494,JAM2
GO:0014015,positive regulation of gliogenesis (GO:0014015),7,1,0.482709423,2.07163969,0.39363042,0.952541245,3569,IL6
GO:1903719,regulation of I-kappaB phosphorylation (GO:1903719),7,1,0.482709423,2.07163969,0.39363042,0.952541245,6376,CX3CL1
GO:0035507,regulation of myosin-light-chain-phosphatase activity (GO:0035507),7,1,0.482709423,2.07163969,0.39363042,0.952541245,3071,NCKAP1L
GO:1901201,regulation of extracellular matrix assembly (GO:1901201),7,1,0.482709423,2.07163969,0.39363042,0.952541245,11117,EMILIN1
GO:0032909,regulation of transforming growth factor beta2 production (GO:0032909),7,1,0.482709423,2.07163969,0.39363042,0.952541245,2627,GATA6
GO:1905459,regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),7,1,0.482709423,2.07163969,0.39363042,0.952541245,3479,IGF1
GO:0050872,white fat cell differentiation (GO:0050872),7,1,0.482709423,2.07163969,0.39363042,0.952541245,8864,PER2
GO:1903514,release of sequestered calcium ion into cytosol by endoplasmic reticulum (GO:1903514),7,1,0.482709423,2.07163969,0.39363042,0.952541245,6262,RYR2
GO:0051386,regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),7,1,0.482709423,2.07163969,0.39363042,0.952541245,66000,TMEM108
GO:0002674,negative regulation of acute inflammatory response (GO:0002674),7,1,0.482709423,2.07163969,0.39363042,0.952541245,114548,NLRP3
GO:0008347,glial cell migration (GO:0008347),7,1,0.482709423,2.07163969,0.39363042,0.952541245,6347,CCL2
GO:1904139,regulation of microglial cell migration (GO:1904139),7,1,0.482709423,2.07163969,0.39363042,0.952541245,6376,CX3CL1
GO:1903524,positive regulation of blood circulation (GO:1903524),7,1,0.482709423,2.07163969,0.39363042,0.952541245,477,ATP1A2
GO:0062043,positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),7,1,0.482709423,2.07163969,0.39363042,0.952541245,7048,TGFBR2
GO:0034350,regulation of glial cell apoptotic process (GO:0034350),7,1,0.482709423,2.07163969,0.39363042,0.952541245,6347,CCL2
GO:1905603,regulation of blood-brain barrier permeability (GO:1905603),7,1,0.482709423,2.07163969,0.39363042,0.952541245,284,ANGPT1
GO:0002664,regulation of T cell tolerance induction (GO:0002664),7,1,0.482709423,2.07163969,0.39363042,0.952541245,7048,TGFBR2
GO:1905598,negative regulation of low-density lipoprotein receptor activity (GO:1905598),7,1,0.482709423,2.07163969,0.39363042,0.952541245,3690,ITGB3
GO:0003174,mitral valve development (GO:0003174),7,1,0.482709423,2.07163969,0.39363042,0.952541245,6659,SOX4
GO:0060347,heart trabecula formation (GO:0060347),7,1,0.482709423,2.07163969,0.39363042,0.952541245,7049,TGFBR3
GO:0051045,negative regulation of membrane protein ectodomain proteolysis (GO:0051045),7,1,0.482709423,2.07163969,0.39363042,0.952541245,7079,TIMP4
GO:1902961,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),7,1,0.482709423,2.07163969,0.39363042,0.952541245,1944,EFNA3
GO:0015939,pantothenate metabolic process (GO:0015939),7,1,0.482709423,2.07163969,0.39363042,0.952541245,8884,SLC5A6
GO:0072539,T-helper 17 cell differentiation (GO:0072539),7,1,0.482709423,2.07163969,0.39363042,0.952541245,3569,IL6
GO:0032490,detection of molecule of bacterial origin (GO:0032490),7,1,0.482709423,2.07163969,0.39363042,0.952541245,284297,SSC5D
GO:0010536,positive regulation of activation of Janus kinase activity (GO:0010536),7,1,0.482709423,2.07163969,0.39363042,0.952541245,3570,IL6R
GO:0036155,acylglycerol acyl-chain remodeling (GO:0036155),7,1,0.482709423,2.07163969,0.39363042,0.952541245,11343,MGLL
GO:0052651,monoacylglycerol catabolic process (GO:0052651),7,1,0.482709423,2.07163969,0.39363042,0.952541245,11343,MGLL
GO:0034382,chylomicron remnant clearance (GO:0034382),7,1,0.482709423,2.07163969,0.39363042,0.952541245,341,APOC1
GO:0060457,negative regulation of digestive system process (GO:0060457),7,1,0.482709423,2.07163969,0.39363042,0.952541245,5733,PTGER3
GO:0033483,gas homeostasis (GO:0033483),7,1,0.482709423,2.07163969,0.39363042,0.952541245,857,CAV1
GO:1903071,positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),7,1,0.482709423,2.07163969,0.39363042,0.952541245,857,CAV1
GO:1903361,protein localization to basolateral plasma membrane (GO:1903361),7,1,0.482709423,2.07163969,0.39363042,0.952541245,857,CAV1
GO:0019065,receptor-mediated endocytosis of virus by host cell (GO:0019065),7,1,0.482709423,2.07163969,0.39363042,0.952541245,857,CAV1
GO:2000064,regulation of cortisol biosynthetic process (GO:2000064),7,1,0.482709423,2.07163969,0.39363042,0.952541245,653,BMP5
GO:0010566,regulation of ketone biosynthetic process (GO:0010566),7,1,0.482709423,2.07163969,0.39363042,0.952541245,1958,EGR1
GO:0030213,hyaluronan biosynthetic process (GO:0030213),7,1,0.482709423,2.07163969,0.39363042,0.952541245,3373,HYAL1
GO:0010752,regulation of cGMP-mediated signaling (GO:0010752),7,1,0.482709423,2.07163969,0.39363042,0.952541245,5138,PDE2A
GO:0002068,glandular epithelial cell development (GO:0002068),7,1,0.482709423,2.07163969,0.39363042,0.952541245,653,BMP5
GO:0003323,type B pancreatic cell development (GO:0003323),7,1,0.482709423,2.07163969,0.39363042,0.952541245,653,BMP5
GO:0015833,peptide transport (GO:0015833),7,1,0.482709423,2.07163969,0.39363042,0.952541245,84976,DISP1
GO:0035850,epithelial cell differentiation involved in kidney development (GO:0035850),7,1,0.482709423,2.07163969,0.39363042,0.952541245,4208,MEF2C
GO:0042415,norepinephrine metabolic process (GO:0042415),7,1,0.482709423,2.07163969,0.39363042,0.952541245,285671,RNF180
GO:0045685,regulation of glial cell differentiation (GO:0045685),7,1,0.482709423,2.07163969,0.39363042,0.952541245,983,CDK1
GO:0045939,negative regulation of steroid metabolic process (GO:0045939),7,1,0.482709423,2.07163969,0.39363042,0.952541245,653,BMP5
GO:0032347,regulation of aldosterone biosynthetic process (GO:0032347),7,1,0.482709423,2.07163969,0.39363042,0.952541245,653,BMP5
GO:0060976,coronary vasculature development (GO:0060976),7,1,0.482709423,2.07163969,0.39363042,0.952541245,2627,GATA6
GO:0006751,glutathione catabolic process (GO:0006751),7,1,0.482709423,2.07163969,0.39363042,0.952541245,79094,CHAC1
GO:0046929,negative regulation of neurotransmitter secretion (GO:0046929),7,1,0.482709423,2.07163969,0.39363042,0.952541245,23208,SYT11
GO:0046600,negative regulation of centriole replication (GO:0046600),7,1,0.482709423,2.07163969,0.39363042,0.952541245,672,BRCA1
GO:1904251,regulation of bile acid metabolic process (GO:1904251),7,1,0.482709423,2.07163969,0.39363042,0.952541245,1066,CES1
GO:0008652,cellular amino acid biosynthetic process (GO:0008652),7,1,0.482709423,2.07163969,0.39363042,0.952541245,2571,GAD1
GO:0006560,proline metabolic process (GO:0006560),7,1,0.482709423,2.07163969,0.39363042,0.952541245,5831,PYCR1
GO:0019359,nicotinamide nucleotide biosynthetic process (GO:0019359),7,1,0.482709423,2.07163969,0.39363042,0.952541245,23498,HAAO
GO:0002484,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),7,1,0.482709423,2.07163969,0.39363042,0.952541245,563,AZGP1
GO:0002486,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",7,1,0.482709423,2.07163969,0.39363042,0.952541245,563,AZGP1
GO:0043376,"regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043376)",7,1,0.482709423,2.07163969,0.39363042,0.952541245,3071,NCKAP1L
GO:0060972,left/right pattern formation (GO:0060972),7,1,0.482709423,2.07163969,0.39363042,0.952541245,5308,PITX2
GO:0002320,lymphoid progenitor cell differentiation (GO:0002320),7,1,0.482709423,2.07163969,0.39363042,0.952541245,6659,SOX4
GO:0071694,maintenance of protein location in extracellular region (GO:0071694),7,1,0.482709423,2.07163969,0.39363042,0.952541245,2201,FBN2
GO:0015696,ammonium transport (GO:0015696),7,1,0.482709423,2.07163969,0.39363042,0.952541245,358,AQP1
GO:0048681,negative regulation of axon regeneration (GO:0048681),7,1,0.482709423,2.07163969,0.39363042,0.952541245,65078,RTN4R
GO:0032908,regulation of transforming growth factor beta1 production (GO:0032908),7,1,0.482709423,2.07163969,0.39363042,0.952541245,2627,GATA6
GO:0043589,skin morphogenesis (GO:0043589),7,1,0.482709423,2.07163969,0.39363042,0.952541245,26154,ABCA12
GO:0015793,glycerol transport (GO:0015793),7,1,0.482709423,2.07163969,0.39363042,0.952541245,358,AQP1
GO:0070327,thyroid hormone transport (GO:0070327),7,1,0.482709423,2.07163969,0.39363042,0.952541245,1428,CRYM
GO:0046984,regulation of hemoglobin biosynthetic process (GO:0046984),7,1,0.482709423,2.07163969,0.39363042,0.952541245,9314,KLF4
GO:0006577,amino-acid betaine metabolic process (GO:0006577),7,1,0.482709423,2.07163969,0.39363042,0.952541245,23743,BHMT2
GO:0071267,L-methionine salvage (GO:0071267),7,1,0.482709423,2.07163969,0.39363042,0.952541245,23743,BHMT2
GO:0035810,positive regulation of urine volume (GO:0035810),7,1,0.482709423,2.07163969,0.39363042,0.952541245,4881,NPR1
GO:0033212,iron import into cell (GO:0033212),7,1,0.482709423,2.07163969,0.39363042,0.952541245,79901,CYBRD1
GO:0003081,regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081),7,1,0.482709423,2.07163969,0.39363042,0.952541245,185,AGTR1
GO:0045899,positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),7,1,0.482709423,2.07163969,0.39363042,0.952541245,2099,ESR1
GO:0090166,Golgi disassembly (GO:0090166),7,1,0.482709423,2.07163969,0.39363042,0.952541245,983,CDK1
GO:0045835,negative regulation of meiotic nuclear division (GO:0045835),7,1,0.482709423,2.07163969,0.39363042,0.952541245,9319,TRIP13
GO:0060926,cardiac pacemaker cell development (GO:0060926),7,1,0.482709423,2.07163969,0.39363042,0.952541245,6910,TBX5
GO:0048634,regulation of muscle organ development (GO:0048634),7,1,0.482709423,2.07163969,0.39363042,0.952541245,1063,CENPF
GO:0048387,negative regulation of retinoic acid receptor signaling pathway (GO:0048387),7,1,0.482709423,2.07163969,0.39363042,0.952541245,2146,EZH2
GO:0003344,pericardium morphogenesis (GO:0003344),7,1,0.482709423,2.07163969,0.39363042,0.952541245,653,BMP5
GO:1901388,regulation of transforming growth factor beta activation (GO:1901388),7,1,0.482709423,2.07163969,0.39363042,0.952541245,2627,GATA6
GO:0070973,protein localization to endoplasmic reticulum exit site (GO:0070973),7,1,0.482709423,2.07163969,0.39363042,0.952541245,120892,LRRK2
GO:0050861,positive regulation of B cell receptor signaling pathway (GO:0050861),7,1,0.482709423,2.07163969,0.39363042,0.952541245,5579,PRKCB
GO:1903288,positive regulation of potassium ion import across plasma membrane (GO:1903288),7,1,0.482709423,2.07163969,0.39363042,0.952541245,482,ATP1B2
GO:0032352,positive regulation of hormone metabolic process (GO:0032352),7,1,0.482709423,2.07163969,0.39363042,0.952541245,1958,EGR1
GO:0035137,hindlimb morphogenesis (GO:0035137),7,1,0.482709423,2.07163969,0.39363042,0.952541245,3899,AFF3
GO:2000739,regulation of mesenchymal stem cell differentiation (GO:2000739),7,1,0.482709423,2.07163969,0.39363042,0.952541245,5156,PDGFRA
GO:2001301,lipoxin biosynthetic process (GO:2001301),7,1,0.482709423,2.07163969,0.39363042,0.952541245,4056,LTC4S
GO:0006266,DNA ligation (GO:0006266),7,1,0.482709423,2.07163969,0.39363042,0.952541245,7153,TOP2A
GO:2000271,positive regulation of fibroblast apoptotic process (GO:2000271),7,1,0.482709423,2.07163969,0.39363042,0.952541245,6422,SFRP1
GO:0032042,mitochondrial DNA metabolic process (GO:0032042),7,1,0.482709423,2.07163969,0.39363042,0.952541245,1763,DNA2
GO:0001672,regulation of chromatin assembly or disassembly (GO:0001672),7,1,0.482709423,2.07163969,0.39363042,0.952541245,6886,TAL1
GO:0001886,endothelial cell morphogenesis (GO:0001886),7,1,0.482709423,2.07163969,0.39363042,0.952541245,6781,STC1
GO:1901660,calcium ion export (GO:1901660),7,1,0.482709423,2.07163969,0.39363042,0.952541245,493,ATP2B4
GO:2000501,regulation of natural killer cell chemotaxis (GO:2000501),7,1,0.482709423,2.07163969,0.39363042,0.952541245,6347,CCL2
GO:0035773,insulin secretion involved in cellular response to glucose stimulus (GO:0035773),7,1,0.482709423,2.07163969,0.39363042,0.952541245,5799,PTPRN2
GO:0003353,positive regulation of cilium movement (GO:0003353),7,1,0.482709423,2.07163969,0.39363042,0.952541245,6869,TACR1
GO:2000155,positive regulation of cilium-dependent cell motility (GO:2000155),7,1,0.482709423,2.07163969,0.39363042,0.952541245,6869,TACR1
GO:1902093,positive regulation of flagellated sperm motility (GO:1902093),7,1,0.482709423,2.07163969,0.39363042,0.952541245,6869,TACR1
GO:0038063,collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),7,1,0.482709423,2.07163969,0.39363042,0.952541245,1288,COL4A6
GO:0070127,tRNA aminoacylation for mitochondrial protein translation (GO:0070127),7,1,0.482709423,2.07163969,0.39363042,0.952541245,55157,DARS2
GO:0006776,vitamin A metabolic process (GO:0006776),7,1,0.482709423,2.07163969,0.39363042,0.952541245,5947,RBP1
GO:0032270,positive regulation of cellular protein metabolic process (GO:0032270),101,8,6.964807392,1.148631908,0.395732111,0.957241737,3624;3569;5347;185;6659;9314;29128;23034,IL6;AGTR1;SOX4;KLF4;INHBA;UHRF1;PLK1;SAMD4A
GO:0006898,receptor-mediated endocytosis (GO:0006898),143,11,9.861063931,1.115498295,0.398765403,0.964191006,154;6622;857;10267;9260;66000;7037;23149;81035;78989;5648,MASP1;RAMP1;CAV1;COLEC12;ADRB2;FCHO1;TFRC;TMEM108;COLEC11;PDLIM7;SNCA
GO:0032212,positive regulation of telomere maintenance via telomerase (GO:0032212),33,3,2.275630138,1.318316167,0.400116814,0.964742144,9212;225689;4751,NEK2;AURKB;MAPK15
GO:0043277,apoptotic cell clearance (GO:0043277),33,3,2.275630138,1.318316167,0.400116814,0.964742144,399;2621;3690,GAS6;ITGB3;RHOH
GO:0046427,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),33,3,2.275630138,1.318316167,0.400116814,0.964742144,3815;2690;3569,IL6;GHR;KIT
GO:0008637,apoptotic mitochondrial changes (GO:0008637),33,3,2.275630138,1.318316167,0.400116814,0.964742144,596;1191;2537,CLU;BCL2;IFI6
GO:2000785,regulation of autophagosome assembly (GO:2000785),33,3,2.275630138,1.318316167,0.400116814,0.964742144,9638;120892;26471,LRRK2;FEZ1;NUPR1
GO:0034308,primary alcohol metabolic process (GO:0034308),33,3,2.275630138,1.318316167,0.400116814,0.964742144,3479;125;126,ADH1B;IGF1;ADH1C
GO:0042339,keratan sulfate metabolic process (GO:0042339),33,3,2.275630138,1.318316167,0.400116814,0.964742144,4958;4969;5549,OGN;PRELP;OMD
GO:0050870,positive regulation of T cell activation (GO:0050870),74,6,5.102928188,1.1757955,0.402691906,0.969255152,399;3569;3071;7037;6347;3572,IL6;IL6ST;CCL2;NCKAP1L;TFRC;RHOH
GO:0007229,integrin-mediated signaling pathway (GO:0007229),74,6,5.102928188,1.1757955,0.402691906,0.969255152,3690;10979;3678;9636;9510;2192,ADAMTS1;FERMT2;ISG15;ITGA5;FBLN1;ITGB3
GO:0090276,regulation of peptide hormone secretion (GO:0090276),74,6,5.102928188,1.1757955,0.402691906,0.969255152,150;3569;775;8864;3708;10411,IL6;ITPR1;PER2;RAPGEF3;ADRA2A;CACNA1C
GO:0017148,negative regulation of translation (GO:0017148),88,7,6.068347034,1.153526646,0.405004772,0.969255152,221662;1978;7298;3488;132864;7832;23034,RBM24;SAMD4A;CPEB2;TYMS;EIF4EBP1;BTG2;IGFBP5
GO:0051173,positive regulation of nitrogen compound metabolic process (GO:0051173),20,2,1.379169781,1.450147783,0.405697216,0.969255152,10365;9314,KLF2;KLF4
GO:1903901,negative regulation of viral life cycle (GO:1903901),20,2,1.379169781,1.450147783,0.405697216,0.969255152,2934;5806,GSN;PTX3
GO:1902410,mitotic cytokinetic process (GO:1902410),20,2,1.379169781,1.450147783,0.405697216,0.969255152,10112;55165,KIF20A;CEP55
GO:0016338,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),20,2,1.379169781,1.450147783,0.405697216,0.969255152,5010;7122,CLDN5;CLDN11
GO:0061515,myeloid cell development (GO:0061515),20,2,1.379169781,1.450147783,0.405697216,0.969255152,3815;3071,NCKAP1L;KIT
GO:0061008,hepaticobiliary system development (GO:0061008),20,2,1.379169781,1.450147783,0.405697216,0.969255152,23242;7049,TGFBR3;COBL
GO:1904031,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),20,2,1.379169781,1.450147783,0.405697216,0.969255152,84722;894,CCND2;PSRC1
GO:0007498,mesoderm development (GO:0007498),20,2,1.379169781,1.450147783,0.405697216,0.969255152,660;4232,BMX;MEST
GO:0071392,cellular response to estradiol stimulus (GO:0071392),20,2,1.379169781,1.450147783,0.405697216,0.969255152,6422;2099,SFRP1;ESR1
GO:0003231,cardiac ventricle development (GO:0003231),20,2,1.379169781,1.450147783,0.405697216,0.969255152,5138;6910,PDE2A;TBX5
GO:0062098,regulation of programmed necrotic cell death (GO:0062098),20,2,1.379169781,1.450147783,0.405697216,0.969255152,330;26471,BIRC3;NUPR1
GO:0034103,regulation of tissue remodeling (GO:0034103),20,2,1.379169781,1.450147783,0.405697216,0.969255152,9464;3953,HAND2;LEPR
GO:0007020,microtubule nucleation (GO:0007020),20,2,1.379169781,1.450147783,0.405697216,0.969255152,22974;11076,TPPP;TPX2
GO:0071542,dopaminergic neuron differentiation (GO:0071542),20,2,1.379169781,1.450147783,0.405697216,0.969255152,7472;4929,NR4A2;WNT2
GO:0001707,mesoderm formation (GO:0001707),20,2,1.379169781,1.450147783,0.405697216,0.969255152,3690;8516,ITGA8;ITGB3
GO:0042398,cellular modified amino acid biosynthetic process (GO:0042398),20,2,1.379169781,1.450147783,0.405697216,0.969255152,2593;79094,GAMT;CHAC1
GO:0001573,ganglioside metabolic process (GO:0001573),20,2,1.379169781,1.450147783,0.405697216,0.969255152,30815;256435,ST6GALNAC6;ST6GALNAC3
GO:0045143,homologous chromosome segregation (GO:0045143),20,2,1.379169781,1.450147783,0.405697216,0.969255152,9232;2177,FANCD2;PTTG1
GO:1904659,glucose transmembrane transport (GO:1904659),20,2,1.379169781,1.450147783,0.405697216,0.969255152,6517;6515,SLC2A4;SLC2A3
GO:0097193,intrinsic apoptotic signaling pathway (GO:0097193),102,8,7.033765881,1.13737081,0.40641767,0.97059063,489;596;2537;3708;1869;672;79094;3090,HIC1;ITPR1;BRCA1;BCL2;E2F1;ATP2A3;IFI6;CHAC1
GO:0032102,negative regulation of response to external stimulus (GO:0032102),116,9,7.999184727,1.125114659,0.407234662,0.972155501,5734;114548;5740;2247;145581;27293;11213;9314;65078,FGF2;KLF4;LRFN5;RTN4R;PTGIS;IRAK3;NLRP3;PTGER4;SMPDL3B
GO:0051246,regulation of protein metabolic process (GO:0051246),47,4,3.241048984,1.234168326,0.408526897,0.97330764,10365;4953;9314;8425,KLF2;KLF4;LTBP4;ODC1
GO:0045739,positive regulation of DNA repair (GO:0045739),47,4,3.241048984,1.234168326,0.408526897,0.97330764,2305;672;8914;2070,FOXM1;TIMELESS;BRCA1;EYA4
GO:0006997,nucleus organization (GO:0006997),47,4,3.241048984,1.234168326,0.408526897,0.97330764,274;55165;6676;23345,SYNE1;BIN1;CEP55;SPAG4
GO:0120163,negative regulation of cold-induced thermogenesis (GO:0120163),47,4,3.241048984,1.234168326,0.408526897,0.97330764,4857;11096;5334;23090,NOVA1;ADAMTS5;PLCL1;ZNF423
GO:0001837,epithelial to mesenchymal transition (GO:0001837),47,4,3.241048984,1.234168326,0.408526897,0.97330764,10439;7049;3082;2260,TGFBR3;OLFM1;FGFR1;HGF
GO:0055072,iron ion homeostasis (GO:0055072),61,5,4.206467831,1.188645724,0.412868084,0.98294329,79901;4609;286133;7037;9843,SCARA5;CYBRD1;TFRC;MYC;HEPH
GO:0006821,chloride transport (GO:0006821),75,6,5.171886677,1.160118227,0.415239728,0.98294329,65010;25932;84561;203859;5348;80727,FXYD1;TTYH3;SLC26A6;SLC12A8;ANO5;CLIC4
GO:0008543,fibroblast growth factor receptor signaling pathway (GO:0008543),75,6,5.171886677,1.160118227,0.415239728,0.98294329,2252;23768;2247;2260;9365;79801,FGF2;FGF7;FGFR1;SHCBP1;KL;FLRT2
GO:0051099,positive regulation of binding (GO:0051099),89,7,6.137305523,1.140565672,0.416508448,0.98294329,3479;857;7122;81620;120892;1440;3925,CLDN5;LRRK2;CSF3;CAV1;CDT1;IGF1;STMN1
GO:0007179,transforming growth factor beta receptor signaling pathway (GO:0007179),89,7,6.137305523,1.140565672,0.416508448,0.98294329,7048;10979;7122;7049;4093;5590;2353,CLDN5;TGFBR2;FOS;TGFBR3;FERMT2;SMAD9;PRKCZ
GO:0098916,anterograde trans-synaptic signaling (GO:0098916),244,18,16.82587132,1.069781152,0.418360213,0.98294329,6622;5577;1740;1837;3779;2571;5354;5376;27115;4359;4884;783;785;3777;9379;9378;4857;6196,PLP1;KCNMB1;NOVA1;NRXN1;DLG2;PMP22;KCNK3;RPS6KA2;MPZ;PDE7B;PRKAR2B;DTNA;CACNB2;NRXN2;CACNB4;NPTX1;GAD1;SNCA
GO:0045661,regulation of myoblast differentiation (GO:0045661),34,3,2.344588627,1.279542162,0.419038978,0.98294329,221662;4208;91653,RBM24;MEF2C;BOC
GO:0045995,regulation of embryonic development (GO:0045995),34,3,2.344588627,1.279542162,0.419038978,0.98294329,983;29127;64321,SOX17;CDK1;RACGAP1
GO:1902653,secondary alcohol biosynthetic process (GO:1902653),34,3,2.344588627,1.279542162,0.419038978,0.98294329,1066;6713;1717,CES1;DHCR7;SQLE
GO:1903305,regulation of regulated secretory pathway (GO:1903305),34,3,2.344588627,1.279542162,0.419038978,0.98294329,83849;23208;120892,LRRK2;SYT15;SYT11
GO:0007044,cell-substrate junction assembly (GO:0007044),34,3,2.344588627,1.279542162,0.419038978,0.98294329,10395;10580;10979,SORBS1;FERMT2;DLC1
GO:0051251,positive regulation of lymphocyte activation (GO:0051251),34,3,2.344588627,1.279542162,0.419038978,0.98294329,3569;3071;6347,IL6;CCL2;NCKAP1L
GO:0045742,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),34,3,2.344588627,1.279542162,0.419038978,0.98294329,150;1839;374,ADRA2A;HBEGF;AREG
GO:0002639,positive regulation of immunoglobulin production (GO:0002639),34,3,2.344588627,1.279542162,0.419038978,0.98294329,3569;2048;7037,IL6;TFRC;EPHB2
GO:1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),34,3,2.344588627,1.279542162,0.419038978,0.98294329,653;23017;672,FAIM2;BMP5;BRCA1
GO:1903828,negative regulation of cellular protein localization (GO:1903828),34,3,2.344588627,1.279542162,0.419038978,0.98294329,4130;81620;2824,CDT1;MAP1A;GPM6B
GO:0034762,regulation of transmembrane transport (GO:0034762),34,3,2.344588627,1.279542162,0.419038978,0.98294329,6622;5579;596,PRKCB;BCL2;SNCA
GO:0043330,response to exogenous dsRNA (GO:0043330),34,3,2.344588627,1.279542162,0.419038978,0.98294329,857;11213;81035,CAV1;COLEC12;IRAK3
GO:0035307,positive regulation of protein dephosphorylation (GO:0035307),34,3,2.344588627,1.279542162,0.419038978,0.98294329,10395;9863;157313,CDCA2;MAGI2;DLC1
GO:0048706,embryonic skeletal system development (GO:0048706),34,3,2.344588627,1.279542162,0.419038978,0.98294329,6495;7483;5156,WNT9A;SIX1;PDGFRA
GO:0007224,smoothened signaling pathway (GO:0007224),34,3,2.344588627,1.279542162,0.419038978,0.98294329,6491;57545;8643,STIL;CC2D2A;PTCH2
GO:0043647,inositol phosphate metabolic process (GO:0043647),48,4,3.310007473,1.208456486,0.424362785,0.98294329,2247;3707;84812;5332,FGF2;PLCD4;PLCB4;ITPKB
GO:0043407,negative regulation of MAP kinase activity (GO:0043407),48,4,3.310007473,1.208456486,0.424362785,0.98294329,10252;1843;11213;5997,DUSP1;RGS2;SPRY1;IRAK3
GO:0051865,protein autoubiquitination (GO:0051865),62,5,4.27542632,1.169474019,0.426756846,0.98294329,672;29089;7732;29128;79845,UHRF1;BRCA1;UBE2T;RNF112;RNF122
GO:0045638,negative regulation of myeloid cell differentiation (GO:0045638),21,2,1.44812827,1.381093127,0.43018597,0.98294329,7538;7704,ZBTB16;ZFP36
GO:0000289,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),21,2,1.44812827,1.381093127,0.43018597,0.98294329,7538;23034,ZFP36;SAMD4A
GO:0010884,positive regulation of lipid storage (GO:0010884),21,2,1.44812827,1.381093127,0.43018597,0.98294329,718;29923,C3;HILPDA
GO:2000242,negative regulation of reproductive process (GO:2000242),21,2,1.44812827,1.381093127,0.43018597,0.98294329,3479;1843,DUSP1;IGF1
GO:0090109,regulation of cell-substrate junction assembly (GO:0090109),21,2,1.44812827,1.381093127,0.43018597,0.98294329,2042;2824,EPHA3;GPM6B
GO:1903035,negative regulation of response to wounding (GO:1903035),21,2,1.44812827,1.381093127,0.43018597,0.98294329,2247;65078,FGF2;RTN4R
GO:0051560,mitochondrial calcium ion homeostasis (GO:0051560),21,2,1.44812827,1.381093127,0.43018597,0.98294329,309;79085,ANXA6;SLC25A23
GO:0010922,positive regulation of phosphatase activity (GO:0010922),21,2,1.44812827,1.381093127,0.43018597,0.98294329,4208;9863,MEF2C;MAGI2
GO:0010543,regulation of platelet activation (GO:0010543),21,2,1.44812827,1.381093127,0.43018597,0.98294329,6403;5156,SELP;PDGFRA
GO:0036150,phosphatidylserine acyl-chain remodeling (GO:0036150),21,2,1.44812827,1.381093127,0.43018597,0.98294329,5320;114884,PLA2G2A;OSBPL10
GO:0071383,cellular response to steroid hormone stimulus (GO:0071383),21,2,1.44812827,1.381093127,0.43018597,0.98294329,477;7035,ATP1A2;TFPI
GO:0050994,regulation of lipid catabolic process (GO:0050994),21,2,1.44812827,1.381093127,0.43018597,0.98294329,150;341,ADRA2A;APOC1
GO:1904886,beta-catenin destruction complex disassembly (GO:1904886),21,2,1.44812827,1.381093127,0.43018597,0.98294329,857;2535,CAV1;FZD2
GO:0015918,sterol transport (GO:0015918),21,2,1.44812827,1.381093127,0.43018597,0.98294329,857;10351,ABCA8;CAV1
GO:0051004,regulation of lipoprotein lipase activity (GO:0051004),21,2,1.44812827,1.381093127,0.43018597,0.98294329,338328;341,GPIHBP1;APOC1
GO:0090181,regulation of cholesterol metabolic process (GO:0090181),21,2,1.44812827,1.381093127,0.43018597,0.98294329,1066;2053,EPHX2;CES1
GO:0009435,NAD biosynthetic process (GO:0009435),21,2,1.44812827,1.381093127,0.43018597,0.98294329,23498;5740,HAAO;PTGIS
GO:0008209,androgen metabolic process (GO:0008209),21,2,1.44812827,1.381093127,0.43018597,0.98294329,8630;6696,SPP1;HSD17B6
GO:0042572,retinol metabolic process (GO:0042572),21,2,1.44812827,1.381093127,0.43018597,0.98294329,125;126,ADH1B;ADH1C
GO:0010656,negative regulation of muscle cell apoptotic process (GO:0010656),8,1,0.551667912,1.812684729,0.435464645,0.98294329,3479,IGF1
GO:0010831,positive regulation of myotube differentiation (GO:0010831),8,1,0.551667912,1.812684729,0.435464645,0.98294329,221662,RBM24
GO:1900247,regulation of cytoplasmic translational elongation (GO:1900247),8,1,0.551667912,1.812684729,0.435464645,0.98294329,132864,CPEB2
GO:0034139,regulation of toll-like receptor 3 signaling pathway (GO:0034139),8,1,0.551667912,1.812684729,0.435464645,0.98294329,857,CAV1
GO:0035315,hair cell differentiation (GO:0035315),8,1,0.551667912,1.812684729,0.435464645,0.98294329,5308,PITX2
GO:0099173,postsynapse organization (GO:0099173),8,1,0.551667912,1.812684729,0.435464645,0.98294329,80728,ARHGAP39
GO:0060049,regulation of protein glycosylation (GO:0060049),8,1,0.551667912,1.812684729,0.435464645,0.98294329,10267,RAMP1
GO:0051584,regulation of dopamine uptake involved in synaptic transmission (GO:0051584),8,1,0.551667912,1.812684729,0.435464645,0.98294329,6622,SNCA
GO:0048023,positive regulation of melanin biosynthetic process (GO:0048023),8,1,0.551667912,1.812684729,0.435464645,0.98294329,9839,ZEB2
GO:1900378,positive regulation of secondary metabolite biosynthetic process (GO:1900378),8,1,0.551667912,1.812684729,0.435464645,0.98294329,9839,ZEB2
GO:0086026,atrial cardiac muscle cell to AV node cell signaling (GO:0086026),8,1,0.551667912,1.812684729,0.435464645,0.98294329,287,ANK2
GO:0010917,negative regulation of mitochondrial membrane potential (GO:0010917),8,1,0.551667912,1.812684729,0.435464645,0.98294329,79845,RNF122
GO:0006208,pyrimidine nucleobase catabolic process (GO:0006208),8,1,0.551667912,1.812684729,0.435464645,0.98294329,1808,DPYSL2
GO:0030832,regulation of actin filament length (GO:0030832),8,1,0.551667912,1.812684729,0.435464645,0.98294329,6387,CXCL12
GO:0090527,actin filament reorganization (GO:0090527),8,1,0.551667912,1.812684729,0.435464645,0.98294329,2934,GSN
GO:2001269,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),8,1,0.551667912,1.812684729,0.435464645,0.98294329,2934,GSN
GO:0051451,myoblast migration (GO:0051451),8,1,0.551667912,1.812684729,0.435464645,0.98294329,6495,SIX1
GO:0010519,negative regulation of phospholipase activity (GO:0010519),8,1,0.551667912,1.812684729,0.435464645,0.98294329,5997,RGS2
GO:0033034,positive regulation of myeloid cell apoptotic process (GO:0033034),8,1,0.551667912,1.812684729,0.435464645,0.98294329,4208,MEF2C
GO:0032429,regulation of phospholipase A2 activity (GO:0032429),8,1,0.551667912,1.812684729,0.435464645,0.98294329,185,AGTR1
GO:0035729,cellular response to hepatocyte growth factor stimulus (GO:0035729),8,1,0.551667912,1.812684729,0.435464645,0.98294329,3082,HGF
GO:0035728,response to hepatocyte growth factor (GO:0035728),8,1,0.551667912,1.812684729,0.435464645,0.98294329,3082,HGF
GO:0042996,regulation of Golgi to plasma membrane protein transport (GO:0042996),8,1,0.551667912,1.812684729,0.435464645,0.98294329,91461,PKDCC
GO:0033145,positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),8,1,0.551667912,1.812684729,0.435464645,0.98294329,55885,LMO3
GO:0002732,positive regulation of dendritic cell cytokine production (GO:0002732),8,1,0.551667912,1.812684729,0.435464645,0.98294329,3815,KIT
GO:0060977,coronary vasculature morphogenesis (GO:0060977),8,1,0.551667912,1.812684729,0.435464645,0.98294329,7049,TGFBR3
GO:0090091,positive regulation of extracellular matrix disassembly (GO:0090091),8,1,0.551667912,1.812684729,0.435464645,0.98294329,3569,IL6
GO:1900272,negative regulation of long-term synaptic potentiation (GO:1900272),8,1,0.551667912,1.812684729,0.435464645,0.98294329,11170,FAM107A
GO:0019439,aromatic compound catabolic process (GO:0019439),8,1,0.551667912,1.812684729,0.435464645,0.98294329,2053,EPHX2
GO:1903286,regulation of potassium ion import (GO:1903286),8,1,0.551667912,1.812684729,0.435464645,0.98294329,482,ATP1B2
GO:0001771,immunological synapse formation (GO:0001771),8,1,0.551667912,1.812684729,0.435464645,0.98294329,6366,CCL21
GO:0060841,venous blood vessel development (GO:0060841),8,1,0.551667912,1.812684729,0.435464645,0.98294329,2294,FOXF1
GO:0002444,myeloid leukocyte mediated immunity (GO:0002444),8,1,0.551667912,1.812684729,0.435464645,0.98294329,3569,IL6
GO:0110053,regulation of actin filament organization (GO:0110053),8,1,0.551667912,1.812684729,0.435464645,0.98294329,6387,CXCL12
GO:0070486,leukocyte aggregation (GO:0070486),8,1,0.551667912,1.812684729,0.435464645,0.98294329,58494,JAM2
GO:2001141,regulation of RNA biosynthetic process (GO:2001141),8,1,0.551667912,1.812684729,0.435464645,0.98294329,4286,MITF
GO:0033668,negative regulation by symbiont of host apoptotic process (GO:0033668),8,1,0.551667912,1.812684729,0.435464645,0.98294329,1511,CTSG
GO:0052041,negative regulation by symbiont of host programmed cell death (GO:0052041),8,1,0.551667912,1.812684729,0.435464645,0.98294329,1511,CTSG
GO:0090281,negative regulation of calcium ion import (GO:0090281),8,1,0.551667912,1.812684729,0.435464645,0.98294329,5350,PLN
GO:1901017,negative regulation of potassium ion transmembrane transporter activity (GO:1901017),8,1,0.551667912,1.812684729,0.435464645,0.98294329,845,CASQ2
GO:2001137,positive regulation of endocytic recycling (GO:2001137),8,1,0.551667912,1.812684729,0.435464645,0.98294329,30846,EHD2
GO:0030104,water homeostasis (GO:0030104),8,1,0.551667912,1.812684729,0.435464645,0.98294329,358,AQP1
GO:0002821,positive regulation of adaptive immune response (GO:0002821),8,1,0.551667912,1.812684729,0.435464645,0.98294329,3572,IL6ST
GO:0010637,negative regulation of mitochondrial fusion (GO:0010637),8,1,0.551667912,1.812684729,0.435464645,0.98294329,7037,TFRC
GO:0061043,regulation of vascular wound healing (GO:0061043),8,1,0.551667912,1.812684729,0.435464645,0.98294329,64094,SMOC2
GO:1904714,regulation of chaperone-mediated autophagy (GO:1904714),8,1,0.551667912,1.812684729,0.435464645,0.98294329,6622,SNCA
GO:1905634,regulation of protein localization to chromatin (GO:1905634),8,1,0.551667912,1.812684729,0.435464645,0.98294329,113130,CDCA5
GO:0009169,purine ribonucleoside monophosphate catabolic process (GO:0009169),8,1,0.551667912,1.812684729,0.435464645,0.98294329,4907,NT5E
GO:2000508,regulation of dendritic cell chemotaxis (GO:2000508),8,1,0.551667912,1.812684729,0.435464645,0.98294329,2621,GAS6
GO:1903977,positive regulation of glial cell migration (GO:1903977),8,1,0.551667912,1.812684729,0.435464645,0.98294329,6376,CX3CL1
GO:1905005,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),8,1,0.551667912,1.812684729,0.435464645,0.98294329,7048,TGFBR2
GO:0019064,fusion of virus membrane with host plasma membrane (GO:0019064),8,1,0.551667912,1.812684729,0.435464645,0.98294329,2621,GAS6
GO:0039663,membrane fusion involved in viral entry into host cell (GO:0039663),8,1,0.551667912,1.812684729,0.435464645,0.98294329,2621,GAS6
GO:0060644,mammary gland epithelial cell differentiation (GO:0060644),8,1,0.551667912,1.812684729,0.435464645,0.98294329,3398,ID2
GO:1904385,cellular response to angiotensin (GO:1904385),8,1,0.551667912,1.812684729,0.435464645,0.98294329,185,AGTR1
GO:0043568,positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568),8,1,0.551667912,1.812684729,0.435464645,0.98294329,3479,IGF1
GO:1903306,negative regulation of regulated secretory pathway (GO:1903306),8,1,0.551667912,1.812684729,0.435464645,0.98294329,150,ADRA2A
GO:0072073,kidney epithelium development (GO:0072073),8,1,0.551667912,1.812684729,0.435464645,0.98294329,25959,KANK2
GO:0006975,DNA damage induced protein phosphorylation (GO:0006975),8,1,0.551667912,1.812684729,0.435464645,0.98294329,1111,CHEK1
GO:1903689,"regulation of wound healing, spreading of epidermal cells (GO:1903689)",8,1,0.551667912,1.812684729,0.435464645,0.98294329,10979,FERMT2
GO:0045839,negative regulation of mitotic nuclear division (GO:0045839),8,1,0.551667912,1.812684729,0.435464645,0.98294329,1111,CHEK1
GO:0014741,negative regulation of muscle hypertrophy (GO:0014741),8,1,0.551667912,1.812684729,0.435464645,0.98294329,5997,RGS2
GO:0021879,forebrain neuron differentiation (GO:0021879),8,1,0.551667912,1.812684729,0.435464645,0.98294329,3624,INHBA
GO:1905247,positive regulation of aspartic-type peptidase activity (GO:1905247),8,1,0.551667912,1.812684729,0.435464645,0.98294329,1944,EFNA3
GO:0017121,plasma membrane phospholipid scrambling (GO:0017121),8,1,0.551667912,1.812684729,0.435464645,0.98294329,57088,PLSCR4
GO:0002295,T-helper cell lineage commitment (GO:0002295),8,1,0.551667912,1.812684729,0.435464645,0.98294329,3569,IL6
GO:0010912,positive regulation of isomerase activity (GO:0010912),8,1,0.551667912,1.812684729,0.435464645,0.98294329,29128,UHRF1
GO:0010533,regulation of activation of Janus kinase activity (GO:0010533),8,1,0.551667912,1.812684729,0.435464645,0.98294329,3570,IL6R
GO:0046469,platelet activating factor metabolic process (GO:0046469),8,1,0.551667912,1.812684729,0.435464645,0.98294329,8605,PLA2G4C
GO:0051006,positive regulation of lipoprotein lipase activity (GO:0051006),8,1,0.551667912,1.812684729,0.435464645,0.98294329,338328,GPIHBP1
GO:0006382,adenosine to inosine editing (GO:0006382),8,1,0.551667912,1.812684729,0.435464645,0.98294329,104,ADARB1
GO:0007549,dosage compensation (GO:0007549),8,1,0.551667912,1.812684729,0.435464645,0.98294329,672,BRCA1
GO:0035886,vascular associated smooth muscle cell differentiation (GO:0035886),8,1,0.551667912,1.812684729,0.435464645,0.98294329,2627,GATA6
GO:0048714,positive regulation of oligodendrocyte differentiation (GO:0048714),8,1,0.551667912,1.812684729,0.435464645,0.98294329,146433,IL34
GO:0030878,thyroid gland development (GO:0030878),8,1,0.551667912,1.812684729,0.435464645,0.98294329,6495,SIX1
GO:0034983,peptidyl-lysine deacetylation (GO:0034983),8,1,0.551667912,1.812684729,0.435464645,0.98294329,9759,HDAC4
GO:0006534,cysteine metabolic process (GO:0006534),8,1,0.551667912,1.812684729,0.435464645,0.98294329,1036,CDO1
GO:0000097,sulfur amino acid biosynthetic process (GO:0000097),8,1,0.551667912,1.812684729,0.435464645,0.98294329,1036,CDO1
GO:1902253,regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),8,1,0.551667912,1.812684729,0.435464645,0.98294329,4487,MSX1
GO:0010510,regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),8,1,0.551667912,1.812684729,0.435464645,0.98294329,5166,PDK4
GO:0050812,regulation of acyl-CoA biosynthetic process (GO:0050812),8,1,0.551667912,1.812684729,0.435464645,0.98294329,5166,PDK4
GO:0070571,negative regulation of neuron projection regeneration (GO:0070571),8,1,0.551667912,1.812684729,0.435464645,0.98294329,65078,RTN4R
GO:0034340,response to type I interferon (GO:0034340),8,1,0.551667912,1.812684729,0.435464645,0.98294329,9636,ISG15
GO:0015844,monoamine transport (GO:0015844),8,1,0.551667912,1.812684729,0.435464645,0.98294329,6581,SLC22A3
GO:0015014,"heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",8,1,0.551667912,1.812684729,0.435464645,0.98294329,55790,CSGALNACT1
GO:0062207,regulation of pattern recognition receptor signaling pathway (GO:0062207),8,1,0.551667912,1.812684729,0.435464645,0.98294329,330,BIRC3
GO:0002903,negative regulation of B cell apoptotic process (GO:0002903),8,1,0.551667912,1.812684729,0.435464645,0.98294329,9212,AURKB
GO:0010839,negative regulation of keratinocyte proliferation (GO:0010839),8,1,0.551667912,1.812684729,0.435464645,0.98294329,687,KLF9
GO:0001915,negative regulation of T cell mediated cytotoxicity (GO:0001915),8,1,0.551667912,1.812684729,0.435464645,0.98294329,3071,NCKAP1L
GO:1902107,positive regulation of leukocyte differentiation (GO:1902107),8,1,0.551667912,1.812684729,0.435464645,0.98294329,3071,NCKAP1L
GO:0003230,cardiac atrium development (GO:0003230),8,1,0.551667912,1.812684729,0.435464645,0.98294329,287,ANK2
GO:0016202,regulation of striated muscle tissue development (GO:0016202),8,1,0.551667912,1.812684729,0.435464645,0.98294329,1063,CENPF
GO:0045682,regulation of epidermis development (GO:0045682),8,1,0.551667912,1.812684729,0.435464645,0.98294329,23764,MAFF
GO:0016446,somatic hypermutation of immunoglobulin genes (GO:0016446),8,1,0.551667912,1.812684729,0.435464645,0.98294329,10721,POLQ
GO:0006264,mitochondrial DNA replication (GO:0006264),8,1,0.551667912,1.812684729,0.435464645,0.98294329,1763,DNA2
GO:1903251,multi-ciliated epithelial cell differentiation (GO:1903251),8,1,0.551667912,1.812684729,0.435464645,0.98294329,10733,PLK4
GO:0006348,chromatin silencing at telomere (GO:0006348),8,1,0.551667912,1.812684729,0.435464645,0.98294329,2146,EZH2
GO:0006695,cholesterol biosynthetic process (GO:0006695),35,3,2.413547116,1.242983814,0.437758278,0.985899217,1066;6713;1717,CES1;DHCR7;SQLE
GO:0048813,dendrite morphogenesis (GO:0048813),35,3,2.413547116,1.242983814,0.437758278,0.985899217,6383;2048;23542,SDC2;MAPK8IP2;EPHB2
GO:0034765,regulation of ion transmembrane transport (GO:0034765),35,3,2.413547116,1.242983814,0.437758278,0.985899217,9472;3757;845,CASQ2;KCNH2;AKAP6
GO:0035335,peptidyl-tyrosine dephosphorylation (GO:0035335),35,3,2.413547116,1.242983814,0.437758278,0.985899217,1847;1843;1850,DUSP1;DUSP8;DUSP5
GO:0050768,negative regulation of neurogenesis (GO:0050768),35,3,2.413547116,1.242983814,0.437758278,0.985899217,4804;3569;65078,IL6;NGFR;RTN4R
GO:0046464,acylglycerol catabolic process (GO:0046464),35,3,2.413547116,1.242983814,0.437758278,0.985899217,11343;2167;2172,MGLL;FABP4;FABP6
GO:0006401,RNA catabolic process (GO:0006401),49,4,3.378965962,1.183794109,0.440090373,0.989619884,7538;1763;2237;10535,ZFP36;DNA2;RNASEH2A;FEN1
GO:1902652,secondary alcohol metabolic process (GO:1902652),49,4,3.378965962,1.183794109,0.440090373,0.989619884,1593;1066;9023;6713,CH25H;CES1;CYP27A1;SQLE
GO:0031623,receptor internalization (GO:0031623),49,4,3.378965962,1.183794109,0.440090373,0.989619884,6622;857;10267;7037,RAMP1;CAV1;TFRC;SNCA
GO:0034332,adherens junction organization (GO:0034332),49,4,3.378965962,1.183794109,0.440090373,0.989619884,83700;10979;57863;8642,CADM3;JAM3;FERMT2;DCHS1
GO:1990266,neutrophil migration (GO:1990266),77,6,5.309803655,1.129985286,0.4402335,0.989619884,6366;3071;5142;2920;6376;6347,PDE4B;CX3CL1;CCL2;CXCL2;NCKAP1L;CCL21
GO:0010951,negative regulation of endopeptidase activity (GO:0010951),63,5,4.344384809,1.150910939,0.440580388,0.990029426,274;12;8434;5176;7079,BIN1;RECK;SERPINA3;TIMP4;SERPINF1